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Abstract 
Vitamin B12 is a fascinating molecule that acts as a co-factor in processes crucial 
to many living things. It is an essential constituent of our diet and an industrially important 
co-factor used in biocatalysis processes, such as the production of 1,3-propanediol. De novo 
synthesis of vitamin B12 is limited to a few representatives of bacteria and archaea. 
Lactobacillus reuteri has been reported to produce vitamin B12, but before this study, our 
knowledge about this process was very limited. The work presented here aimed at 
characterizing all aspects related to vitamin B12 production in L. reuteri using a 
multidisciplinary approach, and exploring its potential applications. 
The native corrinoid produced by L. reuteri under anaerobiosis was analyzed by 
HPLC, MS and NMR and found to contain adenine, instead of 5,6-dimethlbenzimidazole, 
in the Co?-ligand. Commonly known as pseudovitamin B12, this compound could play a 
role in assessing the capability of vitamin B12-dependent enzymes to utilize alternative 
cofactors, and in understanding the impact of analogues in vitamin B12 metabolism. 
The anaerobic biosynthetic pathway converting glutamate into vitamin B12 was 
found to be encoded in one single stretch of the chromosome, neighbored by clusters of 
genes encoding glycerol reduction, metabolosome assembly and cobalt transport. The 
control of expression of these clusters appears to be part of the same regulon, in which a 
single regulatory protein plays a pivotal role. Genome-scale analysis tools such as cDNA 
microarrays and metabolic network modeling, exposed unsuspected liaisons between 
glycerol utilization, vitamin B12 synthesis and amino acid metabolism. This provided new 
leads that resulted in a 20-fold increase in vitamin B12 production without the usage of 
genetic manipulation. The possibility of combining the production of folate and vitamin B12 
in the same L. reuteri cell was also illustrated and applied to the fermentation of substrates 
of plant origin. 
The findings reported here, besides their scientific relevance, can be applied to the 
improvement/development of fermentation process with increased vitamin B12 production. 
Ultimately, the work presented here might also be used to ensure an adequate vitamin B12 
intake in humans. 
 
Keywords: vitamin B12, Lactobacillus reuteri, lactic acid bacteria, genome-scale model, 
omics, biosynthesis. 
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GENERAL INTRODUCTION  
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Vitamin B12 is a captivating molecule that is associated with several fundamental 
processes that sustain life. For humans, it is an essential nutrient in our diet and a co-factor 
of great relevance in biotechnological transformations. In this Chapter, a brief description 
of the illustrious history of B12 research will be presented, followed by some general 
aspects relative to its chemistry and biochemistry. We will review our current 
understanding of how this complex molecule is synthesized in Nature and its importance in 
human nutrition, describing a particular species of lactic acid bacteria, Lactobacillus 
reuteri, which unlike others in this group can synthesize B12. A brief account of the most 
modern research approaches is provided. The Chapter ends with a short overview of the 
thesis. 
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Brief historical background of vitamin B12 research 
In resemblance to so many other discoveries, vitamin B12 was first stumbled upon 
while studying a condition caused by its absence. Minot and Murphy reported in 1926 that 
by submitting their patients to a diet including whole liver they were able to cure pernicious 
anemia (67). They explained their remarkable finding by postulating the presence of an 
“extrinsic factor” in liver, whose identity was going to remain elusive for more than 20 
years to come. For their efforts related to liver therapy in cases of anemia, Minot and 
Murphy (along with Whipple) were attributed the first Nobel Prize related to vitamin B12 
research in 1934.  
The race to identify the mysterious “extrinsic factor” culminated in the isolation of 
a red crystalline compound from liver that was able to cure pernicious anemia. Two 
principal pharmaceutical companies separated by the Atlantic Ocean achieved this 
independently within the same year. The discovery was carried by a group at Glaxo in the 
UK headed by Smith and a group at Merck in the USA lead by Folkers, and at this stage the 
“extrinsic factor” was designated vitamin B12 (78). Within the same year, vitamin B12 was 
also found to be present in milk powder, beef extract and culture broth of several bacteria 
(77), and was reported to be a growth factor for Lactobacillus lactis that lead to the 
development of a vitamin B12 bioassay (90, 91). Soon, the presence of cobalt was 
recognized (79), along with the identification of analogues that retained biological activity 
(29, 36), namely pseudo-B12 (72). 
The isolation of vitamin B12 along with the realization that this molecule was 
structurally much more complex than anything that had previously been solved, triggered 
research on the determination of its exact crystal structure. Hodgkin pioneered X-ray 
crystallography of complex molecules and in 1955 she revealed the intricately complex 
three-dimensional structure of vitamin B12 (cyanocobalamin) with a very high level of 
accuracy (48, 49). Shortly after Barker had crystallized the first biologically active 
coenzyme forms of (pseudo)-B12 (7), Lenhert and Hodgkin repeated the feat, and solved the 
structure of adenosylcobalamin in 1961 (55). For her efforts, Hodgkin was awarded in 1964 
the second Nobel Prize related to vitamin B12 research in its relatively short history. In 
1962, an alternative ?-axial ligand was found to be present in biologically active forms of 
vitamin B12. This methyl radical was demonstrated to be involved in methionine synthesis 
in bacteria (47). 
Another important event in the history of vitamin B12 was its chemical synthesis. 
This test of persistence that dragged throughout the ‘60s and ‘70s was headed by 
Eschenmoser and by yet another Nobel Prize laureate, Woodward. It involved the 
participation of over one hundred scientists and culminated in a highly complicated 
chemical synthesis process involving around 70 steps (35). It became apparent that the 
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industrial production of vitamin B12 was not going to rely on chemical synthesis, since it 
was obviously far too technically challenging and economically unviable. At this stage, 
much attention turned to how this remarkable molecule was synthesized in Nature. 
It was only in 1985 that the first gene sequence associated with B12 biosynthesis 
was identified (115). With the arise of molecular genetics in combination with well-
established biochemistry and chemistry expertise, it took less than ten years for the groups 
of Blanche at Rhône-Poulenc Rorer, Battersby at Cambridge UK and Scott in Texas to 
elucidate most of the aerobic biosynthesis pathway (8). The recognition of a biosynthetic 
route towards B12 that did not depend on molecular oxygen by the group of Scott 
constituted a turning point in B12 history. It lead to the intense study of B12 biosynthesis in 
Propionibacterium shermanii by Scott himself and co-workers, and additionally to the 
study of the more genetically accessible anaerobic B12 producer, Salmonella typhimurium, 
in the groups of Roth, Warren, amongst others (115). Even though much progress has been 
made, the complete anaerobic route towards B12 biosynthesis remains to be elucidated. 
Since the discovery of the two alternative upper ligands back in the early ‘60s, 
several adenosyl- and methyl-cobamide dependent enzymes have been identified. In 
general, these reactions are responsible for the catalysis of methyl transfers and carbon 
backbone rearrangements (115). Much progress has been achieved since then in the 
elucidation of their mechanisms and stereochemistry. In the last decade of the XX century, 
the three-dimensional structure of methionine synthase was solved (33, 34), followed 
shortly by that of methylmalonyl CoA mutase (60), the other B12-dependent reaction known 
to be present in humans (5). In 1999, the structures of two other B12-dependent enzymes in 
bacteria were solved, namely for glutamate mutase (76) and diol dehydratase (89). 
 
Figure 1.1. PubMed entries with B12 in the title from 1948 until 2007. 
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In 1948 the term vitamin B12 first appeared in the scientific records (78). Over the 
past 60 years, more than 7000 peer-reviewed papers have been published in relation to it 
(Fig. 1.1). This aided the improvement of technological issues surrounding its production, 
reduced the negative effects to human health caused by its deficiency, and last, but 
definitely not least, contributed to our better understanding of the world and the underlying 
principles that govern it. 
 
Chemical structure of vitamin B12 
A vast variety of analogues of vitamin B12 have been described, and are generally 
considered the most complex of all small molecules known. Their shared molecular 
architecture consists of a ring-contracted porphinoid with a cobalt ion chelated at the center 
of a tetrapyrrole-derived macrocycle. The metal ion is covalently bond to an “upper” or 
?-ligand, and further coordinated with an axial “lower” or ?-ligand (Fig. 1.2). The nature of 
these radicals determines the designation of the corrinoid. The term vitamin B12 refers 
strictly to cyanocobalamin, since this was the first form found after the compound was 
isolated from liver. However, in this thesis the term vitamin B12 refers to any compound 
with the described structure.   
In naturally occurring analogues of vitamin B12, it is either an adenosyl or a methyl 
group that is present in the ?-ligand. The adenosyl group is found in B12 analogues that act 
as a co-factor in rearrangement or reductase reactions, while the methyl group is present in 
the upper ligand of the co-factor that is involved in B12-dependent methionine synthesis. 
Soon after the isolation of vitamin B12, it was observed at Organon in the Netherlands 1950, 
that a treatment with KCN greatly improved its stability (109, 118). Although this was not 
completely clear at that time, this treatment promoted the replacement of the upper ligand 
present in biologically active forms by a cyano moiety. The latter is only found in the ?-
ligand of synthetic preparations of vitamin B12 and not in naturally occurring analogues. 
Cobalamin, the best-studied form of vitamin B12, is a cobamide in which 
5,6-dimethylbenzimidazole is the aglycon attached to the ?-ligand bound in an atypical 
?-glycosidic linkage from its N-1 to the C-1 of ribose. Besides the different known radicals 
that can be found as ?-ligands connected via a Co-C bond, different microorganisms have 
been described to synthesize B12 analogues that contain bases in the ?-ligand other than 
5,6-dimethylbenzimadazole. These are most commonly benzimidales, purines and phenolic 
compounds. The evolutionary significance of the existence of such a wide variety of natural 
forms of vitamin B12 is still under debate. 
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Figure 1.2. Shared structure of B12 analogues 
along with possible alternatives found in the ?- and ?-ligands. 
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Vitamin B12-dependent enzymes 
Intriguingly, B12 biosynthesis is limited to a few representatives of bacteria and 
archaea (61) while B12-dependent enzymes are widespread throughout all domains of life 
(80). In fact, only in plants and fungi have there not been any B12-dependent processes 
identified yet (25). Generally, B12-dependent reactions are described to catalyze methyl 
transfers and carbon backbone rearrangements (see Table 1.1). 
 
Table 1.1. B12-dependent reactions and their distribution 
Enzyme Description Distribution 
B12-dependent 
methionine synthase 
Involved in catalyzing the conversion of 
homocysteine to methionine using a methyl group 
donated by methyltetrahydrofolate (63). 
Bacteria, 
animals 
Methylmalonyl-CoA 
mutase 
Involved in catalyzing the interconversion of 
(2R)-methylmalonyl-CoA to succinyl-CoA (6). 
Bacteria, 
animals 
Ribonucleotide 
reductases (class II) 
Involved in catalyzing the reduction of 
ribonucleosides diphosphates (NDPs) and 
triphosphates (NTPs) to form the corresponding 
deoxyribonucleotides (38). 
Bacteria, 
Archaea 
Glutamate mutase Involved in catalyzing the interconversion 
between (S)-glutamate and (2S,3S)-3-
methylaspartate (18). 
Bacteria 
2-Methyleneglutarate 
mutase 
Involved in catalysing the equilibration of 2-
methyleneglutarate with (R)-3-methylitaconate 
(idem). 
Bacteria 
Diol and glycerol 
dehydratase 
Involved in catalyzing the conversion of glycerol 
to ?-hydroxypropionaldehyde, 1,2-propanediol to 
propionaldehyde, and 1,2-ethanediol to 
acetaldehyde (106). 
Bacteria 
Ethanolamine 
ammonia-lyase 
Involved in catalyzing the conversion of 
ethanolamine and other short-chain vicinal amino 
alcohols to ammonia and the oxo product (4). 
Bacteria 
Aminomutases Involved in catalysing the transferring of an 
amino group between two adjacent carbon atoms 
of an amino acid (40). 
Bacteria 
Isobutyryl-CoA 
mutase 
Involved in catalyzing the interconversion of 
isobutyryl-CoA and n-butyryl-CoA (121). 
Bacteria 
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Besides the reactions listed in Table 1.1, B12-dependent reactions have also been 
described to be essential in reductive dehalogenases found in bacteria (92, 119). 
Additionally, corrinoids have also been found to play a crucial role in methanogenesis (84) 
and acetogensis (73). 
 
Biosynthesis of vitamin B12  
The biosynthesis of coenzyme B12 is commonly divided in three parts: (i) the 
synthesis of uroporphyrinogen III from either glutamyl-tRNA or glycine and succinyl-CoA; 
(ii) the corrin ring synthesis, which differs between the anaerobic pathway starting with the 
insertion of cobalt into an early intermidiate, and the aerobic pathway where the cobalt 
chelation reaction occurs only after corrin ring synthesis; (iii) and the corrin ring 
adenosylation, attachment of the amino-propanol arm and assembly of the nucleotide loop 
bridging the lower ligand to the cobalt at the core of the corrin ring.  
 
(i) Synthesis of uroporphyrinogen III (Fig. 1.3) 
Two different pathways have been described to culminate in the synthesis of the 
first common precursor of all identified tetrapyrroles, 5-aminolevulinate. The C4-Way 
(Shemin-Way) derives from succinyl-CoA and glycine, which are condensed into 5-
aminlevulinate in a single enzymatic reaction, catalyzed by 5-aminolevulinate synthase 
(E.C. 2.3.1.37) (52, 99, 113). The C5-Way is a two-step enzymatic conversion. First tRNA-
bound glutamate is reduced by glutamyl-tRNA reductase (E.C. 1.2.1.-) to glutamate-1-
semialdehyde (86), which is then rearranged to 5-aminolevulinate via an intramolecular 
shift of the amino group from the C-2 to the C-1, catalyzed by glutamate-1-semialdehyde 
2,1-aminomutase (E.C. 5.4.3.8). In some microorganisms, 5-aminolevulinate was found to 
be transported into the cell from the environment (61). 
The assembly of uroporphyrinogen III from 5-aminolevulinate requires three 
additional enzymatic reactions. First, the formation of the first pyrrole derivative, 
porphobilinogen, is catalyzed by porphobilinogen synthase (E.C. 4.2.1.24) through the 
combination of two 5-aminolevulinate molecules (44, 120). This is followed by the 
porphobilinogen deaminase (EC 2.5.1.61) mediated polymerization and rearrangement of 
four porphobilinogen molecules to form hydroxymethylbilane (66, 114). The latter is then 
finally cyclized by uroporphyrinogen III synthase (E.C. 4.2.1.75) (10). Uroporphyrinogen 
III is the first macrocyclic intermediate on the biosynthetic pathways of all tetrapyrroles, 
and its architectural blueprint is easily recognizable in their structure. Not surprisingly, the 
genes encoding these last two reactions are widely spread throughout the genomes of all 
domains of life (115). Uroporphyrinogen III is also the last common precursor shared by all 
tetrapyrroles. Its decarboxylation and oxidation leads to protoporphyrin IX, the precursor of 
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chlorophyll and haem. Its methylation forms precorrin-2, the branching point of the 
biosynthetic routes of sirohaem, coenzyme F430, haem d1 and coenzyme B12 (Fig. 1.3). 
 
 
Figure 1.3. Synthesis of uroporphyrinogen III 
CHAPTER 1 
 
 20 
(ii) Synthesis of the corrin ring (Fig. 1.4) 
The methylation of uroporphyrinogen III to precorrin-2 is actually a two-step 
reaction that involves the donation of two S-adenosyl-L-methionine (SAM)-derived methyl 
groups. Both methylations are catalyzed by a single enzyme, uroporphyrinogen-III C-
methyltransferase (EC 2.1.1.107). The first methylation occurs at carbon 2 forming 
precorrin-1, which is then released from the enzyme. The subsequent methylation occurs at 
position 7 of precorrin-1, leading to the formation of precorrin-2 (116). At this point 
coenzyme B12 biosynthesis splits in two different routes depending on oxygen dependency. 
The order of methylation and amidation appears to be the same in both of these pathways. 
However, the method used for ring contraction and the moment in which cobalt is inserted 
is different. As a consequence, even though several corrin ring biosynthesis genes are 
homologous between organisms that use the different routes, some genes are unique and 
can be used to predict which pathway a given organism uses. 
The aerobic or late cobalt insertion pathway. This route starts immediately with 
the methylation of precorrin-2 at position 20 to form precorrin-3A. This reaction is 
catalyzed by precorrin-2 C20-methyltransferase (EC 2.1.1.130) using a SAM derived 
methyl group (31, 81, 82). The next step constitutes one of the crucial differences between 
the aerobic and anaerobic routes, as it is dependent on the availability of molecular oxygen. 
Precorrin-3A is oxidized by an iron-sulfur protein, precorrin-3B synthase (EC 1.14.13.83), 
which incorporates oxygen at position 20 of the macrocycle (31, 88). Precorrin-3B is then 
methylated at position 17 giving rise to precorrin-4, catalyzed by precorrin-3B C17-
methyltransferase (EC 2.1.1.131) (31, 88). It is after this methylation that the ring 
contraction is thought to occur, since it requires the presence of the methyl group donor, 
SAM, for the reaction to take place. Precorrin-5 is then formed through the SAM dependent 
methylation of precorrin-4 at position 11 via precorrin-4 C11-methyltransferase (EC 
2.1.1.133) (26). The SAM-dependent methylation of precorrin-5 at position 1 is catalyzed 
by precorrin-6A synthase (deacetylating) (EC 2.1.1.152) and associated with the release of 
an acetyl group as acetate (31). Precorrin-6A is transformed into precorrin-6B by the 
NADPH-dependent precorrin-6A reductase (EC 1.3.1.54), which catalyzes the reduction of 
the double bound between positions 18 and 19 (13, 115). Via precorrin-6Y C5,15-
methyltransferase (decarboxylating) (EC 2.1.1.132) two SAM-derived methyl groups are 
then donated to precorrin-6B at positions 5 and 15, concomitantly with the decarboxylation 
of the acetate side chain at position 12, forming precorrin-8X. Unpublished studies suggest 
that there is no other intermediate between precorrin-8X and the subsequent step (Martin 
Warren, personal communication).   
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Figure 1.4. Aerobic route of corrin ring synthesis. 
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Hydrogenobyrinic acid is then formed as a result of the migration of the methyl 
group from position 11 to position 12 promoted by precorrin-8X 11,12-methylmutase (EC 
5.4.1.2), and completing the synthesis of the corrin ring (26, 105). The next step is the 
amidation of the c and subsequently, a side chains by means of a Mg
2+
, ATP and 
glutamine-dependent process catalyzed by hydrogenobyrinic acid a,c-diamide synthase 
(glutamine-hydrolysing) (EC 6.3.5.9) (115). Finally, at this stage cobalt is inserted via a 
heterotrimeric and ATP-dependent chelatase reaction catalyzed by hydrogenobyrinic acid 
a,c-diamide cobaltochelatase (EC 6.6.1.2), forming cob(II)yrinic acid a,c-diamide (32). 
The anaerobic or early cobalt insertion pathway. This pathway starts with the 
conversion of precorrin-2 to sirohydrochlorin catalyzed by precorrin-2 dehydrogenase (EC 
1.3.1.76) (87, 115). Sirohydrochlorin is where the anaerobic coenzyme B12 biosynthesis 
pathway definitely branches from the one to sirohaem, depending on whether it is cobalt or 
iron that is chelated (9). Unlike in the aerobic pathway, the chelatase reaction is here ATP-
independent and catalyzed by sirohydrochlorin cobaltochelatase (EC 4.99.1.3) early in the 
synthesis of the corrin ring (17). Co-precorrin-2 is then methylated at position 20 by Co-
precorrin-2 C20-methyltransferase (EC 2.1.1.151) forming Co-precorrin-3 (93). In contrast 
to the aerobic route, which requires the incorporation of molecular oxygen in position 20 of 
Co-precorrin-3 before the methylation at position 17, in the anaerobic route the latter is 
methylated directly via Co-precorrin-3B C17-methyltransferase (EC 2.1.1.131) using SAM 
as the methyl group donor (115). From Co-precorrin-4 onwards, there are some 
intermediates that have not been identified yet but deduced by analogy to the well-studied 
late cobalt insertion pathway. Such parallels should be drawn with a reasonable degree of 
caution, since the history of B12 biosynthesis is prosperous with surprises. There is evidence 
that Co-precorrin-4 is converted by Co-precorrin-4 C11-methyltransferase (EC 2.1.1.133) 
to Co-precorrin-5A resorting to SAM as the methyl donor (83). The formation of Co-
Precorrin-5B is thought to be catalyzed by Co-precorrin-5A C20-acyltransferase (EC 2.3.1.-
), concomitant with the release of acetaldehyde (in contrast with the aerobic route, where 
acetate was formed) (115). Co-precorrin-6A is then assumed to be formed by methylation 
at position 1 via Co-precorrin-5B C1-methyltransferase (EC 2.1.1.-) (61). Co-precorrin-6A 
is reduced to Co-precorrin-6B in a process catalyzed by Co-precorrin-6A reductase (EC 
1.3.1.54) (115). At this stage, based on the presence of two subunits, often encoded by two 
separate genes, Co-precorrin-6B is thought to be methylated twice separately forming Co-
precorrin-7, and subsequently, Co-precorrin-8X. This process is considered to be catalyzed 
by the SAM-dependent Co-precorrin-6Y C5,15-methyltransferase [decarboxylating] 
subunits CbiE and CbiT (EC 2.1.1.132) (idem). Cobyrinic acid is formed through the 
activity of Co-precorrin-8X methylmutase (EC 5.4.1.2) that promotes the migration of the 
methyl group from position 11 to postion 12 (82, 83). In resemblance to the late cobalt 
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insertion pathway, amidation of the corrin ring occurs first at side chains c and 
subsequently a, here catalyzed by the Mg
2+
, ATP and glutamine dependent cobyrinic acid 
a,c-diamide synthase (EC 6.3.1.-), and resulting in the formation of cob(II)yrinic acid a,c-
diamide (115). From cob(II)yrinic acid a,c-diamide onwards differences between the 
anaerobic and aerobic pathways are considerably attenuated and reside mostly on the 
genetic level.  
 
(iii) Corrin ring adenosylation, attachment of the amino-propanol arm and assembly of the 
nucleotide loop bridging the lower ligand to the cobalt at the core of the corrin ring (Fig. 
1.5).  
Corrin ring adenosylation. Before adenosylation actually occurs, steps are taken to 
ensure that the cobalt is ligated securely. First cob(II)yrinic acid a,c-diamide is reduced to 
cob(I)yrinic acid a,c-diamide catalyzed by an enzyme that remained elusive until recently, 
cob(II)yrinic acid a,c-diamide reductase (EC 1.16.8.1) (54). Adenosylation is catalyzed by 
cob(I)yrinic acid a,c-diamide adenosyltransferase (EC 2.5.1.17) forming adenosyl cobyrinic 
acid a,c-diamide (11, 94, 97, 111), which is then the initial substrate of the final amidase, 
adenosylcobyric acid synthase (glutamine-hydrolysing) (EC 6.3.5.10). The latter will 
catalyze a four-step amidation sequence of the b, d, e and g side chains, culminating in 
adenosylcobyric acid hexaamide (12). Besides cob(I)yrinic acid a,c-diamide, 
adenosyltransferase (EC 2.5.1.17) can use other substrates, such as cobinamide or 
cobalamin (37). 
Attachment of the amino-propanol arm. The aminopropanol group that is attached 
to the f side chain of coenzyme B12 is derived from either glycine or threonine metabolism. 
It can be attached as (R)-1-aminopropan-2-ol to adenosylcobyric acid hexaamide 
originating adenosylcobinamide, which is then phosphorilated by adenosylcobinamide 
kinase (EC 2.7.1.156) to form adenosylcobinamide phosphate using either ATP or GTP 
(68). Or in alternative, (R)-1-aminopropan-2-yl phosphate derived from L-threonine 
phosphate via threonine-phosphate decarboxylase (EC 4.1.1.81) can be attached to 
adenosylcobyric acid hexaamide and originate directly adenosylcobinamide phosphate, 
skipping the kinase step (20). Both the attachment of (R)-1-aminopropan-2-ol and (R)-1-
aminopropan-2-yl phosphate is catalyzed by adenosylcobinamide (phosphate) synthase (EC 
6.3.1.10) (115). 
Assembly of the nucleotide loop. The nucleotide loop is an important structure 
bridging the ?-axial ligand to the corrin ring. It contains two unusual features, namely the 
presence of a ?-glycosidic bond (rather than ?) joining the base to the ribose, and linking 
the (R)-1-aminopropan-2-ol to the nucleotide in a phosphodiester bond, in which the 3’-OH 
group (rather than 5’-) from the ribosyl moiety participates. 
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Figure 1.5. Corrin ring adenosylation, attachment of the amino-propanol arm and assembly 
of the nucleotide loop. 
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To achieve the assembly of such a structure, it is required that both cobinamide and the 
?-ligand base are activated separately before being joined. Adenosylcobinamide phosphate 
is activated by adenosylcobinamide-phosphate guanylyltransferase (EC 2.7.7.62) forming 
adenosylcobinamide-GDP (68). The activation of the base requires two enzymatic 
reactions. First the phosphoribosyl moiety of nicotinate mononucleotide is transferred to 
5,6-dimethylbenzimidazole originating N
1
-(5-phospho-?-D-ribosyl)-5,6-
dimethylbenzimidazole (commonly known as ?-ribazole-5’-P) (21, 41, 43). This step is 
mediated by nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase (EC 
2.4.2.21), which has also been shown to function with substrates other than 5,6-
dimethylbenzimidazol, such as adenine (22, 42). The second step is the removal of the 
phosphate group of ?-ribazole-5’-P mediated by ?-ribazole-5'-phosphate phosphatase (EC 
3.1.3.73), yielding ?-ribazole (69). The assembly of the activated cobinamide and ?-ligand 
base is mediated by adenosylcobinamide-GDP ribazoletransferase (EC 2.7.8.26), finally 
yielding coenzyme B12 (19, 57).  
 
Vitamin B12 and human nutrition 
Humans have an auxotrophic requirement for vitamin B12 with a recommended 
nutrient intake (RNI) for healthy adults of 2.4 μg/day. The fact that B12-dependent enzymes 
are present in neither plants nor fungi, has significant implications for the dietary sources 
and availability of vitamin B12. The B12 synthesized by a few representatives of bacteria and 
archaea is the only source of this vitamin, which enters the human food chain mostly 
through incorporation into foods of animal origin. Dietary sources with a significant 
vitamin B12 content include meat (liver), poultry, milk and derivatives, eggs, amongst 
others.  
 
Table 1.2. Recommended nutrient intake (RNI) for vitamin B12 in different age groups 
Age (years) RNI (μg/day) Age (years) RNI (μg/day) 
0 – 0.5 0.4 10 – 18 2.4 
0.5 – 1 0.7 19 – 65 2.4 
1 – 3 0.9 > 65 2.4 
4 – 6 1.2 Pregnant 2.6 
7 – 9 1.8 Lactating 2.8 
Source: FAO/WHO (12) 
 
 
Vitamin B12 deficiency has been demonstrated to lead to pernicious anemia, and 
neurological dysfunction, amongst other complications (95). The onset of vitamin B12 
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deficiency symptoms is often delayed by the increased intake of folate. This masking of B12 
deficiency has resulted in the restriction of folate intake levels and prevented folate 
fortification in many countries (39). Strict vegetarian dietary regimes tend to be poor in 
vitamin B12, which has boosted the popularity of fortifying vegetarian foodstuffs with B12 
(1). Another risk group are the elderly, most often not because of a diet poor in B12, but 
most often because of malabsorption phenomena. 
 The absorption of vitamin B12 in human is a complex process. Protein-bound B12 
present in food is only released in the stomach by the action of a high concentration of 
hydrochloric acid. At this stage, free B12 is immediately bound to haptocorrin, a 
glycoprotein secreted in the mouth by the salivary glands and also to a certain extent in the 
stomach itself. Haptocorrin protects B12 from chemical denaturation by the acidic pH 
characteristic of the stomach. Also in the stomach, in the parietal cells (same that secrete 
hydrochloric acid), yet another glycoprotein involved in B12 absorption is made. The latter 
is known as the intrinsic factor and will eventually bind vitamin B12 enabling its active 
absorption. When entering the duodenum, haptocorrin is attacked by pancreatic proteases, 
releasing B12 once again. With the rise in pH in the transition from the stomach to the 
duodenum, intrinsic factor acquires an increasing binding affinity for vitamin B12. 
Absorption of vitamin B12 will then finally occur by receptor-mediated endocytosis in the 
terminal ileum, where the specific receptor cubulin complexes with intrinsic factor bound to 
B12 (5). As a consequence, B12 produced by colonic bacterial fermentations is most likely 
not reachable to the host. However, it has been suggested that B12 produced by a 
microorganism capable of colonizing proximal to the ileum would potentially be host-
accessible (2). 
 
Lactic acid bacteria 
Lactic acid bacteria (LAB) are Gram-positive rods or cocci with a low G+C 
content in their chromosome. They share the common feature of producing lactic acid as 
the major end product of carbohydrate metabolism. Taxonomically, LAB comprise a 
relatively large clade of the Bacilli, one of the three classes within the Firmicutes phylum. 
More specifically, the genera that make up LAB belong to the order of the Lactobacillales, 
and include Aerococcus, Carnobacterium, Enterococcus, Lactobacillus, Lactococcus, 
Leuconostoc, Oenococcus, Pediococcus, Streptococcus, Tetragenococcus, Vagococcus, and 
Weisella. 
LAB inhabit several ecological niches. Some of their representatives are 
autochonous of the gastro-intestinal tract (GI-tract) of humans and other animals (108), but 
by large they are found in decomposing plant material. The phenotypic traits of acidifying 
the environment and producing antimicrobial agents inhibit the growth of spoilage agents, 
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leading to the establishment of a fortuitous symbiotic relationship with humans. 
Historically, humans have domesticated LAB for thousands of years by incorporating them 
in our food fermentation processes. This is supported by anthropological evidence, but also 
by the genetic adaptation of LAB to these new environments as evidenced by their genomic 
features (15, 107). This long history of safe use contributed greatly to their prominent role 
in the food industry, being responsible for the manufacturing of several fermented foods 
and beverages. Their economic, industrial and nutritional value is clearly demonstrated by 
the wide variety of applications. For instance: 
 
• LAB are the main components of dairy starter cultures, transforming milk into 
products such as yogurt or cheese, and extending its shelf-life by lowering the pH due to 
lactic acid production; 
• LAB contribute to the wellbeing of human mucosal surfaces throughout most of 
the digestive tract (108); 
• LAB may also produce bacteriocins (anti-microbial peptides or proteins) that 
improve the durability of fermented foods (30, 100); 
• LAB may contribute to the organoleptic profile of fermented foods. For example, 
with the production of compounds such as diacetyl, acetaldehyde, alanine, amongst others 
(27, 50, 64, 98); 
• LAB can improve the texture and rheological properties of food by the synthesis 
of exopolysaccharides (14, 74); 
• More recently, LAB have been studied to produce novel foods with improved 
nutritional value (nutraceuticals) (51).  
  
With the burst of the –omics revolution much of the focus of LAB research has 
been channeled to genome-wide studies. Since the release of the first complete LAB 
genome in 2001 (16), more than 50 genomic sequences of LAB have been deduced, 
including 27 species (Table 1.3). Only L. brevis, L. casei, L. salivarius and Leuconostoc 
mesenteroides have not yet had at least on of their sequenced strains assembled into a single 
contig. The genera Aerococcus, Carnobacterium, Tetragenococcus, Vagococcus, and 
Weisella have not yet had any of their representatives sequenced. However, as this thesis is 
being written there are sequencing projects running for Carnobacterium at the Marine 
Microbial Genome Sequencing Project (https://research.venterinstitute.org/moore/).  
The analysis of all these genomes produced a wealth of information without 
precedent (71). Ever more often, one can find in literature related to LAB, accounts of 
genome-wide analysis instead of the separate study of individual fragments of it (96). The 
full extent of the impact of the genome-sequencing boom in the LAB field is yet hard to 
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determine, but expected to be large. The comparative genomics studies published so far 
indicate that the occurrence of lateral gene transfer events is more common than previously 
suspected (58, 59). This is in part attributed to the large number of phages, plasmids and 
mobile elements typically found in LAB (110).  
 
Table 1.3. Overview of genome sequencing of LAB available at ERGO database (70) in 
the spring of 2008
a. 
 
Family Organism Name 
Genome 
sequences 
available 
Average 
Genome 
size (kb) 
Average 
number 
of ORF 
Average 
number of 
contigs 
Enterococcaceae Enterococcus faecalis 2 2,763 2,747 83 
Lactobacillus brevisb. 1 2,340 2,218 3 
Lactobacillus caseib. 1 2,924 2,771 2 
Lactobacillus delbrueckii 2 1,860 1,642 1 
Lactobacillus fermentum 1 2,098 1,843 1 
Lactobacillus gasseri 1 1,894 1,755 1 
Lactobacillus helveticus 1 2,080 1,610 1 
Lactobacillus johnsonii 1 1,992 1,821 1 
Lactobacillus plantarum 1 3,308 3,053 1 
Lactobacillus reuteri 2 2,087 2,011 52 
Lactobacillus sakei 1 1,884 1,884 1 
Lactobacillus salivariusb. 1 2,133 2,017 4 
Pediococcus pentosaceus 1 1,832 1,755 1 
Lactobacillaceae 
Lactobacillus acidophilus 1 1,993 1,864 1 
Leuconostoc mesenteroidesb. 1 2,075 2,005 2 
Leuconostocacaea 
Oenococcus oeni 1 1,780 1,691 1 
Lactococcus lactis 3 2,497 2,454 3 
Streptococcus agalactiae 3 2,166 2,071 1 
Streptococcus equi 1 2,253 2,232 1 
Streptococcus gordonii 1 2,196 2,051 1 
Streptococcus mutans 1 2,030 1,945 1 
Streptococcus pneumoniae 5 2,123 2,059 41 
Streptococcus pyogenes 12 1,880 1,897 1 
Streptococcus suis 4 1,915 2,019 142 
Streptococcus thermophilus 2 1,830 1,816 2 
Streptococcaceae 
Streptococcus uberis 1 1,852 1,849 1 
a. Source: http://ergo.integratedgenomics.com/ERGO 
b. Species for which there is no closed genome sequence 
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Lactobacillus reuteri 
Lactobacillus reuteri is widely spread in the GI-tract of humans and other 
mammals (112) and is a predominant microbe in several food and feed fermentations, 
namely in sourdoughs of different cereals such as rye and wheat (65). Although it has been 
highlighted for this heterofermentative lactic acid bacterium that human intervention 
studies showing relevant benefits remain to be reported (85), potential probiotic effects 
such as reducing the incidence and gravity of diarrhea of multiple origins in humans (117), 
triggering anti-inflamatory activity in human cell lines (56), and reducing cholesterolemia 
in mice (102), amongst others, have been described for several strains of L.reuteri. 
L. reuteri has the ability of producing and excreting reuterin (100), a mixture of 
monomeric, hydrated monomeric and cyclic dimeric forms of 3-hydroxypropionaldehyde 
(3-HPA) (101). 3-HPA inhibits several yeasts, moulds and protozoa, along with Gram-
positive and Gram-negative bacteria (23). It has been proposed that the resilience of L. 
reuteri in a complex environment, such as the GI-tract, is linked to the significant growth 
advantage that is conferred by the production of this broad spectrum antimicrobial (23). 
The production of 3-HPA is catalyzed by a B12-dependent enzyme, glycerol dehydratase 
(EC 4.2.1.30) (28). 3-HPA can be used to recycle NAD
+
 through its reduction to 1,3-
propanediol, by 1,3-propanediol dehydrogenase (E.C. 1.1.1.202). Under the current 
economical, political and environmental conditions, the production of 1,3-propanediol is of 
great biotechnological interest since it is a starting material for the production of plastics 
such as polyesters, polyethers and polyurethanes (28). 
Not long before the work described in this thesis was initiated, a compound in its 
cyano form was isolated from L. reuteri CRL1098, which was capable of fulfilling the 
auxotrophic vitamin B12 requirements of three different indicator strains (103). In the same 
study, L. reuteri’s chromosomal DNA was found to contain sequences homologous to one 
complete, and two partial genes involved in the anaerobic biosynthesis of coenzyme B12. 
One encoding CobA/HemD, a 464 amino-acid bifunctional protein with S-adenosyl-L-
methionine-uroporphyrinogen III methyltansferase and uroporphyrinogen III synthase 
activities from Selemonas ruminantium (3) and Listeria sps. (45). And the other two, 
predicted to encode fragments homologous to the anaerobic cobalt chelatase CbiK and 
precorrin-6-reductase (cbiJ) from Salmonella sps (75). This finding was truly remarkable 
since it was the first account ever of a lactic acid bacterium producing cobalamin. Even to 
date, with all the recent genome sequencing efforts, L. reuteri remains the only LAB in 
which the presence of B12 biosynthetic genes was found. L. coryniformis has also been 
reported to produce cobalamin (62), but the authors do not provide any genetic evidence of 
the presence of a B12 biosynthesis gene cluster. Furthermore, the levels reported to be 
produced by L. coryniformis are very low (0.7 ng/ml) in comparison to the ones reported 
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for L. reuteri using the same bioassay to quantify vitamin B12 (over 700-fold difference) 
(103). 
The sequencing of two L. reuteri strains is at the moment on going at the Joint 
Genome Institute (JGI) and the draft genome sequences have been made available. The 
genome of the type strain of L. reuteri (JCM1112) is now circularized. This strain is a 
human isolate that cannot persist in the GI-tract of mice. In contrast, strain 100-23, whose 
genome has not been assembled past 103 contigs, is rodent-specific. The comparison of the 
genome sequences of these two strains is expected to help in the elucidation of unique host-
microbe interactions. 
L. reuteri JCM1112 will be shown in this thesis to produce B12. The fact that the 
whole genome sequence is available enables the development of genome-wide analysis 
tools. These can be used to understand the impact of producing this co-factor on different 
metabolic pathways and information transfer levels (46). Additionally, they can generate 
leads for potential metabolic engineering targets to be used in the increase of B12 
production (104). 
 
 
Figure 1.6. COG distribution of Lactobacillus reuteri JCM1112 predicted ORFs. C, energy 
production and conversion; D, cell division and chromosome partitioning; E, amino acid 
transport and metabolism; F, nucleotide transport and metabolism; G, carbohydrate 
transport and metabolism; H coenzyme metabolism; I, lipid metabolism; J, translation, 
ribosomal structure and biogenesis; K, transcription; L, DNA replication, recombination 
and repair; M, cell envelope biogenesis, outer membrane; N, cell motility and secretion; O, 
posttranslational modification, protein turnover, chaperones; P, inorganic ion transport and 
metabolism; Q, secondary metabolites biosynthesis, transport and catabolism; R, general 
function prediction only; S, function unknown; T, signal transduction mechanisms; U, 
intracellular trafficking, secretion, and vesicular transport; V, defense mechanisms. 
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The draft genome sequence available at JGI evidences that L. reuteri JCM1112 
has an average size LAB genome (2 Mbp). It has a G+C content of 38.8% and is predicted 
to harbor 1900 ORFs. The distribution of the predicted gene products of L. reuteri 
throughout the different categories of clusters of orthologous groups is present in Fig. 1.6. 
It is relevant here to highlight the elevated proportion of genes that are orthologuos to genes 
involved in amino acid transport and metabolism (E, 8%) and coenzyme biosynthesis (H, 
5%) compared to L. plantarum (over two-fold increase) (53). L. reuteri has a genome 
approximately two thirds smaller than that of L. plantarum, and yet it contains more genes 
in absolute terms associated to categories E and H. 
 
Modeling and –omics approaches 
A genome sequence paves the way to the possibility of performing genome-scale 
analysis. It has been hypothesized that the transferring of sequence information between 
biopolymers (DNA, RNA, and proteins) obeys a set information flow scheme. This was 
enunciated by the Nobel Prize laureate Francis Crick shortly after the discovery of 
molecules encoding genetic information (24). Information encoded in DNA (genome) will 
be transferred to RNA (transcriptome), which will be transferred to proteins (proteome), 
which will subsequently determine metabolite concentrations (metabolome).  
Omics technologies aim to measure these different information levels as 
exhaustively as possible. It is then the goal of systems biology to integrate these different 
levels of information to define a particular state of the biological system under examination. 
This is most often achieved by mathematical representations of the system with varying 
levels of complexity and detail. These mathematical representations are designated as 
models, and help challenge our understanding of a biological system. They enable to a 
certain extent the prediction of how the system will react to specific perturbations 
generating hypothesis that will then be challenged with experimentation. 
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Thesis overview 
In this thesis, combining multiple scientific disciplines to target a central 
biological theme, we explore several aspects of B12 production in L. reuteri. We start by 
reporting on the chemical characterization of the corrinoid produced by L. reuteri (Chapter 
2) and proceed to identify the gene cluster that encodes the machinery necessary for its 
synthesis (Chapter 3). Then the genome-scale metabolic network of L. reuteri is 
reconstructed and used to predict and interpret the transcriptional and physiological 
response to the presence of glycerol (Chapter 4). The leads acquired in this study are used 
to (i) characterize a regulon that includes vitamin B12 production, glycerol utilization and 
assembly of metabolosomes (Chapter 5), and (ii) increase vitamin B12 production in L. 
reuteri by changing the availability of amino acids in the medium (Chapter 6). The 
flexibility of L. reuteri for the combined production of vitamins is illustrated, and applied to 
the enrichment of substrates in vitamin content by fermentation (Chapter 7). We end by 
reviewing how our major findings fit with those of others, and discuss how they helped to 
shape our current understanding of vitamin B12, particularly in relation to LAB (Chapter 
8).  
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CHAPTER 2 
PSEUDOVITAMIN B12 IS THE CORRINOID PRODUCED BY 
LACTOBACILLUS REUTERI CRL1098 UNDER ANAEROBIC 
CONDITIONS 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Lactobacillus reuteri CRL1098 has been reported to produce a compound with 
vitamin B12 activity (Taranto et al., Journal of Bacteriology, 185, 5643-5647). Here we 
report on the chemical characterization of this corrinoid-like molecule purified in its cyano 
form. High performance liquid chromatography coupled to an ultraviolet diode array 
detector, mass spectrometry and nuclear magnetic resonance spectroscopy has enabled us to 
identify the compound as Co?-[?-(7-adenyl)]-Co?-cyanocobamide. Commonly known as 
pseudovitamin B12, this molecule differs from cobalamin in the ?-ligand, where it has 
adenine instead of 5,6-dimethylbenzimidazole bound in a ?-glycosidic linkage to C-1 of 
ribose. L. reuteri is the first lactic acid bacterium in which the production of a 
cobalamin-like molecule has been identified and the first microorganism reported to 
produce exclusively pseudo-B12. 
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Introduction 
Lactobacillus reuteri is a Gram-positive, heterofermentative lactic acid bacterium, 
frequently found in the gastrointestinal tracts of humans and other animals (14, 15). 
Relevant probiotic properties such as the lowering of blood cholesterol levels (21), and a 
direct anti-inflammatory activity (8, 9, 16) have been demonstrated for this microorganism. 
During growth on glucose and in the presence of glycerol, L. reuteri possesses the ability to 
produce and excrete reuterin (19) (Fig. 2.1). This broad spectrum antimicrobial is a mixture 
of monomeric, hydrated monomeric and cyclic dimeric forms of 3-
hydroxypropionaldehyde (3-HPA) (20). The synthesis of reuterin is mediated by a B12-
dependent enzyme, glycerol dehydratase, which catalyses the conversion of glycerol to 3-
HPA (3). 
We have reported, previously, that a compound isolated in its cyano form from L. 
reuteri CRL1098 was capable of fulfilling the auxotrophic B12 requirements of three 
indicator strains (22). In the same study, DNA-sequences predicted to encode enzymes of 
the anaerobic B12 biosynthesis pathway were identified in the chromosome of L. reuteri. 
A great variety of vitamin B12 analogues can be found in nature. They share a 
structural architecture consisting of a corrin ring with a cobalt ion chelated at the core. 
Cobalamin, the best studied corrinoid, is a cobamide in which 5,6 dimethylbenzimidazole  
(DMB) is the aglycon attached to the ?-ligand bound in an ?-glycosidic linkage from its N-
1 to the C-1 of ribose.  B12 biosynthesis is only found in a few prokaryotes (11). Some have 
been described to synthesize B12 analogues that contain bases in the ?-ligand other than 
DMB, namely other benzimidazoles, purines and phenolic compounds (13).  
Here we report on the chemical characterization of the corrinoid-like molecule 
isolated from L. reuteri in its cyanided form. Using high performance liquid 
chromatography (HPLC) coupled to an ultraviolet diode array detector (UV-DAD) 
followed by mass spectrometry and nuclear magnetic resonance spectroscopy, we have 
concluded that the corrinoid produced by L. reuteri CRL1098 cultured under anaerobic 
condition is pseudovitamin B12. First reported in 1952 by Pfiffer et al. (4) this B12 analogue 
differs from cobalamin in the ?-ligand, where DMB appears substituted by adenine. 
Because the majority of the structure is conserved, it has been suggested that this molecule 
could play a role in assessing the capability of B12-dependent enzymes to utilize alternative 
cofactors (12), and in understanding the impact of B12 analogues in vitamin B12 metabolism 
(6, 7). 
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Figure 2.1. Schematic representation of glycerol metabolism in L. reuteri. 
 
Materials and Methods 
Preparation of cultures and cell-extracts. A culture of L. reuteri CRL1098 was 
inoculated in vitamin B12-free assay medium (Difco), grown at 37°C for 16 h and 
transferred three times. Two different growth conditions, with and without adding DMB 
(100 mg/l), were used in these studies. Cell-extracts were prepared from a 10 L batch 
culture flushed with a mixture of 95% N2 and 5% CO2, containing approximately 50 μg/L 
of corrinoid. After harvesting, cells were washed twice in 0.1 M phosphate buffer, pH 7.0, 
resuspended in 10 ml of extraction buffer consisting of 0.1 M Na2HPO4, pH 4.5 (citric acid) 
and containing 0.005% KCN. The cell suspension was separated in 10 aliquots of 1 ml 
each, disrupted with 1 g of glass beads (0.1 mm diameter) in a FastPrep FP120 (Qbiogene, 
Carlsbad, Calif.) and again combined. Extraction buffer was then added up to a final 
volume of 20 ml and autoclaved (120°C for 15 min). The mixture was cleared by 
centrifugation (8,000 x g for 10 min), and the supernatant was passed over an Isolute solid-
phase extraction (SPE) column (500 mg C18 end-capped column with a 3-ml reservoir 
volume) previously activated with 2 ml of acetonitrile. The column was washed twice with 
2 volumes of distilled water to remove salts and other hydrophilic contaminants. 
Subsequently, the corrinoid was eluted with 1 volume of 50% acetonitrile and concentrated 
to dryness in vacuo at 30°C. The residue was dissolved in 5 ml of sterile distilled water and 
stored in the dark at -20°C until further use. 
Corrinoid isolation. The corrinoid was purified from cell-extracts of L. reuteri by 
reverse-phase high performance liquid chromatography (RP-HPLC) with a Waters 
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(Milford, Mass.) 600E system automated gradient controller, a 250- by 3-mm Betasil 
phenyl column (Thermo Hypersil-Keystone, Waltham, Mass.), and a SPD-M10A VP Diode 
Array Detector (Shimadzu Corporation, Kyoto, Japan). The fraction showing a UV-DAD 
spectrum similar to that of cyanocobalamin was collected manually and lyophilised at 
30°C.  
Mass spectroscopy. The sample collected from the RP-HPLC was dissolved
 
in 100 
?l of an aqueous solution containing 30% acetonitrile and 0.1% formic acid. Mass 
spectrometric analyses of the corrinoid purified from L. reuteri were performed on a Quatro 
II triple-quadrupole mass spectrometer (Micromass, Inc., Altrincham, UK) equipped with 
an electrospray ionization (ESI) probe, operated in the positive ion mode. Experiments 
were carried out under the following conditions: capillary voltage 4.2 kV, cone voltage 36 
V, extraction voltage 5V, source temperature 80°C, desolvation temperature 120°C. 
Nuclear Magnetic Resonance spectroscopy. Proton nuclear magnetic resonance 
(
1
H-NMR) spectra were acquired on a Bruker DRX500 spectrometer (Bruker, Rheinstetten, 
Germany) usings a 5 mm inverse-detection probe head. The sample purified from the RP-
HPLC was lyophilised at 30°C and dissolved in 10% D2O, which allows the detection of 
amide resonances. Spectra were recorded at 303 K with pre-saturation of the water signal, 
using an 8.25 s pulse width corresponding to a 75
o
 flip angle and a repetition delay of 3 s. 
 
Results 
During purification, UV-DAD spectra data and retention times obtained by RP-
HPLC analyses showed that L. reuteri CRL1098 grown under anaerobic conditions 
produces one major cobalamin-like molecule, in a ratio of ?100:1 in relation to other minor 
corrinoid species. The identification and characterization of the major cobamide produced 
by this strain was based on the application of three different techniques: RP-HPLC isolation 
coupled to UV-DAD spectrum determination, mass spectrometry analysis and NMR 
spectrometry studies. 
Corrinoid isolation. To isolate and purify the native corrinoid produced by L. 
reuteri, cell-extracts were eluted on a C18-SPE column followed by RP-HPLC. The cell-
extracts from L. reuteri revealed a peak with a retention time of 36.31 min (Fig. 2.2A). 
Although the peak displayed similar UV-DAD spectra, this retention time did not agree 
with the one of the cyanocobalamin standard (37.83 min). The spectrum of the standard 
showed a peak of maximal absorbance at 350 nm and two other at 512 and 550 nm, 
respectively. The same pattern was observed when the isolated cobamide produced by L. 
reuteri was analyzed (Fig. 2.2B). Identical chromatography patterns and UV-spectra were 
recorded for the corrinoids isolated from L. reuteri CRL1098 grown in the presence or 
absence of DMB. 
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Figure 2.2A. HPLC chromatogram of the cell-extract and UV-DAD spectrum (inset) of the 
corrinoid produced by L. reuteri under anaerobic conditions in the presence of DMB. The 
same pattern was observed in the absence of DMB. 
 
Figure 2.2B. HPLC chromatograms and UV-DAD spectra (inset) of the purified corrinoid 
produced from L. reuteri CRL1098 and the cyanocobalamin standard. Although their 
retention time does not coincide, both the spectra of the corrinoid purified from L. reuteri 
and the cyanocobalamin standard, display a peak of maximal absorbance at 350 nm and two 
other at 512 and 550 nm, respectively. 
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Mass spectroscopy. The mass spectrometry data (Fig. 2.3) obtained for the 
corrinoid produced by L. reuteri provided evidence that the complete molecule has a very 
similar m/z value to the one of methylcobalamin, 1344.6 and 1344.8 respectively. In both 
the mass spectra of the isolated compound and of the standard, the peaks corresponding to 
the displacement of both the ?-ligand along with the ribosyl-bound aglycon (m/z 1183.6) 
and cobinamide (m/z 971.6) were identified. The presence of such peaks in the mass 
spectrum of our sample is highly suggestive that it is indeed a B12 analogue. 
However, when all signals displayed on the mass spectra were considered in 
detail, the fractions in which only the upper ligand was not present, revealed a mass 
variation of 15.1 for the methylcobalamin standard (m/z 1329.7) and 26.0 for the isolated 
compound (m/z 1318.6), corresponding to the displacement of a methyl and a cyano 
radical, respectively. This implied that the ?-ligand of methylcobalamin and the isolated 
compound differed approximately 11 mass units. 
A peak with an m/z value of 359.3 was identified in the methylcobalamin 
standard, but not in the corrinoid purified from L. reuteri. This peak is derived from the 
lower ligand in which DMB is the aglycon attached by a glycosyl bound from its N-1 to the 
C-1 of ribofuranose 3-phosphate. Instead, another peak is present in the mass spectrum of 
the corrinoid purified from L. reuteri with an m/z value of 348.2, once again implying a 
mass variation of approximately 11 in the ?-ligand. Furthermore, the peaks with an m/z 
value of 456.9 and 486.5, corresponding to different fractionation in which the corrin ring 
and the upper ligand are displaced (Fig. 2.4A), could be identified in the methylcobalamin 
standard but not in the corrinoid purified from L. reuteri. Hence, the possibility that the 
compound produced by L. reuteri had DMB in the lower ligand was ruled out. 
The mass spectrum recorded for the isolated compound showed a peak 
corresponding to the sole displacement of the cyano radical (m/z 1318.6), which was in 
accordance with the substitution in the lower ligand of the DMB moiety by adenine. Also 
the observed peak with an m/z value of 348.2 corroborated this substitution, and thus, 
explained the difference of 11 mass units mentioned above. This observation implied that 
the corrinoid extracted from L. reuteri was actually Co?-[?-(7-adenyl)]-Co?-
cyanocobamide, commonly known as pseudo-B12. Furthermore, the observed peaks in the 
spectrum with m/z values of 433.3 and 457.1 were consistent with this proposed structure 
and represent different fragmenting of the lower ligand containing adenine instead of DMB 
(Fig. 2.4B). 
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Figure 2.3A. Mass spectrometry spectrum of methylcobalamin. The peak with an m/z value of 
1344.8 corresponds to the intact molecule; 1329.7 corresponds to the displacement of the upper 
ligand, the methyl radical; 1183.6 corresponds to the displacement of both the upper ligand and 
DMB; 971.6 corresponds to cobinamide; 359.3 corresponds to the lower ligand in which DMB is the 
aglycon attached to ribofuranose 3-phosphate. The peaks with an m/z value of 486.5 and 456.9 
correspond to different fractioning in which both the corrin ring and the upper ligand have been 
displaced (see Fig. 2.4A). 
Figure 2.3B. Mass spectrometry spectrum of the corrinoid purified from Lactobacillus 
reuteri. The peak with an m/z value of 1344.6 corresponds to the intact molecule; 1318.6 
corresponds to the displacement of the upper ligand, a cyano radical; 1183.6 corresponds to the 
displacement of both the upper ligand and adenine; 971.6 corresponds to cobinamide; 348.2 
corresponds to the lower ligand in which adenine is the aglycon attached to ribofuranose 3-phosphate. 
The peaks with an m/z value of 457.1 and 433.3 correspond to different fractioning in which both the 
corrin ring and the upper ligand have been displaced (see Fig. 2.4B). 
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Figure 2.4. Chemical structure of (A) methylcobalamin and (B) pseudovitamin B12: likely 
structures and measured m/z values of different fractions of the lower ligand. 
 
 
Nuclear Magnetic Resonance spectroscopy. Additionally, a 
1
H-NMR spectrum 
taken of the corrinoid purified from L. reuteri (Fig. 2.5) showed striking similarities with 
published NMR spectra of pseudovitamin B12. In fact, a comparison between the acquired 
signals and those obtained for pseudovitamin B12 by Hoffman et al. (5) showed only six 
signals that were not present in the published spectrum. However, these signals are also not 
present in the spectra of other corrinoids, and therefore, we have assumed they are caused 
either by minor contaminants (peaks marked 2, 4 and 5 in Fig. 2.5), or by substances used 
during sample preparation (peaks marked 1, 3 and 6 in Fig. 2.5). Furthermore, the presence 
in the 
1
H-NMR spectrum of a characteristic sharp signal around 8 ppm is indicative of a 
highly unshielded aromatic proton in its structure, which, by itself, rules out the 
identification of the corrinoid as cobalamin or factor A, both molecules lacking such a 
proton. Pseudovitamin B12, on the other hand, has such a proton in its structure. 
A 
1
H homonuclear correlation spectrum was recorded and showed no visible 
correlations to the three signals at lower-field (8-9 ppm) (data not shown). This is in 
agreement with the proposed structure for the ?-ligand of the native corrinoid of L. reuteri, 
and dismisses the possibility of the presence of [N8-methyl]-adeninyl-cobamide. 
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Figure 2.5. Proton nuclear magnetic resonance spectrum of the corrinoid purified from L. 
reuteri. 1H-NMR spectrum was acquired on a Bruker DRX500 spectrometer using a 5 mm inverse-
detection probe head and recorded with presaturation of the water signal, using an 8.25 s pulse width 
corresponding to a 75
o
 flip angle and a repetition delay of 3 s. The sample was dissolved in 10% D2O. 
Peaks marked 1 through 6 have been assigned to contaminants. 
 
Discussion 
The corrinoid extracted by L. reuteri under anaerobic conditions has been 
identified as Co?-[?-(7-adenyl)]-Co?-cyanocobamide, commonly known as pseudovitamin 
B12. The results obtained performing mass spectrometry and nuclear magnetic resonance 
spectroscopy enabled us to identify the corrin ring with an atom of cobalt at the core, a 
cyano radical as the ?-ligand, and adenine as the aglycon bound by a glycosyl link from its 
N-1 to the C-1 of the ribose forming the ?-ligand. 
During the purification of the corrinoid produced by L. reuteri, the difference in 
retention time between our sample and the cyanocobalamin standard was suggested to be 
due to a difference in the phosphorylation state of the molecule. This was supported by a 
previous report on the in vitro synthesis of the cobalamin nucleotide loop (10), in which, 
the compound was identified as cyanocobalamin-5’-phosphate using mass spectrometry. 
Based on this, we collected the purified molecule with the same UV-DAD spectrum as 
cyanocobalamin and performed mass spectrometry analysis for molecular characterisation. 
Considering all the cobalamin analogues known (13), pseudovitamin B12 was the only one 
with full spectral consistency based on the mass spectra collected. This analogue has a 
structure similar to that of cobalamin except for the lower ligand, in which, the DMB 
moiety is substituted by adenine. The mass spectrometry results reported here enabled the 
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identification of several peaks corresponding to the fractioning of the lower ligand 
containing an adenine base (Fig. 2.3B). Additional NMR studies were performed to confirm 
the identity of the corrinoid. The conjunction of all the spectral information acquired makes 
it clear that the corrinoid extracted from L. reuteri was indeed pseudo-B12. 
Recently, the gene bluB has been shown to be necessary for the aerobic 
biosynthesis of DMB in Sinorhizobium meliloti (18). It is involved in the fragmentation and 
contraction of flavin mononucleotide to form D-erythrose 4-phosphate and DMB in the 
presence of oxygen. The recently released genome sequence of L. reuteri JCM1112 (DOE 
Joint Genome Institute, GeneBank Accession nr. CP000705) lacks a homologue of bluB 
and the growth of this lactic acid bacterium is impaired in the presence of oxygen. As a 
consequence, we consider the presence of such pathway in L. reuteri to be unlikely. 
Salmonella enterica has been reported to be able to incorporate exogenous DMB into the 
lower ligand producing cobalamin (2).  We could not detect a similar behaviour for L. 
reuteri CRL1098, which is not completely unexpected. Both phenotypically and 
phylogenetically, these two species are quite different, and thus, it is not surprising that they 
have different uptake capacities. 
Some genera of cyanobacteria have been reported to contain pseudo-B12 amongst 
other corrinoids (23, 24). The same applies to Clostridium cochlearium (5), another Gram-
positive bacterium with a low G+C content in its DNA. Interestingly, L. reuteri is the first 
microorganism reported to biosynthesize pseudovitamin B12 as its sole corrinoid product. 
Pseudo-B12 is not commercially available and until now its supply has solely relied on 
guided biosynthesis or chemical synthesis (1, 17, 25). Vitamin B12 and several of its 
analogues act as cofactors, catalyzing methyl-transfer and carbon-backbone rearrangement 
reactions. The comparison of the cofactor efficacy of the different analogues enables the 
elucidation of complex enzyme-cofactor interactions. Future studies of the capability of 
B12-dependent enzymes to use pseudo-B12 as a cofactor, may rely on L. reuteri for its 
provision. Ultimately, this will help in the effort to elucidate the relevance of the lower 
ligand and Co-N coordination for enzymatic activity.  
In humans, in vitro studies on B12 binding proteins have shown that only intrinsic 
factor can present a real bottleneck for the uptake of pseudo-B12 (17). However, 
comparative in vivo studies establishing the efficacy of B12 analogues with ?-ligands other 
than DMB to correct B12 deficiency remain to be carried out. L. reuteri is the first lactic 
acid bacterium reported to produce a cobalamin-like molecule. Besides the system of 
producing pseudovitamin B12 characterised here, the possibility to engineer the production 
of other corrinoids is currently under investigation. L. reuteri possesses the GRAS status 
(Generally Regarded As Safe), and therefore, could eventually be used to increase the 
nutritional value of fermented food and feed products. 
CHAPTER 2 
 
 54 
References 
1. Brandt, L. J., L. Goldberg, L. H. Bernstein, and G. Greenberg. 1979. The 
effect of bacterially produced vitamin B12 analogues (cobamides) on the in vitro 
absorption of cyanocabalamin. Am J Clin Nutr 32:1832-6. 
2. Carkeet, C., S. R. Dueker, J. Lango, B. A. Buchholz, J. W. Miller, R. Green, 
B. D. Hammock, J. R. Roth, and P. J. Anderson. 2006. Human vitamin B12 
absorption measurement by accelerator mass spectrometry using specifically 
labeled (14)C-cobalamin. Proc Natl Acad Sci U S A 103:5694-9. 
3. Daniel, R., T. A. Bobik, and G. Gottschalk. 1998. Biochemistry of coenzyme 
B12-dependent glycerol and diol dehydratases and organization of the encoding 
genes. FEMS Microbiol Rev 22:553-66. 
4. Davis, B. D. 1952. Utilization of pseudovitamin B12 by mutants of Escherichia 
coli. J Bacteriol 64:432-3. 
5. Hoffmann, B., M. Oberhuber, E. Stupperich, H. Bothe, W. Buckel, R. Konrat, 
and B. Krautler. 2000. Native corrinoids from Clostridium cochlearium are 
adeninylcobamides: spectroscopic analysis and identification of pseudovitamin B12 
and factor A. J Bacteriol 182:4773-82. 
6. Kanazawa, S., and V. Herbert. 1983. Noncobalamin vitamin B12 analogues in 
human red cells, liver, and brain. Am J Clin Nutr 37:774-7. 
7. Latner, A. L., and L. Raine. 1957. Effect of analogues on the uptake of vitamin 
B12 by the intact rat. Nature 180:1197-8. 
8. Ma, D., P. Forsythe, and J. Bienenstock. 2004. Live Lactobacillus reuteri is 
essential for the inhibitory effect on tumor necrosis factor alpha-induced 
interleukin-8 expression. Infect Immun 72:5308-14. 
9. Madsen, K. L., J. S. Doyle, L. D. Jewell, M. M. Tavernini, and R. N. Fedorak. 
1999. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. 
Gastroenterology 116:1107-14. 
10. Maggio-Hall, L. A., and J. C. Escalante-Semerena. 1999. In vitro synthesis of 
the nucleotide loop of cobalamin by Salmonella typhimurium enzymes. Proc Natl 
Acad Sci U S A 96:11798-803. 
11. Martens, J. H., H. Barg, M. J. Warren, and D. Jahn. 2002. Microbial 
production of vitamin B12. Appl Microbiol Biotechnol 58:275-85. 
12. Mishra, P. K., and D. G. Drueckhammer. 1998. Novel cofactor derivatives and 
cofactor-based models. Curr Opin Chem Biol 2:758-65. 
13. Renz, P. 1999. Biosynthesis of the 5,6-dimethylbenzimidazole moiety of 
cobalamin and of the other bases found in natural corrinoids, p. 557-575. In R. 
Banerjee (ed.), Chemistry and Biochemistry of B12. John Wiley & sons, Inc. 
14. Reuter, G. 2001. The Lactobacillus and Bifidobacterium microflora of the human 
intestine: composition and succession. Curr Issues Intest Microbiol 2:43-53. 
PSEUDOVITAMIN B12 IS THE CORRINOID PRODUCED BY LACTOBACILLUS REUTERI 
CRL1098 UNDER ANAEROBIC CONDITIONS 
 55 
15. Roos, S., and H. Jonsson. 2002. A high-molecular-mass cell-surface protein from 
Lactobacillus reuteri 1063 adheres to mucus components. Microbiology 148:433-
42. 
16. Rosenfeldt, V., E. Benfeldt, S. D. Nielsen, K. F. Michaelsen, D. L. Jeppesen, N. 
H. Valerius, and A. Paerregaard. 2003. Effect of probiotic Lactobacillus strains 
in children with atopic dermatitis. J Allergy Clin Immunol 111:389-95. 
17. Stupperich, E., and E. Nexo. 1991. Effect of the cobalt-N coordination on the 
cobamide recognition by the human vitamin B12 binding proteins intrinsic factor, 
transcobalamin and haptocorrin. Eur J Biochem 199:299-303. 
18. Taga, M. E., N. A. Larsen, A. R. Howard-Jones, C. T. Walsh, and G. C. 
Walker. 2007. BluB cannibalizes flavin to form the lower ligand of vitamin B12. 
Nature 446:449-53. 
19. Talarico, T. L., I. A. Casas, T. C. Chung, and W. J. Dobrogosz. 1988. 
Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus 
reuteri. Antimicrob Agents Chemother 32:1854-8. 
20. Talarico, T. L., and W. J. Dobrogosz. 1989. Chemical characterization of an 
antimicrobial substance produced by Lactobacillus reuteri. Antimicrob Agents 
Chemother 33:674-9. 
21. Taranto, M. P., M. Medici, G. Perdigon, A. P. Ruiz Holgado, and G. F. 
Valdez. 2000. Effect of Lactobacillus reuteri on the prevention of 
hypercholesterolemia in mice. J Dairy Sci 83:401-3. 
22. Taranto, M. P., J. L. Vera, J. Hugenholtz, G. F. De Valdez, and F. Sesma. 
2003. Lactobacillus reuteri CRL1098 produces cobalamin. J Bacteriol 185:5643-
7. 
23. Watanabe, F., H. Katsura, S. Takenaka, T. Fujita, K. Abe, Y. Tamura, T. 
Nakatsuka, and Y. Nakano. 1999. Pseudovitamin B(12) is the predominant 
cobamide of an algal health food, spirulina tablets. J Agric Food Chem 47:4736-
41. 
24. Watanabe, F., S. Takenaka, H. Kittaka-Katsura, S. Ebara, and E. Miyamoto. 
2002. Characterization and bioavailability of vitamin B12-compounds from edible 
algae. J Nutr Sci Vitaminol (Tokyo) 48:325-31. 
25. Zagalak, B., and J. Pawelkiewicz. 1965. Synthesis and properties of Co-adenine 
nucleoside analogues of coenzyme B12. Acta Biochim Pol 12:219-28. 
CHAPTER 2 
 
 56 
 
 
CHAPTER 3 
THE COMPLETE COENZYME B12 BIOSYNTHESIS GENE CLUSTER 
OF LACTOBACILLUS REUTERI 
 
 
 
 
 
 
Abstract 
The coenzyme B12 production pathway in Lactobacillus reuteri has been deduced 
using a combination of genetic, biochemical and bioinformatics approaches. The coenzyme 
B12 gene cluster of L. reuteri CRL1098 has the unique feature of clustering together the cbi, 
cob and hem genes. It consists of 29 open reading frames encoding the complete enzymatic 
machinery necessary for de novo biosynthesis. Transcriptional analysis showed it to be 
expressed as two tandem transcripts of approximately 22 and 4 kb, carrying cobD, 
cbiABCDETFGHJ, cobA/hemD, cbiKLMNQOP, sirA, hemACBL, and cobUSC, hemD, 
cobT, respectively. Both transcripts appear to be similarly regulated, and under the 
conditions assayed, are induced in the late-exponential growth phase. Evidence for a 
regulatory mechanism of negative feedback inhibition by vitamin B12 itself was observed. 
Comparative genomics analysis of the coding sequences showed them to be most similar to 
those coding for the anaerobic coenzyme B12 pathways previously characterised in a few 
representatives of the genera Listeria and Salmonella. This contrasts with the trusted 
species phylogeny and suggests horizontal gene transfer of the B12 biosynthesis genes. G+C 
content and codon adaptation index analysis is suggestive that the postulated transfer of 
these genes was not a recent event. Additional comparative genomics and transcriptional 
analysis of the sequences acquired during this study suggests a functional link between 
coenzyme B12 biosynthesis and reuterin production, which might be implicated in L. 
reuteri’s success colonizing the gastrointestinal tract. This information on gene 
organisation, gene transcription and gene acquisition is relevant for the development of 
(fermented) foods and probiotics enriched in vitamin B12. 
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Introduction 
Lactobacillus reuteri is a Gram-positive, heterofermentative, lactic acid bacterium, 
widely spread throughout the gastrointestinal tract (GI tract) of humans and other animals 
(46). Although presently marketed as a probiotic, human intervention studies showing 
relevant benefits remain to be reported (32). Nonetheless, potential probiotic effects have 
been demonstrated and include lowering blood cholesterol levels in mice (40), and 
stimulating anti-inflammatory activity in human cell lines (19). 
L. reuteri possesses the unique ability of producing and excreting reuterin (38). 
This broad spectrum antimicrobial compound is a mixture of monomeric, hydrated 
monomeric and cyclic dimeric forms of 3-hydroxypropionaldehyde (3-HPA) (39). The 
synthesis of reuterin is mediated by glycerol dehydratase (EC 4.2.1.30), a B12-dependent 
enzyme, which is involved in catalysing the conversion of glycerol to 3-HPA (12). 
We have reported the isolation of a compound from L. reuteri CRL1098, capable 
of fulfilling the auxotrophic vitamin B12 requirements of three different indicator strains 
(41). In the same study, L. reuteri genomic DNA was found to contain sequences 
homologous to genes involved in the anaerobic coenzyme B12 biosynthesis pathway, 
including, cysG/hemD from Selemonas ruminantium (4), Listeria innocua and Listeria 
monocytogenes (15), and cbiK and cbiJ from Salmonella typhimurium (25). 
Vitamin B12 consists of a tetrapyrrolic-derived corrin ring with a cobalt ion 
chelated at the core. Along with chlorophyll, coenzyme F430 and heme, amongst others, it 
constitutes one of the most structurally complex classes of cofactors. Various B12 
derivatives with different upper axial ligands act as essential cofactors in many important 
enzymatic reactions responsible for the catalysis of methyl transfers and carbon backbone 
rearrangements (20). Coenzyme B12 biosynthesis is limited to a few representatives of 
bacteria and archaea (22). It appears that B12-dependent enzymes are absent from plants and 
fungi, but widely spread in prokaryotes, protists and animals (11, 27).  
In humans, vitamin B12 deficiency has been demonstrated to lead to pernicious 
anemia, and neurological dysfunction, amongst other complications (35). Three proteins are 
known to participate in the uptake and transport of vitamin B12, namely haptocorrin, 
intrinsic factor and transcobalamin II. Absorption of vitamin B12 occurs by receptor-
mediated endocytosis in the terminal ileum, where the specific receptor cubulin complexes 
with intrinsic factor bound to B12 (6). As a consequence, B12 produced by colonic bacteria 
is most likely inaccessible to the host. However, it has been suggested that B12 produced by 
a microorganism capable of colonising proximal to the ileum, such as L. reuteri, would 
potentially be host-accessible (2). 
L. reuteri was the first lactic acid bacterium reported to possess the capability of 
producing B12  (41). Increasing our understanding on how this GRAS (Generally Regarded 
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as Safe) organism encodes, acquired and maintains a biosynthetic pathway of such 
complexity and magnitude is of great importance to the medical field and for the food and 
feed industries. 
In this study, we extend the analysis of the presumed coenzyme B12 biosynthesis 
gene cluster of L. reuteri and describe the presence of a complete gene cluster encoding all 
the enzymatic machinery necessary for the de novo synthesis of this important cofactor. 
Additional comparative genomics and transcriptional analysis of the new sequences 
acquired during this study suggests a functional link between coenzyme B12 biosynthesis 
and reuterin production, which might be implicated in L. reuteri’s success colonizing the GI 
tract. 
 
Materials and Methods 
Strains, media and culture conditions. L. reuteri CRL1098, isolated from 
sourdough, was obtained from the CERELA stock culture collection. It was cultivated at 
37ºC in MRS medium and in vitamin B12 assay medium (Sigma, Zwijndrecht, Netherlands) 
supplemented when mentioned with 1 mg/L of cyanocobalamin (Sigma-Aldrich, 
Zwijndrecht, Netherlands). The Escherichia coli strain XL-1 Blue MRA (P2) was obtained 
from Stratagene (La Jolla, USA) and cultivated at 37ºC under aerobic conditions in TY 
medium. Salmonella enterica serovar Typhimurium LT2 derivative strains TT25720 
(metE2119::MudJ), and TT25722 [metE2119::MudJ, cobS2621::Frt(sw)] (5) were kindly 
provided by Prof. John R. Roth, and cultivated at 37ºC in TY, or in minimal E medium 
(21), supplemented with 100 nM cyanocobalamin when required. 
Nucleotide sequence analysis. Sequence of the B12 biosynthesis gene cluster of L. 
reuteri was carried out by screening two genomic ?-phage libraries, and finalized by both 
inverted PCR and genomic primer walking. Total genomic DNA was isolated from L. 
reuteri according to standard molecular biology techniques (31). 
A Southern blot analysis of a partial digestion of L. reuteri’s chromosomal DNA 
with the restriction enzymes BamHI and BglII, using a cysG/hemD (41) probe amplified 
from the same strain, showed that the signals obtained correspond to DNA fragments larger 
than 15 kb for both restriction enzymes (data not shown). Based on this knowledge, two L. 
reuteri genomic ?-phage libraries were constructed by the separate ligation of BglII and 
BamHI digested L. reuteri genomic DNA into Lambda-DASH II/BamHI vector and 
packaged with a Gigapack III Gold packaging extract (Stratagene, La Jolla, USA) 
according to the manufacturers recommendations. For the amplification of the Lambda-
DASH II/BamHI libraries a lysogenic P2 strain, E.coli XL-1 Blue MRA (P2) was used. 
Titer determination of bacteriophages, blotting of plaques on nylon membranes, and ?-
DNA isolation were all performed according to the manufacturer’s recommendations. 
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Probes purified through the JETPURE PCR Product Purification Kit (GENOMED, Bad 
Oeynhausen, Germany), were amplified, radioactively labelled with ?32P-ATP (GE 
Healthcare Europe Gmbh, Belgium), and hybridized on membranes according to standard 
procedures (31). Membranes were exposed to BioMax MS or BioMax MR X-ray film 
manufactured by Kodak for at least 5 hours at -80ºC before developing. Sequencing of two 
~15 kb non-overlapping inserts containing B12-related DNA was carried out at Greenomics 
(Wageningen, The Netherlands).  
For gap-closure between the two inserts, we resorted to inverted PCR. According 
to procedures previously described (31), HindIII digested genomic DNA of L. reuteri was 
ligated to pNZ8048 (37) digested with the same endonuclease. The ligation mixture was 
directly used as a template on a PCR reaction using a primer designed on the vector and 
another based on the 5’ flanking region of the known sequence at the time. The resulting 
amplicon was isolated from an agarose gel and sequenced directly at Baseclear, The 
Netherlands. 
Further sequencing efforts aimed at closing gaps and extending the flanking regions of the 
known sequence was done through genomic primer walking carried out at GATC Biotech, 
Germany. 
The new sequence information obtained using the three different approaches 
described above, was analyzed and assembled resorting to in-house scripts, and online 
programs available from the Biology WorkBench of the San Diego Supercomputer Centre 
(http://workbench.sdsc.edu/). Standard RNA regulatory motif searches were performed in 
Rfam (16) and using Riboswitch finder (8).  Predicted open reading frames were manually 
annotated based on homology searches using the Blast algorithm (3). Finally, all sequence 
information was deposited at GenBank database under accession n. º AY780645. 
Complementation studies. A fragment containing cobS was amplified from L. 
reuteri’s genomic DNA using Herculase II DNA polymerase (Stratagene, La Jolla, USA), 
and primers LREf28196_28215 and LREr29724_29704 (Table 3.1). Additionally, a 
fragment containing the native cob operon promoter (23) was amplified from Salmonella 
enterica strain TT25720 using primers 5’-GACACCATTGTGGATGAGGTGGAG-3’ and 
5’-GATGATCGATCATACCGGCTCCTGATGT-3’ (ClaI cleavage site underlined). 3’-A 
overhangs were added to both fragments by incubating the PCR reactions directly with 1 
unit of Taq DNA polymerase for 3 min at 72ºC. The A-tailed fragments were then purified 
with the JETPURE PCR Product Purification Kit (GENOMED, Bad Oeynhausen, 
Germany) and digested with ClaI. The modified fragments were again purified with the 
same method and simultaneously cloned in pGEM-T Easy Vector (Promega Benelux BV, 
Leiden, The Netherlands), resulting in pNZ7749. The Salmonella enterica strain TT25722 
CHAPTER 3 
 
 62 
was transformed with this vector as previously described (31), and its phenotype was 
characterized in minimal E medium (21). 
 
Table 3.1. Oligonucleotide primers used in RT-PCR reactions 
Primer Nucleotide sequence (5’ – 3’) Strand* Location 
LREf5899_5921 GCACCGTCGCAACAATATCCCAC + IS 
LREf6317_6340 CGTTTTCTTTGATTTTAGTAGGTG + cobD 
LREr7366_7343 CTGCCACTCGATAGTATTGTCGGC - cobD 
LREf7343_7366 GCCGACAATACTATCGAGTGGCAG + cobD 
LREr8862_8843 CACGAATGAGGGTCACCAAG - cbiB 
LREf8843_8862 CTTGGTGACCCTCATTCGTG + cbiB 
LREr10437_10416 GGTGTGACGGCCATACTCATCA - cbiC and cbiD 
LREf10416_10437 TGATGAGTATGGCCGTCACACC + cbiC and cbiD 
LREr11947_11927 GTTCGCCCATGACTACTTGTC - cbiE 
LREf11927_11947 GACAAGTAGTCATGGGCGAAC + cbiE 
LREr13430_13411 CACCTAAGAACTTACCAACC - cbiF 
LREf13411_13430 GGTTGGTAAGTTCTTAGGTG + cbiF 
LREr14920_14900 GAGCAGCAGCTGCAATACTTG - cbiH 
LREf14900_14920 CAAGTATTGCAGCTGCTGCTC + cbiH 
LREr16411_16391 CTAGCCCAGCAATTGCACTAG - cysG/hemD 
LREf16391_16411 CTAGTGCAATTGCTGGGCTAG + cysG/hemD 
LREr17886_17864 GTAAAAGCACTATGCGCTGTTCC - cbiK 
LREf17864_17886 GGAACAGCGCATAGTGCTTTTAC + cbiK 
LREr19409_19388 CGACTAACTTTCATTGCTCGAC - cbiM 
LREf19388_19409 GTCGAGCAATGAAAGTTAGTCG + cbiM 
LREr20906_20887 CGCCGTAAATTTCGAAGTCC - cbiO 
LREf20887_20906 GGACTTCGAAATTTACGGCG + cbiO 
LREr22471_22451 GCTACTAAATCTGCGTTCGTG - cbiP 
LREf22451_22471 CACGAACGCAGATTTAGTAGC + cbiP 
LREr24150_24130 CCTTGCTAAAGCCCATATTGC - hemA 
LREf24130_24150 GCAATATGGGCTTTAGCAAGG + hemA 
LREr25669_25648 CCTTAGCCAATAACTGATCAGC - hemC 
LREf25648_25669 GCTGATCAGTTATTGGCTAAGG + hemC 
LREr26711_26683 GGTGGGTTTGTTTTGAGTAAATTAGATAC - 
intergenic 
region 
LREf26684_26718 GTGGGTTTGTTTTGAGTAAATTAGATACAACAAAG + 
intergenic 
region 
LREr27526_27499 CTGGGAGTCCACCACCGATTACTTTGCC - hemL 
LREf27499_27518 GGCAAAGTAATCGGTGGTGG + hemL 
LREr27987_27967 CTTGGTTGCCGCATTAAATGC - hemL 
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Primer Nucleotide sequence (5’ – 3’) Strand* Location 
LREr28269_28250† GTTCATCGACGTGCTGATAC - cobU 
LREf28250_28269 GTATCAGCACGTCGATGAAC + cobU 
LREr29724_29704‡ GGTATAGGTTAATGGAGCTGC - cobC 
LREf29704_29724 GCAGCTCCATTAACCTATACC + cobC 
LREr31148_31129 CTGCTATCGACATTGCTGGT - cobT 
LREf31129_31148 ACCAGCAATGTCGATAGCAG + cobT 
LREr31756_31737 GAAGTCCATCTCCTGCAATG - cobT 
LREr32212_32193 CCTTGTGGCAACAGTCTTCT - hypothetical 
LREf32193_32212 AGAAGACTGTTGCCACAAGG + hypothetical 
LREf33354_33373 GGAATTCGCAACTCACGAAG + rpsO 
LREr33545_33526 GCAGGTAAATCAGTCCGACG - rpsO 
LREr33809_33790 TCGCGTACACCACCAAAAGG - 
metallo 
lactamase 
LREf33790_33809 CCTTTTGGTGGTGTACGCGA + 
metallo 
lactamase 
LREr35516_35496 CCACGACCACGATGATGTTCT - 
metallo 
lactamase 
LREf35496_35516 AGAACATCATCGTGGTCGTGG + 
metallo 
lactamase 
LREr36538_36518 CGCAATCAAAGCAGTTGAACG - hypothetical 
* Primer were designed to the coding strand (+) or non-coding strand (-) 
† Primer also used in Q-RT-PCR experiment 
‡ Primer also used in complementation studies 
 
Transcriptional analysis. The transcriptional organization of the vitamin B12 gene 
cluster of L. reuteri was determined by Northern blots, reverse transcriptase PCR (RT-
PCR) and quantitative reverse transcriptase PCR (Q-RT-PCR). Cells were cultured in batch 
fermentations of MRS medium, vitamin B12 assay medium (commercial rich broth lacking 
B12) and vitamin B12 assay medium supplemented with vitamin B12 to a final concentration 
of 1 mg/L. RNA was isolated according to standard procedures (31) from samples collected 
at different time points, namely, mid-log, late-log and stationary phases. The integrity and 
concentration of the RNA was analysed with a 2100 Bioanalyzer manufactured by Agilent 
Technologies (Amstelveen, The Netherlands). Northern blotting of RNA obtained from 
late-log cells cultivated in MRS was performed as previously described (17, 29). Probes 
were amplified from genomic DNA of L. reuteri by PCR using primer pairs designed to 
locate them throughout the cluster, namely on cbiC, cbiP, and cobT. Subsequent 
hybridization with radiolabelled probes was carried out according to standard molecular 
biology techniques described earlier (31). RT-PCR analysis of samples obtained from cells 
cultured in MRS was performed by systematically amplifying overlapping fragments 
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throughout the full extension of the B12 biosynthesis cluster and flanking regions. All RNA 
samples were diluted to the same concentration and an extra DNAse I (Invitrogen, Breda, 
The Netherlands) treatment was implemented to eliminate possible remaining chromosomal 
DNA contamination. First strand cDNA synthesis was carried out using Superscript III 
reverse transcriptase from Invitrogen according to the manufacture’s recommendations. 
Primers were manually designed and are listed on Table 3.1. To quantify the differential 
expression of the two operons within the B12 biosynthesis gene cluster between late- and 
mid-log phases and in the presence or absence of B12, we performed Q-RT-PCR. 
Amplification was carried out in 96-well plates in an ABI Prism 7700 from Applied 
Biosystems using the fluorescent agent SYBR Green for detection. Reactions were set up 
using the SYBR Green Master Mix from the same manufacturer following its 
recommendations. Specificity and product detection were checked after amplification by 
determining the temperature dependent melting curves. Primers were designed with the 
Primer Express software package (Applied Biosystems, The Netherlands) to have a Tm 
between 59 and 61ºC and an amplicon size of 100 ± 20 bp (Table 3.2.). Comparisons were 
established between the different growth phases and the different culture media. 
 
Table 3.2. Oligonucleotide primers used in Q-RT-PCR reactions 
Primer Nucleotide sequence (5’ – 3’) Strand* Location 
LREf65_84 CAATAACGCCAAGTGAAGCC + pduU 
LREr211_192 CCACATGACGCAAAGCTGAT - pduU 
LREf2543_2562 ATTCAATGTCGGCAGGGTCT + pduV 
LREr2628_2609 GGCTGGCTTCTGTTCAATGT - pduV 
LREf7315_7334 CGCCAATGTGATGATTACGC + cobD 
LREr7431_7412 CAGCTCACGTCGTAACACTT - cobD 
LREf8403_8422 GCAGAGTGTGGTGGCTTAAT + cbiA 
LREr8505_8486 GCGGTGTCATCTCACTCATA - cbiA 
LREf9418_9437 TCCAGCACGAATCACATGGT + cbiB 
LREr9561_9542 CCTGCAACAACAGCTTCACT - cbiB 
LREf22014_22033 GCTGATGCACCAGTAATCCT + cbiP 
LREr22119_22100 TAATGCGTTGCTGGTCTTCG - cbiP 
LREf26313_26332 CGTGATGCTGCTGATGGTTC + hemB 
LREr26410_26391 GCTACTTCGCGCAATGCTTC - hemB 
LREf27503_27522 AAGTAATCGGTGGTGGACTC + hemL 
LREr27605_27586 GACAACGTTCCGGCATGATA - hemL 
LREf28196_28215† TCGAATTCAGCGTCACCAAG + cobU 
LREf31622_31641 GCTCTCGGTCTTGATCCTTA + cobT 
LREr31723_31704 GAGCATTGCCTTCACTCCAT - cobT 
LREf33369_33388 CGAAGGAGACACTGGTTCTA + rpsO 
LREr33511_33492 AGTTACGACGGTGACCAATC - rpsO 
* Primer were designed to the coding strand (+) or noncoding strand (-) 
† Primer also used in complementation studies 
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Phylogenetic analysis. Each individual B12-related amino acid sequence reported 
in this study was entered as a string to search for distantly related homologues using the 
PSI-BLAST algorithm (3). Sequence entries found homologues were retrieved in 03/07 
from ERGO (http://ergo.integratedgenomics.com/ERGO/) (24), and separately aligned 
using the MUSCLE algorithm (14). From the alignment of the proteins encoded by the 
coenzyme B12 biosynthesis cluster, a neighbour joining tree was obtained using ClustalW 
(42), analyzed in LOFT (43), and visualized in MEGA3 (18). An identical exercise was 
carried out for the predicted product of the rpsO gene that is located downstream of the 
vitamin B12 gene cluster of L. reuteri, and for the 16S RNA gene. Finally, the topology of 
all trees was compared. 
G+C content and codon adaptation index. G+C content and codon adaptation 
index (33) was calculated using the geecee, cusp and cai scripts, part of EMBOSS: 
European Molecular Biology Open Software Suite (26). Comparisons were established 
between the coenzyme B12 biosynthesis gene cluster of L. reuteri presented here and the 
draft genome sequence of L. reuteri JCM1112 obtained by the DOE Joint Genome Institute 
and deposited at GeneBank under accession n.° CP000705. A similar exercise was 
performed for Listeria innocua Clip11262 (15) and Salmonella enterica typhi Ty2 (13), for 
which we compared the G+C content and codon usage of their vitamin B12 clusters to their 
published genomes.  
 
Results 
Operon organization.  A sequence of approximately 43.4 kb was assembled from 
the L. reuteri genome through the combined effort of the different molecular biology 
techniques, and was found to harbour a coenzyme B12 gene cluster encoding the complete 
enzymatic machinery necessary for its biosynthesis. An overview of the organization of this 
gene cluster (Fig. 3.1) reveals that all predicted genes are in the same orientation with only 
few intergenic regions. Similar to what has been reported for Salmonella typhimurium (30), 
we observed that approximately  half of the genes (46%) are overlapping and predicted to 
be translationally coupled. 
The previously published sequence encoding the fusion protein homologous to 
CysG/HemD (41), is flanked by the large cluster of 17 cbi genes (Fig. 3.1). The cbi gene 
order is conserved amongst different B12 producers, notably representatives of Listeria and 
Salmonella (see Fig. 3.1). Quite unexpectedly, the hem genes are located directly 
downstream of the cbi genes. To our knowledge this genomic organisation has not yet been 
described. These genes are predicted to encode uroporphyrinogen III synthesis from 5-
aminolevulinate, a derivative of glutamyl-tRNA. A cluster of five cob genes is located 
further downstream. 
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This cluster is predicted to be involved in the attachment of the amino-propanol arm and 
assembly of the nucleotide loop, which connects the lower cobalt ligand to the corrin ring. 
Upstream of the B12 biosynthesis gene cluster are several genes predicted to be involved in 
the formation of polyhedral bodies, namely pduU and pduV (10). 
The detailed comparison of the predicted coding sequences of L. reuteri CRL1098 
and the draft genome sequence of L. reuteri JCM1112, recently released by the DOE Joint 
Genome Institute, demonstrates that they are mostly identical (Table 3.3). The few 
exceptions are due to minor changes in the N-terminus (CbiA and CbiB), or in the C-
terminus (CbiD and CobD), or finally, due to the neutral replacement of residues with the 
same chemical properties (CbiC and CobU). 
 
Table 3.3. ORFs of the coenzyme B12 biosynthesis gene cluster of Lactobacillus reuteri 
CRL1098: Comparison on amino acid level to Lactobacillus reuteri JCM1112, Listeria 
monocytogenes and Salmonella typhimurium. See legend of Fig. 3.1 for functional 
annotation of the genes. 
L. reuteri 
CRL1098 
L. reuteri 
JCM1112 
Listeria 
monocytogenes 
Salmonella 
typhimurium 
Name Length Length Identity Length Identity Length Identity 
cobD 369 362 99 361 41 364 34 
cbiA 454 454 99 452 48 459 44 
cbiB 319 319 99 315 52 319 44 
cbiC 227 227 99 210 56 210 55 
cbiD 349 383 97 373 51 379 46 
cbiE 200 200 100 198 51 201 38 
cbiT 184 184 100 189 49 192 42 
cbiF 253 253 100 249 72 257 65 
cbiG 351 351 100 343 41 351 32 
cbiH 241 241 100 241 61 241 58 
cbiJ 252 252 100 250 39 263 29 
cysG/hemD 464 464 100 493 38 457 46 
cbiK 259 259 100 261 46 264 45 
cbiL 237 237 100 236 46 237 34 
cbiM 248 248 100 244 61 245 54 
cbiN 110 103 100 98 58 93 53 
cbiQ 225 225 100 225 37 225 34 
cbiO 267 267 100 268 49 271 48 
cbiP 501 501 100 511 56 506 52 
sirA 152 152 100 159 37 311 37 
hemA 421 421 100 435 40 418 25 
hemC 305 305 100 309 48 318 39 
hemB 323 323 100 324 64 324 53 
hemL 412 431 100 429 58 426 52 
cobU 186 196 94 185 40 181 39 
cobS 253 253 100 248 36 247 32 
cobC 196 271 100 191 32 202 28 
hemD 236 236 100 493 26 246 23 
cobT 356 350 100 - - 356 41 
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 Complementation studies. To experimentally support our functional annotation of 
the newly sequenced coenzyme B12 biosynthesis gene cluster of L. reuteri, we performed 
complementation studies in Salmonella enterica mutants TT25720 (metE2119::MudJ) and 
TT25722 [metE2119::MudJ, cobS2621::Frt(sw)] (5). When cultured in minimal medium 
lacking methionine, both strains are dependent on the B12-dependent methionine synthase 
(MetH), since they lack MetE activity. However, due to the additional cobS mutation, strain 
TT25722 has auxotrophic requirements for B12, while strain TT25720 can rely on its own 
native production of this co-factor. 
We transformed the double mutant TT25722 with pNZ7749, harbouring a 
fragment containing cobS amplified from L. reuteri under control of the native cob operon 
promoter from Salmonella enterica (23). Growth experiments were then performed in 
minimal E plates using strains TT25720 and TT25722 as a positive and negative control, 
respectively. When we complement the double mutant with cobS from L. reuteri, we 
reconstitute its ability to grow in minimal medium lacking methionine without the 
exogenous supplementation of vitamin B12, and therefore, relying solely on its own native 
coenzyme B12 production (Fig. 3.2).  
 
 
 
Figure 3.2. Phenotypic characterization of complemented Salmonella mutant. Minimal E 
agarose plate with (1) Salmonella enterica TT25720 (metE2119::MudJ); (2) Salmonella 
enterica TT25722 [metE2119::MudJ, cobS2621::Frt(sw)]; (3) Salmonella enterica 
TT25722 pNZ7749 (harbouring cobS from L. reuteri); (4) empty  
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Transcription analysis. In order to determine the transcriptional organization of the 
B12 biosynthesis gene cluster we performed Northern blot analysis included in the online 
version of this paper. As a consequence of the relative rarity of the transcripts encoding B12 
biosynthesis enzymes and their remarkably large size, we could predict that technical 
difficulties with the Northern blots would not allow conclusive determination of the exact 
size of the different operons within this gene cluster. Nonetheless, probes were designed to 
be complementary to sequences from the beginning and end of the predicted operons and 
their use in Northern hybridizations revealed the presence of two transcripts, one with a size 
over 20 kb and another of 4 kb (see Supplementary Materials, Fig. S1.). 
To further characterise the transcriptional organization of this gene cluster, a RT-
PCR based strategy was implemented. It consisted of systematically amplifying 
overlapping RT-PCR fragments all throughout the full extension of the cluster and flanking 
regions. To validate the specificity of the designed primer pairs, all reactions were tested in 
parallel using chromosomal DNA of L. reuteri as a positive control. The absence of any 
chromosomal DNA contamination was established by carrying out all reactions using RT 
negative samples as a template, for a negative control. The results from the RT-PCR 
experiments (Table 3.4 and Fig. 3.3), confirmed that the B12 biosynthesis gene cluster is 
expressed in two separate, but tandem, operons approximately sized 22 and 4 kb. The large 
transcript includes the genes cobD, cbiABCDETFGHJ, cobA/hemD, cbiKLMNQOP, sirA 
and hemACBL. The 4 kb transcript derives from the cobUSC, hemD and cobT genes. 
 
Table 3.4. Summary of RT-PCR reactions 
Primer pair 
Product* 
mid log   late log 
Size 
(bp) 
Location 
LREf5899_5921 LREr7366_7343 - - 1467 IS, cobD 
LREf6317_6340 LREr7366_7343 + +++ 1049 cobD 
LREf7343_7366 LREr8862_8843 + +++ 1519 cobD, cbiAB 
LREf8843_8862 LREr10437_10416 + +++ 1594 cbiBCD 
LREf10416_10437 LREr11947_11927 + +++ 1531 cbiDE 
LREf11927_11947 LREr13430_13411 + +++ 1503 cbiETF 
LREf13411_13430 LREr14920_14900 + +++ 1509 cbiFGH 
LREf14900_14920 LREr16411_16391 + +++ 1511 cbiHJ, cysG/hemD 
LREf16391_16411 LREr17886_17864 + +++ 1495 cysG/hemD, cbiK 
LREf17864_17886 LREr19409_19388 + +++ 1545 cbiKLM 
LREf19388_19409 LREr20906_20887 + +++ 1518 cbiMNQO 
LREf20887_20906 LREr22471_22451 + +++ 1584 cbiOP 
LREf22451_22471 LREr24150_24130 + +++ 1699 cbiP, sirA, hemA 
LREf24130_24150 LREr25669_25648 + +++ 1539 hemAC 
LREf25648_25669 LREr26711_26683 + +++ 1063 hemCB 
LREf26684_26718 LREr27526_27499 + +++ 842 hemBL 
LREf27499_27518 LREr27987_27967 + +++ 488 hemL 
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Primer pair 
Product* 
mid log   late log 
Size 
(bp) 
Location 
LREf27499_27518 LREr28269_28250 - - 770 hemL, cobU 
LREf28250_28269 LREr29724_29704 + +++ 1474 cobUSC 
LREf29704_29724 LREr31148_31129 + +++ 1444 cobC, hemD, cobT 
LREf31129_31148 LREr31756_31737 + +++ 627 cobT 
LREf31129_31148 LREr32212_32193 - - 1083 cobT, hypothetical 
LREf32193_32212 LREr33545_33526 - - 1352 Hypothetical 
LREf33354_33373 LREr33545_33526 ++ ++ 191 rpsO 
LREf33354_33373 LREr33809_33790 - - 455 rpsO, metalo ?-lactamase 
LREf33790_33809 LREr35516_35496 ++ ++ 1726 metalo ?-lactamase 
LREf35496_35516 LREr36538_36518 - - 1042 
metalo ?-lactamase, 
hypothetical 
* Symbols refer to relative abundance of products on agarose gel. Increasing number of “+” 
corresponds to increasing intensity of band (see Fig. 3.3 for illustration); “-” corresponds to 
absence of expected band, indicating that both genes are not part of the same transcript. 
 
The intensities of the RT-PCR amplicons were compared between samples 
collected from the same MRS culture at different time points (see Fig. 3.3 for illustration). 
This suggested that for cells cultured in MRS the expression of the B12 gene cluster is 
strengthened during late-exponential phase in comparison to mid-log phase. The rpsO gene, 
located immediately downstream from the B12 gene cluster, served as a control for the 
transcriptional analysis. RT-PCR samples of this gene collected from the same culture at 
different time points showed that it is expressed constitutively throughout the growth curve, 
in contrast to the neighbouring B12 genes. 
 
 
Figure 3.3. RT-PCR amplicons from different loci collected at different time points. Lane 
A, RT negative samples (negative control); Lane B, sample collected at mid-log phase; 
Lane C, sample collected at late-log phase; Lane D, L. reuteri’s chromosomal DNA 
(positive control). 
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To quantify the differential expression first evidenced by the RT-PCR 
experiments, quantitative RT-PCR (Q-RT-PCR) was carried out on different loci 
throughout the entire cluster, using a locus on the rpsO gene as a reference. The results are 
in accordance with the previous RT-PCR based observation, and confirm that for cells 
cultivated in MRS the cluster is indeed strongly induced during late-exponential growth 
(Fig. 3.4.A.). The operon carrying the cbi and hem genes is up-regulated 4.56 ± 0.92 fold 
during late-exponential growth when compared to mid-log phase. Similarly, the smaller 
operon carrying the cob and hemD genes is up-regulated by a factor of 5.03 ± 0.32, between 
late- and mid-log phases. The same approach was performed on two loci upstream of the 
B12 biosynthesis gene cluster predicted to encode PduU and PduV. We observed an average 
up-regulation of 5.91 ± 3.25 for these transcripts, similar to the one observed for the B12 
gene cluster (Fig. 3.4.B.). 
In order to confirm that the observed up-regulation of the B12 biosynthetic genes 
during late-log is not caused by the exhaustion of the vitamin B12 present in MRS, further 
experimentation was carried out. We analysed by Q-RT-PCR samples obtained from cells 
grown in B12 assay medium, which is B12 free, and in B12 assay medium supplemented with 
cyanocobalamin (Fig. 3.4.B.). In the absence of B12 we observed that during late-log phase 
the cbi and hem operon was up-regulated 6.89 ± 0.93, slightly more than what was 
observed for MRS. In the presence of an excess of exogenous B12 there was a 3.47 ± 0.90 
fold change between late- and mid-log growth phases for this same operon. Even though 
this up-regulation is diminished in comparison to the one in the absence of exogenous B12, 
it is still quite considerable. Similar results were observed for the cob operon, up-regulated 
6.35 ± 0.73 and 3.31 ± 0.56 in the absence and presence of exogenous B12, respectively. 
The up-regulation in MRS of the transcript levels of the pdu loci was also observed in the 
absence of B12 from the medium. For these we observed a fold-change of 3.76 ± 2.2 in the 
absence of exogenous B12 and 1.98 ± 0.68 when there was an excess of B12. 
To characterise in greater detail the specific impact of B12 supplementation for 
each growth phase, additional comparisons were established between the cultures lacking 
exogenous B12 and the ones with an excess of cyanocobalamin (Fig. 3.4.C.). During 
exponential phase, expression of the B12 biosynthesis genes does not vary significantly with 
the absence of exogenous vitamin B12 (average fold-change of 0.96 ± 0.08 for the cbi and 
hem operon, and 0.92 ± 0.08 for the cob operon). During late-log phase, even though in 
both conditions the abundance of B12 biosynthesis transcripts is increased relative to mid-
log, in the absence of vitamin B12 supplementation, their induction is stronger. For late-log, 
when we compared the levels for cells cultured in the absence of exogenous B12 in relation 
to the ones cultivated in its presence, we determined an average fold-change of 1.90 ± 0.22 
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Figure 3.4. Differential gene expression as determined by Q-RT-PCR. A. Differential 
expression of the coenzyme B12 biosynthesis genes in late-log relative to mid-log in cells 
cultivated in MRS. B. Average fold change between late-log and mid-log growth phases of 
pdu genes, cbi and hem operon and cob operon from L. reuteri cells cultured in MRS (grey 
bars), B12-free medium (white bars) and B12-free medium supplemented with 1 mg/ml 
cyanocobalamin (black bars). C. Differential expression of B12 biosynthesis genes between 
cells cultivated in B12-free medium and in B12-free medium supplemented with 1 mg/ml 
cyanocobalamin during mid-log (white bars) and late-log (grey bars) growth phases. 
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for the cbi and hem operon, and 1.82 ± 0.08 for the cob operon.  
In silico analysis and comparative genomics. We determined the phylogeny of 
each predicted individual amino acid sequence encoded by the B12 gene cluster. We then 
compared them amongst each other, and with the deduced protein sequence of a control 
gene, rpsO, for which we performed the same exercise. The RpsO protein tree resembled 
the canonical phylogenetic topology deduced from 16S rRNA sequences (see 
Supplementary Material, Fig. S2.). In contrast, the predicted B12 proteins of L. reuteri were 
found to repeatedly cluster together with those of the genus Listeria, and closely 
neighboured by those of the genus Salmonella and other closely related ?-Proteobacteria. 
(see Fig. 3.5 for illustration). This is suggestive of a common origin for the coenzyme B12 
production pathway in these organisms. Variations to the mentioned tree topology were 
observed for sirA, hemACBL and cobT, and are addressed later in the discussion. 
Both the G+C content and codon adaptation index (33) of the B12 cluster were 
compared with the draft genome sequence of L. reuteri JCM1112. The average G+C 
content of the coenzyme B12 biosynthesis gene cluster (36%) does not differ significantly 
from the average of the draft genome sequence of L. reuteri available at the date of analysis 
(39%). Concerning codon usage, again we did not observe any significant differences 
between the coenzyme B12 gene cluster of L. reuteri and other L. reuteri sequences. The 
average codon adaptation index for the genes of this cluster was calculated to be 
0.69 ± 0.026, and we did not detect the usage of any rare codon. Additionally, we also 
compared the G+C content and codon usage of the B12 biosynthesis clusters of Listeria 
innocua Clip11262 (15), 39%, and Salmonella enterica typhi Ty2 (13), 56%, with their 
published genomes, 38% and 52% respectively. 
 
Discussion 
The biosynthesis of coenzyme B12 from uroporphyrinogen III, the last shared 
metabolic precursor of the various tetrapyrrolic cofactors, requires about 25 enzymes, and 
has two different routes described: (i) the aerobic pathway studied in Pseudomonas 
denitrificans (7); (ii) and the anaerobic pathway partially resolved in Salmonella enterica, 
Bacillus megaterium and Propionibacterium shermanii (28). This biosynthetic pathway is 
commonly divided in three parts: (i) the synthesis of uroporphyrinogen III from either 
glutamyl-tRNA or glycine and succinyl-CoA; (ii) the corrin ring synthesis, which differs 
between the anaerobic pathway starting with the insertion of cobalt into precorrin-2, and the 
aerobic pathway where the cobalt chelation reaction occurs only after corrin ring synthesis; 
(iii) and the corrin ring adenosylation, attachment of the amino-propanol arm and assembly 
of the nucleotide loop bridging the lower ligand to the cobalt at the core of the corrin ring. 
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Figure 3.5. Bootstrapped neighbour-joining phylogenetic tree of the CbiC protein. 
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In L. reuteri we have found all genes necessary to encode the complete anaerobic 
biosynthesis pathway of coenzyme B12. Remarkably, and unlike other B12-producing 
prokaryotes, all the three different parts of B12 biosynthesis are clustered together in one 
continuous stretch of the chromosome. This presents a great advantage if considering 
metabolic engineering strategies aiming at transferring B12 production capability, as has 
been done before for other complex B vitamins (36, 47). 
Based on the homology paradigm, our functional annotation of the newly 
sequenced coenzyme B12 biosynthesis gene cluster of L. reuteri, was experimentally 
verified for cobS by the complementation of Salmonella mutant TT25722 (5) lacking MetE 
and CobS activity. If cultured in minimal medium lacking methionine, this strain relies on 
the B12-dependent methionine synthase (MetH), and has auxotrophic requirements for this 
co-factor. When we transformed TT25722 with pNZ7749, harbouring a fragment 
containing cobS amplified from L. reuteri, we reconstituted its ability to grow in minimal 
medium depending on its own native coenzyme B12 production, and indirectly showed the 
functionality of cobS from L. reuteri (Fig. 3.2). Another example of functional evidence can 
be found in the recent report of the crystal structure of the PduO-type ATP:Co(I)rrinoid 
adenosyltransferase (34) also sequenced within the course of this study. 
Northern blotting and RT-PCR have shown that both the cbi genes, responsible for 
corrin ring synthesis, and the hem genes, responsible for the synthesis of uroporphyrinogen-
III, are transcribed together as part of a nearly 22-kb multicistronic operon. Although 
remarkably large, similar sized transcripts have been detected in other lactic acid bacteria 
(44). The cob genes are clustered in the same orientation, but expressed in a different 
operon of approximately 4 kb, situated just downstream of the previously mentioned cbi 
and hem transcript (Fig. 3.1). 
The results from the Q-RT-PCR experiment, corrobated the hypothesis emergent 
from the RT-PCR studies, that the B12 biosynthesis gene cluster is strongly induced during 
late-exponential growth phase (Fig. 3.4A). Both operons are approximately five times up-
regulated in late-exponential growth when compared to mid-log, as determined by Q-RT-
PCR for cells cultured in MRS broth.  To ensure that the observed induction of the B12 
biosynthesis genes in late-log is not due to the depletion of B12 pools in MRS, we carried 
out additional experiments in B12 free medium. We compared the induction of these genes 
between late-log and mid-log, for cultures in the absence or presence of excessive 
exogenous B12. Although there was some variation in the levels of induction, it was clear 
that in all conditions assayed the B12 biosynthesis transcripts are more abundant in late-log 
in comparison with mid-log (Fig. 3.4.B.). 
The lower induction of the B12 biosynthesis genes during late-log in the medium 
supplemented with B12 (Fig. 3.4.C) suggests the presence of a regulatory feedback 
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mechanism, which inhibits the biosynthesis of this costly co-factor whenever it is available 
from the environment. Vitamin B12 metabolism has been shown to be often regulated by a 
conserved RNA structural element, known as riboswitch (45). We searched the coenzyme 
B12 biosynthesis gene cluster of L. reuteri for such conserved motifs using Rfam (16) and 
Riboswitch finder (8), but none could be found. The presence of a transposase immediately 
upstream of the first gene of the B12 cluster might have disturbed the riboswitch. The 
regulatory gene pocR (9), which is often in between the B12 biosynthesis and pdu clusters is 
not in such location in the chromosome of L. reuteri. In fact, this common regulator can be 
found at the far end of the adjacent pdu operon in the recently released genome of L. reuteri 
JCM1112. Its presence is in agreement with the experimental evidence gathered during this 
study suggesting co-regulation between the B12 cluster and the pdu genes located 
immediately upstream. PocR has been shown to be an activator of the coenzyme B12 
biosynthesis cluster (9), and is likely to be involved in the observed negative feedback 
phenomena. Furthermore, PocR itself has been shown to be activated under carbon and 
redox control (1), which explains why we observed in all conditions assayed an induction 
of the B12 biosynthesis cluster during late-log in comparison to mid-log.  
The topology of the phylogenetic tree obtained for the predicted product of the 
rpsO gene (data not shown), is similar to the canonical phylogenetic trees deduced from 
16S rRNA sequences (see Supplementary material, Fig. S2.). In contrast, the phylogenetic 
comparison of all predicted amino acid sequences related to B12 biosynthesis showed that L. 
reuteri systematically clusters together with members of the genus Listeria, and closely 
neighbours the genus Salmonella and closely related Enterobacteriaceae. An illustration of 
a B12 biosynthesis protein phylogenetic tree is here depicted for CbiC, which was found to 
follow this topological pattern (Fig. 3.5). Exceptions of this topology include the products 
of sirA and hemABCL, for which L. reuteri clusters with Listeria and related genera of 
Gram-positive bacteria, while the Enterobacteriaceae are now clustering with other 
?-Proteobacteria, likely because their hem genes are properly adapted to aerobic conditions 
as well. In addition the CobT protein is not encoded by the Listeria genomes, which may 
have suffered gene loss, while L. reuteri still clusters with Salmonella and closely related 
genera. 
L. reuteri was the first lactic acid bacterium reported to produce coenzyme B12, 
and the recently released genome sequences of a dozen lactic acid bacteria show no traces 
of genes related to B12 production. This observation, combined with the great differences in 
topology of the B12 related trees and the canonical phylogenetic tree, suggest the acquisition 
of this capability through the occurrence of horizontal gene transfer. This promiscuity 
related to B12 metabolism between some genera of the Firmicutes and ?-Proteobacteria has 
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been noted before when the phylogeny of the B12 regulatory motifs was being investigated 
(45).  
The G+C content of L. reuteri’s B12 biosynthesis gene cluster does not clearly 
differ from the rest of its available genomic sequences, and the average codon adaptation 
index of this cluster is elevated, indicating that it is well suited to L. reuteri’s translational 
machinery. The same holds true for the B12 homologues Listeria and Salmonella, indicating 
that the postulated horizontal gene transfer is not a recent event. 
Associated with its survival strategy, L. reuteri is capable of producing and excreting 
reuterin, a broad spectrum antimicrobial (38, 39). The production of this key component for 
its competitiveness is mediated by a B12-dependent enzyme, glycerol dehydratase, 
responsible for catalysing the conversion of glycerol to 3-HPA, an intermediate of 
1,3-propanediol on the glycerol catabolism pathway. The hypothesis that the acquisition of 
reuterin production and production of coenzyme B12 was a single event is supported by the 
following observations: (i) the genes involved in reuterin production are located just 
upstream of the B12 biosynthesis gene cluster; (ii) both sets of genes show similar 
phylogeny; and (iii) both sets of genes have similar expression patterns and seem to be part 
of the same regulon. This evolutionary event has presumably resulted in the speciation of L. 
reuteri from the other Lactobacillae species, and possibly, might have had a great 
importance in its evolution to colonize the GI tract. 
L. reuteri possesses the GRAS status and is an industrially relevant microrganism. 
From a biotechnological point of view, the findings reported in this study, can be applied 
for natural enrichment of (fermented) foods with B12. Furthermore, they shed light on L. 
reuteri as a good candidate to investigate the possibility of in situ delivery of vitamin B12 in 
the GI tract. 
 
CHAPTER 3 
 
 78 
References 
1. Ailion, M., T. A. Bobik, and J. R. Roth. 1993. Two global regulatory systems 
(Crp and Arc) control the cobalamin/propanediol regulon of Salmonella 
typhimurium. J Bacteriol 175:7200-8. 
2. Albert, M. J., V. I. Mathan, and S. J. Baker. 1980. Vitamin B12 synthesis by 
human small intestinal bacteria. Nature 283:781-2. 
3. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, 
and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of 
protein database search programs. Nucleic Acids Res 25:3389-402. 
4. Anderson, P. J., B. Entsch, and D. B. McKay. 2001. A gene, cobA + hemD, 
from Selenomonas ruminantium encodes a bifunctional enzyme involved in the 
synthesis of vitamin B12. Gene 281:63-70. 
5. Anderson, P. J., J. Lango, C. Carkeet, A. Britten, B. Krautler, B. Hammock, 
and J. R. Roth. 2007. One pathway incorporates two a-ligands (adenine or 
dimethylbenzimidazole) into B12 cofactors in Salmonella enterica. Manuscript in 
preparation. 
6. Banerjee, R. 2006. B12 trafficking in mammals: A for coenzyme escort service. 
ACS Chem Biol 1:149-59. 
7. Battersby, A. R. 1994. How nature builds the pigments of life: the conquest of 
vitamin B12. Science 264:1551-7. 
8. Bengert, P., and T. Dandekar. 2004. Riboswitch finder--a tool for identification 
of riboswitch RNAs. Nucleic Acids Res 32:W154-9. 
9. Bobik, T. A., M. Ailion, and J. R. Roth. 1992. A single regulatory gene 
integrates control of vitamin B12 synthesis and propanediol degradation. J 
Bacteriol 174:2253-66. 
10. Bobik, T. A., G. D. Havemann, R. J. Busch, D. S. Williams, and H. C. Aldrich. 
1999. The propanediol utilization (pdu) operon of Salmonella enterica serovar 
Typhimurium LT2 includes genes necessary for formation of polyhedral 
organelles involved in coenzyme B(12)-dependent 1, 2-propanediol degradation. J 
Bacteriol 181:5967-75. 
11. Croft, M. T., A. D. Lawrence, E. Raux-Deery, M. J. Warren, and A. G. Smith. 
2005. Algae acquire vitamin B12 through a symbiotic relationship with bacteria. 
Nature 438:90-3. 
12. Daniel, R., T. A. Bobik, and G. Gottschalk. 1998. Biochemistry of coenzyme 
B12-dependent glycerol and diol dehydratases and organization of the encoding 
genes. FEMS Microbiol Rev 22:553-66. 
13. Deng, W., S.-R. Liou, G. Plunkett III, G. F. Mayhew, D. J. Rose, V. Burland, 
V. Kodoyianni, D. C. Schwartz, and F. R. Blattner. 2003. Comparative 
Genomics of Salmonella enterica Serovar Typhi Strains Ty2 and CT18. J. 
Bacteriol. 185:2330-2337. 
THE COMPLETE COENZYME B12 BIOSYNTHESIS GENE CLUSTER OF 
LACTOBACILLUS REUTERI 
 79 
14. Edgar, R. C. 2004. MUSCLE: a multiple sequence alignment method with 
reduced time and space complexity. BMC Bioinformatics 5:113. 
15. Glaser, P., L. Frangeul, C. Buchrieser, C. Rusniok, A. Amend, F. Baquero, P. 
Berche, H. Bloecker, P. Brandt, T. Chakraborty, A. Charbit, F. Chetouani, E. 
Couve, A. de Daruvar, P. Dehoux, E. Domann, G. Dominguez-Bernal, E. 
Duchaud, L. Durant, O. Dussurget, K. D. Entian, H. Fsihi, F. Garcia-del 
Portillo, P. Garrido, L. Gautier, W. Goebel, N. Gomez-Lopez, T. Hain, J. 
Hauf, D. Jackson, L. M. Jones, U. Kaerst, J. Kreft, M. Kuhn, F. Kunst, G. 
Kurapkat, E. Madueno, A. Maitournam, J. M. Vicente, E. Ng, H. Nedjari, G. 
Nordsiek, S. Novella, B. de Pablos, J. C. Perez-Diaz, R. Purcell, B. Remmel, 
M. Rose, T. Schlueter, N. Simoes, A. Tierrez, J. A. Vazquez-Boland, H. Voss, 
J. Wehland, and P. Cossart. 2001. Comparative genomics of Listeria species. 
Science 294:849-52. 
16. Griffiths-Jones, S., A. Bateman, M. Marshall, A. Khanna, and S. R. Eddy. 
2003. Rfam: an RNA family database. Nucleic Acids Res 31:439-41. 
17. Kuipers, O. P., M. M. Beerthuyzen, R. J. Siezen, and W. M. De Vos. 1993. 
Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. 
Requirement of expression of the nisA and nisI genes for development of 
immunity. Eur J Biochem 216:281-91. 
18. Kumar, S., K. Tamura, and M. Nei. 2004. MEGA3: Integrated software for 
Molecular Evolutionary Genetics Analysis and sequence alignment. Brief 
Bioinform 5:150-63. 
19. Ma, D., P. Forsythe, and J. Bienenstock. 2004. Live Lactobacillus reuteri is 
essential for the inhibitory effect on tumor necrosis factor alpha-induced 
interleukin-8 expression. Infect Immun 72:5308-14. 
20. Maggio-Hall, L. A., and J. C. Escalante-Semerena. 1999. In vitro synthesis of 
the nucleotide loop of cobalamin by Salmonella typhimurium enzymes. Proc Natl 
Acad Sci U S A 96:11798-803. 
21. Maloy, S. R., V. L. Stewart, and R. K. Taylor. 1996. Genetic analysis of 
pathogenic bacteria: a laboratory manual. Cold Spring Harbor Laboratory Press, 
Plainview, N.Y. 
22. Martens, J. H., H. Barg, M. J. Warren, and D. Jahn. 2002. Microbial 
production of vitamin B12. Appl Microbiol Biotechnol 58:275-85. 
23. O'Toole, G. A., M. R. Rondon, and J. C. Escalante-Semerena. 1993. Analysis 
of mutants of Salmonella typhimurium defective in the synthesis of the nucleotide 
loop of cobalamin. J Bacteriol 175:3317-26. 
24. Overbeek, R., N. Larsen, T. Walunas, M. D'Souza, G. Pusch, E. Selkov, Jr., 
K. Liolios, V. Joukov, D. Kaznadzey, I. Anderson, A. Bhattacharyya, H. 
Burd, W. Gardner, P. Hanke, V. Kapatral, N. Mikhailova, O. Vasieva, A. 
Osterman, V. Vonstein, M. Fonstein, N. Ivanova, and N. Kyrpides. 2003. The 
ERGO genome analysis and discovery system. Nucleic Acids Res 31:164-71. 
CHAPTER 3 
 
 80 
25. Raux, E., A. Lanois, F. Levillayer, M. J. Warren, E. Brody, A. Rambach, and 
C. Thermes. 1996. Salmonella typhimurium cobalamin (vitamin B12) biosynthetic 
genes: functional studies in S. typhimurium and Escherichia coli. J Bacteriol 
178:753-67. 
26. Rice, P., I. Longden, and A. Bleasby. 2000. EMBOSS: the European Molecular 
Biology Open Software Suite. Trends Genet 16:276-7. 
27. Rodionov, D. A., A. G. Vitreschak, A. A. Mironov, and M. S. Gelfand. 2003. 
Comparative genomics of the vitamin B12 metabolism and regulation in 
prokaryotes. J Biol Chem 278:41148-59. 
28. Roessner, C. A., and A. I. Scott. 2006. Fine-tuning our knowledge of the 
anaerobic route to cobalamin (vitamin B12). J Bacteriol 188:7331-4. 
29. Roest, K., H. G. Heilig, H. Smidt, W. M. de Vos, A. J. Stams, and A. D. 
Akkermans. 2005. Community analysis of a full-scale anaerobic bioreactor 
treating paper mill wastewater. Syst Appl Microbiol 28:175-85. 
30. Roth, J. R., J. G. Lawrence, M. Rubenfield, S. Kieffer-Higgins, and G. M. 
Church. 1993. Characterization of the cobalamin (vitamin B12) biosynthetic genes 
of Salmonella typhimurium. J Bacteriol 175:3303-16. 
31. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 
3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 
32. Saxelin, M., S. Tynkkynen, T. Mattila-Sandholm, and W. M. de Vos. 2005. 
Probiotic and other functional microbes: from markets to mechanisms. Curr Opin 
Biotechnol 16:204-11. 
33. Sharp, P. M., and W. H. Li. 1987. The codon Adaptation Index--a measure of 
directional synonymous codon usage bias, and its potential applications. Nucleic 
Acids Res 15:1281-95. 
34. St Maurice, M., P. E. Mera, M. P. Taranto, F. Sesma, J. C. Escalante-
Semerena, and I. Rayment. 2007. Structural characterization of the active site of 
the PduO-type ATP:Co(I)rrinoid adenosyltransferase from Lactobacillus reuteri. J 
Biol Chem 282:2596-605. 
35. Stabler, S. P. 1999. B12 and Nutrition, p. 343-365. In R. Banerjee (ed.), Chemistry 
and Biochemistry of B12. John Wiley & sons, Inc. 
36. Sybesma, W., C. Burgess, M. Starrenburg, D. van Sinderen, and J. 
Hugenholtz. 2004. Multivitamin production in Lactococcus lactis using metabolic 
engineering. Metab Eng 6:109-15. 
37. Sybesma, W., M. Starrenburg, M. Kleerebezem, I. Mierau, W. M. de Vos, 
and J. Hugenholtz. 2003. Increased production of folate by metabolic engineering 
of Lactococcus lactis. Appl Environ Microbiol 69:3069-76. 
38. Talarico, T. L., I. A. Casas, T. C. Chung, and W. J. Dobrogosz. 1988. 
Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus 
reuteri. Antimicrob Agents Chemother 32:1854-8. 
THE COMPLETE COENZYME B12 BIOSYNTHESIS GENE CLUSTER OF 
LACTOBACILLUS REUTERI 
 81 
39. Talarico, T. L., and W. J. Dobrogosz. 1989. Chemical characterization of an 
antimicrobial substance produced by Lactobacillus reuteri. Antimicrob Agents 
Chemother 33:674-9. 
40. Taranto, M. P., M. Medici, G. Perdigon, A. P. Ruiz Holgado, and G. F. 
Valdez. 2000. Effect of Lactobacillus reuteri on the prevention of 
hypercholesterolemia in mice. J Dairy Sci 83:401-3. 
41. Taranto, M. P., J. L. Vera, J. Hugenholtz, G. F. De Valdez, and F. Sesma. 
2003. Lactobacillus reuteri CRL1098 produces cobalamin. J Bacteriol 185:5643-
7. 
42. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: 
improving the sensitivity of progressive multiple sequence alignment through 
sequence weighting, position-specific gap penalties and weight matrix choice. 
Nucleic Acids Res 22:4673-80. 
43. van der Heijden, R. T., B. Snel, V. van Noort, and M. A. Huynen. 2007. 
Orthology prediction at Scalable Resolution by Phylogenetic Tree analysis. BMC 
Bioinformatics 8:83. 
44. van Kranenburg, R., M. Kleerebezem, and W. M. de Vos. 2000. Nucleotide 
sequence analysis of the lactococcal EPS plasmid pNZ4000. Plasmid 43:130-6. 
45. Vitreschak, A. G., D. A. Rodionov, A. A. Mironov, and M. S. Gelfand. 2003. 
Regulation of the vitamin B12 metabolism and transport in bacteria by a conserved 
RNA structural element. Rna 9:1084-97. 
46. Walter, J., N. C. Heng, W. P. Hammes, D. M. Loach, G. W. Tannock, and C. 
Hertel. 2003. Identification of Lactobacillus reuteri genes specifically induced in 
the mouse gastrointestinal tract. Appl Environ Microbiol 69:2044-51. 
47. Wegkamp, A., M. Starrenburg, W. M. de Vos, J. Hugenholtz, and W. 
Sybesma. 2004. Transformation of folate-consuming Lactobacillus gasseri into a 
folate producer. Appl Environ Microbiol 70:3146-8. 
 
 
CHAPTER 3 
 
 82 
 
CHAPTER 4 
THE IMPACT OF GLYCEROL ON THE METABOLISM OF 
LACTOBACILLUS REUTERI STUDIED BY FUNCTIONAL GENOMICS 
AND GENOME-SCALE MODELING 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Lactobacillus reuteri is a heterofermentative lactic acid bacterium best known for 
its ability to co-ferment glucose and glycerol. Its genome sequence has recently been 
deduced enabling the implementation of genome-wide analysis. In this study, we developed 
a dedicated cDNA microarray platform, and a genome-scale metabolic network model of L. 
reuteri, and use them to revisit the co-fermentation of glucose and glycerol. The model was 
used to simulate experimental conditions and to visualize and integrate experimental data, 
in particular the global transcriptional response of L. reuteri to the presence of glycerol. We 
show how the presence of glycerol affects cell physiology and triggers specific regulatory 
mechanisms, allowing simultaneously a better yield and more efficient biomass formation. 
Furthermore, we were able to predict and demonstrate for this well-studied condition, the 
involvement of previously unsuspected metabolic pathways, for instance, related to amino 
acids and vitamins. These could be used as leads in future studies aiming at the increased 
production of industrially relevant compounds, such as vitamin B12 or 1,3-propanediol. 
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Introduction 
Lactobacillus reuteri is an heterofermentative, Gram-positive lactic acid bacterium 
ubiquitous in the gastrointestinal tract (GI-tract) of humans and other mammals (49).  In 
addition, L. reuteri is a predominant microbe in several food and feed fermentations, 
notably in sourdoughs of different cereals (21). L. reuteri is best known for its ability to co-
ferment glucose and glycerol. In the presence of the latter, it has the ability of producing 
and excreting reuterin (41), a mixture of monomeric, hydrated monomeric and cyclic 
dimeric forms of 3-hydroxypropionaldehyde (3-HPA) (42). This broad spectrum 
antimicrobial is active against not only Gram-positive and Gram-negative bacteria, but also 
has an inhibitory effect over several yeasts, moulds and protozoa (7). As a consequence, 
reuterin is assumed to confer significant growth advantage to L. reuteri in complex 
environments, such as the GI-tract (7).  
 Reuterin synthesis is mediated by a B12-dependent glycerol dehydratase (EC 
4.2.1.30) (9), and L. reuteri is capable of synthesizing this co-factor de novo (32, 33). 3-
HPA can be further reduced by 1,3-propanediol dehydrogenase (E.C. 1.1.1.202) to 1,3-
propanediol, a compound with biotechnological interest (9). As L. reuteri has a 
predominantly anaerobic lifestyle, production of 1,3-propanediol contributes to the 
recycling of NAD
+
 in this organism. 
Recently the genome sequence of the type strain of L. reuteri was sequenced (ref. 
and website), enabling the development of dedicated genome-wide analysis tools. Amongst 
these, cDNA microarrays are particularly useful to probe the transcriptional response of 
microbial cells to particular changes in environment (13). Typically, these experiments 
generate large data sets that are difficult to process, integrate, visualize and finally, interpret 
(15). Stoichiometric genome scale models have been shown to at least partially resolve 
such issues, whilst generating new insights in the physiology of the modeled organism (8, 
45). Recently, tools have been made available to accelerate the time-consuming task of 
developing genome scale models based on genomic sequences (22, 29, 40). These are 
particularly useful when models of closely related species are available. Genome-scale 
metabolic models have been reported for both Lactococcus lactis (25) and L. plantarum 
WCFS1 (47), a member of the same genus as L. reuteri that shares many ecological niches 
(16). More recently, the metabolic network of yet another Firmicute, Bacillus subtilis, has 
been modeled (24). 
Here we report the development of a genome-scale metabolic network model of L. 
reuteri to simulate experimental conditions and to visualize experimental data, in particular 
the global transcriptional response to the presence of glycerol. We show how the presence 
of glycerol affects cell physiology and triggers specific regulatory mechanisms, allowing 
simultaneously a better yield and more efficient biomass formation. 
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Materials and Methods 
Construction of the genome scale metabolic model. The in silico reconstruction of 
the genome-scale metabolic network of L. reuteri was initiated by implementing 
AUTOGRAPH (22). This semi-automatic method combines orthology with existing 
manually curated metabolic networks to predict gene-reaction associations. In contrast to 
other tools available to automate network reconstruction (29, 40), this method has the 
advantage of exploiting the efforts that have been invested into curating other metabolic 
networks. In addition, it has been benchmarked with another lactic acid bacteria with the 
encouraging recovery of 74-85% of the gene-reaction associations in the manually curated 
network (22). The method consists of (i) establishing pairwise orthologous relationships 
between a query species (L. reuteri in this case) and species for which curated metabolic 
networks are available, (ii) transfer the original gene-reaction association of the orthologous 
genes to the query species, (iii) and finally establish a reconciled list of gene-reaction 
associations for the query species. 
Amongst the increasing number of manually curated genome-scale metabolic 
networks available, we chose the one of L. plantarum (47), Lactococcus lactis (22, 25) and 
B. subtillis (24) based on phylogenetic and phenotypic proximity. Additionally, the model 
of E. coli (11, 31) was also used because it is the most comprehensive compilation of 
prokaryotic pathways experimentally validated. We established orthologous relationships 
between the draft genome sequence of L. reuteri JCM1112 released by JGI in 03/2006 and 
those of E. coli (4), B. subtilis (18), Lactococcus lactis (6) and L. plantarum (16) using 
Inparanoid with default settings (23). An in-house PERL script was implemented to 
produce the initial metabolic network of gene-reaction associations based on phylogenetic 
proximity followed by level of homology between hits. The fully automated version of the 
model was implemented and further developed within the SimPheny™ software platform 
(Genomatica, Inc., San Diego, CA). It was also within this computational environment that 
we implemented constraint-based modeling techniques, in particular Flux Balance Analysis 
(FBA) (30, 48) and Flux Variability Analysis (FVA) (20), based on linear programming 
techniques as described elsewhere (20, 48). The manual curation of the L. reuteri model 
began with the comparison of the automated gene-reaction associations with the annotation 
available within the ERGO bioinformatics suite 
(http://ergo.integratedgenomics.com/ERGO/) (26). Network gaps were analyzed and 
identified as previously described (47), by performing in silico growth experiments using 
FBA and by visual inspection of the model projected on metabolic maps. In order to 
validate our in silico reconstruction of the metabolic network of L. reuteri, we implemented 
a similar approach as carried out for E. coli (12) and L. plantarum (46). We compared the 
amino acid and vitamin requirements of L. reuteri determined from single omission growth 
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experiments in chemically defined medium (CDM), with those predicted by our constructed 
model. 
Strains, media and culture conditions. The type-strain of L. reuteri (ATCC 23272, 
DSM 20016, JCM1112 or F275) was obtained from the Japanese Collection of 
Microorganisms (Riken, Japan). This human isolate was cultured at 37ªC in CDM similar to 
the one described previously (46), but without vitamin B12. When mentioned, the medium 
was supplemented with 0.5% glycerol (v/v). 
Single omission growth experiments. Single omission growth experiments were 
performed by cultivating L. reuteri in single amino acid- or vitamin-deficient CDM. 
Overnight batch cutures of L. reuteri inoculated with cells washed twice in 0.85 % NaCl 
(w/v) were propagated with an initial optical densitity at 600 nm (OD600) of 0.05 during 
five consecutive serial transfers. Only then, was the final biomass formation taken into 
account to avoid interference of the carryover of undesired compounds. If the final OD600 
was lower than 10% of that obtained with complete CDM, L. reuteri JCM1112 was 
considered to have an auxotrophic requirement for the omitted amino acid or vitamin.  
Fermentation conditions. Fermentations were carried out in a batch set-up 
consisting of four vessels with a reaction volume of 400 ml. Temperature was kept constant 
at 37°C throughout all fermentations, and along with pH, it was continuously monitored. 
The cultures were continually stirred and the media vessels were gassed with O2-free N2 
(15 ml/min) for 1 hour prior to inoculation. Fermentors were inoculated to an initial OD600 
of 0.05 from an exponentially growing culture of CDM without glycerol. Biomass 
formation was monitored by periodic measurements of OD600, and if mentioned, pH was 
fixed to 5.8 by titration with 5 M NaOH. Throughout the course of the fermentations, 
supernatant samples were harvested by rapidly forcing 5 ml of culture through a 22 μm 
filter and storing immediately at -20°C until further analysis. Samples for B12 analysis 
prepared as described below were also harvested through out different time-points of the 
growth curve. Transcriptomics samples were harvested at two time points, namely at OD600 
1 (corresponding to mid-logarithmic phase), and 15 minutes after exponential growth 
ceased (corresponding to early-stationary phase), and prepared as described below. 
End-product and amino acid analysis. We determined the extracellular 
concentration of acetate, 1,2-butanediol, butyrate, citrate, ethanol, formate, glucose, 
glycerol, 3-hydroxybutanone (acetoin), 3-hydroxypropionaldehyde, 1,2- and 1,3-
propanediol, propionate, pyruvate and succinate in several time points through out the 
course of the fermentation by HPLC as previously described (7, 39). The extracellular 
concentrations at different time-points of all standard amino acids were determined by RP-
CHAPTER 4 
 
 88 
HPLC as dabsyl derivatives (17), with a detection limit of 50 μM except for asparagine and 
glutamine (0.1 and 0.2 mM, respectively).   
Coenzyme B12 analysis. The production of B12 by L. reuteri under the different 
fermentation conditions was determined according to the Official Methods of Analysis of 
AOAC International, using the L. delbrueckii subsp. lactis ATCC 7830 vitamin B12 assay 
(14). Cell extracts for B12 analysis were prepared as previously described for L. reuteri 
CRL1098 (32). 
Growth rate determination. L. reuteri JCM1112 and derivative strain were 
cultivated in CDM in the presence or absence of glycerol, in 96 well or 384 well 
microplates (Greiner, Alphen a/d Rijn, The Netherlands) using a checkerboard format 
distribution (10). Plates were incubated at 37°C in a Genios microplate reader (Tecan, 
Zurich, Switzerland) and growth was monitored by measuring optical density at 595 nm 
every 15 min. All measurements were independently performed at least twice in at least 40 
biological replicates. Maximum specific growth rate (μmax) was determined in a high-
throughput fashion by in-house scripts that calculate μ for every five consecutive time 
points through out the growth curve and return its maximum value per well.  
Microarray design. Microarrays were spotted on the Agilent 11K platform 
(Agilent Technologies, Santa Clara, CA, USA). The custom probe design was based on the 
draft genome sequence of L. reuteri JCM1112 released by JGI (retrieved in 03/2006). A 
total of 9551 unique 60-mers with a theoretical melting temperature of approximately 82ºC 
were selected, probing 1700 (out of 1900) predicted coding regions (~90% coverage). The 
melting temperature was estimated using the nearest neighbor calculations (27), for a Na
+
 
and oligonucleotide concentration of 1 M and 10
-12
 M, respectively. Probes were designed 
all throughout the sequence of the coding regions, representing them with 6 unique probes 
or more in 82.9% of the cases, and leaving only 3.9% to be represented by less than 3. The 
full details of this microarray platform are available at the Gene Expression Omnibus 
(http://www.ncbi.nlm.nih.gov/geo) under accession number GPL6856. 
RNA isolation. Cultures were sampled at different time points from different 
conditions by rapid quenching using a cold methanol method (28). Total RNA was 
extracted and purified as previously described (35) introducing the following minor 
modifications: (i) liquid nitrogen was used to cool the cell pellet, instead of cooled 60% 
(vol/vol) ethylene glycol; (ii) three treatments of 40 seconds intercalated with 1 minute on 
ice were implemented to disrupt the cells; (iii) further purification using the High Pure 
RNA Isolation kit (Roche Diagnostics, Germany) was carried out following the 
manufacturer’s recommendations, except for the on column DNAse I treatment time, which 
we extended to 60 min. RNA samples were aliquoted and stored at -80°C. Concentration 
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was determined with a ND-1000 spectrophotometer (NanoDrop Technologies Inc., USA), 
and its integrity was analyzed using a 2100 Bioanalyzer (Agilent Technologies, Santa 
Clara, CA, USA). Samples in which the 23S/16S RNA ratio was superior to 1.6 were 
considered satisfactory and used for further labeling. 
cDNA synthesis and labeling. First strand cDNA synthesis from 10 μg of RNA per 
sample was carried out using Superscript III reverse transcriptase (Invitrogen, Breda, The 
Netherlands) according to the manufacture’s recommendations. Newly synthesized cDNA 
was purified and labeled with cyanine 3 and cyanine 5 for all samples. Indirect labeling was 
performed with the CyScribe first-strand cDNA labeling kit (Amersham, United Kingdom) 
according to the recommendations of the manufacturer. Labeling efficacy and cDNA 
concentration was determined using the ND-1000 spectrophotometer (NanoDrop 
Technologies Inc., USA). 
Microarray hybridization. Hybridizations were carried out using 0.5 μg of labeled 
cDNA per dye, and all samples were hybridized at least once with each label to enable the 
identification of potential dye effects.  A total of twelve microarrays (Agilent Technologies) 
were used in this study in samples originated from two different fermentation set-ups. An 
initial exploratory experiment consisting of a simple dye swap with samples from early-
stationary growth phase harvested from batch fermentations in the presence or absence of 
glycerol was performed requiring one slide (two microarrays). Subsequently a hybridization 
scheme consisting of a loop design comprised of ten microarrays was carried out to analyze 
the transcriptome of mid-logarithmic and early-stationary growth phase cells from pH-
controlled batch fermentations in the presence or absence of glycerol. The following 
samples were hybridized per array labeled with cyanine3 and cyanine5, respectively: exp-
F1 and sta-F1, sta-F1 and sta-F2, sta-F2 and exp-F2, exp-F2 and exp-F1, exp-F2 and exp-
F3, exp-F3 and exp-F4, exp-F4 and sta-F4, sta-F4 and sta-F1, sta-F2 and exp-F4, exp-F4 
and exp-F3. Here, F1 and F3 represent completely independent biological duplicates 
cultured in the absence of glycerol, and F2 and F4 represent duplicates cultured in the 
presence of glycerol. The prefix exp- and sta- stand for cells harvested at mid logarithmic 
and early stationary growth phases, respectively. Hybridizations were carried out for 17 h at 
60°C and slides were subsequently washed according to the manufacturer’s procedures and 
dried as described elsewhere (35), before proceeding immediately with scanning. 
Scanning and microarray data analysis. Slides were scanned with a ScanArray 
Express scanner (Perkin-Elmer), using a resolution of 10 μm. Image analysis, spot 
quantification and data extraction were done using ImaGene (BioDiscovery) version 5.6. 
Microarrays were analyzed as previously described (35), after normalization by local fitting 
of an M-A plot applying the loess algorithm (52) using the Limma package (36) in R 
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(http://www.r-project.org). Statistical significance was determined from variation in 
biological duplicates by implementation of the eBayes function included in Limma (cross-
probe variance estimation) and false discovery rate adjustment of the p-values (37). In order 
to characterize the response of L. reuteri to glycerol, comparisons were established (i) 
during exponential growth phase (mid-logarithmic phase response), (ii) during early 
stationary growth phase (early-stationary phase response), and (iii) by comparing the 
differences between early-stationary and mid-logarithmic cells cultured with and without 
glycerol (phase shift response). Only transcripts with an average absolute log2 (ratio) 
greater than 0.585 and a p-value smaller than 0.05 were considered for analysis. The three 
lists of differentially regulated genes were projected on metabolic maps of the genome-
scale model developed in this study. 
Microarray accession numbers. The microarray platform developed in this study 
is available at the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under 
accession number GPL6856. The microarray data were deposited in the same repository 
under accession number pending GSE11885. 
Motif searches. The upstream regions of differentially regulated genes were 
analyzed for the presence of regulatory motifs using MEME (2). Transcriptional Units 
(TUs) were predicted for L. reuteri as described previously (51). We used for motif 
detection the 300 bp sequence directly upstream of TUs found to harbor differentially 
regulated genes. MEME was run with default settings except for the motif length (-minw 8 
and –maxw 40), the total number of motifs to be found (-nmotifs 10) and the number of 
motif occurances (-minsites 5). All motifs were subsequently used to search the complete 
genome of L. reuteri using MAST with default settings (3). 
 
Results 
Genome-scale metabolic network model. A first fully automated version of the 
metabolic model of L. reuteri obtained with AUTOGRAPH (22) included 645 genes 
(~35%) associated to 457 reactions, involving 552 metabolites and contained a total of 270 
network gaps. This list of many-to-many gene-reaction associations was compared with the 
genome annotation available within the ERGO bioinformatics suite (26) and 
inconsistencies were manually corrected. About 17% of the initial gene-reaction 
associations were deleted and 47% permutated. A total of 299 new reactions were entered, 
bestowing the model with the idiosyncrasies of L. reuteri, including B12 biosynthesis (33) 
and the B12-dependent usage of glycerol as an H
+
 acceptor (9). The improved version of the 
model (supplementary material 4.S1) used here to simulate the impact of glycerol on the 
metabolic network of L. reuteri includes 563 genes (30% of total number predicted from 
closed genome) and 623 reactions, involving 659 metabolites and containing a total of 187 
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network gaps. 523 reactions (16%) are not associated with a gene, but inferred from 
biochemical and/or physiological data available or acquired during the course of this study. 
These include (i) key enzymes such as phosphofructokinase (PFK), for which no 
unambiguous encoding gene is found, but activity has been reported (1); (ii) vitamin 
transport systems, such as p-aminobenzoate uptake, which has been demonstrated recently 
for this strain but is not associated to a gene (34); (iii) amino acid uptake systems, as amino 
acids were demonstrated here to be consumed by L. reuteri and yet no specific transported 
is associated to them; (iv) spontaneous reactions, such as oxidative decarboxylation of 
acetolactate or dissociation of NH4
+
, which were derived from literature or inferred by 
similarity to other genome scale models. 
Under the conditions assayed, we have found L. reuteri to have an auxotrophic 
requirement for ten amino acids, namely arginine, glutamate, histidine, leucine, methionine, 
phenylalanine, threonine, tryptophan, valine and tyrosine. Overall, the amino acid single 
omission experiments corroborated in silico predictions in 18 out of 20 cases. The two 
exceptions are arginine and isoleucine. Arginine can theoretically be synthesized from 
aspartate and glutamine, and it was not predicted to be essential. However, L. reuteri and 
several other lactobacilli can not rely on de novo synthesis of arginine countering in silico 
predictions (46). A possible explanation could be that these lactic acid bacteria contain the 
arginine-ornithine pathway that is one of the few non-sugar degradation pathways 
generating metabolic energy. Concerning isoleucine, no route towards its biosynthesis 
could be predicted. The growth of L. reuteri was significantly (80 %) reduced in the 
absence of isoleucine but was not completely abolished. This can most likely be explained 
by the presence of trace amounts of isoleucine in the stock of one of the many components 
of CDM like it has been shown previously for L. plantarum (46). Therefore, we did not 
impose any additional constraints to the model because of these minor incongruences. 
Concerning vitamin and co-factor requirements, L. reuteri has a surprisingly small amount 
of auxotrophies. In fact, only three vitamins were found to be essential in the conditions 
assayed, namely nicotinate, panthothenate and thiamin.  
Model simulations. Constraint-based modeling techniques were implemented to 
explore and predict the impact of glycerol on the metabolic capabilities and growth rate of 
L. reuteri. First, fine-tuning of the ATP-related parameters was performed  as previously 
described (24, 47). Briefly, the ATP-related maintenance factor was adjusted in the model 
until the in silico growth rate, using all experimentally determined fluxes as boundaries of 
the system, was equal to the observed growth rate.  The dominance of the 
phosphoketolase pathway (PKP) over the Embden-Meyerhof (EMP) glycolytic route has 
been clearly demonstrated for L. reuteri (1). This was soon realized to be an important 
constraint, since in its absence, FBA would always predict EMP to be optimal, with 
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important consequences for the growth rate. The ratio between the EMP and the PKP 
pathways was only allowed to fluctuate between 0.19 and 0.36 as determined previously  
(idem), and this constraint was implemented in all simulations presented hereafter. Using 
the measured consumption rates of CDM components to constrain the solution space and 
setting biomass formation as the objective function, product formation was predicted. The 
optimal solution predicted by FBA was compatible with the production of either lactate and 
a proton or ethanol and carbon dioxide (Table 4.1, simulation A). Flux variability analysis 
showed that the metabolic network can freely distribute fluxes between these 
stoichiometrically equivalent routes, with the exception of a minimum flux to ethanol as a 
result of the imposed split ratio between the PKP and EMP. 
Subsequently, we proceeded to simulate in silico the effect of glycerol in the 
metabolism of L. reuteri cultivated in CDM. This was realized by performing a robustness 
analysis of the exchange reaction for glycerol, i.e. titrating glycerol into the system and 
assessing what is its impact on the maximal growth rate, using the constraints of simulation 
A (Fig. 4.1). The model predicts that glycerol will have a prominent effect on the growth 
rate of L. reuteri cultured in CDM with a predicted increase as high as 30%. At glycerol 
uptake rates higher than 19.54 mmol.h
-1
.gDW
-1
, the model predicts a growth rate limitation 
other than energetic. 
 
Figure 4.1. In silico simulation (robustness analysis) of the effect of an increasing glycerol 
consumption rate on the set objective function (growth rate). 
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Table 4.1. Flux variability analysis of model simulations under different constraints setting 
maximized biomass formation as objective function. The full simulation details are 
available in Table 4.S2.1 (supplementary material 4.S2)  
Simulation A Simulation B  Simulation C 
Reaction  
Median Span Median Span Median Span 
EX_etoh(e) 31.3864 30.4692 23.8455 46.3075 12.6146 23.8457 
EX_lac-L(e) 15.2342 30.4684 17.4053 34.8105 11.7898 23.5796 
EX_h(e) 14.4984 30.4684 16.0263 34.8105 21.6417 23.5796 
EX_co2(e) 33.0311 30.4684 31.2728 34.8105 25.6573 23.5796 
EX_ac(e) 0.2844 0.0008 5.7485 11.4970 11.3639 0.2661 
E
x
ch
an
g
e
 r
e
ac
ti
o
n
s 
EX_13ppd(e) 0.0004 0.0008 16.4424 11.4970 22.0579 0.2661 
ACALD -31.3864 30.4692 -23.8455 46.3075 -12.6146 23.8457 
ALCD2x -31.3864 30.4692 -23.8455 46.3075 -12.6146 23.8457 
PDH 15.2342 30.4684 17.4053 34.8105 11.7898 23.5796 
PTAr -17.1069 0.0008 -7.5254 11.4970 -1.9100 0.2661 
GLYK 0.0004 0.0008 5.7485 11.4970 0.1330 0.2661 
DHAPT 0.0004 0.0008 5.7485 11.4970 0.0000 0.2661 
TPI 6.2921 0.0008 10.4971 11.4970 4.8817 0.2661 
GLYCDx 0.0004 0.0008 5.7485 11.4970 0.0000 0.2661 
GDHYD 0.0004 0.0008 16.4424 11.4970 22.0579 0.2661 
PPN13D -0.0004 0.0008 -16.4424 11.4970 -22.0579 0.2661 
ACKr -0.2182 0.0008 -5.6732 11.4970 -11.2887 0.2661 
PYK 5.3667 0.0008 9.4452 11.4970 3.8297 0.2661 
ENO 30.1429 0.0008 28.7105 11.4970 23.0950 0.2661 
PGM 30.1429 0.0008 28.7105 11.4970 23.0950 0.2661 
GAPD 30.1429 0.0008 28.7105 11.4970 23.0950 0.2661 
N
et
w
o
rk
 r
ea
ct
io
n
s 
PGK 30.1429 0.0008 28.7105 11.4970 23.0950 0.2661 
Note: In simulation A the measured uptake fluxes of CDM components were used as constraints; in simulation B 
the measured uptake fluxes of components of CDM supplemented with glycerol were entered as constraints; 
simulation C is similar to simulation B, except that now the fluxes GLYCDx and GDHYD were made irreversible 
in resemblance to what is suggested by the expression data.; Median and Span are expressed as mmol.h-1.gDW-1; 
EX_etoh(e), exchange of ethanol; EX_lac-L(e), exchange of lactate; EX_h(e), exchange of protons; EX_co2(e), 
exchange of carbon dioxide; EX_ac(e), exchange of acetate; EX_13ppd(e), exchange of 1,3-propanediol; ACALD, 
acetaldehyde dehydrogenase (acetylating); ALCD2x, alcohol dehydrogenase; PDH, pyruvate dehydrogenase; 
PTAr, phosphotransacetylase; GLYK, glycerate kinase; DHAPT, dihydroxyacetone phosphotransferase; TPI, 
triosephosphate isomerase; GLYCDx, glycerol dehydrogenase; GDHYD, glycerol dehydratase; PPN13D, 1,3-
propanediol dehydrogenase; ACKr, acetate kinase; PYK, pyruvate kinase; ENO, enolase; PGM, phosphoglycerate 
mutase; GAPD, glyceraldehyde 3-phosphate dehydrogenase; PGK, phosphoglycerate kinase. 
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We experimentally determined the consumption rate of glycerol under these 
conditions and found it to be close to, but somewhat higher than, the in silico predicted 
optimal uptake rate (22.19 mmol.h
-1
.gDW
-1
). Consequently, when using this flux to 
constrain the glycerol exchange reaction in a new simulation (data not shown), glycerol was 
not totally consumed. A very significant reduced cost (i .e. impact on the objective function 
if the flux to a certain metabolite slightly increases) was observed for several amino acids. 
This reduced cost, most prominently observed for aspartate, indicated that either these 
amino acids limit growth during glucose/glycerol co-fermentation, or amino acid fluxes are 
affected by the presence of glycerol (note that we used the fluxes of the glucose 
fermentation to constrain these fluxes). 
At this stage, we used data on the consumption rate of all amino acids as boundary 
conditions to the network in a new simulation (Table 4.1, simulation B). We found that also 
in the glycerol/glucose co-fermentation growth is most likely energy-limited. FVA of this 
simulation reflects a second degree of freedom, besides the one found for simulation A. 
Even though most glycerol is going to 1,3-propanediol, a significant amount is free within 
the FBA-predicted optimum to be channeled to pyruvate yielding ATP, and subsequently 
be converted to acetate and ethanol generating more ATP and NAD
+
, respectively. The 
span of several reactions of lower glycolysis confirms this interpretation of the network 
behavior. 
To challenge our interpretation of the previous simulation, we constrained the 
reversibility of glycerol dehydrogenase and glycerol dehydratase (so that no glycerol could 
be channeled into glycolysis whilst still allowing biosynthesis of glycerol 3-phosphate) and 
ran a new simulation (Table 4.1, simulation C). FVA of this new metabolic network state 
confirmed that under these conditions glycerol is indeed mostly used as an electron 
acceptor, enabling the re-routing of acetyl phosphate adjuvant of the phosphoketolase 
pathway to acetate instead of ethanol, leading to the production of extra ATP. Again, the 
flexibility between lactate and proton or ethanol and carbon dioxide production remains as 
two stoichiometrically equivalent routes. 
Characterization of growth in the presence or absence of glycerol.  In the presence 
of glycerol, the differences in the metabolism of L. reuteri result in a shift in end-product 
formation and a faster acidification rate (data not shown). In an attempt to distinguish  the 
effect of glycerol from other potential responses evoked by a varying pH, we chose to carry 
out further experimentation in a fixed pH environment. Under such conditions, L. reuteri 
reaches a final cell density in CDM complemented with glycerol approximately 30% higher 
than in CDM alone (Fig. 4.2).  
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 Figure 4.2. L. reuteri biomass formation and sampling scheme in pH-controlled batch 
fermentations of CDM in the presence (black squares) or absence (white squares) of 
glycerol and growth rate determination in 96-well microtiterplates (inset).  
 
In CDM without glycerol, one molecule of glucose yields one molecule of lactate 
and 0.9 molecules of ethanol (Fig. 4.3a.). While in CDM supplemented with glycerol, one 
molecule of glucose is converted to one molecule of lactate, 0.3 molecules of ethanol and 
0.6 molecules of acetate, along with the formation of 1.2 molecules of 1,3-propanediol 
derived from glycerol (Fig. 4.3b.).  
The utilization of glycerol as an electron acceptor is initiated with a B12-dependent 
reaction. We did not supply any exogenous source of B12, and therefore, to run this pathway 
L. reuteri relied on its own native production. We measured B12 production under both 
conditions and indeed in CDM supplemented with glycerol it is five fold higher compared 
with CDM without (Fig. 4.4). 
The examination of the growth curves (Fig. 4.2) indicates that the increase in 
biomass yield in the presence of glycerol is accompanied by an increase in μmax as well. We 
observed a 22% increase of μmax in batch fermentations regardless of whether pH was fixed 
or not, and this was confirmed by the accurate determination of μmax (inset Fig. 4.2).  
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Figure 4.3. Substrate consumption and product formation by L. reuteri during 
pH-controlled batch fermentations of CDM (a.) in comparison to CDM supplemented with 
glycerol (b.)  
 
Finally, in order to challenge previously unsuspected model predictions, we 
measured the consumption rate of all twenty standard amino acids in pH-controlled batch 
fermentations of CDM in the presence or absence of glycerol. Twelve were found to have 
their consumption rate affected by the presence of glycerol (Table 4.2). Only the 
consumption rate of arginine, histidine and tyrosine was decreased, while the consumption 
rate of alanine, aspartate, cysteine, glutamate, glycine, isoleucine, leucine, methionine and 
serine was increased. 
 
 
 
Figure 4.4. Vitamin B12 production by L. reuteri in CDM supplemented with glycerol 
(black squares) or not (white squares). 
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Table 4.2. Consumption rate of amino acids that are affected by the presence of glycerol 
 
Consumption rate (mmol.h
-1
.gDW
-1
) in the presence of: 
 Glucose Glucose and Glycerol 
Alanine 0.27 ± 0.09 0.36 ± 0.05 
Arginine 0.57 ± 0.06 0.39 ± 0.09 
Aspartate 0.40 ± 0.02 0.56 ± 0.05 
Cysteine 0.42 ± 0.03 0.58 ± 0.17 
Glutamate 0.22 ± 0.01 0.30 ± 0.06 
Glycine 0.37 ± 0.06 0.65 ± 0.02 
Histidine 0.07 ± 0.03 0.04 ± 0.01 
Isoleucine 0.17 ± 0.08 0.25 ± 0.08 
leucine 0.26 ± 0.08 0.38 ± 0.02 
Methionine 0.07 ± 0.00 0.13 ± 0.04 
Serine 0.55 ± 0.02 0.60 ± 0.03 
Tyrosine 0.20 ± 0.13 0.13 ± 0.01 
 
Global transcriptional response of L. reuteri to the presence of glycerol. To gain a 
broader perspective on the effects of cultivating L. reuteri in the presence of glycerol, we 
developed and applied cDNA microarrays to study its genome-wide transcriptional 
response. To assist in experimental design, and simultaneously develop and validate our 
transcriptomic platform and procedures, we carried out an exploratory set of experiments. 
Worth mentioning is the comparison of the transcriptional response of L. reuteri during 
late-logarithmic phase of batch fermentations of CDM supplemented, or not, with glycerol. 
These microarray results suggested a change in flux distribution leading to different end 
products, and as expected, glycerol-utilizing genes were differentially expressed, along with 
the B12-biosynthesis cluster. For reasons already explained above, to isolate as much as 
possible the specific glycerol response from other indirect effects, the main focus of the 
transcriptome experiments was directed to the pH-controlled batch fermentations. Three 
comparisons were carried out to study the effect of glycerol specifically in mid-exponential 
phase (exp) and in early–stationary phase (sta), and to identify changes caused by the 
presence of glycerol in the transcriptional response between mid-log and early-stationary 
growth phases (phase shift, exp-sta). Defining differential as an absolute Log2 (ratio) > 
0.585 and a p-value < 0.05, we found 228 differentially regulated genes (93 up- and 135 
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down-) in the mid-logarithmic phase response, 643 in the early-stationary phase response 
(325 up- and 318 down-), and 479 in the phase shift response (231 up- and 248 down-) data 
sets (Fig. 4.5). Respectively, 98, 186 and 48 genes are unique to exponential, stationary and 
phase shift comparisons and only 92 are found in all. A detailed list of all genes found to be 
differentially expressed is available as supplementary material 4.S3 (Table 4.S3.1). 
 
 
 
Figure 4.5. Overlap between comparisons established to identify mid-log and late-log 
specific glycerol responses, and to detect the effect of glycerol in the response to the shift 
between mid-logarithmic and early-stationary growth phases. 
 
In order to facilitate the analysis of the expression data, we clustered the genes that 
were differentially expressed according to the category of their assigned COG (44). The full 
distribution is available in Table 4.S3.2 (supplementary material 4.S3) and a small selection 
is present in Fig. 4.6. Considering the model predictions and the measured flux distribution 
already presented here, it is not surprising that a large proportion of the genes found to be 
differentially expressed by glycerol is involved in energy production and conversion (34% 
in exp and exp-sta, and 47% in sta), and strikingly overrepresented as up-regulated in the 
COG category comprising genes involved in secondary metabolites biosynthesis, transport 
and catabolism. We found key genes regulated in the presence of glycerol that can account 
for the observed shift from ethanol to acetate production relying on the formation of 1,3-
propanediol to regenerate NAD
+
 (Fig. 4.2). Amongst others, alcohol dehydrogenase (EC 
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1.1.1.1), phosphate acetyltransferase (EC 2.3.1.8) and pyruvate dehydrogenase ?- and ?-
subunits were down-regulated in the presence of glycerol, while acetate kinase, 1,3-
propanediol dehydrogenase (EC 1.1.1.202) and all the subunits of the B12-dependent 
glycerol dehydratase (EC 4.2.1.30) were up-regulated.  
 
 
Figure 4.6. Distribution of transcripts whose expression was affected by glycerol during 
early-stationary growth phase throughout a selection of COGs (see Supplementary Material 
4.S3, Table 4.S3.2 for full distribution). Transcripts were considered to be differentially 
regulated for M > |0.585| and p-value < 0.05. Between brackets is the total number of genes 
from the genome of L. reuteri included in the corresponding COG. Light and dark grey bars 
represent proportion of up-regulated transcripts in the presence or absence of glycerol, 
respectively. 
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There is another obvious overrepresentation of up-regulated genes by glycerol in 
the coenzyme transport and metabolism category (Fig. 4.6). This can be accounted for by 
the up-regulation of the full length of the ~26 kb B12-biosynthesis gene cluster, causing the 
increased production of this co-factor.  
The response to glycerol also involved the differential regulation of genes assigned to 
categories such as D – cell cycle control, cell division, chromosome partitioning; J – 
translation, ribosomal structure and biogenesis; and M – cell wall biogenesis. These are 
most likely related to the increased μmax in the presence of glycerol, which was predicted by 
constraint-based modeling tools and experimentally verified (Fig. 4.2). 
The response of L. reuteri to glycerol had a conspicuous effect in genes assigned 
to amino acid transport and metabolism. Almost 50% of the 130 genes included in this 
category were differentially regulated, of which 60-70% emerged as being up-regulated in 
response to glycerol (Fig. 4.6). This previously unsuspected observation can be partially 
attributed to the increased metabolic activity of cells cultivated in CDM supplemented with 
glycerol, since this puts an increased demand on protein synthesis. However, this cannot 
fully explain the drop in consumption rate measured for three amino acids and the large 
amount of genes involved in amino acid metabolism that are up-regulated in the presence of 
glycerol. This issue will be further addressed later.  
Motif searches. We searched the upstream region of the transcriptional units 
harboring genes that were differentially regulated for the presence of conserved motifs. The 
mid-logarithmic phase response data set, proved to be the most useful for this purpose. It 
contains the least number of transcriptional units (Fig. 4.5), increasing the chances that a 
particular motif is overrepresented. We analyzed all motifs that had a lower E-value than 
the Shine-Dalgarno sequence and found three to be relevant (Fig. 4.7). 
 
 
Figure 4.7. Regulatory motifs overrepresented in the upstream regions of TUs found to 
harbor differently regulated genes in the mid-logarithmic phase response data set. From left 
to right, a. CRE-box; b. T-box; c. motif X (putatively associated with lipid metabolism). 
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Two of them (Fig 7a. and b.) were easily recognizable as a carbon responsive 
element (CRE-box) and a regulatory motif involved in amino acid metabolism (T-box). The 
motif present in Fig. 4.7c. remains to the best of our knowledge uncharacterized. It displays 
a possible inverted repeat structure, and its distribution throughout the genome of L. reuteri 
suggests it to be most likely associated with lipid metabolism (Table 4.3). 
 
Table 4.3. Downstream genes of the motif X (Fig. 4.7c.) 
ORF Function Position E-value 
Lreu_0025 phosphatidylglycerophosphatase A -67 1.0 x 10
-15
 
Lreu_0932 Fibronectin-binding A domain protein -132 2.4 x 10
-14
 
Lreu_1841 unknown function DUF915, hydrolase family protein -3 2.4 x 10
-14
 
Lreu_1865 type I phosphodiesterase/nucleotide pyrophosphatase -1244 2.4 x 10
-14
 
Lreu_1887 diguanylate phosphodiesterase -30 2.4 x 10
-14
 
Lreu_0942 2,5-didehydrogluconate reductase -26 3.5 x 10
-14
 
 
 
Discussion 
Glycerol has an effect on the growth behavior of L. reuteri, which extends far 
beyond what was previously thought, improving greatly the growth performance of this 
humane isolate. Here we integrate in silico predictions with information from the several 
experimental approaches, discussing from a systems biology perspective, the effect of 
glycerol in the several branches of metabolism and different levels of information transfer. 
Effect of glycerol on the redox balance of central carbon metabolism. 
Maximization of biomass formation in model simulations of L. reuteri cultured in CDM 
supplemented with glycerol predicted a shift from ethanol to acetate formation leading to 
additional ATP production. This shift was indeed observed experimentally (Fig. 4.3). 
However, the production of acetate leads to a redox unbalance since it does not permit the 
regeneration of any NAD(P)
+
 moiety. This metabolic strategy is only viable because 
glycerol is used here as an electron acceptor, regenerating one NAD
+
 per 1,3-propanediol 
molecule formed. As stated above, L. reuteri has been shown to possess two distinctive 
glycolytic routes (1), the PKP being clearly dominant over the EMP. Via the PKP two 
additional NAD(P)H molecules are formed, which are balanced by the conversion of acetyl 
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phosphate to ethanol. When glycerol is present, acetyl phosphate can be converted to 
acetate yielding one ATP with a theoretical acetate:1,3-propanediol ratio of 2:1. This ratio 
was observed experimentally with the synthesis of 1.2 molecules of 1,3-propanediol per 0.6 
molecules of acetate deriving from 1 molecule of glucose. 
The synthesis of 1,3-propanediol from glycerol is a two-step enzymatic 
conversion, relying on the B12-dependent glycerol dehydratase and 1,3-propanediol 
dehydrogenase (9). Recently, the presence of microcompartments (metabolosomes) has 
been shown in the L. reuteri strain used, along with their connection with glycerol and diol 
dehydratase activity (38). The genes encoding the metabolosomes and the several subunits 
of the dehydratase are clearly up-regulated in the presence of glycerol, corroborating model 
simulations and the measured flux distribution (Fig. 4.3). Since B12 is not present in CDM, 
under these conditions L. reuteri must synthesize it de novo. The B12 biosynthesis gene 
cluster was found to be upregulated in the presence of glycerol. The increased production of 
this industrially relevant compound was confirmed and is a valuable asset of the 
glucose/glycerol co-fermentation (Fig. 4.4). The model was not useful for quantitative 
predictions related to B12, which can be easily understood as it represents only a minor 
elemental flux. For instance, the flux to B12 is at least five orders of magnitude smaller than 
the one to lactate. Another feature of B12 production is the clear increase during the later 
stages of growth. This has been reported for a different strain in a medium without glycerol 
(33), and was here observed both in the presence and absence of glycerol. 
FVA of the model simulation in which, the measured uptake fluxes of components 
of CDM supplemented with glycerol were entered as constraints, permitted a span between 
1,3-propanediol and acetate (Table 4.1, simulation B). Interestingly, the fermentation of 
glycerol through a dismutation process involving an oxidative pathway and another for the 
regeneration of reduced equivalents has been extensively characterized in Klebsiella 
pneumoniae and Clostridium freundii (9). However, under these conditions lactobacilli 
have not been reported to be able to grow on glycerol as their sole carbon source (38). To 
the best of our knowledge, the reason for this remains elusive. The transcriptome results 
shed some light on this issue, by evidencing a sharp downregulation of several reactions 
crucial for the channeling of glycerol to the lower part of glycolysis, namely glycerol 
dehydrogenase, glycerol kinase, dihydroxyacetone phosphate synthetase, amongst others. 
Interestingly, through an arduous process of adaptation, L. plantarum has been evolved to 
grow in the presence of heme and oxygen (for regeneration of reduced equivalents) with 
glycerol as its sole carbon source. Enzymes that we have found to be tightly repressed in 
the presence of glycerol are, in the adapted strain, severely deregulated by the presence of a 
single point mutation in a promoter region (Teusink, et al. personal communication). 
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Effect of glycerol on growth rate. We have reported that the synthesis of B12, 
together with the activation of the flanking cluster that encodes the assembly of 
metabolosomes and glycerol dehydratase subunits, requires the expression of ~2% of the 
total genome of L. reuteri (33). Yet, model simulations indicate an increase in μmax as high 
as 30% in CDM supplemented with glycerol (Fig. 4.1). For all conditions tested, in the 
presence of glycerol L. reuteri has a higher μmax when compared to the same situation 
without glycerol. The increase in μmax when an external electron acceptor is available has 
also been observed previously (1). They report an increase of 46% when fructose is 
supplied in addition to glucose. 
Considering all the changes in primary metabolism that we have described above, 
it was not surprising to find a CRE-box as being overrepresented in the systematic analysis 
of all cis regions of genes that were differentially regulated with glycerol (Fig. 4.7a.). This 
is the binding site of the general carbon catabolite control protein, CcpA, that regulates 
several PTS systems and other genes involved in sugar metabolism. Even though it can act 
as an activator in special circumstances, it is most often a repressor (53). The CRE-box is 
mostly found upstream of genes that are down-regulated with glycerol. This is indicative of 
a decreased carbon catabolite repression when glycerol is available due to which glycolysis 
can operate faster, a situation that is compatible with the observed increase in μmax. 
Effect of glycerol on amino acid metabolism. A model simulation in which the 
measured glycerol uptake rate was added as a constraint to simulation A (Table 4.1), first 
suggested the effect of glycerol on amino acid metabolism. The incongruence between 
measured and predicted growth rate indicated that either the limitation was no longer 
energetic, or that the consumption rates of amino acids were significantly altered. The latter 
turned out to be correct, as evidenced by the measured fluxes and transcriptome response. 
In accordance, we found a regulatory motif with structure typical of a T-box clearly 
overrepresented in the upstream region of TUs that harbor genes that were up-regulated 
with glycerol. T-boxes are associated with regulation of amino acid availability and are 
usually located upstream of aminoacyl tRNA synthetases and amino acid transport and 
biosynthesis genes (51), which was confirmed by the output of the MAST search (data not 
shown). 
Even though lactic acid bacteria have amino acid auxotrophies, they still conserve 
a considerable, yet varying, degree of flexibility to interconvert the amino acids that they 
scavenge from the environment. This interconnectivity is complex and hard to navigate 
through unaided with visualization tools. Illustrating the potential of the genome scale 
metabolic model to visualize experimental data, we have projected the expression profiles 
of the differentially expressed genes in the stationary-phase response data set, on a  
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metabolic map depicting the interconnectivity of the amino acids found to have a different 
consumption rate in the presence or absence of glycerol (Fig. 4.8). This exercise enabled us 
to identify some previously unsuspected differences between the amino acid metabolism of 
cells cultured in the presence or absence of glycerol described below. 
The consumption rates of alanine, leucine and glycine are increased in the 
presence of glycerol. This is in accordance with the microarray results, in which their 
cognate aminoacyl tRNA synthetases are up-regulated. For proline, the corresponding 
aminoacyl tRNA synthetase was also found to be up-regulated in the presence of glycerol, 
but we could not see a repercussion of this on the consumption rate of this amino acid. The 
additional source of proline became obvious when the transcriptomics data were projected 
on the metabolic map. Glutamate has an increased consumption rate and yet most reactions 
known to use it as a substrate, except for two, are either not differentially expressed or 
down-regulated. One upregulated reaction leads to glutamine, which can be easily 
understood by the fact that the latter is not present in CDM. Whereas the other, is the first-
step in an amino acid interconversion pathway that culminates in proline, and for which at 
least one more reaction surpasses the stringency of our criteria to be considered up-
regulated. 
Several transcripts associated to reactions related to sulfur amino acids were 
up-regulated in the presence of glycerol. This was corroborated by the measured 
consumption rates, however the underlying reason remains elusive. The consumption rate 
of serine is also slightly increased and since its conversion to glycine is clearly down-
regulated, it is most likely being channeled to cysteine biosynthesis. This is supported by 
the fact that the expression of Lreu_1553 encoding cysteine synthase (EC 2.5.1.47) tends to 
be upregulated more than two-fold (p-value < 0.1). We speculate that this increased uptake 
and biosynthesis of cysteine might be related to either metal ion binding and/or its 
involvement in the reduction of proteins by thiol-disulfide exchange. The fact that 
Lreu_0539, encoding thioredoxin, is also up-regulated tentatively supports the latter 
conjecture. 
 
 
 
 
 
Figure 4.8. (opposite page) Projection of the expression profiles of the 
differentially regulated genes in the stationary-phase response data set, on a metabolic map 
depicting the interconnectivity of the amino acids found to have a different consumption 
rate in the presence or absence of glycerol. 
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From the three amino acids whose consumption rates were lower in the presence 
of glycerol, only histidine also shows a down-regulation of the related aminoacyl tRNA 
synthetase. We could not find any significant change in amino acid composition of 
differentially regulated proteins that could eventually account for this observation. 
Nonetheless, the transcriptomic data is in full accordance with measured fluxes. 
As for arginine, the lower expression of the arginine/ornithine antiporter is in 
agreement with the decrease in consumption rate in the presence of glycerol. However, 
since the esterification of arginine to its cognate tRNA does not appear down-regulated, it is 
not unreasonable to hypothesize that there might be an additional source of this amino acid. 
The projection of the microarray data on the metabolic maps evidences aspartate as the 
most likely candidate. The uptake rate of aspartate is 40% higher in the presence of 
glycerol, and in resemblance with glutamate, most reactions using it as a substrate do not 
appear to be up-regulated. Besides aspartate racemase (EC 5.1.1.13), only Lreu_0731 
encoding argininosuccinate synthetase (EC 6.3.4.5) appeared up-regulated in the presence 
of glycerol. Argininosuccinate can be cleaved into fumarate and arginine by 
argininosuccinate lyase (EC 4.3.2.1), whose encoding gene, Lreu_0732 showed a tendency 
to be up-regulated (1.5-fold change, p-value < 0.2). 
Finally, the decreased uptake of tyrosine seems to be intimately related to the 
increased uptake of isoleucine. For a reason not completely understood, in the presence of 
glycerol, L. reuteri reduces its consumption rate of tyrosine proportionally to its increase in 
that of isoleucine (0.07 versus 0.08 μmol.l-1.h-1.gDW-1). The latter is then converted to 
tyrosine via tyrosine aminotransferase, of which the enconding gene, Lreu_1200, is up-
regulated in the presence of glycerol. 
Final remarks. In this study, we have constructed a genome-scale metabolic 
network model of L. reuteri and used it to deepen our understanding of the physiological 
and transcriptional responses during glucose and glycerol co-fermentation. We were able to 
predict and demonstrate for this well-studied condition, the involvement of previously 
unsuspected metabolic pathways, for instance, related to amino acids. Briefly, the genome-
scale model proved to be very useful (i) for the identification of stoichiomterically 
equivalent metabolic routes which are compatible with maximization of the objective 
function; (ii) for the visualization of large experimental data sets; and (iii) for the 
integration of model predictions with experimental data. 
Part of the predictive power of FBA in L. reuteri resides in the absence of 
pyruvate formate lyase (PFL). In the genome-scale models of other lactic acid bacteria, 
FBA stubbornly predicts acetate in detriment of lactate to be produced, since this route 
yields extra free energy (47). This is in contrast with L. reuteri where we have shown to be 
a reasonable agreement between model-simulated and experimentally determined fluxes. 
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FBA has revealed that the heterofermentative behavior of L. reuteri appears to be 
justified by the dominance of PKP over EMP. A finding that can most likely be 
extrapolated to other biological systems. The fact that the primary metabolism of L. reuteri 
is so much dependent on external electron acceptors instigates us to hypothesize about the 
surplus of such compounds in its environmental niche. This has also been noted previously 
while studying another human isolate of L. reuteri, strain ATCC 55730 (1). 
The multiple comparisons established for the measurements of the global 
transcriptome response were important to gain new insight into potential regulatory 
mechanisms. Additionally, they provided us with new leads for metabolic engineering that 
could potentially assist the development/improvement of industrially relevant processes, as 
foreseen previously (45). The modeling exercise demonstrated here of 1,3-propanediol 
production independent of exogenous vitamin B12 supply, is particularly relevant in the 
current economical and environmental context. 1,3-propanediol can be used as a starting 
material for the production of plastics, providing an alternative to oil-based non-renewable 
sources (9).  
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Content of supplementary materials to Chapter 4 
• Supplementary material S1 to Chapter 4: Genome-scale metabolic network model. 
This document presents the full details of all reactions and their many-to-many 
associations with genes. Abbreviations of metabolites and reactions are provided, 
along with EC codes if they exist. Page 114. 
• Supplementary material S2 to Chapter 4: Model simulations. Here one can find the 
full details of the several in silico simulations carried out in this study. Both the given 
constraints and the flux variability analysis output are listed for all model reactions. 
Maximal biomass formation (i.e. maximize growth rate) was set as the objective 
function. Page 143. 
• Supplementary material S3 to Chapter 4: cDNA microarrays experiments. This file 
consists of two tables, one listing the complete array results and one depicting their 
relative abundance through out the several categories of clusters of orthologous groups 
(COG). Page 179. 
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Content of supplementary material S1 of Chapter 4: 
Genome-scale metabolic network model 
• Table 4.S1.1. Complete list of model reactions and their many-to-many associations 
with genes. EC numbers are provided when available. Page 115. 
• Table 4.S1.2. Complete list of model metabolites and their abbreviation. Page 131.  
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Table 4.S1.1. Complete list of model reactions and their many-to-many associations with 
genes. EC numbers are provided when available. 
Abbrev. Name Equation Genea. EC number 
G6PI Glucose-6-phosphate isomerase [c] : g6p <==> g6p-B RLRE01355 EC-5.3.1.9 
MNTD D-mannitol dehydrogenase [c] : mnl + nad <==> fru + h + nadh RLRE00076 EC-1.1.1.67 
MNTD2 mannitol 2-dehydrogenase (NADP+ as 
acceptor) 
[c] : mnl + nadp <==> fru + h + nadph RLRE00076  
MCMAT2 Butyryl-[acyl-carrier protein]:malonyl-[acyl-
carrier-protein]C-acyltransferase 
(decarboxylating) 
[c] : butacp + h + malacp --> 3oxhacp + acp + 
co2 
RLRE01405 EC-2.3.1.41 
MCMAT3 Hexanoyl-[acyl-carrier protein]:malonyl-[acyl-
carrier-protein] C-acyltransferase 
[c] : h + hexacp + malacp --> 3oxocacp + acp + 
co2 
RLRE01405 EC-2.3.1.41 
MCMAT4 Octanoyl-[acyl-carrier protein]:malonyl-[acyl-
carrier-protein]   C-acyltransferase 
(decarboxylating) 
[c] : h + malacp + octacp --> 3oxdeacp + acp + 
co2 
RLRE01405 EC-2.3.1.41 
MCMAT5 Decanoyl-[acyl-carrier protein]:malonyl-[acyl-
carrier-protein] C-acyltransferase 
[c] : decacp + h + malacp --> 3oxddacp + acp + 
co2 
RLRE01405 EC-2.3.1.41 
MCMAT6 Dodecanoyl-[acyl-carrier-protein]:malonyl-
[acyl-carrier-protein]  C-acyltransferase 
[c] : ddeacp + h + malacp --> 3oxtdacp + acp + 
co2 
RLRE01405 EC-2.3.1.41 
MCMAT7 Tetradecanoyl-[acyl-carrier-protein]:malonyl-
[acyl-carrier-protein]  C-acyltransferase 
[c] : h + malacp + tdeacp --> 3oxhdacp + acp + 
co2 
RLRE01405 EC-2.3.1.41 
MCMAT8 Hexadecanoyl-[acyl-carrier-protein]:malonyl-
[acyl-carrier-protein]  C-acyltransferase 
[c] : h + hdeacp + malacp --> 3oxocdacp + acp + 
co2 
RLRE01405 EC-2.3.1.41 
G1SAT glutamate-1-semialdehyde aminotransferase [c] : glu1sa <==> 5aop RLRE00281 EC-5.4.3.8 
HMBS hydroxymethylbilane synthase [c] : h2o + (4) ppbng --> hmbil + (4) nh4 RLRE00279 EC-4.3.1.8 
PPBNGS porphobilinogen synthase [c] : (2) 5aop --> h + (2) h2o + ppbng RLRE00280 EC-4.2.1.24 
R05218 Cob(II)yrinate a,c diamide <=> Cob(I)yrinate 
a,c diamide 
[c] : (2) co2dam + nadh --> (2) co1dam + h + nad RLRE00255  
SHCHD sirohydrochlorin dehydrogenase [c] : nadp + shcl --> (2) h + nadph + srch RLRE00277  
SRCHCOC sirohydrochlorin cobaltochelatase [c] : cobalt2 + srch --> coprec2 + (2) h RLRE00270  
UPP3MT uroporphyrinogen methyltransferase [c] : (2) amet + uppg3 --> (2) ahcys + h + shcl RLRE00269 EC-2.1.1.107 
UPP3S uroporphyrinogen-III synthase [c] : hmbil --> h2o + uppg3 RLRE00269 EC-4.2.1.75 
2HXICDH L-2-hydroxyisocaproate dehydrogenase [c] : 4mop + h + nadh <==> 2hxic-L + nad RLRE00966, 
RLRE00183, 
RLRE00434 
2MPDH 2-methylpropanol dehydrogenase [c] : 2mpal + h + nadh <==> 2mpol + nad RLRE00247  
AALDH aryl-alcohol dehydrogenase [c] : h + nadh + pacald <==> nad + pea RLRE00720, 
RLRE01618 
EC-1.1.1.90 
ABTA 4-aminobutyrate transaminase [c] : 4abut + akg --> glu-L + sucsal RLRE01065 EC-2.6.1.19 
ACACT1 acetyl-CoA C-acetyltransferase [c] : (2) accoa --> aacoa + coa  EC-2.3.1.9 
ACALD acetaldehyde dehydrogenase (acetylating) [c] : acald + coa + nad <==> accoa + h + nadh RLRE00555 EC-1.2.1.10 
ACALDt acetaldehyde reversible transport acald[e] <==> acald[c]   
ACBIPGT Adenosyl cobainamide GTP transferase [c] : adcobap + gtp + h --> adgcoba + ppi RLRE00282  
ACCOAC acetyl-CoA carboxylase [c] : accoa + atp + hco3 --> adp + h + malcoa + pi RLRE00830, 
RLRE01404, 
RLRE01400, 
RLRE01401, 
RLRE01402 
EC-6.4.1.2 
ACGALpts N-acetylgalactosamine PTS acgala[e] + pep[c] --> acgal6p[c] + pyr[c] RLRE00126, 
RLRE00764 
TC-4.A.6 
ACGAMT UDP-N-
acetylglucosamine:undecaprenylphosphate N-
acetylglucosamine -1-phosphate transferase 
[c] : uacgam + udcpp --> ump + unaga   
ACGApts N-Acetyl-D-glucosamine transport via 
PEP:Pyr PTS 
acgam[e] + pep[c] --> acgam6p[c] + pyr[c] RLRE00126, 
RLRE00764 
 
ACHBS 2-aceto-2-hydroxybutanoate synthase [c] : 2obut + h + pyr --> 2ahbut + co2 RLRE01210  
ACKr acetate kinase [c] : ac + atp <==> actp + adp RLRE00506, 
RLRE00248 
EC-2.7.2.1 
ACLDC acetolactate decarboxylase [c] : alac-S + h --> actn-R + co2 RLRE01209 EC-4.1.1.5 
ACLS acetolactate synthase (Also catalyzes ACHBS) [c] : h + (2) pyr --> alac-S + co2 RLRE01210 EC-4.1.3.18 
ACPS2 acyl-carrier protein synthase [c] : apoACP + coa --> acp + h + pap RLRE00613, 
RLRE01408 
EC-2.7.8.7 
ACt6 acetate transport in/out via proton symport ac[e] + h[e] <==> ac[c] + h[c]  TC-2.A.1.13 
ACTD acetoin dehydrogenase [c] : actn-R + nad <==> diact + h + nadh RLRE01049 EC-1.1.1.5 
ACTNdiff (R)-acetoin diffusion actn-R[e] <==> actn-R[c]   
ACTPASE acylphosphatase [c] : actp + h2o --> ac + h + pi RLRE01467 EC-3.6.1.7 
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Abbrev. Name Equation Genea. EC number 
ADA Adenosine deaminase [c] : adn + h + h2o --> ins + nh4 RLRE00559 EC-3.5.4.4 
ADCL 4-aminobenzoate synthase [c] : 4adcho --> 4abz + h + pyr   
ADCOBAK Adenosyl cobinamide kinase [c] : adcoba + atp --> adcobap + adp + h RLRE00282  
ADCOBAPS Adenosylcobinamide-phosphate synthase [c] : 1ap2olp + adcobhex + atp --> adcobap + adp 
+ pi 
RLRE00260  
ADEt2 adenine transport via proton symport 
(reversible) 
ade[e] + h[e] <==> ade[c] + h[c]   
ADK1 adenylate kinase [c] : amp + atp <==> (2) adp  EC-2.7.4.3 
ADK2 adenylate kinase (Inorganic triphosphate) [c] : amp + pppi <==> adp + ppi  EC-2.7.4.3 
ADPDS acetyl-diaminopimelate deacetylase [c] : al26da + h + h2o --> 26dap-LL + ac RLRE00627 EC-3.5.1.47 
ADPRDP ADPribose diphosphatase [c] : adprib + h2o --> amp + (2) h + r5p RLRE00641 EC-3.6.1.13 
ADPT adenine phosphoribosyltransferase [c] : ade + prpp --> amp + ppi RLRE01305, 
RLRE00452 
EC-2.4.2.7 
ADPTA acetyldiaminopimelate transaminase [c] : akg + al26da + h <==> acamoxm + glu-L RLRE00624  
ADSL1 adenylosuccinate lyase [c] : dcamp --> amp + fum RLRE01206 EC-4.3.2.2 
ADSL2 adenylosuccinate lyase [c] : 25aics --> aicar + fum RLRE01206 EC-4.3.2.2 
ADSS adenylosuccinate synthetase [c] : asp-L + gtp + imp --> dcamp + gdp + (2) h + 
pi 
 EC-6.3.4.4 
AGAT_LRE 1-Acyl-glycerol-3-phosphate acyltransferase 
(Lb plantarum specific) 
[c] : (0.12) 2chdeacp + (0.32) 2cocdacp + (0.01) 
agly3p_LRE + (0.25) cpocdacp + (0.26) hdeacp + 
(0.02) ocdacp + (0.03) tdeacp --> acp + (0.01) 
pa_LRE 
RLRE00916 EC-2.3.1.51 
AGDC N-acetylglucosamine-6-phosphate deacetylase [c] : acgam6p + h2o --> ac + gam6p  EC-3.5.1.25 
AHCYSNS adenosylhomocysteine nucleosidase [c] : ahcys + h2o --> ade + rhcys RLRE00639 EC-3.2.2.9 
AHMMPS 4-amino-5-hydroxymethyl-2-
methylpyrimidine synthetase 
[c] : air + h2o --> 4ahmmp + gcald + (0.5) o2 + 
pi 
RLRE01633  
AICART phosphoribosylaminoimidazolecarboxamide 
formyltransferase 
[c] : 10fthf + aicar <==> fprica + thf RLRE01420 EC-2.1.2.3 
AIRC phosphoribosylaminoimidazole carboxylase [c] : air + co2 --> 5aizc + h RLRE01208, 
RLRE01052, 
RLRE01207, 
RLRE01208 
EC-4.1.1.21 
ALA_Lt6 L-alanine transport in/out via proton symport ala-L[e] + h[e] <==> ala-L[c] + h[c]  TC-2.A.25 
ALALAC D-alanine-D-lactate ligase (reversible) [c] : ala-D + atp + lac-D <==> adp + alalac + pi RLRE01706  
ALAR alanine racemase [c] : ala-L <==> ala-D RLRE00614 EC-5.1.1.1 
ALATA_L L-alanine transaminase [c] : akg + ala-L <==> glu-L + pyr  EC-2.6.1.2 
ALATA_Lr alanine transaminase [c] : ala-L + pydx <==> h + pydam + pyr  EC-2.6.1.30 
ALATRS Alanyl-tRNA synthetase [c] : ala-L + atp + trnaala --> alatrna + amp + h + 
ppi 
RLRE00478, 
RLRE00479 
EC-6.1.1.7 
ALCD19 alcohol dehydrogenase (glycerol) [c] : glyald + h + nadh <==> glyc + nad RLRE00955, 
RLRE01297 
EC-1.1.1.1 
ALCD19_D alcohol dehydrogenase (D-glyceraldehyde to 
glycerol, NADP) 
[c] : glyald + h + nadph <==> glyc + nadp RLRE00460 EC-1.1.1.21 
ALCD19_L alcohol dehydrogenase (L-glyceraldehyde to 
glycerol, NADP) 
[c] : Lglyald + h + nadph <==> glyc + nadp RLRE00460  
ALCD2x alcohol dehydrogenase (ethanol: NAD) [c] : etoh + nad <==> acald + h + nadh RLRE00955, 
RLRE01297, 
RLRE00555 
EC-1.1.1.1 
ALDD2x aldehyde dehydrogenase (acetaldehyde, NAD) [c] : acald + h2o + nad --> ac + (2) h + nadh RLRE00555 EC-1.2.1.3 
ALDD8x aldehyde dehydrogenase (D-glyceraldehyde, 
NAD) 
[c] : glyald + h2o + nad --> glyc-R + (2) h + nadh RLRE00555 EC-1.2.1.3 
ALKP alkaline phosphatase [c] : dhap + h2o --> dha + pi  EC-3.1.3.1 
ALOX oxidative decarboxylation of acetolacate 
(chemical) 
[c] : alac-S + h + (0.5) o2 --> co2 + diact + h2o   
AMAA N-acetylmuramoyl-L-alanine amidase [c] : acmama + h2o --> acmam + ala-L RLRE00591, 
RLRE00174 
EC-3.5.1.28 
AMANAPE N-acetylmannosamine 6-phoshpate epimerase [c] : acmanap --> acgam6p RLRE00546, 
RLRE00188 
 
AMANK N-acetyl-D-mannosamine kinase [c] : acmana + atp --> acmanap + adp + h RLRE00301 EC-2.7.1.60 
AMMQT7 S-adenosylmethione:2-demthylmenaquinone 
methyltransferase (menaquinone 7) 
[c] : 2dmmq7 + amet + nadph --> ahcys + mql7 + 
nadp 
RLRE01381  
AMMQT8_2 S-adenosylmethione:2-demethylmenaquinone 
methyltransferase 
[c] : 2dmmq8 + amet --> ahcys + h + mqn8 RLRE01381  
ANTIMt1 antimonite  transporter via uniport antim[c] --> antim[e] RLRE01250 TC-2.A.59 
AP4AH bis(5'-nucleosyl)-tetraphosphatase [c] : ap4a + h2o --> (2) adp + (2) h RLRE01379 EC-3.6.1.41 
APAT apolipoprotein N-acyl transferase [c] : accoa + h2o + thdp <==> acamoxm + coa RLRE00628 EC-2.3.1.89 
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APRAUR 5-amino-6-(5-phosphoribosylamino)uracil 
reductase 
[c] : 5apru + h + nadph --> 5aprbu + nadp RLRE01152 EC-1.1.1.193 
ARABRr arabinose reductase [c] : arab-L + h + nadph <==> abt-L + nadp RLRE00460 EC-1.1.1.21 
ARAI L-arabinose isomerase [c] : arab-L <==> rbl-L RLRE01513 EC-5.3.1.4 
araphe2 aromatic amino acid aminotransferase - 
phenylalanine 
[c] : 3mop + phe-L <==> ile-L + phpyr RLRE00855  
aratry2 aromatic amino acid aminotransferase - 
tryptophan 
[c] : 3mop + trp-L <==> ile-L + indpyr RLRE01324  
aratyr2 aromatic amino acid aminotransferase - 
tyrosine 
[c] : 3mop + tyr-L <==> 34hpp + ile-L RLRE00840  
aratyr4 aromatic amino acid aminotransferase - 
tyrosine 
[c] : indpyr + tyr-L <==> 34hpp + trp-L RLRE00840  
ARBt2 L-arabinose transport via proton symport arab-L[e] + h[e] <==> arab-L[c] + h[c] RLRE01516  
ARGabc L-arginine transport via ABC system arg-L[e] + atp[c] + h2o[c] --> adp[c] + arg-L[c] + 
h[c] + pi[c] 
RLRE01664, 
RLRE01665 
TC-3.A.1.3 
ARGDI arginine deiminase [c] : arg-L + h2o --> citr-L + h + nh3 RLRE01446 EC-3.5.3.6 
ARGORNt3 Arginine/ornithine antiporter arg-L[e] + orn-L[c] <==> arg-L[c] + orn-L[e] RLRE00773, 
RLRE00710, 
RLRE00195, 
RLRE00052, 
RLRE00774 
TC-2.A.3.2 
ARGSL argininosuccinate lyase [c] : argsuc <==> arg-L + fum RLRE00828 EC-4.3.2.1 
ARGSS argininosuccinate synthase [c] : asp-L + atp + citr-L --> amp + argsuc + h + 
ppi 
RLRE00827 EC-6.3.4.5 
ARGt2 L-arginine transport in via proton symport arg-L[e] + h[e] --> arg-L[c] + h[c] RLRE00773  
ARGTRS Arginyl-tRNA synthetase [c] : arg-L + atp + trnaarg --> amp + argtrna + h 
+ ppi 
RLRE01694 EC-6.1.1.19 
ARSNAt1 Arsenate transporter arsna[c] --> arsna[e] RLRE01250  
ARSt1 arsenite transporter via uniport arsni2[c] --> arsni2[e] RLRE01250  
ASAD aspartate-semialdehyde dehydrogenase [c] : aspsa + nadp + pi <==> 4pasp + h + nadph RLRE00623 EC-1.2.1.11 
ASNN L-asparaginase [c] : asn-L + h2o --> asp-L + nh4 RLRE00431 EC-3.5.1.1 
ASNS1 asparagine synthase (glutamine-hydrolysing) [c] : asp-L + atp + gln-L + h2o --> amp + asn-L + 
glu-L + h + ppi 
RLRE00465 EC-6.3.5.4 
ASNS2 asparagine synthetase [c] : asp-L + atp + nh4 --> amp + asn-L + h + ppi  EC-6.3.1.1 
ASNt6 L-asparagine transport in/out via proton 
symport 
asn-L[e] + h[e] <==> asn-L[c] + h[c]  TC-2.A.3 
ASNTRS Asparaginyl-tRNA synthetase [c] : asn-L + atp + trnaasn --> amp + asntrna + h 
+ ppi 
RLRE00417 EC-6.1.1.22 
ASPCT aspartate carbamoyltransferase [c] : asp-L + cbp --> cbasp + h + pi RLRE01219 EC-2.1.3.2 
ASPK aspartate kinase [c] : asp-L + atp <==> 4pasp + adp RLRE00630 EC-2.7.2.4 
ASPR aspartase racemase [c] : asp-D <==> asp-L RLRE01548 EC-5.1.1.13 
ASPt6 L-aspartate transport in via proton symport asp-L[e] + h[e] <==> asp-L[c] + h[c]   
ASPTA1 aspartate transaminase [c] : akg + asp-L <==> glu-L + oaa RLRE00583 EC-2.6.1.1 
ASPTA2 aspartate transaminase [c] : 4hglu + akg <==> 4h2oxg + glu-L RLRE00583 EC-2.6.1.1 
ASPTA4 aspartate transaminase [c] : akg + cys-L + h <==> glu-L + mercppyr RLRE00583 EC-2.6.1.1 
ASPTA5 aspartate transaminase [c] : akg + tyr-L <==> 34hpp + glu-L RLRE00583 EC-2.6.1.1 
ASPTA6 aspartate transaminase [c] : akg + phe-L <==> glu-L + phpyr RLRE00583 EC-2.6.1.1 
ASPTRS Aspartyl-tRNA synthetase [c] : asp-L + atp + trnaasp --> amp + asptrna + h 
+ ppi 
RLRE00589 EC-6.1.1.12 
ATPM ATP maintenance requirment [c] : atp + h2o --> adp + h + pi   
ATPS3r ATP synthase (three protons for one ATP) adp[c] + (3) h[e] + pi[c] <==> atp[c] + (2) h[c] + 
h2o[c] 
RLRE00753, 
RLRE00756, 
RLRE00757, 
RLRE00758, 
RLRE00759, 
RLRE00760, 
RLRE00755, 
RLRE00754 
EC-3.6.3.14,  
BTDD-RR (R,R)-butanediol dehydrogenase [c] : btd-RR + nad <==> actn-R + h + nadh RLRE01049 EC-1.1.1.4 
BTDt1-RR (R,R)-butanediol transport in/out via diffusion 
reversible 
btd-RR[c] <==> btd-RR[e]   
BTMAT1 Butyryl-[acyl-carrier protein]:malonyl-CoA C-
acyltransferase 
[c] : 2beacp + h + nadh --> butacp + nad RLRE01399 EC-1.3.1.10 
BTNt2i Biotin uptake btn[e] + h[e] --> btn[c] + h[c]   
CBIA Cobyrinic acid a,c-diamide synthase (EC 
6.3.1.-) 
[c] : (2) atp + cobrnt + (2) gln-L + (2) h2o --> (2) 
adp + co2dam + (2) glu-L + (2) pi 
RLRE00259  
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CBIAT Cobinamide adenyltransferase [c] : atp + cbi + h2o <==> adcoba + pi + ppi RLRE00244, 
RLRE00256 
 
CBMK2 Carbamate kinase [c] : atp + co2 + nh4 --> adp + cbp + (2) h RLRE01361 EC-2.7.2.2 
CBPS carbamoyl-phosphate synthase (glutamine-
hydrolysing) 
[c] : (2) atp + gln-L + h2o + hco3 --> (2) adp + 
cbp + glu-L + (2) h + pi 
RLRE01122, 
RLRE00357, 
RLRE01123, 
RLRE00358 
EC-6.3.5.5 
CDPMEK 4-(cytidine 5'-diphospho)-2-C-methyl-D-
erythritol kinase 
[c] : 4c2me + atp --> 2p4c2me + adp + h RLRE01081  
CELBpts cellobiose transport via PEP:Pyr PTS cellb[e] + pep[c] --> 6pgg[c] + pyr[c] RLRE00437, RLRE00126, 
RLRE00764, RLRE00785, 
RLRE00440 
CFAS180 cyclopropane fatty acid synthase (n18:0) [c] : 2cocdacp + amet --> ahcys + cpocdacp + h RLRE01213 EC-2.1.1.79 
CGPT CDP-glycerol glycerophosphotransferase [c] : cdpglyc + unagama --> cmp + h + 
unagamagp 
RLRE01604 EC-2.7.8.12 
CHLabc choline transport via ABC system atp[c] + chol[e] + h2o[c] --> adp[c] + chol[c] + 
h[c] + pi[c] 
RLRE00973, RLRE00974, 
RLRE00975 
CHLt6 choline transport in/out via proton symport chol[e] + h[e] <==> chol[c] + h[c] RLRE00976 TC-2.A.15 
CLPNS_LRE Cardiolipin Synthase (LRE specific) [c] : (0.02) pg_LRE <==> (0.01) clpn_LRE + 
glyc 
RLRE00851, 
RLRE00009 
 
CMLDC 4-carboxymuconolactone decarboxylase [c] : 2c25dho --> 5odhf2a + co2 + h RLRE00441 EC-4.1.1.44 
CO2t CO2 transport out via diffusion co2[e] <==> co2[c]   
Coabc Cobalt transport via ABC system atp[c] + cobalt2[e] + h2o[c] --> adp[c] + 
cobalt2[c] + h[c] + pi[c] 
RLRE00273, RLRE00275, 
RLRE01651, RLRE01650, 
RLRE00274, RLRE01649 
COBALTt5 cobalt transport in/out via permease (no H+) cobalt2[c] <==> cobalt2[e] RLRE00042 TC-1.A.35 
COBAT cob(I)alamin adenosyltransferase [c] : cobamcoa + pi + ppi <==> atp + cbl1 + h + 
(0.5) h2o2 
RLRE00244, 
RLRE00256 
EC-2.5.1.17 
COPREC2M
T 
Precorrin-2 C20-methyltransferase [c] : amet + coprec2 --> ahcys + coprec3 RLRE00271  
COPREC3M
T 
Precorrin-3B C17-methyltransferase (EC 
2.1.1.131) 
[c] : amet + coprec3 --> ahcys + coprec4 RLRE00267  
COPREC4M
T 
Precorrin-4 C11-methyltransferase (EC 
2.1.1.133) 
[c] : amet + coprec4 --> ahcys + coprec5 RLRE00265  
COPREC6M
T 
Precorrin-6Y C5,15-methyltransferase 
[decarboxylating] E.C. 2.1.1.132 
[c] : (2) amet + codhprec6 --> (2) ahcys + co2 + 
coprec8 
RLRE00263, 
RLRE00264 
 
COPREC6R Precorrin-6X reductase (EC 1.3.1.54) [c] : coprec6 + h + nadh --> codhprec6 + nad RLRE00268  
COPREC6R2 Precorrin-6X reductase (EC 1.3.1.54) [c] : coprec6 + h + nadph --> codhprec6 + nadp RLRE00268  
COPRECI Precorrin-8X methylmutase (EC 5.4.1.2) [c] : coprec8 --> cobrnt RLRE00261  
COPRECT Precorrin-6A synthase (deacetylating) [c] : amet + coprec5 + h2o --> acald + ahcys + 
coprec6 
RLRE00266, 
RLRE00262 
 
CPSS_LRE CPS synthase complex, LRE specific [c] : dtdp6dm + (5) h2o + (2) udpg + (2) udpgal 
<==> CPS_LRE + dtdp + (6) h + (3) udp + ump 
RLRE00212, RLRE00222, 
RLRE00207, RLRE01200, 
RLRE00205, RLRE00201 
CPSS_LRE2 CPS synthase complex, LRE specific [c] : (2) dtdp6dm + (4) h2o + udpg + udpgal 
<==> CPS_LRE2 + (2) dtdp + (5) h + udp + ump 
RLRE00212, RLRE00222, 
RLRE00207, RLRE01200, 
RLRE00205, RLRE00201 
CRCT CTP:D-ribitol-5-phosphate 
cytidylyltransferase 
[c] : ctp + h + rbt5p --> cdprbtl + ppi  EC-2.7.7.40 
CRPT_25 CDP-ribitol phosphoribitoltransferase (25 units 
with ribitol-P) 
[c] : (25) cdprbtl + unagamagp --> (25) cmp + 
(25) h + unRTA 
RLRE01603, RLRE01622, 
RLRE01623 
CSND Cytosine deaminase [c] : csn + h + h2o --> nh4 + ura RLRE00559 EC-3.5.4.1 
CTPS1_#1 CTP synthase (NH3) [c] : atp + nh4 + utp --> adp + ctp + (2) h + pi RLRE00467 EC-6.3.4.2 
CTPS2 CTP synthase (glutamine) [c] : atp + gln-L + h2o + utp --> adp + ctp + glu-
L + (2) h + pi 
RLRE00467 EC-6.3.4.2 
Cuabc Copper transport via ABC system atp[c] + cu2[e] + h2o[c] --> adp[c] + cu2[c] + 
h[c] + pi[c] 
RLRE01365+
RLRE01364 
TC-3.A.3 
Cut1 Copper export via ATPase atp[c] + cu2[c] + h2o[c] --> adp[c] + cu2[e] + 
h[c] + pi[c] 
RLRE01366 TC-3.A.3 
CYSabc L-cysteine transport via ABC system atp[c] + cys-L[e] + h2o[c] --> adp[c] + cys-L[c] 
+ h[c] + pi[c] 
RLRE01165+RLRE01164+RLR
E01166 
CYSDabc D-cysteine transport via ABC system atp[c] + cys-D[e] + h2o[c] --> adp[c] + cys-D[c] 
+ h[c] + pi[c] 
RLRE01165+RLRE01164+RLR
E01166 
CYSS cysteine synthase [c] : acser + h2s --> ac + cys-L + h RLRE00702, 
RLRE00008 
EC-4.2.99.8 
CYSt6 L-cysteine transport in via proton symport cys-L[e] + h[e] <==> cys-L[c] + h[c]   
CYSTabc L-cystine transport via ABC system atp[c] + cyst-L[e] + h2o[c] --> adp[c] + cyst-L[c] 
+ h[c] + pi[c] 
RLRE01165+
RLRE01164+
RLRE01166 
TC-3.A.1.3 
CYSTGL cystathionine g-lyase [c] : cysth-L + h2o --> 2obut + cys-L + nh4 RLRE01167 EC-4.4.1.1 
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CYSTL cystathionine b-lyase [c] : cysth-L + h2o --> hcys-L + nh4 + pyr RLRE00443, 
RLRE01167 
EC-4.4.1.8 
CYSTRS Cysteinyl-tRNA synthetase [c] : atp + cys-L + trnacys --> amp + cystrna + h 
+ ppi 
RLRE01157 EC-6.1.1.16 
CYTB_B2 menaquinol oxidase (7:1 protons) (2) h[c] + mql7[c] + (0.5) o2[c] --> (2) h[e] + 
h2o[c] + mqn7[c] 
RLRE00740, 
RLRE00741, 
RLRE00742, 
RLRE00739 
,  
CYTD cytidine deaminase [c] : cytd + h + h2o --> nh4 + uri RLRE01063 EC-3.5.4.5 
CYTDK1 cytidine kinase (ATP) [c] : atp + cytd --> adp + cmp + h   
CYTDK2 cytidine kinase (GTP) [c] : cytd + gtp --> cmp + gdp + h   
CYTDK3 cytidine kinase (ITP) [c] : cytd + itp --> cmp + h + idp   
CYTK1 cytidylate kinase (CMP) [c] : atp + cmp <==> adp + cdp RLRE01190 EC-2.7.4.14 
CYTK2 cytidylate kinase (dCMP) [c] : atp + dcmp <==> adp + dcdp RLRE01190 EC-2.7.4.14 
D-LACt2 D-lactate transport via proton symport h[e] + lac-D[e] <==> h[c] + lac-D[c]   
DADA Deoxyadenosine deaminase [c] : dad-2 + h + h2o --> din + nh4 RLRE00559  
DADNK deoxyadenosine kinase [c] : atp + dad-2 --> adp + damp + h RLRE00514, 
RLRE00131 
EC-2.7.1.76 
DAGGT_LR
E 
1,2-diacylglycerol 3-glucosyltransferase (LRE 
specific) 
[c] : (0.01) dag_LRE + (2) udpg --> (0.01) 
dgdag_LRE + (2) h + (2) udp 
RLRE00864, 
RLRE00865 
EC-2.4.1.157 
DAGK_LRE Diacylglycerol kinase (LRE specific) [c] : atp + (0.01) dag_LRE --> adp + h + (0.01) 
pa_LRE 
RLRE00833, 
RLRE01059 
EC-2.7.1.107 
DALTAL D-Alanine lipoteichoic acid ligase [c] : (0.01) LTA_LRE + (25) ala-D + (25) atp --> 
(0.01) LTAala_LRE + (25) adp + (25) pi 
RLRE00610, 
RLRE01220, 
RLRE00611, 
RLRE00608 
EC-6.3.2.16 
DAPDC diaminopimelate decarboxylase [c] : 26dap-M + h --> co2 + lys-L RLRE00629 EC-4.1.1.20 
DAPE diaminopimelate epimerase [c] : 26dap-LL <==> 26dap-M RLRE00631 EC-5.1.1.7 
DARTAL D-Alanine ribitol teichoic acid ligase [c] : RTA + (25) ala-D + (25) atp --> RTAala + 
(25) adp + (25) pi 
RLRE00610, RLRE01220, 
RLRE00611, RLRE00608 
DASYN_LR
E 
CDP-Diacylglycerol synthetase (LRE specific) [c] : ctp + h + (0.01) pa_LRE <==> (0.01) 
cdpdag_LRE + ppi 
RLRE00672 EC-2.7.7.41 
DB4PS 3,4-Dihydroxy-2-butanone-4-phosphate [c] : ru5p-D --> db4p + for + h RLRE01154  
DCYTD deoxycytidine deaminase [c] : dcyt + h + h2o --> duri + nh4 RLRE01063 EC-3.5.4.14 
DDMAT5 Dodecanoyl-[acyl-carrier protein]: malonyl-
CoA  C-acyltransferase 
[c] : 2tddacp + h + nadh --> ddeacp + nad RLRE01399 EC-1.3.1.10 
DEMAT4 Decanoyl-[acyl-carrier protein]:malonyl-CoA  
C-acyltransferase 
[c] : 2tdeacp + h + nadh --> decacp + nad RLRE01399 EC-1.3.1.10 
DGNSK deoxyguanosine kinase [c] : atp + dgsn --> adp + dgmp + h RLRE00514, 
RLRE00131 
EC-2.7.1.113 
DHAPT Dihydroxyacetone phosphotransferase [c] : dha + pep --> dhap + pyr   
DHAt Dihydroxyacetone transport via facilitated 
diffusion 
dha[e] <==> dha[c] RLRE00229  
DHDPRy dihydrodipicolinate reductase (NADPH) [c] : 23dhdp + h + nadph --> nadp + thdp RLRE00625 EC-1.3.1.26 
DHDPS dihydrodipicolinate synthase [c] : aspsa + pyr --> 23dhdp + h + (2) h2o RLRE00626 EC-4.2.1.52 
DHFOR2 dihydrofolate reductase [c] : dhf + nadp <==> fol + nadph RLRE01182 EC-1.5.1.3 
DHFR dihydrofolate reductase [c] : dhf + h + nadph <==> nadp + thf RLRE01182 EC-1.5.1.3 
DHFS dihydrofolate synthase [c] : atp + dhpt + glu-L --> adp + dhf + h + pi RLRE01598, 
RLRE00737 
EC-6.3.2.12 
DHNPA dihydroneopterin aldolase [c] : dhnpt --> 2ahhmp + gcald RLRE01601 EC-4.1.2.25 
DHORD6 dihydoorotic acid dehydrogenase (NAD) [c] : dhor-S + nad <==> h + nadh + orot RLRE01217 EC-1.3.1.14 
DHORTS dihydroorotase [c] : dhor-S + h2o <==> cbasp + h RLRE01218 EC-3.5.2.3 
DHPPDA_#1 diaminohydroxyphosphoribosylaminopyrimidi
ne deaminase 
[c] : 25dhpp + h + h2o --> 5apru + nh4 RLRE01152 EC-3.5.4.26 
DHPS3 dihydropteroate synthase [c] : 2ahhmd + 4abz --> dhpt + ppi RLRE01596 EC-2.5.1.15 
DIACTt diacetyl diffusion diact[c] <==> diact[e]   
DINSK deoxyinosine kinase [c] : atp + din --> adp + dimp RLRE00514, 
RLRE00131 
 
DKGLCNR1 2,5-diketo-D-gluconate reductase [c] : 25dkglcn + h + nadph --> 2dhguln + nadp RLRE00429, RLRE01511, 
RLRE00002, RLRE01486 
DKGLCNR2
x 
2,5-diketo-D-gluconate reductase (NADH) [c] : 25dkglcn + h + nadh --> 5dglcn + nad RLRE00429, RLRE01511, 
RLRE00002, RLRE01486 
DKGLCNR2
y 
2,5-diketo-D-gluconate reductase (NADPH) [c] : 25dkglcn + h + nadph --> 5dglcn + nadp RLRE00429, RLRE01511, 
RLRE00002, RLRE01486 
DMATT dimethylallyltranstransferase [c] : dmpp + ipdp --> grdp + ppi RLRE01562, 
RLRE01385 
EC-2.5.1.1 
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DNAS_LRE DNA synthesis, LRE specific [c] : (1.37) atp + (0.28) datp + (0.22) dctp + (0.22) dgtp + (0.28) dttp + (1.37) h2o --> 
(0.01) DNA_LRE + (1.37) adp + (1.37) h + (1.37) pi + ppi 
DNMPPA Dihydroneopterin monophosphate 
dephosphorylase 
[c] : dhpmp + h2o --> dhnpt + h + pi   
DNTPPA Dihydroneopterin triphosphate 
pyrophosphatase 
[c] : ahdt + h2o --> dhpmp + ppi RLRE01597  
DPCOAK dephospho-CoA kinase [c] : atp + dpcoa --> adp + coa + h RLRE01539 EC-2.7.1.24 
DPMVD diphosphomevalonate decarboxylase [c] : 5dpmev + atp --> adp + co2 + ipdp + pi RLRE00340 EC-4.1.1.33 
DPR 2-dehydropantoate 2-reductase [c] : 2dhp + h + nadph --> nadp + pant-R RLRE00584, 
RLRE00084 
EC-1.1.1.169 
DRBK Deoxyribokinase [c] : atp + drib --> 2dr5p + adp + h RLRE01090, 
RLRE01556 
EC-2.7.1.15 
DRIBt2 deoxyribose transport in via proton symporter drib[e] + h[e] --> drib[c] + h[c] RLRE01554, 
RLRE01553 
 
DRPA deoxyribose-phosphate aldolase [c] : 2dr5p --> acald + g3p RLRE01426 EC-4.1.2.4 
DTMPK dTMP kinase [c] : atp + dtmp <==> adp + dtdp RLRE00564 EC-2.7.4.9 
DURADy dihydrouracil dehydrogenase (NADP) [c] : 56dura + nadp <==> h + nadph + ura RLRE00535, 
RLRE00534 
EC-1.3.1.2 
DURIK1 deoxyuridine kinase (ATP:Deoxyuridine) [c] : atp + duri --> adp + dump + h RLRE00770  
DURIPP purine-nucleoside phosphatase (deoxyuridine) [c] : duri + pi <==> 2dr1p + ura RLRE01423 EC-2.4.2.1 
DUTPDP dUTP diphosphatase [c] : dutp + h2o --> dump + h + ppi RLRE01160 EC-3.6.1.23 
DXPS 1-deoxy-D-xylulose 5-phosphate synthase [c] : g3p + h + pyr --> co2 + dxyl5p RLRE01018, 
RLRE01369 
 
ENO enolase [c] : 2pg <==> h2o + pep  EC-4.2.1.11 
EPPP exopolyphosphatase [c] : h2o + polypi --> (2) h + pi RLRE01071, 
RLRE00572, 
RLRE00570 
EC-3.6.1.11 
ETOHt1 ethanol transport in/out via diffusion etoh[e] <==> etoh[c]   
FA120ACPH fatty-acyl-ACP hydrolase [c] : ddcaACP + h2o <==> ACP + ddca + h RLRE00569 EC-3.1.2.14 
FA140ACPH fatty-acyl-ACP hydrolase [c] : h2o + myrsACP <==> ACP + h + ttdca RLRE00569 EC-3.1.2.14 
FA141ACPH fatty-acyl-ACP hydrolase [c] : h2o + tdeACP <==> ACP + h + ttdcea RLRE00569 EC-3.1.2.14 
FA160ACPH fatty-acyl-ACP hydrolase [c] : h2o + palmACP <==> ACP + h + hdca RLRE00569 EC-3.1.2.14 
FA161ACPH fatty-acyl-ACP hydrolase [c] : h2o + hdeACP <==> ACP + h + hdcea RLRE00569 EC-3.1.2.14 
FA180ACPH fatty-acyl-ACP hydrolase [c] : h2o + ocdcaACP <==> ACP + h + ocdca RLRE00569 EC-3.1.2.14 
FA181ACPH fatty-acyl-ACP hydrolase [c] : h2o + octeACP <==> ACP + h + ocdcea RLRE00569 EC-3.1.2.14 
FA182ACPH fatty-acyl-ACP hydrolase [c] : h2o + ocdcyaACP <==> ACP + h + ocdcya RLRE00569 EC-3.1.2.14 
FABM1 Fatty acid enoyl isomerase (FabM reaction) [c] : 2thdeacp <==> 2chdeacp   
FABM2 Fatty acid enoyl isomerase (FabM reaction, 
18:1) 
[c] : 2tocdacp <==> 2cocdacp   
FBA fructose-bisphosphate aldolase [c] : fdp <==> dhap + g3p RLRE00789 EC-4.1.2.13 
FCLT Heme B synthesis reaction [c] : fe2 + ppp9 --> h + pheme RLRE00701 EC-4.99.1.1 
FLVR flavin reductase [c] : h + nadph + ribflv --> nadp + ribflvRD RLRE01276 EC-1.5.1.30 
FMETDF formylmethionine deformylase [c] : fmet + h2o --> for + met-L RLRE01469, 
RLRE01638 
EC-3.5.1.31 
FMETTRS Methionyl-tRNA formyltransferase [c] : 10fthf + mettrna --> fmettrna + thf RLRE01440 EC-2.1.2.9 
FMNAT FMN adenylyltransferase [c] : atp + fmn + h --> fad + ppi RLRE00661 EC-2.7.7.2 
FORt formate transport via diffusion for[e] <==> for[c]   
FRTT farnesyltranstransferase [c] : frdp + ipdp --> ggdp + ppi RLRE01562, 
RLRE01385 
EC-2.5.1.29 
FRUK fructokinase [c] : atp + fru --> adp + f6p + h RLRE00333, 
RLRE00334 
EC-2.7.1.4 
FRUpts D-fructose transport via PEP:Pyr PTS fru[e] + pep[c] --> f1p[c] + pyr[c] RLRE00126, RLRE00764, 
RLRE01568 
FTHFCL 5-formyltetrahydrofolate cyclo-ligase [c] : 5fothf + atp --> adp + methf + pi  EC-6.3.3.2 
FTHFL formate-tetrahydrofolate ligase [c] : atp + for + thf --> 10fthf + adp + pi RLRE01211 EC-6.3.4.3 
FUCt L-fucose transport via proton symport fuc-L[e] + h[e] <==> fuc-L[c] + h[c] RLRE01554, 
RLRE01553 
 
FUM fumarase [c] : fum + h2o <==> mal-L RLRE00724 EC-4.2.1.2 
G1PACT glucosamine-1-phosphate N-acetyltransferase [c] : accoa + gam1p --> acgam1p + coa + h RLRE01343 EC-2.3.1.157 
G1PPDM glucose-1-phosphate phosphodismutase [c] : (2) g1p --> g16bp + glc-D RLRE01239 EC-2.7.1.41 
G1PTMT glucose-1-phosphate thymidylyltransferase [c] : dttp + g1p + h --> dtdpglc + ppi RLRE00206 EC-2.7.7.24 
G35DP guanosine-3',5'-bis(diphosphate) 3'-
diphosphatase 
[c] : gdpdp + h2o --> gdp + ppi RLRE00586 EC-3.1.7.2 
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G3PCT glycerol-3-phosphate cytidylyltransferase [c] : ctp + glyc3p + h --> cdpglyc + ppi RLRE00672 EC-2.7.7.39 
G3PD1 glycerol-3-phosphate dehydrogenase (NAD) [c] : glyc3p + nad <==> dhap + h + nadh RLRE00958 EC-1.1.1.94 
G3PD2 glycerol-3-phosphate dehydrogenase (NADP) [c] : glyc3p + nadp <==> dhap + h + nadph RLRE00958 EC-1.1.1.94 
G5SADs L-glutamate 5-semialdehyde dehydratase 
(spontaneous) 
[c] : glu5sa <==> 1pyr5c + h + h2o   
G5SD glutamate-5-semialdehyde dehydrogenase [c] : glu5p + h + nadph --> glu5sa + nadp + pi RLRE00580 EC-1.2.1.41 
G6PDA glucosamine-6-phosphate deaminase [c] : gam6p + h2o --> f6p + nh4 RLRE01192 EC-3.5.99.6 
G6PDHy glucose 6-phosphate dehydrogenase [c] : g6p + nadp <==> 6pgl + h + nadph RLRE00216 EC-1.1.1.49 
GALK2 galactokinase [c] : a-gal-D + atp --> adp + gal1p + h RLRE01263 EC-2.7.1.6 
GALM aldose 1-epimerase [c] : gal <==> a-gal-D RLRE00717 EC-5.1.3.3 
GALS3 a-galactosidase (melibiose) [c] : h2o + melib --> gal + glc-D RLRE00336 EC-3.2.1.22 
GALSZ beta-galactosidase [c] : h2o + lcts --> gal + glc-D RLRE01171, 
RLRE01386 
EC-3.2.1.23 
GALT galactose-1-phosphate uridylyltransferase [c] : gal1p + h + utp <==> ppi + udpgal RLRE01262 EC-2.7.7.10 
GALTpts Galactitol transport via PEP:Pyr PTS galt[e] + pep[c] --> galt1p[c] + pyr[c] RLRE00126, 
RLRE00764 
 
GALU UTP-glucose-1-phosphate uridylyltransferase [c] : g1p + h + utp <==> ppi + udpg RLRE00959 EC-2.7.7.9 
GAPD glyceraldehyde-3-phosphate dehydrogenase 
(NAD) 
[c] : g3p + nad + pi <==> 13dpg + h + nadh  EC-1.2.1.12 
GARFT phosphoribosylglycinamide formyltransferase [c] : 10fthf + gar <==> fgam + h + thf RLRE01419 EC-2.1.2.2 
GAT1_LRE glycerol 3-phosphate acyltransferase (Lb 
plantarum specific) 
[c] : (0.12) 2chdeacp + (0.32) 2cocdacp + (0.25) cpocdacp + glyc3p 
+ (0.26) hdeacp + (0.02) ocdacp + (0.03) tdeacp --> acp + (0.01) 
agly3p_LRE 
EC-2.3.1.15 
GCALDt Glycoaldehydye reversible transport gcald[e] <==> gcald[c]   
GDHYD glycerol dehydratase [c] : glyc <==> 3hppnl + h2o RLRE00236, 
RLRE00240, 
RLRE00232, 
RLRE00237, 
RLRE00233, 
RLRE00235, 
RLRE00234 
EC-4.2.1.28 
GF6PTA glutamine-fructose-6-phosphate transaminase [c] : f6p + gln-L --> gam6p + glu-L  EC-2.6.1.16 
GGLUGABH gammaglutamyl-gamma-aminobutyrate 
hydrolase 
[c] : ggluabt + h2o --> 4abut + glu-L RLRE01230  
GHMT glycine hydroxymethyltransferase [c] : ser-L + thf <==> gly + h2o + mlthf RLRE00563, 
RLRE00766 
EC-2.1.2.1 
GK1 guanylate kinase (GMP:ATP) [c] : atp + gmp <==> adp + gdp RLRE01436 EC-2.7.4.8 
GK2 guanylate kinase (GMP:dATP) [c] : datp + gmp <==> dadp + gdp RLRE01436 EC-2.7.4.8 
GLCNt2 D-gluconate transport via proton symport, 
reversible 
glcn-D[e] + h[e] <==> glcn-D[c] + h[c] RLRE00371, 
RLRE00620 
 
GLCpts D-glucose transport via PEP:Pyr PTS glc-D[e] + pep[c] --> g6p[c] + pyr[c] RLRE00126, RLRE01426, 
RLRE00764 
GLNabc L-glutamine transport via ABC system atp[c] + gln-L[e] + h2o[c] --> adp[c] + gln-L[c] + 
h[c] + pi[c] 
RLRE00811, 
RLRE01672, 
RLRE01673, 
RLRE00808, 
RLRE00809, 
RLRE00810 
TC-3.A.1.3 
GLNS glutamine synthetase [c] : atp + glu-L + nh4 --> adp + gln-L + h + pi RLRE01322 EC-6.3.1.2 
GLNTAL glutamyl-tRNA(Gln):L-glutamine amido-
ligase (ADP-forming) 
[c] : atp + gln-L + glutrna + h2o <==> adp + 
glntrna + glu-L + h + pi 
RLRE01058, RLRE01057, 
RLRE01056 
GLTAL Glucose lipoteichoic acid ligase [c] : (0.01) LTA_LRE + (25) udpg --> (0.01) 
LTAglc_LRE + (25) h + (25) udp 
RLRE01128, RLRE01626, 
RLRE01127 
GLU5K glutamate 5-kinase [c] : atp + glu-L --> adp + glu5p RLRE00581 EC-2.7.2.11 
GLUCYSL glutamate-cysteine ligase [c] : atp + cys-L + glu-L --> adp + glucys + h + pi RLRE01232 EC-6.3.2.2 
GLUN glutaminase [c] : gln-L + h2o --> glu-L + nh4 RLRE01624, 
RLRE00797 
EC-3.5.1.2 
GLUPRT glutamine phosphoribosyldiphosphate 
amidotransferase 
[c] : gln-L + h2o + prpp --> glu-L + ppi + pram RLRE01417 EC-2.4.2.14 
GLUR glutamate racemase [c] : glu-D <==> glu-L RLRE00487 EC-5.1.1.3 
GLUt4 L-glutamate:Na+ symporter glu-L[e] + na1[e] <==> glu-L[c] + na1[c] RLRE01257 TC-2.A.27 
GLUt6 L-glutamate transport in/out via proton 
symporter 
glu-L[e] + h[e] <==> glu-L[c] + h[c] RLRE01257 TC-2.A.23 
GLUTRR glutamyl-tRNA reductase [c] : glutrna + (2) h + nadph --> glu1sa + nadp + 
trnaglu 
RLRE00278  
GLUTRS Glutamyl-tRNA synthetase [c] : atp + glu-L + trnaglu --> amp + glutrna + h + 
ppi 
RLRE01323 EC-6.1.1.17 
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GLYBabc glycine betaine transport via ABC system atp[c] + glyb[e] + h2o[c] --> adp[c] + glyb[c] + 
h[c] + pi[c] 
RLRE00973, 
RLRE00974, 
RLRE00975 
TC-3.A.1.12 
GLYBt6 betaine (glycine betaine) transport in/out via 
proton symport 
glyb[e] + h[e] <==> glyb[c] + h[c] RLRE00976 TC-2.A.1.6 
GLYCDx Glycerol dehydrogenase [c] : glyc + nad <==> dha + h + nadh RLRE00056 EC-1.1.1.6 
GLYCK glycerate kinase [c] : atp + glyc-R --> 3pg + adp + h RLRE00619 EC-2.7.1.31 
GLYCt1 glycerol transport via uniport (facilitated 
diffusion) 
glyc[e] --> glyc[c] RLRE00870  
GLYCt5 glycerol transport in/out via diffusion 
reversible 
glyc[c] <==> glyc[e] RLRE00229  
GLYK glycerol kinase [c] : atp + glyc --> adp + glyc3p + h  EC-2.7.1.30 
GLYt6 glycine transport in/out via proton symport gly[e] + h[e] <==> gly[c] + h[c]  TC-2.A.3.1 
GLYTRS Glycyl-tRNA synthetase [c] : atp + gly + trnagly --> amp + glytrna + h + 
ppi 
RLRE00836, 
RLRE00837 
EC-6.1.1.14 
GMPR GMP reductase [c] : gmp + (2) h + nadph --> imp + nadp + nh4 RLRE01225 EC-1.7.1.7 
GMPS2 GMP synthase (glutamine-hydrolysing) [c] : atp + gln-L + h2o + xmp --> amp + glu-L + 
gmp + (2) h + ppi 
RLRE01045, 
RLRE00424 
EC-6.3.5.2 
GNK gluconokinase [c] : atp + glcn-D --> 6pgc + adp + h RLRE00369 EC-2.7.1.12 
GPDDA1 Glycerophosphodiester phosphodiesterase (sn-
Glycero-3-phosphocholine) 
[c] : g3pc + h2o --> chol + glyc3p + h RLRE01228 EC-3.1.4.46 
GPDDA2 Glycerophosphodiester phosphodiesterase 
(Glycerophosphoethanolamine) 
[c] : g3pe + h2o --> etha + glyc3p + h RLRE01228 EC-3.1.4.46 
GPDDA3 Glycerophosphodiester phosphodiesterase 
(Glycerophosphoserine) 
[c] : g3ps + h2o --> glyc3p + h + ser-L RLRE01228 EC-3.1.4.46 
GPDDA4 Glycerophosphodiester phosphodiesterase 
(Glycerophosphoglycerol) 
[c] : g3pg + h2o --> glyc + glyc3p + h RLRE01228 EC-3.1.4.46 
GPDDA5 Glycerophosphodiester phosphodiesterase 
(Glycerophosphoinositol) 
[c] : g3pi + h2o --> glyc3p + h + inost RLRE01228 EC-3.1.4.46 
GRTAL Glucose ribitol teichoic acid ligase [c] : RTA + (25) udpg --> RTAglc + (25) h + (25) 
udp 
RLRE00191  
GRTT geranyltranstransferase [c] : grdp + ipdp --> frdp + ppi RLRE01562, 
RLRE01385 
EC-2.5.1.10 
GTHRD glutathione-disulfide reductase [c] : (2) gthrd + nadp <==> gthox + h + nadph RLRE00166 EC-1.8.1.7 
GTHS glutathione synthase [c] : atp + glucys + gly --> adp + gthrd + h + pi RLRE01232 EC-6.3.2.3 
GTPCI GTP cyclohydrolase I [c] : gtp + h2o --> ahdt + for + h RLRE01599 EC-3.5.4.16 
GTPCII GTP cyclohydrolase II [c] : gtp + (3) h2o --> 25dhpp + for + (2) h + ppi RLRE01154 EC-3.5.4.25 
GTPDPK GTP diphosphokinase [c] : atp + gtp --> amp + gdptp + h RLRE01517, 
RLRE01237, 
RLRE01236, 
RLRE00586 
EC-2.7.6.5 
GUAPRT guanine phosphoribosyltransferase [c] : gua + prpp --> gmp + ppi RLRE01305, 
RLRE00452 
 
GUAt2 guanine transport in via proton symport gua[e] + h[e] --> gua[c] + h[c]   
H2Ot5 H2O transport via diffusion h2o[e] <==> h2o[c]   
HACD1 3-hydroxyacyl-CoA dehydrogenase 
(acetoacetyl-CoA) 
[c] : aacoa + h + nadh <==> 3hbycoa + nad RLRE01434 EC-1.1.1.35 
HBUHL1 (3R)-3-Hydroxybutanoyl-[acyl-carrier-protein] 
hydro-lyase 
[c] : 3hbacp --> 2beacp + h2o RLRE00538, 
RLRE01411, 
RLRE01403 
EC-4.2.1.58 
HBUR1 (3R)-3-Hydroxybutanoyl-[acyl-carrier 
protein]:NADP+ oxidoreductase 
[c] : aaacp + h + nadph --> 3hbacp + nadp RLRE01093, 
RLRE01406 
EC-1.1.1.100 
HCO3E carbonate dehydratase (HCO3 equilibration 
reaction) 
[c] : co2 + h2o <==> h + hco3  EC-4.2.1.1 
HCYSMT homocysteine S-methyltransferase [c] : amet + hcys-L --> ahcys + h + met-L RLRE01011 EC-2.1.1.10 
HDDHL5 (3R)-3-Hydroxybutanoyl-[acyl-carrier-protein] 
hydro-lyase 
[c] : 3hddacp --> 2tddacp + h2o RLRE00538, 
RLRE01411, 
RLRE01403 
EC-4.2.1.58 
HDDR5 3R)-3-Hydroxydodecanoyl-[acyl-carrier-
protein]:NADP+ oxidoreductase 
[c] : 3oxddacp + h + nadph --> 3hddacp + nadp RLRE01093, 
RLRE01406 
EC-1.1.1.100 
HDEHL4 (3R)-3-Hydroxybutanoyl-[acyl-carrier-protein] 
hydro-lyase 
[c] : 3hdeacp --> 2tdeacp + h2o RLRE00538, 
RLRE01411, 
RLRE01403 
EC-4.2.1.58 
HDER4 (3R)-3-Hydroxydecanoyl-[acyl-carrier-
protein]:NADP+ oxidoreductase 
[c] : 3oxdeacp + h + nadph --> 3hdeacp + nadp RLRE01093, 
RLRE01406 
EC-1.1.1.100 
HDMAT7 Hexadecanoyl-[acyl-carrier protein]:malonyl-
CoA  C-acyltransferase 
[c] : 2thdeacp + h + nadh --> hdeacp + nad RLRE01399 EC-1.3.1.10 
HEMAT2 Hexanoyl-[acyl-carrier protein]:malonyl-CoA 
C-acyltransferase 
[c] : 2theacp + h + nadh --> hexacp + nad RLRE01399 EC-1.3.1.10 
HETZK hydroxyethylthiazole kinase [c] : 4mhetz + atp --> 4mpetz + adp + h RLRE00933 EC-2.7.1.50 
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HEXTT trans-hexaprenyltranstransferase [c] : hexdp + ipdp --> hepdp + ppi RLRE01385 EC-2.5.1.30 
HHDHL7 (3R)-3-Hydroxypalmitoyl-[acyl-carrier-
protein] hydro-lyase 
[c] : 3hpaacp --> 2thdeacp + h2o RLRE00538, 
RLRE01411, 
RLRE01403 
EC-4.2.1.58 
HHDR7 (3R)-3-Hydroxypalmitoyl-[acyl-carrier-
protein]:NADP+ oxidoreductase 
[c] : 3oxhdacp + h + nadph --> 3hpaacp + nadp RLRE01093, 
RLRE01406 
EC-1.1.1.100 
HHYHL2 (3R)-3-Hydroxybutanoyl-[acyl-carrier-protein] 
hydro-lyase 
[c] : 3hhacp --> 2theacp + h2o RLRE00538, 
RLRE01411, 
RLRE01403 
EC-4.2.1.58 
HHYR2 (3R)-3-Hydroxyhexanoyl-[acyl-carrier-
protein]:NADP+ oxidoreductase 
[c] : 3oxhacp + h + nadph --> 3hhacp + nadp RLRE01093, 
RLRE01406 
EC-1.1.1.100 
HISabc L-histidine transport via ABC system atp[c] + h2o[c] + his-L[e] --> adp[c] + h[c] + his-
L[c] + pi[c] 
RLRE00732, RLRE00731, 
RLRE00730 
HISDC histidine decarboxylase [c] : h + his-L --> co2 + hista RLRE00048 EC-4.1.1.22 
HISTAap histide/histamine antiporter his-L[c] + hista[e] <==> his-L[e] + hista[c]   
HISTRS Histidyl-tRNA synthetase [c] : atp + his-L + trnahis --> amp + h + histrna + 
ppi 
RLRE00046, 
RLRE00065 
EC-6.1.1.21 
HMGCOAR Hydroxymethylglutaryl CoA reductase [c] : coa + mev-R + (2) nadp <==> (2) h + 
hmgcoa + (2) nadph 
RLRE01072, 
RLRE00931 
EC-1.1.1.34 
HMGCOAS Hydroxymethylglutaryl CoA synthase [c] : coa + h + hmgcoa <==> aacoa + accoa + h2o RLRE00912 EC-4.1.3.5 
HMPabc Hydroxymethylpyrimidine ABC transporter 4ahmmp[e] + atp[c] + h2o[c] --> 4ahmmp[c] + 
adp[c] + h[c] + pi[c] 
RLRE00694
+RLRE0069
5 
 
HMPK1 hydroxymethylpyrimidine kinase (ATP) [c] : 4ahmmp + atp --> 4ampm + adp + h RLRE00934 EC-2.7.1.49 
HOCHL3 ((3R)-3-Hydroxybutanoyl-[acyl-carrier-
protein] hydro-lyase 
[c] : 3hocacp --> 2toceacp + h2o RLRE00538, 
RLRE01411, 
RLRE01403 
EC-4.2.1.58 
HOCR3 (3R)-3-Hydroxyoctanoyl-[acyl-carrier-
protein]:NADP+ oxidoreductase 
[c] : 3oxocacp + h + nadph --> 3hocacp + nadp RLRE01093, 
RLRE01406 
EC-1.1.1.100 
HODHL8 (3R)-3-Hydroxyoctadecanoyl-[acyl-carrier-
protein] hydro-lyase 
[c] : 3hocdacp --> 2tocdacp + h2o RLRE00538, 
RLRE01411, 
RLRE01403 
EC-4.2.1.58 
HODR8 (3R)-3-Hydroxyoctadecanoyl-[acyl-carrier-
protein]:NADP+ oxidoreductase 
[c] : 3oxocdacp + h + nadph --> 3hocdacp + nadp RLRE01093, 
RLRE01406 
EC-1.1.1.100 
HPPK 2-amino-4-hydroxy-6-
hydroxymethyldihydropteridine 
diphosphokinase 
[c] : 2ahhmp + atp --> 2ahhmd + amp + h RLRE01600 EC-2.7.6.3 
HSAT Acetyl-CoA:L-homoserine O-acetyltransferase [c] : accoa + hom-L <==> achms + coa RLRE00007 EC-2.3.1.31 
HSDy homoserine dehydrogenase (NADPH) [c] : hom-L + nadp <==> aspsa + h + nadph  EC-1.1.1.3 
HTDHL6 (3R)-3-Hydroxypalmitoyl-[acyl-carrier-
protein] hydro-lyase 
[c] : 3htdacp --> 2ttdeacp + h2o RLRE00538, 
RLRE01411, 
RLRE01403 
EC-4.2.1.58 
HTDR6 3R)-3-Hydroxytetradecanoyl-[acyl-carrier-
protein]:NADP+ oxidoreductase 
[c] : 3oxtdacp + h + nadph --> 3htdacp + nadp RLRE01093, 
RLRE01406 
EC-1.1.1.100 
HXANt2 hypoxanthine transport in via proton symport h[e] + hxan[e] --> h[c] + hxan[c]   
HXPRT hypoxanthine phosphoribosyltransferase 
(Hypoxanthine) 
[c] : hxan + prpp --> imp + ppi RLRE01305, 
RLRE00452 
EC-2.4.2.8 
HYPOE hypothetical enzyme [c] : h2o + pyam5p --> pi + pydam   
ICDHy isocitrate dehydrogenase (NADP) [c] : icit + nadp <==> akg + co2 + nadph RLRE00637 EC-1.1.1.42 
ILEt2 L-isoleucine transport in via proton symport h[e] + ile-L[e] --> h[c] + ile-L[c] RLRE00300  
ILEt6 L-isoeucine transport in/out via proton 
symport 
h[e] + ile-L[e] <==> h[c] + ile-L[c] RLRE00027, 
RLRE01221, 
RLRE01222 
TC-2.A.26 
ILETRS Isoleucyl-tRNA synthetase [c] : atp + ile-L + trnaile --> amp + h + iletrna + 
ppi 
RLRE00643 EC-6.1.1.5 
IMPC IMP cyclohydrolase [c] : h2o + imp <==> fprica RLRE01420 EC-3.5.4.10 
INSt2r inosine transport in via proton symport, 
reversible 
h[e] + ins[e] <==> h[c] + ins[c]   
IPDDI isopentenyl-diphosphate D-isomerase [c] : ipdp <==> dmpp RLRE00338 EC-5.3.3.2 
kaasIII beta-ketoacyl-ACP synthase III [c] : accoa + h + malacp --> aaacp + co2 + coa RLRE01409  
Kabc potassium transport via ABC system atp[c] + h2o[c] + k[e] --> adp[c] + h[c] + k[c] + 
pi[c] 
RLRE01274, 
RLRE01273 
EC-3.6.3.12 
L-LACt2 L-lactate reversible transport via proton 
symport 
h[e] + lac-L[e] <==> h[c] + lac-L[c]   
LAR lactate racemase [c] : lac-L <==> lac-D  EC-5.1.2.1 
LCTSt6 lactose transport in/out via proton symport h[e] + lcts[e] <==> h[c] + lcts[c] RLRE01387 TC-2.A.1.5 
LDH_D D-lactate dehydrogenase [c] : lac-D + nad <==> h + nadh + pyr RLRE00289 EC-1.1.1.28 
LDH_L L-lactate dehydrogenase [c] : lac-L + nad <==> h + nadh + pyr RLRE00332 EC-1.1.1.27 
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LEUt2 L-leucine transport in via proton symport h[e] + leu-L[e] --> h[c] + leu-L[c] RLRE00300  
LEUt6 L-leucine transport in/out via proton symport h[e] + leu-L[e] <==> h[c] + leu-L[c] RLRE00027, RLRE01221, 
RLRE01222 
LEUTRS Leucyl-tRNA synthetase [c] : atp + leu-L + trnaleu --> amp + h + leutrna + 
ppi 
RLRE00521 EC-6.1.1.4 
LPGS_LRE lysylphosphatidyl-glycerol synthetase [c] : lystrna + (0.01) pg_LRE --> (0.01) 
lyspg_LRE + trnalys 
RLRE00819  
LTAS_LRE Lipoteichoic acid synthase (LRE specific) [c] : (0.01) dgdag_LRE + (0.25) pg_LRE --> (0.01) LTA_LRE + 
(0.25) dag_LRE 
EC-2.7.8.20 
LYSDC lysine decarboxylase [c] : h + lys-L --> 15dap + co2 RLRE00184 EC-4.1.1.18 
LYSt6 L-lysine transport in/out via proton symport h[e] + lys-L[e] <==> h[c] + lys-L[c] RLRE00213 TC-2.A.3 
LYSTRS Lysyl-tRNA synthetase [c] : atp + lys-L + trnalys --> amp + h + lystrna + 
ppi 
RLRE01575 EC-6.1.1.6 
M1PD mannitol-1-phosphate 5-dehydrogenase [c] : mnl1p + nad <==> f6p + h + nadh RLRE00025 EC-1.1.1.17 
MACPMT Malonyl-CoA:[acyl-carrier-protein] S-
malonyltransferase 
[c] : acp + malcoa --> coa + malacp RLRE01407 EC-2.3.1.39 
MALLAC malolactic enzyme [c] : h + mal-L --> co2 + lac-L RLRE00723  
MALP maltose phosphorylase [c] : malt + pi <==> g1p-B + glc-D RLRE01240, 
RLRE00455 
EC-2.4.1.8 
MALT alpha-glucosidase [c] : h2o + malt --> (2) glc-D RLRE00937 EC-3.2.1.20 
MALt6 malate symporter h[e] + mal-L[e] <==> h[c] + mal-L[c] RLRE00444  
MAN6PI mannose-6-phosphate isomerase [c] : man6p <==> f6p RLRE01659 EC-5.3.1.8 
MANpts D-mannose transport via PEP:Pyr PTS man[e] + pep[c] --> man6p[c] + pyr[c] RLRE00126, RLRE00764, 
RLRE00727, RLRE00729 
MDH malate dehydrogenase [c] : mal-L + nad <==> h + nadh + oaa RLRE00649 EC-1.1.1.37 
METabc L-methionine transport via ABC system atp[c] + h2o[c] + met-L[e] --> adp[c] + h[c] + 
met-L[c] + pi[c] 
RLRE00967, RLRE00968, 
RLRE00969 
METACH O-Acetyl-L-homoserine acetate-lyase (adding 
methanethiol) 
[c] : achms + h2s <==> ac + h + hcys-L RLRE00091 EC-4.2.99.10 
METAT methionine adenosyltransferase [c] : atp + h2o + met-L --> amet + pi + ppi RLRE00522 EC-2.5.1.6 
METDabc D-methionine transport via ABC system atp[c] + h2o[c] + met-D[e] --> adp[c] + h[c] + 
met-D[c] + pi[c] 
RLRE00967, RLRE00968, 
RLRE00969 
METt6 L-methionine transport in/out via proton 
symport 
h[e] + met-L[e] <==> h[c] + met-L[c]  TC-2.A.3.8 
METTRS Methionyl-tRNA synthetase [c] : atp + met-L + trnamet --> amp + h + mettrna 
+ ppi 
RLRE01076 EC-6.1.1.10 
MEVK mevalonate kinase [c] : atp + mev-R --> 5pmev + adp + h RLRE00341 EC-2.7.1.36 
MEVK2 mevalonate kinase (ctp) [c] : ctp + mev-R --> 5pmev + cdp + h RLRE00341 EC-2.7.1.36 
MEVK3 mevalonate kinase (gtp) [c] : gtp + mev-R --> 5pmev + gdp + h RLRE00341 EC-2.7.1.36 
MEVK4 mevalonate kinase (utp) [c] : mev-R + utp --> 5pmev + h + udp RLRE00341 EC-2.7.1.36 
MGt5 magnesium transport in/out via permease (no 
H+) 
mg2[c] <==> mg2[e] RLRE00042 TC-1.A.35 
MI1PP myo-inositol 1-phosphatase [c] : h2o + mi1p-D --> inost + pi RLRE00516 EC-3.1.3.25 
MNabc manganese transport via ABC system atp[c] + h2o[c] + mn2[e] --> adp[c] + h[c] + 
mn2[c] + pi[c] 
RLRE01341
+RLRE0133
9+RLRE013
40 
TC-3.A.1.15 
MNLpts mannitol transport via PEP:Pyr PTS mnl[e] + pep[c] --> mnl1p[c] + pyr[c] RLRE00022, RLRE00126, 
RLRE00024, RLRE00764 
MNt2 manganese transport in via proton symport h[e] + mn2[e] --> h[c] + mn2[c] RLRE01271, 
RLRE00077 
TC-2.A.55 
MNt6 manganese transport in/out via proton symport h[e] + mn2[e] <==> h[c] + mn2[c] RLRE01271, 
RLRE00077 
TC-2.A.55 
MOADCST MoaD:cysteine sulfur transferase [c] : MCOOH + atp + cys-L + h2o --> MCOSH + 
amp + ppi + ser-L 
RLRE00745, RLRE00638, 
RLRE00318, RLRE00744 
MTAN methylthioadenosine nucleosidase [c] : 5mta + h2o --> 5mtr + ade RLRE00639 EC-3.2.2.16 
MTHFC methenyltetrahydrofolate cyclohydrolase [c] : h2o + methf <==> 10fthf + h RLRE01565, 
RLRE01566 
EC-3.5.4.9 
MTHFD methylenetetrahydrofolate dehydrogenase 
(NADP) 
[c] : mlthf + nadp <==> methf + nadph RLRE01565, 
RLRE01566 
EC-1.5.1.5 
MTHPTGH
M 
5-methyltetrahydropteroyltriglutamate-
homocysteine S-methyltransferase 
[c] : 5mthglu + hcys-L --> met-L + thglu RLRE00087, 
RLRE01382 
EC-2.1.1.14 
NACUP Nicotinic acid uptake nac[e] --> nac[c]   
NADH4 NADH dehydrogenase (Menaquinone 7 & no 
proton) 
[c] : h + mqn7 + nadh --> mql7 + nad RLRE00738 EC-1.6.5.3 
NADK NAD kinase [c] : atp + nad --> adp + h + nadp RLRE00383 EC-2.7.1.23 
NADN NAD nucleosidase [c] : h2o + nad --> adprib + h + ncam  EC-3.2.2.5 
NADPH12 Quinone oxidoreductase [c] : h + nadph + ubq8 --> nadp + ubq8h2 RLRE01687 EC-1.6.5.5 
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NADS1 NAD synthase (nh4) [c] : atp + dnad + nh4 --> amp + h + nad + ppi RLRE01545 EC-6.3.1.5 
NAPRT NAPRTase [c] : h + nac + prpp --> nicrnt + ppi RLRE01086, 
RLRE01546 
EC-2.4.2.11 
NAt7 sodium transport in/out via proton antiport 
(one H+) 
h[e] + na1[c] <==> h[c] + na1[e] RLRE01691, 
RLRE00698, 
RLRE01690, 
RLRE01066 
TC-2.A.36 
NDPK1 nucleoside-diphosphate kinase (ATP:GDP) [c] : atp + gdp <==> adp + gtp RLRE01068 EC-2.7.4.6 
NDPK2 nucleoside-diphosphate kinase (ATP:UDP) [c] : atp + udp <==> adp + utp RLRE01068 EC-2.7.4.6 
NDPK3 nucleoside-diphosphate kinase (ATP:CDP) [c] : atp + cdp <==> adp + ctp RLRE01068 EC-2.7.4.6 
NDPK4 nucleoside-diphosphate kinase (ATP:dTDP) [c] : atp + dtdp <==> adp + dttp RLRE01068 EC-2.7.4.6 
NDPK5 nucleoside-diphosphate kinase (ATP:dGDP) [c] : atp + dgdp <==> adp + dgtp RLRE01068 EC-2.7.4.6 
NDPK6 nucleoside-diphosphate kinase (ATP:dUDP) [c] : atp + dudp <==> adp + dutp RLRE01068 EC-2.7.4.6 
NDPK7 nucleoside-diphosphate kinase (ATP:dCDP) [c] : atp + dcdp <==> adp + dctp RLRE01068 EC-2.7.4.6 
NDPK8 nucleoside-diphosphate kinase (ATP:dADP) [c] : atp + dadp <==> adp + datp RLRE01068 EC-2.7.4.6 
NDPK9 nucleoside-diphophate kinase (ATP:IDP) [c] : atp + idp <==> adp + itp RLRE01068 EC-2.7.4.6 
NH3t ammonia transport via diffusion nh3[e] <==> nh3[c] RLRE00165  
NH4DIS nh4 Dissociation [c] : nh4 <==> h + nh3   
NH4DISex nh4 Dissociation extracellular [e] : nh4 <==> h + nh3   
NNAMr nicotinamidase, reversible [c] : h2o + ncam <==> nac + nh4 RLRE01087 EC-3.5.1.19 
NNAT nicotinate-nucleotide adenylyltransferase [c] : atp + h + nicrnt --> dnad + ppi  EC-2.7.7.18 
NNDMBRT nicotinate-nucleotide-dimethylbenzimidazole 
phosphoribosyltransferase 
[c] : dmbzid + nicrnt --> 5prdmbz + h + nac RLRE00286 EC-2.4.2.21 
NOX1 NADH oxidase (H2O2 forming) [c] : h + nadh + o2 --> h2o2 + nad RLRE01226  
NOX2 NADH oxidase (H2O forming) [c] : (2) h + (2) nadh + o2 --> (2) h2o + (2) nad RLRE01226  
NPHS naphthoate synthase [c] : sbzcoa --> coa + dhna RLRE00312 EC-4.1.3.36 
NTD1 5'-nucleotidase (dUMP) [c] : dump + h2o --> duri + pi RLRE01195 EC-3.1.3.5 
NTD10 5'-nucleotidase (XMP) [c] : h2o + xmp --> pi + xtsn RLRE01195 EC-3.1.3.5 
NTD11 5'-nucleotidase (IMP) [c] : h2o + imp --> ins + pi RLRE01195 EC-3.1.3.5 
NTD2 5'-nucleotidase (UMP) [c] : h2o + ump --> pi + uri RLRE01195 EC-3.1.3.5 
NTD3 5'-nucleotidase (dCMP) [c] : dcmp + h2o --> dcyt + pi RLRE01195 EC-3.1.3.5 
NTD4 5'-nucleotidase (CMP) [c] : cmp + h2o --> cytd + pi RLRE01195 EC-3.1.3.5 
NTD5 5'-nucleotidase (dTMP) [c] : dtmp + h2o --> pi + thymd RLRE01195 EC-3.1.3.5 
NTD6 5'-nucleotidase (dAMP) [c] : damp + h2o --> dad-2 + pi RLRE01195 EC-3.1.3.5 
NTD7 5'-nucleotidase (AMP) [c] : amp + h2o --> adn + pi RLRE01195 EC-3.1.3.5 
NTD8 5'-nucleotidase (dGMP) [c] : dgmp + h2o --> dgsn + pi RLRE01195 EC-3.1.3.5 
NTD9 5'-nucleotidase (GMP) [c] : gmp + h2o --> gsn + pi RLRE01195 EC-3.1.3.5 
NTR3B nitrate reductase (2) h[c] + mql7[c] + no3[c] --> (2) h[e] + h2o[c] 
+ mqn7[c] + no2[c] 
RLRE01249 EC-1.7.99.4,  
OCBT ornithine carbamoyltransferase [c] : cbp + orn-L <==> citr-L + h + pi RLRE01360 EC-2.1.3.3 
OCDMAT8 Octadecanoyl-[acyl-carrier protein]:malonyl-
CoA  C-acyltransferase 
[c] : 2tocdacp + h + nadh --> nad + ocdacp RLRE01399 EC-1.3.1.10 
OCMAT3 Octanoyl-[acyl-carrier protein]:malonyl-CoA 
C-acyltransferase 
[c] : 2toceacp + h + nadh --> nad + octacp RLRE01399 EC-1.3.1.10 
OMPDC orotidine-5'-phosphate decarboxylase [c] : h + orot5p --> co2 + ump RLRE01216 EC-4.1.1.23 
ORNt2 ornithine transport in via proton symport h[e] + orn-L[e] --> h[c] + orn-L[c] RLRE00773  
OROt6 Orotic acid transport in/out via proton 
symporter 
h[e] + orot[e] <==> h[c] + orot[c]   
ORPT orotate phosphoribosyltransferase [c] : orot5p + ppi <==> orot + prpp RLRE01215 EC-2.4.2.10 
P5CRr pyrroline-5-carboxylate reductase [c] : 1pyr5c + (2) h + nadph <==> nadp + pro-L RLRE00579 EC-1.5.1.2 
PABAt para aminobenzoic acid transport 4abz[e] <==> 4abz[c]   
PAPPT5 phospho-N-acetylmuramoyl-pentapeptide-
transferase (meso-2,6-diaminopimelate) 
[c] : udcpp + ugmdalac --> uagmdalac + ump RLRE01108 EC-2.7.8.13 
PDH pyruvate dehydrogenase [c] : coa + nad + pyr --> accoa + co2 + nadh RLRE01634, 
RLRE01637, 
RLRE01636, 
RLRE01635 
EC-1.2.1.51 
PFK phosphofructokinase [c] : atp + f6p --> adp + fdp + h RLRE00632 EC-2.7.1.11 
PGAMT phosphoglucosamine mutase [c] : gam1p <==> gam6p RLRE01550 EC-5.4.2.10 
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PGDH phosphogluconate dehydrogenase [c] : 6pgc + nadp --> co2 + nadph + ru5p-D  EC-1.1.1.44 
PGGH 6-phospho-beta-glucosidase [c] : 6pgg + h2o --> g6p + glc-D RLRE00441 EC-3.2.1.86 
PGGT4 peptidoglycan glycosyltransferase [c] : uaagmdalac --> PGlac2 + udcpdp RLRE01695, RLRE00346, 
RLRE01109 
PGI glucose-6-phosphate isomerase [c] : g6p <==> f6p RLRE01355 EC-5.3.1.9 
PGK phosphoglycerate kinase [c] : 13dpg + adp <==> 3pg + atp  EC-2.7.2.3 
PGL 6-phosphogluconolactonase [c] : 6pgl + h2o --> 6pgc + h RLRE01117 EC-3.1.1.31 
PGLYCP phosphoglycolate phosphatase [c] : 2pglyc + h2o --> glyclt + pi RLRE00686 EC-3.1.3.18 
PGM phosphoglycerate mutase [c] : 3pg <==> 2pg RLRE00790, 
RLRE01035, 
RLRE00635, 
RLRE01422, 
RLRE01169, 
RLRE00251, 
RLRE00053 
EC-5.4.2.1 
PGMT phosphoglucomutase [c] : g1p <==> g6p RLRE01496 EC-5.4.2.2 
PGMT_B b-phosphoglucomutase [c] : g6p-B <==> g1p-B RLRE01239 EC-5.4.2.6 
PGPP_LRE Phosphatidylglycerol phosphate phosphatase 
(LRE specific) 
[c] : h2o + (0.01) pgp_LRE --> (0.01) pg_LRE + 
pi 
RLRE00987 EC-3.1.3.27 
PGSA_LRE Phosphatidylglycerol synthase (LRE specific) [c] : (0.01) cdpdag_LRE + glyc3p <==> cmp + h 
+ (0.01) pgp_LRE 
RLRE00726 EC-2.7.8.5 
PHEt6 L-phenylalanine transport in/out via proton 
symport 
h[e] + phe-L[e] <==> h[c] + phe-L[c]  TC-2.A.3.1 
PHETRS Phenylalanyl-tRNA synthetase [c] : atp + phe-L + trnaphe --> amp + h + phetrna 
+ ppi 
 EC-6.1.1.20 
PIabc phosphate transport via ABC system atp[c] + h2o[c] + pi[e] --> adp[c] + h[c] + (2) 
pi[c] 
RLRE01283, 
RLRE01281, 
RLRE01280, 
RLRE01282, 
RLRE01284 
TC-3.A.1.7 
PIt6 phosphate transport in/out via proton 
symporter 
h[e] + pi[e] <==> h[c] + pi[c]  TC-2.A.20 
PKL phosphoketolase [c] : pi + xu5p-D <==> actp + g3p + h2o RLRE00295 EC-4.1.2.9 
PMANM phosphomannomutase [c] : man1p <==> man6p RLRE01496 EC-5.4.2.8 
PMEVK phosphomevalonate kinase [c] : 5pmev + atp --> 5dpmev + adp RLRE00339 EC-2.7.4.2 
PMPK phosphomethylpyrimidine kinase [c] : 4ampm + atp --> 2mahmp + adp RLRE00934 EC-2.7.4.7 
PNS1 purine nucleosidase (adenosine) [c] : adn + h2o --> ade + rib-D RLRE00691 EC-3.2.2.1 
PNS2 purine nucleosidase (guanosine) [c] : gsn + h2o --> gua + rib-D RLRE00691 EC-3.2.2.1 
PNS3 purine nucleosidase (inosine) [c] : h2o + ins --> hxan + rib-D RLRE00691 EC-3.2.2.1 
PNS4 purine nucleosidase (xanthosine) [c] : h2o + xtsn --> rib-D + xan RLRE00691 EC-3.2.2.1 
PNTK pantothenate kinase [c] : atp + pnto-R --> 4ppan + adp + h RLRE01043 EC-2.7.1.33 
PNTOt2 Pantothenate reversible transport via proton 
symport 
h[e] + pnto-R[e] <==> h[c] + pnto-R[c]   
PPA inorganic diphosphatase [c] : h2o + ppi --> h + (2) pi RLRE00363 EC-3.6.1.1 
PPCDC phosphopantothenoylcysteine decarboxylase [c] : 4ppcys + h --> co2 + pan4p RLRE01438 EC-4.1.1.36 
PPDt1 1,3-propanediol transport in/out via diffusion 
reversible 
13ppd[c] <==> 13ppd[e]   
PPIK polyphosphate kinase [c] : atp + ppi --> adp + pppi RLRE00571 EC-2.7.4.1 
PPM phosphopentomutase [c] : r1p <==> r5p RLRE01425, 
RLRE00979 
EC-5.4.2.7 
PPM2 phosphopentomutase (deoxyribose) [c] : 2dr1p <==> 2dr5p RLRE01425, 
RLRE00979 
EC-5.4.2.7 
PPN13D 1,3-propanediol dehydrogenase [c] : 13ppd + nad <==> 3hppnl + h + nadh RLRE00989 EC-1.1.1.202 
PPNCL phosphopantothenate-cysteine ligase [c] : 4ppan + ctp + cys-L --> 4ppcys + cdp + h + 
pi 
RLRE01438 EC-6.3.2.5 
PRAGS phosphoribosylglycinamide synthetase [c] : atp + gly + pram --> adp + gar + h + pi RLRE01421 EC-6.3.4.13 
PRAIS phosphoribosylaminoimidazole synthetase [c] : atp + fpram --> adp + air + h + pi RLRE01418 EC-6.3.3.1 
PRASCS phosphoribosylaminoimidazolesuccinocarboxa
mide synthase 
[c] : 5aizc + asp-L + atp <==> 25aics + adp + h + 
pi 
RLRE01413 EC-6.3.2.6 
PRFGS phosphoribosylformylglycinamidine synthase [c] : atp + fgam + gln-L + h2o --> adp + fpram + 
glu-L + (2) h + pi 
RLRE01416, 
RLRE01414, 
RLRE01415 
EC-6.3.5.3 
PROt6 L-proline transport in/out via proton symport h[e] + pro-L[e] <==> h[c] + pro-L[c]  TC-2.A.3.1 
PROTRS Prolyl-tRNA synthetase [c] : atp + pro-L + trnapro --> amp + h + ppi + 
protrna 
RLRE00670 EC-6.1.1.15 
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PROTS_LRE
_v6.0 
protein synthesis_LRE belonging to biomass 
version 6.0 
[c] : (0.125) alatrna + (0.04) argtrna + (0.06) asntrna + (0.06) asptrna + (0.306) atp + 
(0.011) cystrna + (0.083) glntrna + (0.023) glutrna + (0.084) glytrna + (2) gtp + (2.306) 
h2o + (0.017) histrna + (0.043) iletrna + (0.078) leutrna + (0.066) lystrna + (0.022) 
mettrna + (0.034) phetrna + (0.04) protrna + (0.056) sertrna + (0.064) thrtrna + (0.006) 
trptrna + (0.028) tyrtrna + (0.06) valtrna --> (0.001) PROT_LRE_v6.0 + (0.306) adp + 
(2) gdp + (2.306) h + (2.306) pi + (0.125) trnaala + (0.04) trnaarg + (0.06) trnaasn + 
(0.06) trnaasp + (0.011) trnacys + (0.106) trnaglu + (0.084) trnagly + (0.017) trnahis + 
(0.043) trnaile + (0.078) trnaleu + (0.066) trnalys + (0.022) trnamet + (0.034) trnaphe 
+ (0.04) trnapro + (0.056) trnaser + (0.064) trnathr + (0.006) trnatrp + (0.028) trnatyr + 
(0.06) trnaval 
PRPPS phosphoribosylpyrophosphate synthetase [c] : atp + r5p <==> amp + h + prpp RLRE01344 EC-2.7.6.1 
PSUDS pseudouridylate synthase [c] : r5p + ura --> h2o + psd5p RLRE01648, 
RLRE00818, 
RLRE00662, 
RLRE00356, 
RLRE00041 
EC-4.2.1.70 
PTAr phosphotransacetylase [c] : accoa + pi <==> actp + coa RLRE01504 EC-2.3.1.8 
PTPAT pantetheine-phosphate adenylyltransferase [c] : atp + h + pan4p <==> dpcoa + ppi RLRE01586 EC-2.7.7.3 
PTPATi pantetheine-phosphate adenylyltransferase [c] : atp + h + pan4p --> dpcoa + ppi RLRE01586 EC-2.7.7.3 
PTRCabc putrescine transport via ABC system atp[c] + h2o[c] + ptrc[e] --> adp[c] + h[c] + pi[c] 
+ ptrc[c] 
RLRE00679, 
RLRE00677, 
RLRE00678, 
RLRE00680 
TC-3.A.1.11 
PUNP1 purine-nucleoside phosphorylase (Adenosine) [c] : adn + pi <==> ade + r1p RLRE01423 EC-2.4.2.1 
PUNP2 purine-nucleoside phosphorylase 
(Deoxyadenosine) 
[c] : dad-2 + pi <==> 2dr1p + ade RLRE01423 EC-2.4.2.1 
PUNP3 purine-nucleoside phosphorylase (Guanosine) [c] : gsn + pi <==> gua + r1p RLRE01423 EC-2.4.2.1 
PUNP4 purine-nucleoside phosphorylase 
(Deoxyguanosine) 
[c] : dgsn + pi <==> 2dr1p + gua RLRE01423 EC-2.4.2.1 
PUNP5 purine-nucleoside phosphorylase (Inosine) [c] : ins + pi <==> hxan + r1p RLRE01423 EC-2.4.2.1 
PUNP6 purine-nucleoside phosphorylase 
(Deoxyinosine) 
[c] : din + pi <==> 2dr1p + hxan RLRE01423 EC-2.4.2.1 
PUNP7 purine-nucleoside phosphorylase (Xanthosine) [c] : pi + xtsn <==> r1p + xan RLRE01423 EC-2.4.2.1 
PYDAMK pyridoxal kinase (Pyridoxamine) [c] : atp + pydam --> adp + h + pyam5p  EC-2.7.1.35 
PYDAMt pyridoxamine transport h[e] + pydam[e] <==> h[c] + pydam[c]   
PYDXK pyridoxal kinase (Pyridoxal) [c] : atp + pydx --> adp + (2) h + pydx5p  EC-2.7.1.35 
PYDXPP Pyridoxal 5-phosphate phosphatase [c] : h + h2o + pydx5p --> pi + pydx   
PYK pyruvate kinase [c] : adp + h + pep --> atp + pyr RLRE00847 EC-2.7.1.40 
PYNP1 pyrimidine-nucleoside phosphorylase 
(cytosine) 
[c] : csn + r1p --> cytd + pi RLRE01424 EC-2.4.2.2 
PYNP1r pyrimidine-nucleoside phosphorylase 
(cytosine) 
[c] : csn + r1p <==> cytd + pi RLRE01424 EC-2.4.2.2 
PYNP2 pyrimidine-nucleoside phosphorylase (uracil) [c] : pi + uri <==> r1p + ura RLRE01424 EC-2.4.2.2 
PYNP3 pyrimidine-nucleoside phosphorylase 
(thymine) 
[c] : 2dr1p + thym --> pi + thymd RLRE01424 EC-2.4.2.2 
PYNP4 pyrimidine-nucleoside phosphorylase 
(pyrimidine nucleoside) 
[c] : pi + pyrin <==> pyrimid + r1p RLRE01424 EC-2.4.2.2 
PYRNS1 pyrimidine nucleosidase (uridine) [c] : h2o + uri --> rib-D + ura RLRE01151 EC-3.2.2.8 
PYRt2 pyruvate reversible transport via proton 
symport 
h[e] + pyr[e] <==> h[c] + pyr[c]   
PYRZAM Pyrazinamidase [c] : h2o + malm --> male + nh4 RLRE01087  
QUIND quinate dehydrogenase (pyrroloquinoline-
quinone) 
[c] : pqqox + quin --> 3dhq + h + pqqrd RLRE01095 EC-1.1.99.25 
R05220 Cob(I)yrinate a,c diamide <=>  Adenosyl 
cobyrinate a,c diamide 
[c] : atp + co1dam + h2o + (0.5) nadh --> 
adcobdam + (0.5) h + (0.5) nad + pi + ppi 
RLRE00244, 
RLRE00256 
 
R05223 Adenosine-GDP-cobinamide + alpha-Ribazole  
<=> Cobamide coenzyme 
[c] : adgcoba + (0.5) h + (0.5) nad + rdmbzi --> 
cobamcoa + gmp + (0.5) nadh 
RLRE00283  
R05225 Adenosyl cobyrinate a,c diamide  <=> 
Adenosyl cobyrinate hexaamide 
[c] : adcobdam + (4) atp + (4) gln-L + (4) h2o --> 
adcobhex + (4) adp + (4) glu-L + (4) h + (4) pi 
RLRE00276  
R05226 Adenosyl cobyrinate hexaamide l <=> 
Adenosyl cobinamide 
[c] : 1ap2ol + adcobhex --> adcoba + h2o RLRE00260  
RAFGH Raffinose galactohydrolase [c] : h2o + raffin --> gal + sucr RLRE00336 EC-3.2.1.22 
RBFK riboflavin kinase [c] : atp + ribflv --> adp + fmn + h RLRE00661 EC-2.7.1.26 
RBFSa riboflavin synthase [c] : 4r5au + db4p --> dmlz + (2) h2o + pi RLRE01153 EC-2.5.1.9 
RBK ribokinase [c] : atp + rib-D --> adp + h + r5p RLRE01090, 
RLRE01556 
EC-2.7.1.15 
RBLK1 L-ribulokinase (L-ribulose) [c] : atp + rbl-L --> adp + h + ru5p-L RLRE01515 EC-2.7.1.16 
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RBLK2 L-ribulokinase (ribitol) [c] : atp + rbt --> adp + h + rbt5p RLRE01515 EC-2.7.1.16 
RBP4E L-ribulose-phosphate 4-epimerase [c] : ru5p-L <==> xu5p-D RLRE01514 EC-5.1.3.4 
RBT5PDHy ribitol-5-phosphate 2-dehydrogenase (NADP) [c] : nadp + rbt5p <==> h + nadph + ru5p-D  EC-1.1.1.137 
RBZP alpha-ribazole-5-phosphatase [c] : 5prdmbz + h2o --> pi + rdmbzi RLRE00284  
RHC ribosylhomocysteinase [c] : h2o + rhcys --> hcys-L + rib-D RLRE01300 EC-3.2.1.148 
RIBFLVt2 riboflavin transport in via proton symport h[e] + ribflv[e] --> h[c] + ribflv[c] RLRE01699  
RNAS_LRE RNA synthesis, L.plantarum specific [c] : (0.66) atp + (0.2) ctp + (0.32) gtp + (0.4) h2o + (0.22) utp --> (0.01) RNA_LRE + 
(0.4) adp + (0.4) h + (0.4) pi + ppi 
RNDR1 ribonucleoside-diphosphate reductase (ADP) [c] : adp + trdrd --> dadp + h2o + trdox RLRE00556, 
RLRE00557 
EC-1.17.4.1 
RNDR2 ribonucleoside-diphosphate reductase (GDP) [c] : gdp + trdrd --> dgdp + h2o + trdox RLRE00556, 
RLRE00557 
EC-1.17.4.1 
RNDR3 ribonucleoside-diphosphate reductase (CDP) [c] : cdp + trdrd --> dcdp + h2o + trdox RLRE00556, 
RLRE00557 
EC-1.17.4.1 
RNDR4 ribonucleoside-diphosphate reductase (UDP) [c] : trdrd + udp --> dudp + h2o + trdox RLRE00556, 
RLRE00557 
EC-1.17.4.1 
RNTR1 ribonucleoside-triphosphate reductase (ATP) [c] : atp + trdrd --> datp + h2o + trdox RLRE00542, 
RLRE00350, 
RLRE00219 
EC-1.17.4.2 
RNTR2 ribonucleoside-triphosphate reductase (GTP) [c] : gtp + trdrd --> dgtp + h2o + trdox RLRE00542, 
RLRE00350, 
RLRE00219 
EC-1.17.4.2 
RNTR3 ribonucleoside-triphosphate reductase (CTP) [c] : ctp + trdrd --> dctp + h2o + trdox RLRE00542, 
RLRE00350, 
RLRE00219 
EC-1.17.4.2 
RNTR4 ribonucleoside-triphosphate reductase (UTP) [c] : trdrd + utp --> dutp + h2o + trdox RLRE00542, 
RLRE00350, 
RLRE00219 
EC-1.17.4.2 
RPE ribulose 5-phosphate 3-epimerase [c] : ru5p-D <==> xu5p-D RLRE01445 EC-5.1.3.1 
RPI ribose-5-phosphate isomerase [c] : r5p <==> ru5p-D RLRE01162 EC-5.3.1.6 
SBTpts D-sorbitol transport via PEP:Pyr PTS pep[c] + sbt-D[e] --> pyr[c] + sbt6p[c] RLRE00126, 
RLRE00764 
 
SDPDS succinyl-diaminopimelate desuccinylase [c] : h2o + sl26da --> 26dap-LL + succ RLRE00970, 
RLRE00964 
EC-3.5.1.18 
SECYSL selenocysteine lyase [c] : dtt_rd + scys-L --> H2Se + ala-L + dtt_ox RLRE00745, 
RLRE00638, 
RLRE00318 
EC-4.4.1.16 
SERAT serine O-acetyltransferase [c] : accoa + ser-L <==> acser + coa  EC-2.3.1.30 
SERD_L L-serine deaminase [c] : ser-L --> nh4 + pyr  EC-4.3.1.17 
SERt3 L-serine transport out via proton antiport h[e] + ser-L[c] --> h[c] + ser-L[e] RLRE00801, RLRE00824, 
RLRE00800 
SERt6 L-serine transport in/out via proton symport h[e] + ser-L[e] <==> h[c] + ser-L[c]  TC-2.A.42 
SERTRS Seryl-tRNA synthetase [c] : atp + ser-L + trnaser --> amp + h + ppi + 
sertrna 
RLRE01242 EC-6.1.1.11 
SHCHD2 sirohydrochlorin dehydrogenase (NAD) [c] : nad + shcl --> (2) h + nadh + srch RLRE00277  
SPMDabc spermidine transport via ABC system atp[c] + h2o[c] + spmd[e] --> adp[c] + h[c] + 
pi[c] + spmd[c] 
RLRE00679, 
RLRE00677, 
RLRE00678, 
RLRE00680 
TC-3.A.1.11 
SSALx succinate-semialdehyde dehydrogenase (NAD) [c] : h2o + nad + sucsal --> (2) h + nadh + succ  EC-1.2.1.16 
SSALy succinate-semialdehyde dehydrogenase 
(NADP) 
[c] : h2o + nadp + sucsal --> (2) h + nadph + succ  EC-1.2.1.16 
SUCBZL o-succinylbenzoate-CoA ligase [c] : atp + coa + sucbz --> amp + ppi + sbzcoa RLRE00313 EC-6.2.1.26 
SUCpts sucrose transport via PEP:Pyr PTS pep[c] + sucr[e] --> pyr[c] + suc6p[c] RLRE00126, RLRE00764, 
RLRE01426 
TAPGL4 teichoic acid peptidoglycan ligase [c] : unRTA --> RTA + udcpp   
TDMAT6 Tetradecanoyl-[acyl-carrier protein]:malonyl-
CoA  C-acyltransferase 
[c] : 2ttdeacp + h + nadh --> nad + tdeacp RLRE01399 EC-1.3.1.10 
TDPDRE dTDP-4-dehydrorhamnose 3,5-epimerase [c] : dtdpddg <==> dtdpddm  EC-5.1.3.13 
TDPDRR dTDP-4-dehydrorhamnose reductase [c] : dtdp6dm + nadp <==> dtdpddm + h + nadph RLRE01021 EC-1.1.1.133 
TDPGDH dTDPglucose 4,6-dehydratase [c] : dtdpglc --> dtdpddg + h2o RLRE01022 EC-4.2.1.46 
THDPS tetrahydropicolinate succinylase [c] : h2o + succoa + thdp --> coa + sl2a6o RLRE00628 EC-2.3.1.117 
THFGLUS Tetrahydrofolate:L-glutamate gamma-ligase 
(ADP-forming) 
[c] : atp + glu-L + thf <==> adp + h + pi + thfglu RLRE01598, 
RLRE00737 
EC-6.3.2.17 
THMabc thiamine transport via ABC system atp[c] + h2o[c] + thm[e] --> adp[c] + h[c] + pi[c] 
+ thm[c] 
  
THMDt2r thymidine transport in via proton symport, 
reversible 
h[e] + thymd[e] <==> h[c] + thymd[c]   
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THRPDC Threonine-phosphate decarboxylase (EC 
4.1.1.81) 
[c] : thrp --> 1ap2olp + co2 RLRE00258  
THRt2 L-threonine transport in via proton symport h[e] + thr-L[e] --> h[c] + thr-L[c]   
THRt3 L-threonine transport out via proton antiport h[e] + thr-L[c] --> h[c] + thr-L[e] RLRE00801, RLRE00824, 
RLRE00800 
THRTRS Threonyl-tRNA synthetase [c] : atp + thr-L + trnathr --> amp + h + ppi + 
thrtrna 
RLRE00079 EC-6.1.1.3 
THZPSN thiazole phosphate synthesis [c] : atp + cys-L + dxyl5p + tyr-L --> 4hba + 
4mpetz + ala-L + amp + co2 + h + h2o + ppi 
RLRE00820  
THZPSN2 thiazole phosphate synthesis [c] : MCOSH + dxyl5p + gly + nadp --> 4mpetz 
+ MCOOH + co2 + (2) h + (2) h2o + nadph 
RLRE00820  
TMDK1 thymidine kinase (ATP:thymidine) [c] : atp + thymd --> adp + dtmp + h RLRE00770 EC-2.7.1.21 
TMDK2 thymidine kinase (GTP:Thymidine) [c] : gtp + thymd --> dtmp + gdp + h RLRE00770 EC-2.7.1.21 
TMDPK thiamine diphosphokinase [c] : atp + thm --> amp + h + thmpp  EC-2.7.6.2 
TMDS thymidylate synthase [c] : dump + mlthf --> dhf + dtmp RLRE01183 EC-2.1.1.45 
TMPPP thiamine-phosphate diphosphorylase [c] : 2mahmp + 4mpetz + h --> ppi + thmmp RLRE00935 EC-2.5.1.3 
TPI triose-phosphate isomerase [c] : dhap <==> g3p RLRE00788, 
RLRE01102, 
RLRE01103 
EC-5.3.1.1 
TRDR thioredoxin reductase (NADPH) [c] : h + nadph + trdox --> nadp + trdrd RLRE01590, 
RLRE00776, 
RLRE00963 
EC-1.8.1.9 
TREpts trehalose transport via PEP:Pyr PTS pep[c] + tre[e] --> pyr[c] + tre6p[c] RLRE00126, RLRE00764, 
RLRE00243, RLRE00454 
TRPt6 L-tryptophan transport in/out via proton 
symport 
h[e] + trp-L[e] <==> h[c] + trp-L[c]  TC-2.A.3.1 
TRPTRS Tryptophanyl-tRNA synthetase [c] : atp + trnatrp + trp-L --> amp + h + ppi + 
trptrna 
RLRE01070 EC-6.1.1.2 
TYRt6 L-tyrosine transport in/out via proton symport h[e] + tyr-L[e] <==> h[c] + tyr-L[c] RLRE01097, 
RLRE00045 
TC-2.A.3.1 
TYRTRS Tyrosyl-tRNA synthetase [c] : atp + trnatyr + tyr-L --> amp + h + ppi + 
tyrtrna 
 EC-6.1.1.1 
UAAGDS UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-
meso-2,6-diaminopimelate synthetase 
[c] : 26dap-M + atp + uamag --> adp + h + pi + 
ugmd 
RLRE00771 EC-6.3.2.13 
UAAGLS1 UDP-N-acetylmuramoyl-L-alanyl-D-
glutamate-lysine synthetase (alpha-glutamate) 
[c] : atp + lys-L + uamag --> adp + (2) h + pi + 
uAgl 
RLRE00464 EC-6.3.2.7 
UAG2E UDP-N-acetylglucosamine 2-epimerase [c] : uacgam <==> uacmam RLRE00546, 
RLRE00188 
EC-5.1.3.14 
UAG2EMA UDP-N-acetyl-D-glucosamine 2-epimerase 
(Hydrolysis) 
[c] : h2o + uacgam <==> acmana + h + udp RLRE00546, 
RLRE00188 
EC-5.1.3.14 
UAGCVT UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 
[c] : pep + uacgam --> pi + uaccg RLRE00783, 
RLRE00752 
EC-2.5.1.7 
UAGDP UDP-N-acetylglucosamine diphosphorylase [c] : acgam1p + h + utp --> ppi + uacgam RLRE01343 EC-2.7.7.23 
UAGPT5 UDP-N-acetylglucosamine-N-acetylmuramyl-
(pentapeptide)pyrophosphoryl-undecaprenol 
N-acetylglucosamine transferase 
[c] : uacgam + uagmdalac --> h + uaagmdalac + 
udp 
RLRE01106  
UAMAGS UDP-N-acetylmuramoyl-L-alanyl-D-
glutamate synthetase 
[c] : atp + glu-D + uama --> adp + h + pi + 
uamag 
RLRE01107 EC-6.3.2.9 
UAMAS UDP-N-acetylmuramoyl-L-alanine synthetase [c] : ala-L + atp + uamr --> adp + h + pi + uama RLRE01620 EC-6.3.2.8 
UAPGR UDP-N-acetylenolpyruvoylglucosamine 
reductase 
[c] : h + nadph + uaccg --> nadp + uamr RLRE01557 EC-1.1.1.158 
UDCPDP undecaprenyl-diphosphatase [c] : h2o + udcpdp --> h + pi + udcpp  EC-3.6.1.27 
UDCPDPS Undecaprenyl diphosphate synthase [c] : frdp + (8) ipdp --> (8) ppi + udcpdp RLRE01385, RLRE00673, 
RLRE01562 
UDCPK undecaprenol kinase [c] : atp + udcp --> adp + h + udcpp  EC-2.7.1.66 
UDPDPS undecaprenyl-diphosphate synthase [c] : decdp + ipdp --> ppi + udcpdp RLRE00673 EC-2.5.1.31 
UDPG4E UDPglucose 4-epimerase [c] : udpg <==> udpgal RLRE00573 EC-5.1.3.2 
UDPGALM UDPgalactopyranose mutase [c] : udpgal --> udpgalfur RLRE00204 EC-5.4.99.9 
UGLDDS1 UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-
L-lysyl-D-alanyl-D-alanine synthetase (alpha-
glutamate) 
[c] : alaala + atp + uAgl --> adp + pi + uAgla RLRE00794 EC-6.3.2.10 
UGLDDS2 UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-
L-lysyl-D-alanyl-D-alanine synthetase 
(gamma-glutamate) 
[c] : alaala + atp + uGgl --> adp + h + pi + uGgla RLRE00794 EC-6.3.2.10 
UGLDDS3 UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-
L-lysyl-D-alanyl-D-lactate synthetase (alpha-
glutamate) 
[c] : alalac + atp + uAgl --> adp + pi + uAglac RLRE00794 EC-6.3.2.10 
UGMDDS2 UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-
meso-2,6-diaminopimeloyl-D-alanyl-D-lactate 
synthetase 
[c] : alalac + atp + ugmd --> adp + h + pi + 
ugmdalac 
RLRE00794  
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UNAGAMA
MT 
N-acetylglucosaminyldiphospho-
undecaprenol-N-acetyl-beta-D-
mannosaminyltransferase 
[c] : uacmam + unaga --> h + udp + unagama  EC-2.4.1.187 
UPPRT uracil phosphoribosyltransferase [c] : prpp + ura --> ppi + ump RLRE00765 EC-2.4.2.9 
URAt2 uracil transport in via proton symport h[e] + ura[e] --> h[c] + ura[c] RLRE00761 TC-2.A.40 
URIDK1 uridylate kinase (UMP) [c] : atp + ump --> adp + udp RLRE01190  
URIDK2 uridylate kinase (dUMP) [c] : atp + dump --> adp + dudp RLRE01190  
URIK1 uridine kinase (ATP:Uridine) [c] : atp + uri --> adp + h + ump  EC-2.7.1.48 
URIK2 uridine kinase (GTP:Uridine) [c] : gtp + uri --> gdp + h + ump  EC-2.7.1.48 
URIK3 uridine kinase (ITP:Uridine) [c] : itp + uri --> h + idp + ump  EC-2.7.1.48 
VALt2 L-valine transport in via proton symport h[e] + val-L[e] --> h[c] + val-L[c] RLRE00300  
VALt6 L-valine transport in/out via proton symport h[e] + val-L[e] <==> h[c] + val-L[c] RLRE00027, 
RLRE01221, 
RLRE01222 
TC-2.A.26 
VALTRS Valyl-tRNA synthetase [c] : atp + trnaval + val-L --> amp + h + ppi + 
valtrna 
RLRE00743 EC-6.1.1.9 
XANt2 xanthine transport in via proton symport h[e] + xan[e] --> h[c] + xan[c] RLRE00044 TC-2.A.40 
XPPT xanthine phosphoribosyltransferase [c] : prpp + xan --> ppi + xmp RLRE01051 EC-2.4.2.22 
XYLK xylulokinase [c] : atp + xylu-D --> adp + h + xu5p-D RLRE01357 EC-2.7.1.17 
YUMPS yUMP synthetase [c] : r5p + ura <==> h2o + psd5p RLRE01648, 
RLRE00818, 
RLRE00662, 
RLRE00356, 
RLRE00041 
EC-4.2.1.70 
a. 
Association between RLRE and Lreu numbering system is available upon request.
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Table 4.S1.2. Complete list of model metabolites and their abbreviation. 
Abbreviation     Official name    Formula         
10fthf 10-Formyltetrahydrofolate C20H21N7O7 
13dpg 3-Phospho-D-glyceroyl phosphate C3H4O10P2 
13ppd Propane-1,3-diol C3H8O2 
15dap 1,5-Diaminopentane C5H16N2 
1ap2ol 1-Aminopropan-2-ol C3H10NO 
1ap2olp D-1-Aminopropan-2-ol O-phosphate C3H10NO4P 
1pyr5c 1-Pyrroline-5-carboxylate C5H6NO2 
23dhdp 2,3-Dihydrodipicolinate C7H5NO4 
25aics (S)-2-[5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido]succinate C13H15N4O12P 
25dhpp 2,5-Diamino-6-hydroxy-4-(5'-phosphoribosylamino)-pyrimidine C9H14N5O8P 
25dkglcn 2,5-diketo-D-gluconate C6H7O7 
26dap-LL LL-2,6-Diaminoheptanedioate C7H14N2O4 
26dap-M meso-2,6-Diaminoheptanedioate C7H14N2O4 
2ahbut (S)-2-Aceto-2-hydroxybutanoate C6H9O4 
2ahhmd 2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate C7H8N5O8P2 
2ahhmp 2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine C7H9N5O2 
2beacp But-2-enoyl-[acyl-carrier protein] C4H4OX 
2c25dho 2-Carboxy-2,5-dihydro-5-oxofuran-2-acetate C7H6O6 
2chdeacp cis-Hexadec-2-enoyl-[acyl-carrier protein] C16H28OX 
2cocdacp cis-Octadec-2-enoyl-[acyl-carrier-protein] C18H32OX 
2dhguln 2-Dehydro-L-gulonate C6H9O7 
2dhp 2-Dehydropantoate C6H9O4 
2dmmq7 2-Demethylmenaquinone 7 C45H62O2 
2dmmq8 2-Demethylmenaquinone 8 C50H70O2 
2dr1p 2-Deoxy-D-ribose 1-phosphate C5H9O7P 
2dr5p 2-Deoxy-D-ribose 5-phosphate C5H9O7P 
2hxic-L L-2-hydroxyisocaproate C6H11O3 
2mahmp 2-Methyl-4-amino-5-hydroxymethylpyrimidine diphosphate C6H8N3O7P2 
2mpal 2-methylpropanal C4H8O 
2mpol 2-methylpropanol C4H10O 
2obut 2-Oxobutanoate C4H5O3 
2p4c2me 2-phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol C14H22N3O17P3 
2pg D-Glycerate 2-phosphate C3H4O7P 
2pglyc 2-Phosphoglycolate C2H2O6P 
2tddacp trans-Dodec-2-enoyl-[acyl-carrier protein] C12H20OX 
2tdeacp trans-Dec-2-enoyl-[acyl-carrier protein] C10H16OX 
2thdeacp trans-Hexadec-2-enoyl-[acyl-carrier protein] C16H28OX 
2theacp trans-Hex-2-enoyl-[acp] C6H8OX 
2tocdacp trans-Octadec-2-enoyl-[acyl-carrier-protein] C18H32OX 
2toceacp trans-Oct-2-enoyl-[acp] C8H12OX 
2ttdeacp trans-Tetradec-2-enoyl-[acyl-carrier protein] C14H24OX 
34hpp 3-(4-Hydroxyphenyl)pyruvate C9H7O4 
3dhq 3-Dehydroquinate C7H9O6 
3hbacp (3R)-3-Hydroxybutanoyl-[acyl-carrier protein] C4H6O2X 
3hbycoa (S)-3-Hydroxybutyryl-CoA C25H38N7O18P3S 
3hddacp (R)-3-Hydroxydodecanoyl-[acyl-carrier protein] C12H22O2X 
3hdeacp (3R)-3-Hydroxydecanoyl-[acyl-carrier protein] C10H18O2X 
3hhacp (R)-3-Hydroxyhexanoyl-[acp] C6H10O2X 
3hocacp (R)-3-Hydroxyoctanoyl-[acyl-carrier protein] C8H14O2X 
3hocdacp (3R)-3-Hydroxyoctadecanoyl-[acyl-carrier protein C18H34O2X 
3hpaacp (3R)-3-Hydroxypalmitoyl-[acyl-carrier protein] C16H30O2X 
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3hppnl 3-Hydroxypropanal C3H6O2 
3htdacp (3R)-3-Hydroxytetradecanoyl-[acyl-carrier protein] C14H26O2X 
3mop (S)-3-Methyl-2-oxopentanoate C6H9O3 
3oxddacp 3-Oxododecanoyl-[acyl-carrier protein] C12H20O2X 
3oxdeacp 3-Oxodecanoyl-[acyl-carrier protein] C10H16O2X 
3oxhacp 3-Oxohexanoyl-[acyl-carrier protein] C6H8O2X 
3oxhdacp 3-Oxohexadecanoyl-[acp] C16H28O2X 
3oxocacp 3-Oxooctanoyl-[acyl-carrier protein] C8H12O2X 
3oxocdacp 3-Oxooctadecanoyl-[acp] C18H32O2X 
3oxtdacp 3-Oxotetradecanoyl-[acyl-carrier protein] C14H24O2X 
3pg 3-Phospho-D-glycerate C3H4O7P 
4abut 4-Aminobutanoate C4H9NO2 
4abz 4-Aminobenzoate C7H6NO2 
4adcho 4-amino-4-deoxychorismate C10H10NO5 
4ahmmp 4-Amino-5-hydroxymethyl-2-methylpyrimidine C6H9N3O 
4ampm 4-Amino-2-methyl-5-phosphomethylpyrimidine C6H8N3O4P 
4c2me 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol C14H23N3O14P2 
4h2oxg D-4-Hydroxy-2-oxoglutarate C5H4O6 
4hba 4-Hydroxy-benzyl alcohol C7H8O2 
4hglu 4-Hydroxy-L-glutamate C5H8NO5 
4mhetz 4-Methyl-5-(2-hydroxyethyl)-thiazole C6H9NOS 
4mop 4-Methyl-2-oxopentanoate C6H9O3 
4mpetz 4-Methyl-5-(2-phosphoethyl)-thiazole C6H8NO4PS 
4pasp 4-Phospho-L-aspartate C4H6NO7P 
4ppan D-4'-Phosphopantothenate C9H15NO8P 
4ppcys N-((R)-4-Phosphopantothenoyl)-L-cysteine C12H20N2O9PS 
4r5au 4-(1-D-Ribitylamino)-5-aminouracil C9H16N4O6 
56dura 5,6-dihydrouracil C4H6N2O2 
5aizc 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate C9H11N3O9P 
5aop 5-Amino-4-oxopentanoate C5H9NO3 
5aprbu 5-Amino-6-(5'-phosphoribitylamino)uracil C9H15N4O9P 
5apru 5-Amino-6-(5'-phosphoribosylamino)uracil C9H13N4O9P 
5dglcn 5-Dehydro-D-gluconate C6H9O7 
5dpmev (R)-5-Diphosphomevalonate C6H10O10P2 
5fothf 5-Formyltetrahydrofolate C20H21N7O7 
5mta 5-Methylthioadenosine C11H15N5O3S 
5mthglu 5-Methyltetrahydropteroyltri-L-glutamate C25H34N8O12 
5mtr 5-Methylthio-D-ribose C6H12O4S 
5odhf2a 5-Oxo-4,5-dihydrofuran-2-acetate C6H5O4 
5pmev (R)-5-Phosphomevalonate C6H10O7P 
5prdmbz N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole C14H17N2O7P 
6pgc 6-Phospho-D-gluconate C6H10O10P 
6pgg 6-Phospho-beta-D-glucosyl-(1,4)-D-glucose C12H21O14P 
6pgl 6-phospho-D-glucono-1,5-lactone C6H9O9P 
ACP acyl carrier protein C11H21N2O7PRS 
CPS_LRE capsular polysaccharide linkage unit, LRE specific C30H59O32P1 
CPS_LRE2 capsular polysaccharide linkage unit, LRE specific C24H47O25P1 
DNA_LRE DNA, LRE specific C978H1128N372O600P100 
H2Se Selenide H2Se 
LTA_LRE lipoteichoic acid (n=25, LRE specific) C12474H24072O14000P2500 
LTAala_LRE Lipoteichoic acid (n=25) with 100% D-Ala substitutions (LRE specific) 
C19974H39072N2500O16500P2
500 
LTAglc_LRE Lipoteichoic acid (n=25 with glucose residues, LRE specific) C27474H49072O26500P2500 
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Lglyald L-Glyceraldehyde C3H6O3 
MCOOH MPT synthase small subunit MoaD MCO2 
MCOSH MPT synthase sulfurylated small subunit (MoaD-SH) MCHOS 
PGlac2 peptidoglycan with D-lac as C-terminal residue to form pentadepsipeptide C40H62N7O22 
PROT_LRE_v
6.0 
L. reuteri-specific protein composition for biomass version 6.0 C4708H7526N1369O1457S33 
RNA_LRE RNA, LRE specific C958H1078N394O696P100 
RTA teichoic acid containing ribitol-P C144H283N2O193P27 
RTAala ribitol teichoic acid (n=25) with D-Ala substitutions C219H433N27O218P27 
RTAglc ribitol teichoic acid (n=25) with glucose substitutions C294H533N2O318P27 
a-gal-D alpha-D galactose C6H12O6 
aaacp Acetoacetyl-[acyl-carrier protein] C4H4O2X 
aacoa Acetoacetyl-CoA C25H36N7O18P3S 
abt-L L-Arabinitol C5H12O5 
ac Acetate C2H3O2 
acald Acetaldehyde C2H4O 
acamoxm N-Acetyl-L-2-amino-6-oxopimelate C9H11NO6 
accoa Acetyl-CoA C23H34N7O17P3S 
acgal6p N-acetylgalactosamine 6-phosphate C8H14NO9P 
acgala N-Acetyl-D-galactosamine C8H15NO6 
acgam N-Acetyl-D-glucosamine C8H15NO6 
acgam1p N-Acetyl-D-glucosamine 1-phosphate C8H14NO9P 
acgam6p N-Acetyl-D-glucosamine 6-phosphate C8H14NO9P 
achms O-Acetyl-L-homoserine C6H11NO4 
acmam N-Acetyl-D-muramoate C11H18NO8 
acmama N-Acetyl-D-muramoyl-L-alanine C14H23N2O9 
acmana N-Acetyl-D-mannosamine C8H15NO6 
acmanap N-Acetyl-D-mannosamine 6-phosphate C8H14NO9P 
acp Acyl-carrier Protein X 
acser O-Acetyl-L-serine C5H9NO4 
actn-R (R)-Acetoin C4H8O2 
actp Acetyl phosphate C2H3O5P 
adcoba Adenosyl cobinamide C58H87CoN16O11 
adcobap Adenosyl cobinamide phosphate C58H88CoN16O14P 
adcobdam Adenosyl cobyrinate diamide C55H71CoN11O15 
adcobhex adenosyl-cobyric acid C55H79CoN15O11 
ade Adenine C5H5N5 
adgcoba Adenosine-GDP-cobinamide C68H98CoN21O21P2 
adn Adenosine C10H13N5O4 
adp ADP C10H12N5O10P2 
adprib ADPribose C15H21N5O14P2 
agly3p_LRE 1-Acyl-sn-glycerol 3-phosphate (Lb reuteri specific) C2037H3836O700P100 
ahcys S-Adenosyl-L-homocysteine C14H20N6O5S 
ahdt 
2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine 
triphosphate 
C9H12N5O13P3 
aicar 5-Amino-1-(5-Phospho-D-ribosyl)imidazole-4-carboxamide C9H13N4O8P 
air 5-amino-1-(5-phospho-D-ribosyl)imidazole C8H12N3O7P 
akg 2-Oxoglutarate C5H4O5 
al26da N6-Acetyl-LL-2,6-diaminoheptanedioate C9H14N2O5 
ala-D D-Alanine C3H7NO2 
ala-L L-Alanine C3H7NO2 
alaala D-Alanyl-D-alanine C6H12N2O3 
alac-S (S)-2-Acetolactate C5H7O4 
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alalac D-Alanyl-D-lactate C6H11NO4 
alatrna L-Alanyl-tRNA(Ala) C18H28NO17P2R3 
amet S-Adenosyl-L-methionine C15H23N6O5S 
amp AMP C10H12N5O7P 
antim Antimonite H4OSb 
ap4a P1,P4-Bis(5'-adenosyl) tetraphosphate C20H24N10O19P4 
apoACP apoprotein [acyl carrier protein] RHO 
arab-L L-Arabinose C5H10O5 
arg-L L-Arginine C6H15N4O2 
argsuc N(omega)-(L-Arginino)succinate C10H17N4O6 
argtrna L-Arginyl-tRNA(Arg) C21H36N4O17P2R3 
arsna Arsenate H1AsO4 
arsni2 arsenite AsH3O3 
asn-L L-Asparagine C4H8N2O3 
asntrna L-Asparaginyl-tRNA(Asn) C19H29N2O18P2R3 
asp-D D-Aspartate C4H6NO4 
asp-L L-Aspartate C4H6NO4 
aspsa L-Aspartate 4-semialdehyde C4H7NO3 
asptrna L-Aspartyl-tRNA(Asp) C19H27NO19P2R3 
atp ATP C10H12N5O13P3 
btd-RR (R,R)-2,3-Butanediol C4H10O2 
btn Biotin C10H15N2O3S 
butacp Butyryl-[acyl-carrier protein] C4H6OX 
cbasp N-Carbamoyl-L-aspartate C5H6N2O5 
cbi Cobinamide C48H75CoN11O8 
cbl1 Cob(I)alamin C62H92CoN13O14P 
cbp Carbamoyl phosphate CH2NO5P 
cdp CDP C9H12N3O11P2 
cdpdag_LRE CDPdiacylglycerol (LRE specific) C4674H8172N300O1500P200 
cdpglyc CDPglycerol C12H19N3O13P2 
cdprbtl CDPribitol C14H23N3O15P2 
cellb cellobiose C12H22O11 
chol Choline C5H14NO 
citr-L L-Citrulline C6H13N3O3 
clpn_LRE Cardiolipin (LRE specific) C7848H14544O1700P200 
cmp CMP C9H12N3O8P 
co1dam Cob(I)yrinate a,c diamide C45H59CoN6O12 
co2 CO2 CO2 
co2dam Cob(II)yrinate a,c diamide C45H60CoN6O12 
coa Coenzyme A C21H32N7O16P3S 
cobalt2 Co2+ Co 
cobamcoa Cobamide coenzyme C72H104CoN18O17P 
cobrnt Cobyrinate C45H54CoN4O14 
codhprec6 Cobalt-dihydro-precorrin 6 C44H48CoN4O16 
coprec2 cobalt-precorrin2 C42H36CoN4O16 
coprec3 Cobalt-precorrin 3 C43H39CoN4O16 
coprec4 Cobalt-precorrin 4 C44H42CoN4O16 
coprec5 Cobalt-precorrin 5 C45H45CoN4O16 
coprec6 Cobalt-precorrin 6 C44H46CoN4O16 
coprec8 Cobalt-precorrin 8 C45H54CoN4O14 
cpocdacp cyclopropanoyl octadecanoyl-[acyl-carrier protein] C19H34OX 
csn Cytosine C4H5N3O 
ctp CTP C9H12N3O14P3 
THE IMPACT OF GLYCEROL ON THE METABOLISM OF LACTOBACILLUS REUTERI 
STUDIED BY FUNCTIONAL GENOMICS AND GENOME-SCALE MODELING 
 135 
Abbreviation     Official name    Formula         
cu2 Cu2+ Cu 
cys-D D-Cysteine C3H7NO2S 
cys-L L-Cysteine C3H7NO2S 
cyst-L L-Cystine C6H12N2O4S2 
cysth-L L-Cystathionine C7H14N2O4S 
cystrna L-Cysteinyl-tRNA(Cys) C18H28NO17P2SR3 
cytd Cytidine C9H13N3O5 
dad-2 Deoxyadenosine C10H13N5O3 
dadp dADP C10H12N5O9P2 
dag_LRE 1,2-Diacylglycerol, LRE specific C3774H7072O500 
damp dAMP C10H12N5O6P 
datp dATP C10H12N5O12P3 
db4p 3,4-dihydroxy-2-butanone 4-phosphate C4H7O6P 
dcamp N6-(1,2-Dicarboxyethyl)-AMP C14H14N5O11P 
dcdp dCDP C9H12N3O10P2 
dcmp dCMP C9H12N3O7P 
dctp dCTP C9H12N3O13P3 
dcyt Deoxycytidine C9H13N3O4 
ddca Dodecanoate C12H23O2 
ddcaACP Dodecanoyl-ACP (n-C12:0ACP) C23H43N2O8PRS 
ddeacp Dodecanoyl-[acyl-carrier protein] C12H22OX 
decacp Decanoyl-[acyl-carrier protein] C10H18OX 
decdp all-trans-Decaprenyl diphosphate C50H81O7P2 
dgdag_LRE Diglucosyl-diacylglycerol C4974H9072O1500 
dgdp dGDP C10H12N5O10P2 
dgmp dGMP C10H12N5O7P 
dgsn Deoxyguanosine C10H13N5O4 
dgtp dGTP C10H12N5O13P3 
dha Dihydroxyacetone C3H6O3 
dhap Dihydroxyacetone phosphate C3H5O6P 
dhf 7,8-Dihydrofolate C19H19N7O6 
dhna 1,4-Dihydroxy-2-naphthoate C11H7O4 
dhnpt 
2-Amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-
dihydropteridine 
C9H13N5O4 
dhor-S (S)-Dihydroorotate C5H5N2O4 
dhpmp Dihydroneopterin monophosphate C9H13N5O7P 
dhpt Dihydropteroate C14H13N6O3 
diact Diacetyl C4H6O2 
dimp dIMP C10H12N4O7P 
din Deoxyinosine C10H12N4O4 
dmbzid 5,6-Dimethylbenzimidazole C9H10N2 
dmlz 6,7-Dimethyl-8-(1-D-ribityl)lumazine C13H18N4O6 
dmpp Dimethylallyl diphosphate C5H9O7P2 
dnad Deamino-NAD+ C21H24N6O15P2 
dpcoa Dephospho-CoA C21H33N7O13P2S 
drib Deoxyribose C5H10O4 
dtdp dTDP C10H13N2O11P2 
dtdp6dm dTDP-6-deoxy-L-mannose C16H24N2O15P2 
dtdpddg dTDP-4-dehydro-6-deoxy-D-glucose C16H22N2O15P2 
dtdpddm dTDP-4-dehydro-6-deoxy-L-mannose C16H22N2O15P2 
dtdpglc dTDPglucose C16H24N2O16P2 
dtmp dTMP C10H13N2O8P 
dtt_ox Oxidized dithiothreitol C4H8O2S2 
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dtt_rd Reduced dithiothreitol C4H10O2S2 
dttp dTTP C10H13N2O14P3 
dudp dUDP C9H11N2O11P2 
dump dUMP C9H11N2O8P 
duri Deoxyuridine C9H12N2O5 
dutp dUTP C9H11N2O14P3 
dxyl5p 1-deoxy-D-xylulose 5-phosphate C5H9O7P 
etha Ethanolamine C2H8NO 
etoh Ethanol C2H6O 
f1p D-Fructose 1-phosphate C6H11O9P 
f6p D-Fructose 6-phosphate C6H11O9P 
fad FAD C27H31N9O15P2 
fdp D-Fructose 1,6-bisphosphate C6H10O12P2 
fe2 Fe2+ Fe 
fgam N2-Formyl-N1-(5-phospho-D-ribosyl)glycinamide C8H13N2O9P 
fmet N-Formyl-L-methionine C6H10NO3S 
fmettrna N-Formylmethionyl-tRNA C21H32NO18P2SR3 
fmn flavin mononucleotide C17H19N4O9P 
fol Folate C19H18N7O6 
for Formate CH1O2 
fpram 2-(Formamido)-N1-(5-phospho-D-ribosyl)acetamidine C8H14N3O8P 
fprica 5-Formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide C10H13N4O9P 
frdp Farnesyl diphosphate C15H25O7P2 
fru D-Fructose C6H12O6 
fuc-L L-Fucose C6H12O5 
fum Fumarate C4H2O4 
g16bp D-Glucose 1,6-bisphosphate C6H10O12P2 
g1p D-Glucose 1-phosphate C6H11O9P 
g1p-B beta-D-Glucose 1-phosphate C6H11O9P 
g3p Glyceraldehyde 3-phosphate C3H5O6P 
g3pc sn-Glycero-3-phosphocholine C8H20NO6P 
g3pe sn-Glycero-3-phosphoethanolamine C5H14NO6P 
g3pg Glycerophosphoglycerol C6H14O8P 
g3pi sn-Glycero-3-phospho-1-inositol C9H18O11P 
g3ps Glycerophosphoserine C6H13NO8P 
g6p D-Glucose 6-phosphate C6H11O9P 
g6p-B beta-D-glucose 6-phosphate C6H11O9P 
gal D-Galactose C6H12O6 
gal1p alpha-D-Galactose 1-phosphate C6H11O9P 
galt Galactitol C6H14O6 
galt1p Galactitol 1-phosphate C6H13O9P 
gam1p D-Glucosamine 1-phosphate C6H13NO8P 
gam6p D-Glucosamine 6-phosphate C6H13NO8P 
gar N1-(5-Phospho-D-ribosyl)glycinamide C7H14N2O8P 
gcald Glycolaldehyde C2H4O2 
gdp GDP C10H12N5O11P2 
gdpdp Guanosine 3',5'-bis(diphosphate) C10H11N5O17P4 
gdptp Guanosine 3'-diphosphate 5'-triphosphate C10H11N5O20P5 
ggdp Geranylgeranyl diphosphate C20H33O7P2 
ggluabt gammaglutamyl-gamma-aminobutyrate C9H15N2O5 
glc-D D-Glucose C6H12O6 
glcn-D D-Gluconate C6H11O7 
gln-L L-Glutamine C5H10N2O3 
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glntrna L-Glutaminyl-tRNA(Gln) C20H31N2O18P2R3 
glu-D D-Glutamate C5H8NO4 
glu-L L-Glutamate C5H8NO4 
glu1sa L-Glutamate 1-semialdehyde C5H9NO3 
glu5p L-Glutamate 5-phosphate C5H8NO7P 
glu5sa L-Glutamate 5-semialdehyde C5H9NO3 
glucys gamma-L-Glutamyl-L-cysteine C8H13N2O5S 
glutrna L-Glutamyl-tRNA(Glu) C20H29NO19P2R3 
gly Glycine C2H5NO2 
glyald D-Glyceraldehyde C3H6O3 
glyb Glycine betaine C5H11NO2 
glyc Glycerol C3H8O3 
glyc-R (R)-Glycerate C3H5O4 
glyc3p sn-Glycerol 3-phosphate C3H7O6P 
glyclt Glycolate C2H3O3 
glytrna Glycyl-tRNA(Gly) C17H26NO17P2R3 
gmp GMP C10H12N5O8P 
grdp Geranyl diphosphate C10H17O7P2 
gsn Guanosine C10H13N5O5 
gthox Oxidized glutathione C20H30N6O12S2 
gthrd Reduced glutathione C10H16N3O6S 
gtp GTP C10H12N5O14P3 
gua Guanine C5H5N5O 
h H+ H 
h2o H2O H2O 
h2o2 Hydrogen peroxide H2O2 
h2s Hydrogen sulfide H2S 
hco3 Bicarbonate CHO3 
hcys-L L-Homocysteine C4H9NO2S 
hdca Hexadecanoate (n-C16:0) C16H31O2 
hdcea hexadecenoate (n-C16:1) C16H29O2 
hdeACP Hexadecenoyl-ACP (n-C16:1ACP) C27H49N2O8PRS 
hdeacp Hexadecanoyl-[acyl-carrier protein] C16H30OX 
hepdp all-trans-Heptaprenyl diphosphate C35H57O7P2 
hexacp Hexanoyl-[acyl-carrier protein] C6H10OX 
hexdp all-trans-Hexaprenyl diphosphate C30H49O7P2 
his-L L-Histidine C6H9N3O2 
hista Histamine C5H10N3 
histrna L-Histidyl-tRNA(His) C21H30N3O17P2R3 
hmbil Hydroxymethylbilane C40H38N4O17 
hmgcoa Hydroxymethylglutaryl-CoA C27H39N7O20P3S 
hom-L L-Homoserine C4H9NO3 
hxan Hypoxanthine C5H4N4O 
icit Isocitrate C6H5O7 
idp IDP C10H11N4O11P2 
ile-L L-Isoleucine C6H13NO2 
iletrna L-Isoleucyl-tRNA(Ile) C21H34NO17P2R3 
imp IMP C10H11N4O8P 
indpyr Indolepyruvate C11H8NO3 
inost myo-Inositol C6H12O6 
ins Inosine C10H12N4O5 
ipdp Isopentenyl diphosphate C5H9O7P2 
itp ITP C10H11N4O14P3 
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k K+ K 
lac-D D-Lactate C3H5O3 
lac-L L-Lactate C3H5O3 
lcts Lactose C12H22O11 
leu-L L-Leucine C6H13NO2 
leutrna L-Leucyl-tRNA(Leu) C21H34O17P2R3N 
lys-L L-Lysine C6H15N2O2 
lyspg_LRE 1-lysyl-phosphatidyl glycerol (LRE specific) C4674H8972N200O1100P100 
lystrna L-Lysine-tRNA (Lys) C21H36N2O17P2R3 
mal-L L-Malate C4H4O5 
malacp Malonyl-[acyl-carrier protein] C3HO3X 
malcoa Malonyl-CoA C24H33N7O19P3S 
male Maleate C4H2O4 
malm Maleamate C4H4NO3 
malt Maltose C12H22O11 
man D-Mannose C6H12O6 
man1p D-Mannose 1-phosphate C6H11O9P 
man6p D-Mannose 6-phosphate C6H11O9P 
melib Melibiose C12H22O11 
mercppyr Mercaptopyruvate C3H4O3S 
met-D D-Methionine C5H10NO2S 
met-L L-Methionine C5H11NO2S 
methf 5,10-Methenyltetrahydrofolate C20H20N7O6 
mettrna L-Methionyl-tRNA (Met) C20H32NO17P2SR3 
mev-R (R)-Mevalonate C6H11O4 
mg2 Mg Mg 
mi1p-D 1D-myo-Inositol 1-phosphate C6H11O9P 
mlthf 5,10-Methylenetetrahydrofolate C20H21N7O6 
mn2 Mn2+ Mn 
mnl D-Mannitol C6H14O6 
mnl1p D-Mannitol 1-phosphate C6H13O9P 
mql7 Menaquinol 7 C46H66O2 
mqn7 Menaquinone 7 C46H64O2 
mqn8 Menaquinone 8 C51H72O2 
myrsACP Myristoyl-ACP (n-C14:0ACP) C25H47N2O8PRS 
na1 Sodium Na 
nac Nicotinate C6H4NO2 
nad Nicotinamide adenine dinucleotide C21H26N7O14P2 
nadh Nicotinamide adenine dinucleotide - reduced C21H27N7O14P2 
nadp Nicotinamide adenine dinucleotide phosphate C21H25N7O17P3 
nadph Nicotinamide adenine dinucleotide phosphate - reduced C21H26N7O17P3 
ncam Nicotinamide C6H6N2O 
nh3 Ammonia H3N 
nh4 Ammonium H4N 
nicrnt Nicotinate D-ribonucleotide C11H12NO9P 
no2 Nitrite NO2 
no3 Nitrate NO3 
o2 O2 O2 
oaa Oxaloacetate C4H2O5 
ocdacp Octadecanoyl-[acyl-carrier protein] C18H34OX 
ocdca octadecanoate (n-C18:0) C18H35O2 
ocdcaACP Octadecanoyl-ACP (n-C18:0ACP) C29H55N2O8PRS 
ocdcea octadecenoate (n-C18:1) C18H33O2 
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ocdcya octadecynoate (n-C18:2) C18H31O2 
ocdcyaACP Octadecynoyl-ACP (n-C18:2ACP) C29H51N2O8PRS 
octacp Octanoyl-[acyl-carrier protein] C8H14OX 
octeACP Octadecenoyl-ACP (n-C18:1ACP) C29H53N2O8PRS 
orn-L L-Ornithine C5H13N2O2 
orot Orotate C5H3N2O4 
orot5p Orotidine 5'-phosphate C10H10N2O11P 
pa_LRE phosphatidic acid (Lb reuteri specific) C3774H6972O800P100 
pacald Phenylacetaldehyde C8H8O 
palmACP Palmitoyl-ACP (n-C16:0ACP) C27H51N2O8PRS 
pan4p Pantetheine 4'-phosphate C11H21N2O7PS 
pant-R (R)-Pantoate C6H11O4 
pap Adenosine 3',5'-bisphosphate C10H11N5O10P2 
pea Phenylethyl alcohol C8H10O 
pep Phosphoenolpyruvate C3H2O6P 
pg_LRE Phospatidylglycerol (LRE specific) C4074H7672O1000P100 
pgp_LRE Phosphatidylglycerophosphate (LRE specific) C4074H7572O1300P200 
phe-L L-Phenylalanine C9H11NO2 
pheme Protoheme C34H31FeN4O4 
phetrna L-Phenylalanyl-tRNA(Phe) C24H32NO17P2R3 
phpyr Phenylpyruvate C9H7O3 
pi Phosphate HO4P 
pnto-R (R)-Pantothenate C9H16NO5 
polypi Polyphosphate HO3P 
ppbng Porphobilinogen C10H13N2O4 
ppi Diphosphate HO7P2 
ppp9 Protoporphyrin C34H32N4O4 
pppi Inorganic triphosphate HO10P3 
pqqox PQQ (Pyrroloquinoline-quinone) oxidized form C14H3N2O8 
pqqrd PQQ (pyrroloquinoline-quinone) reduced form C14H5N2O8 
pram 5-Phospho-beta-D-ribosylamine C5H11NO7P 
pro-L L-Proline C5H9NO2 
protrna L-Prolyl-tRNA(Pro) C20H30NO17P2R3 
prpp 5-Phospho-alpha-D-ribose 1-diphosphate C5H8O14P3 
psd5p Pseudouridine 5'-phosphate C9H11N2O9P 
ptrc Putrescine C4H14N2 
pyam5p Pyridoxamine 5'-phosphate C8H11N2O5P 
pydam Pyridoxamine C8H12N2O2 
pydx Pyridoxal C8H9NO3 
pydx5p Pyridoxal 5'-phosphate C8H7NO6P 
pyr Pyruvate C3H3O3 
pyrimid Pyrimidine C4H4N2 
pyrin Pyrimidine nucleoside C9H14N2O4 
quin Quinate C7H12O6 
r1p alpha-D-Ribose 1-phosphate C5H9O8P 
r5p alpha-D-Ribose 5-phosphate C5H9O8P 
raffin Raffinose C18H32O16 
rbl-L L-Ribulose C5H10O5 
rbt Ribitol C5H12O5 
rbt5p D-Ribitol 5-phosphate C5H11O8P 
rdmbzi N1-(alpha-D-ribosyl)-5,6-dimethylbenzimidazole C14H18N2O4 
rhcys S-Ribosyl-L-homocysteine C9H17NO6S 
rib-D D-Ribose C5H10O5 
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Abbreviation     Official name    Formula         
ribflv Riboflavin C17H20N4O6 
ribflvRD Reduced riboflavin C17H22N4O6 
ru5p-D D-Ribulose 5-phosphate C5H9O8P 
ru5p-L L-Ribulose 5-phosphate C5H9O8P 
sbt-D D-Sorbitol C6H14O6 
sbt6p D-Sorbitol 6-phosphate C6H13O9P 
sbzcoa O-Succinylbenzoyl-CoA C32H39N7O20P3S 
scys-L L-Selenocysteine C3H7NO2Se 
ser-L L-Serine C3H7NO3 
sertrna L-Seryl-tRNA(Ser) C18H28NO18P2R3 
shcl Sirohydrochlorin C42H41N4O16 
sl26da N-Succinyl-LL-2,6-diaminoheptanedioate C11H16N2O7 
sl2a6o N-Succinyl-2-L-amino-6-oxoheptanedioate C11H12NO8 
spmd Spermidine C7H22N3 
srch Sirochlorin C42H38N4O16 
suc6p Sucrose 6-phosphate C12H21O14P 
sucbz o-Succinylbenzoate C11H8O5 
succ Succinate C4H4O4 
succoa Succinyl-CoA C25H35N7O19P3S 
sucr Sucrose C12H22O11 
sucsal Succinic semialdehyde C4H5O3 
tdeACP Tetradecenoyl-ACP (n-C14:1ACP) C25H45N2O8PRS 
tdeacp Tetradecanoyl-[acyl-carrier protein] C14H26OX 
thdp 2,3,4,5-Tetrahydrodipicolinate C7H7NO4 
thf 5,6,7,8-Tetrahydrofolate C19H21N7O6 
thfglu Tetrahydrofolyl-[Glu](2) C24H27N8O9 
thglu Tetrahydropteroyltri-L-glutamate C24H32N8O12 
thm Thiamin C12H17N4OS 
thmmp Thiamin monophosphate C12H16N4O4PS 
thmpp Thiamine diphosphate C12H16N4O7P2S 
thr-L L-Threonine C4H9NO3 
thrp L-Threonine phosphate C4H10NO6P 
thrtrna L-Threonyl-tRNA(Thr) C19H30NO18P2R3 
thym Thymine C5H6N2O2 
thymd Thymidine C10H14N2O5 
trdox Oxidized thioredoxin X 
trdrd Reduced thioredoxin XH2 
tre Trehalose C12H22O11 
tre6p alpha,alpha'-Trehalose 6-phosphate C12H21O14P 
trnaala tRNA(Ala) C15H23O16P2R3 
trnaarg tRNA(Arg) C15H23O16P2R3 
trnaasn tRNA(Asn) C15H23O16P2R3 
trnaasp tRNA(Asp) C15H23O16P2R3 
trnacys tRNA(Cys) C15H23O16P2R3 
trnaglu tRNA (Glu) C15H23O16P2R3 
trnagly tRNA(Gly) C15H23O16P2R3 
trnahis tRNA(His) C15H23O16P2R3 
trnaile tRNA(Ile) C15H23O16P2R3 
trnaleu tRNA(Leu) C15H23O16P2R3 
trnalys tRNA(Lys) C15H23O16P2R3 
trnamet tRNA(Met) C15H23O16P2R3 
trnaphe tRNA(Phe) C15H23O16P2R3 
trnapro tRNA(Pro) C15H23O16P2R3 
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Abbreviation     Official name    Formula         
trnaser tRNA(Ser) C15H23O16P2R3 
trnathr tRNA(Thr) C15H23O16P2R3 
trnatrp tRNA(Trp) C15H23O16P2R3 
trnatyr tRNA(Tyr) C15H23O16P2R3 
trnaval tRNA(Val) C15H23O16P2R3 
trp-L L-Tryptophan C11H12N2O2 
trptrna L-Tryptophanyl-tRNA(Trp) C26H33N2O17P2R3 
ttdca tetradecanoate C14H27O2 
ttdcea tetradecenoate (n-C14:1) C14H25O2 
tyr-L L-Tyrosine C9H11NO3 
tyrtrna L-Tyrosyl-tRNA(Tyr) C24H32NO18P2R3 
uAgl UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysine C34H51N7O24P2 
uAgla UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-alanine C40H62N9O26P2 
uAglac UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-lactate C40H61N8O27P2 
uGgl UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysine C34H52N7O24P2 
uGgla 
UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-
alanine 
C40H62N9O26P2 
uaagmdalac 
Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-
D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-lactate C95H151N7O29P2 
uaccg UDP-N-acetyl-3-O-(1-carboxyvinyl)-D-glucosamine C20H26N3O19P2 
uacgam UDP-N-acetyl-D-glucosamine C17H25N3O17P2 
uacmam UDP-N-acetyl-D-mannosamine C17H25N3O17P2 
uagmdalac 
Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-
diaminopimeloyl-D-alanyl-D-lactate 
C87H138N6O24P2 
uama UDP-N-acetylmuramoyl-L-alanine C23H33N4O20P2 
uamag UDP-N-acetylmuramoyl-L-alanyl-D-glutamate C28H39N5O23P2 
uamr UDP-N-acetylmuramate C20H28N3O19P2 
ubq8 Ubiquinone-8 C49H74O4 
ubq8h2 Ubiquinol-8 C49H76O4 
udcp Undecaprenol C55H90O 
udcpdp Undecaprenyl diphosphate C55H89O7P2 
udcpp Undecaprenyl phosphate C55H89O4P 
udp UDP C9H11N2O12P2 
udpg UDPglucose C15H22N2O17P2 
udpgal UDPgalactose C15H22N2O17P2 
udpgalfur UDP-D-galacto-1,4-furanose C15H22N2O17P2 
ugmd 
UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-
diaminopimelate C35H51N7O26P2 
ugmdalac 
UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-
alanyl-D-lactate 
C41H60N8O29P2 
ump UMP C9H11N2O9P 
unRTA undecaprenyl-teichoic acid with ribitol C199H372N2O197P28 
unaga Undecaprenyl diphospho N-acetyl-glucosamine C63H103NO12P2 
unagama Undecaprenyl-diphospho-N-acetylglucosamine-N-acetylmannosamine C71H116N2O17P2 
unagamagp 
Undecaprenyl-diphospho-N-acetylglucosamine-N-acetylmannosamine-
glycerolphosphate 
C74H122N2O22P3 
uppg3 Uroporphyrinogen III C40H36N4O16 
ura Uracil C4H4N2O2 
uri Uridine C9H12N2O6 
utp UTP C9H11N2O15P3 
val-L L-Valine C5H11NO2 
valtrna L-Valyl-tRNA(Val) C20H32NO17P2R3 
xan Xanthine C5H4N4O2 
xmp Xanthosine 5'-phosphate C10H11N4O9P 
xtsn Xanthosine C10H12N4O6 
xu5p-D D-Xylulose 5-phosphate C5H9O8P 
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Abbreviation     Official name    Formula         
xylu-D D-Xylulose C5H10O5 
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Content of supplementary material S2 to Chapter 4: 
Model simulations 
• Table 4.S2.1. Full details of the several in silico simulations carried out in this study. In 
simulation A the measured uptake fluxes of CDM components were used as 
constraints. In simulation B the measured uptake fluxes of components of CDM 
supplemented with glycerol were entered as constraints. Simulation C is similar to 
simulation B, except that now the fluxes GLYCDx and GDHYD were made 
irreversible in resemblance to what is suggested by the expression data. For list of 
reaction abbreviations, please see supplementary material 1. Page 142. 
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Table 4.S2.1. Full details of the several in silico simulations carried out in this study. In 
simulation A the measured uptake fluxes of CDM components were used as constraints. In 
simulation B the measured uptake fluxes of components of CDM supplemented with 
glycerol were entered as constraints. Simulation C is similar to simulation B, except that 
now the fluxes GLYCDx, GDHYD, G3PD and G3PD2 were made irreversible in 
resemblance to what is suggested by the expression data. For list of reaction abbreviations, 
please see supplementary material 1. 
Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
EX_13ppd(e) 0.0E+00 ? 0.0E+00 8.2E-04 0.0E+00 ? 1.1E+01 2.2E+01 0.0E+00 ? 2.2E+01 2.2E+01 
EX_4abz(e) -1.0E-01 1.0E+00 -4.5E-06 -4.5E-06 -1.0E-01 1.0E+00 -5.1E-06 -5.1E-06 -1.0E-01 1.0E+00 -5.1E-06 -5.1E-06 
EX_ac(e) 0.0E+00 ? 2.8E-01 2.8E-01 0.0E+00 ? 0.0E+00 1.1E+01 0.0E+00 ? 1.1E+01 1.1E+01 
EX_acald(e) 0.0E+00 ? 0.0E+00 1.4E-13 0.0E+00 ? 0.0E+00 -1.6E-12 0.0E+00 ? 0.0E+00 5.2E-13 
EX_actn-R(e) 0.0E+00 ? 0.0E+00 8.5E-14 0.0E+00 ? 0.0E+00 -8.1E-13 0.0E+00 ? 0.0E+00 1.8E-13 
EX_ade(e) -1.0E-01 1.0E+00 2.2E-02 2.2E-02 -1.0E-01 1.0E+00 2.5E-02 2.5E-02 -1.0E-01 1.0E+00 2.5E-02 2.5E-02 
EX_ala-L(e) -3.6E-01 1.0E+00 -2.4E-01 -2.4E-01 -4.0E-01 1.0E+00 -1.4E-01 -1.4E-01 -4.0E-01 1.0E+00 -1.4E-01 -1.4E-01 
EX_arg-L(e) -6.3E-01 1.0E+00 -4.4E-02 -4.4E-02 -4.8E-01 1.0E+00 -5.0E-02 -5.0E-02 -4.8E-01 1.0E+00 -5.0E-02 -5.0E-02 
EX_asp-L(e) -4.2E-01 1.0E+00 -4.2E-01 -4.2E-01 -6.1E-01 1.0E+00 -6.1E-01 -6.1E-01 -6.1E-01 1.0E+00 -6.1E-01 -6.1E-01 
EX_btd-RR(e) 0.0E+00 ? 0.0E+00 6.8E-13 0.0E+00 ? 0.0E+00 -1.2E-12 0.0E+00 ? 0.0E+00 8.9E-13 
EX_btn(e) -1.0E-01 1.0E+00 0.0E+00 0.0E+00 -1.0E-01 1.0E+00 0.0E+00 0.0E+00 -1.0E-01 1.0E+00 0.0E+00 0.0E+00 
EX_co2(e) -? ? 1.8E+01 4.8E+01 -? ? 1.4E+01 4.9E+01 -? ? 1.4E+01 3.7E+01 
EX_cobalt2(e) -1.0E-01 1.0E+00 0.0E+00 0.0E+00 -1.0E-01 1.0E+00 0.0E+00 0.0E+00 -1.0E-01 1.0E+00 0.0E+00 0.0E+00 
EX_cys-L(e) -4.5E-01 1.0E+00 9.4E-03 9.4E-03 -7.5E-01 1.0E+00 1.1E-02 1.1E-02 -7.5E-01 1.0E+00 1.1E-02 1.1E-02 
EX_dha(e) 0.0E+00 ? 0.0E+00 6.6E-14 0.0E+00 ? 0.0E+00 -7.8E-13 0.0E+00 ? 0.0E+00 6.8E-14 
EX_diact(e) 0.0E+00 ? 0.0E+00 1.8E-13 0.0E+00 ? 0.0E+00 -4.6E-13 0.0E+00 ? 0.0E+00 2.7E-13 
EX_etoh(e) 0.0E+00 ? 1.6E+01 4.7E+01 0.0E+00 ? 6.9E-01 4.7E+01 0.0E+00 ? 6.9E-01 2.5E+01 
EX_for(e) 0.0E+00 ? 4.5E-06 4.5E-06 0.0E+00 ? 5.1E-06 5.1E-06 0.0E+00 ? 5.1E-06 5.1E-06 
EX_gcald(e) 0.0E+00 ? 4.5E-06 4.5E-06 0.0E+00 ? 5.1E-06 5.1E-06 0.0E+00 ? 5.1E-06 5.1E-06 
EX_glc(e) -2.5E+01 0.0E+00 -2.5E+01 -2.5E+01 -1.9E+01 0.0E+00 -1.9E+01 -1.9E+01 -1.9E+01 0.0E+00 -1.9E+01 -1.9E+01 
EX_gln-L(e) -4.3E-01 1.0E+00 -4.3E-01 -4.3E-01 -6.7E-01 1.0E+00 -4.9E-01 -4.9E-01 -6.7E-01 1.0E+00 -4.9E-01 -4.9E-01 
EX_glu-L(e) -2.4E-01 1.0E+00 -2.4E-01 -2.4E-01 -3.6E-01 1.0E+00 -3.6E-01 -3.6E-01 -3.6E-01 1.0E+00 -3.6E-01 -3.6E-01 
EX_glyc(e) 0.0E+00 0.0E+00 0.0E+00 0.0E+00 -2.2E+01 0.0E+00 -2.2E+01 -2.2E+01 -2.2E+01 0.0E+00 -2.2E+01 -2.2E+01 
EX_gua(e) -1.0E-01 1.0E+00 -2.5E-02 -2.5E-02 -1.0E-01 1.0E+00 -2.9E-02 -2.9E-02 -1.0E-01 1.0E+00 -2.9E-02 -2.9E-02 
EX_h(e) -? ? -7.4E-01 3.0E+01 -? ? -1.4E+00 3.3E+01 -? ? 9.9E+00 3.3E+01 
EX_h2o(e) -? ? 4.6E+00 4.6E+00 -? ? 1.6E+01 1.6E+01 -? ? 1.6E+01 1.6E+01 
EX_his-L(e) -1.0E-01 1.0E+00 -1.9E-02 -1.9E-02 -1.0E-01 1.0E+00 -2.1E-02 -2.1E-02 -1.0E-01 1.0E+00 -2.1E-02 -2.1E-02 
EX_hxan(e) 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
EX_ile-L(e) -2.5E-01 1.0E+00 -4.7E-02 -4.7E-02 -3.3E-01 1.0E+00 -5.4E-02 -5.4E-02 -3.3E-01 1.0E+00 -5.4E-02 -5.4E-02 
EX_ins(e) -1.0E-01 1.0E+00 -1.9E-12 4.4E-16 -1.0E-01 1.0E+00 4.9E-12 -3.9E-13 -1.0E-01 1.0E+00 -1.9E-12 4.9E-14 
EX_lac-D(e) 0.0E+00 0.0E+00 0.0E+00 0.0E+00 0.0E+00 0.0E+00 0.0E+00 0.0E+00 0.0E+00 0.0E+00 0.0E+00 0.0E+00 
EX_lac-L(e) 0.0E+00 ? 0.0E+00 3.0E+01 0.0E+00 ? 0.0E+00 3.5E+01 0.0E+00 ? 0.0E+00 2.4E+01 
EX_leu-L(e) -3.3E-01 1.0E+00 -8.6E-02 -8.6E-02 -4.0E-01 1.0E+00 -9.8E-02 -9.8E-02 -4.0E-01 1.0E+00 -9.8E-02 -9.8E-02 
EX_lys-L(e) -2.6E-01 1.0E+00 -8.0E-02 -8.0E-02 -2.2E-01 1.0E+00 -9.1E-02 -9.1E-02 -2.2E-01 1.0E+00 -9.1E-02 -9.1E-02 
EX_mal-L(e) 0.0E+00 ? 0.0E+00 8.0E-13 0.0E+00 ? 0.0E+00 -3.7E-12 0.0E+00 ? 0.0E+00 5.8E-13 
EX_met-L(e) -7.0E-02 1.0E+00 -4.6E-02 -4.6E-02 -1.7E-01 1.0E+00 -5.2E-02 -5.2E-02 -1.7E-01 1.0E+00 -5.2E-02 -5.2E-02 
EX_nac(e) -1.0E-01 1.0E+00 -9.1E-04 -9.1E-04 -1.0E-01 1.0E+00 -1.0E-03 -1.0E-03 -1.0E-01 1.0E+00 -1.0E-03 -1.0E-03 
EX_nh3(e) -? ? 2.1E-01 2.1E-01 -? ? 2.2E-01 2.2E-01 -? ? 2.2E-01 2.2E-01 
EX_orn-L(e) 0.0E+00 ? 0.0E+00 -7.2E-15 0.0E+00 ? 0.0E+00 -4.9E-13 0.0E+00 ? 0.0E+00 2.9E-13 
EX_phe-L(e) -2.2E-01 1.0E+00 -3.7E-02 -3.7E-02 -2.0E-01 1.0E+00 -4.3E-02 -4.3E-02 -2.0E-01 1.0E+00 -4.3E-02 -4.3E-02 
EX_pi(e) -? ? -5.7E-01 -5.7E-01 -? ? -6.5E-01 -6.5E-01 -? ? -6.5E-01 -6.5E-01 
EX_pnto-R(e) -1.0E-01 1.0E+00 -9.1E-05 -9.1E-05 -1.0E-01 1.0E+00 -1.0E-04 -1.0E-04 -1.0E-01 1.0E+00 -1.0E-04 -1.0E-04 
EX_pro-L(e) -2.4E-01 1.0E+00 4.4E-01 4.4E-01 -4.1E-01 1.0E+00 5.9E-01 5.9E-01 -4.1E-01 1.0E+00 5.9E-01 5.9E-01 
EX_pydam(e) -1.0E-01 1.0E+00 -4.5E-07 -4.5E-07 -1.0E-01 1.0E+00 -5.1E-07 -5.1E-07 -1.0E-01 1.0E+00 -5.1E-07 -5.1E-07 
EX_pyr(e) 0.0E+00 ? 0.0E+00 1.7E-13 0.0E+00 ? 0.0E+00 -1.6E-12 0.0E+00 ? 0.0E+00 3.6E-13 
EX_ribflv(e) -1.0E-01 1.0E+00 0.0E+00 0.0E+00 -1.0E-01 1.0E+00 0.0E+00 0.0E+00 -1.0E-01 1.0E+00 0.0E+00 0.0E+00 
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Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
EX_ser-L(e) -5.7E-01 1.0E+00 -5.7E-01 -5.7E-01 -6.3E-01 1.0E+00 -6.3E-01 -6.3E-01 -6.3E-01 1.0E+00 -6.3E-01 -6.3E-01 
EX_thm(e) -1.0E-01 1.0E+00 -4.5E-06 -4.5E-06 -1.0E-01 1.0E+00 -5.1E-06 -5.1E-06 -1.0E-01 1.0E+00 -5.1E-06 -5.1E-06 
EX_thr-L(e) -3.0E-01 1.0E+00 -7.0E-02 -7.0E-02 -2.7E-01 1.0E+00 -8.0E-02 -8.0E-02 -2.7E-01 1.0E+00 -8.0E-02 -8.0E-02 
EX_trp-L(e) -3.0E-02 1.0E+00 -6.6E-03 -6.6E-03 -7.0E-02 1.0E+00 -7.5E-03 -7.5E-03 -7.0E-02 1.0E+00 -7.5E-03 -7.5E-03 
EX_tyr-L(e) -3.2E-01 1.0E+00 -3.1E-02 -3.1E-02 -1.4E-01 1.0E+00 -3.5E-02 -3.5E-02 -1.4E-01 1.0E+00 -3.5E-02 -3.5E-02 
EX_ura(e) -1.0E-01 1.0E+00 -6.7E-02 -6.7E-02 -1.0E-01 1.0E+00 -7.6E-02 -7.6E-02 -1.0E-01 1.0E+00 -7.6E-02 -7.6E-02 
EX_val-L(e) -2.8E-01 1.0E+00 -6.6E-02 -6.6E-02 -2.4E-01 1.0E+00 -7.5E-02 -7.5E-02 -2.4E-01 1.0E+00 -7.5E-02 -7.5E-02 
EX_xan(e) -1.0E-01 1.0E+00 1.7E-14 0.0E+00 -1.0E-01 1.0E+00 4.1E-13 0.0E+00 -1.0E-01 1.0E+00 -9.5E-14 0.0E+00 
2HXICDH -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
2MPDH -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
AALDH -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
ABTA 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ACACT1 0.0E+00 ? 1.0E-03 1.0E-03 0.0E+00 ? 1.1E-03 1.1E-03 0.0E+00 ? 1.1E-03 1.1E-03 
ACALD -? ? -4.7E+01 -1.6E+01 -? ? -4.7E+01 -6.9E-01 -? ? -2.5E+01 -6.9E-01 
ACALDt -? ? -1.4E-13 0.0E+00 -? ? 1.6E-12 0.0E+00 -? ? -5.2E-13 0.0E+00 
ACBIPGT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ACCOAC 0.0E+00 ? 6.5E-01 6.5E-01 0.0E+00 ? 7.4E-01 7.4E-01 0.0E+00 ? 7.4E-01 7.4E-01 
ACGALpts 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ACGAMT 0.0E+00 ? 6.2E-03 6.2E-03 0.0E+00 ? 7.1E-03 7.1E-03 0.0E+00 ? 7.1E-03 7.1E-03 
ACGApts 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ACHBS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ACKr -? ? -2.2E-01 -2.2E-01 -? ? -1.1E+01 7.5E-02 -? ? -1.1E+01 -1.1E+01 
ACLDC 0.0E+00 ? 0.0E+00 6.8E-13 0.0E+00 ? 0.0E+00 -1.2E-12 0.0E+00 ? 0.0E+00 4.1E-13 
ACLS 0.0E+00 ? 0.0E+00 6.8E-13 0.0E+00 ? 0.0E+00 -1.2E-12 0.0E+00 ? 0.0E+00 4.1E-13 
ACPS2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ACt6 -? ? -2.8E-01 -2.8E-01 -? ? -1.1E+01 0.0E+00 -? ? -1.1E+01 -1.1E+01 
ACTD -? ? 0.0E+00 1.8E-13 -? ? 0.0E+00 -4.6E-13 -? ? 0.0E+00 2.7E-13 
ACTNdiff -? ? -8.5E-14 0.0E+00 -? ? 8.1E-13 0.0E+00 -? ? -1.8E-13 0.0E+00 
ACTPASE 0.0E+00 ? 0.0E+00 -2.0E-14 0.0E+00 ? 0.0E+00 -8.1E-13 0.0E+00 ? 0.0E+00 1.6E-13 
ADA 0.0E+00 ? 0.0E+00 1.1E-14 0.0E+00 ? 0.0E+00 -2.1E-13 0.0E+00 ? 0.0E+00 4.6E-14 
ADCL 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ADCOBAK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ADCOBAPS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ADEt2 -? ? -2.2E-02 -2.2E-02 -? ? -2.5E-02 -2.5E-02 -? ? -2.5E-02 -2.5E-02 
ADK1 -? ? -? 1.4E+00 -? ? -? 1.6E+00 -? ? -? 1.6E+00 
ADK2 -? ? 0.0E+00 ? -? ? 0.0E+00 ? -? ? 0.0E+00 ? 
ADPDS 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
ADPRDP 0.0E+00 ? 0.0E+00 -1.0E-14 0.0E+00 ? 0.0E+00 -1.3E-13 0.0E+00 ? 0.0E+00 2.3E-14 
ADPT 0.0E+00 ? 0.0E+00 -1.0E-13 0.0E+00 ? 0.0E+00 -4.8E-13 0.0E+00 ? 0.0E+00 1.4E-14 
ADPTA -? ? -6.6E-02 -6.6E-02 -? ? -7.5E-02 -7.5E-02 -? ? -7.5E-02 -7.5E-02 
ADSL1 0.0E+00 ? 6.3E-02 6.3E-02 0.0E+00 ? 7.2E-02 7.2E-02 0.0E+00 ? 7.2E-02 7.2E-02 
ADSL2 0.0E+00 ? 8.5E-02 8.5E-02 0.0E+00 ? 9.6E-02 9.6E-02 0.0E+00 ? 9.6E-02 9.6E-02 
ADSS 0.0E+00 ? 6.3E-02 6.3E-02 0.0E+00 ? 7.2E-02 7.2E-02 0.0E+00 ? 7.2E-02 7.2E-02 
AGAT_LRE 0.0E+00 ? 4.3E-02 4.3E-02 0.0E+00 ? 4.9E-02 4.9E-02 0.0E+00 ? 4.9E-02 4.9E-02 
AGDC 0.0E+00 ? 0.0E+00 1.2E-15 0.0E+00 ? 0.0E+00 -2.3E-13 0.0E+00 ? 0.0E+00 1.4E-13 
AHCYSNS 0.0E+00 ? 2.2E-02 2.2E-02 0.0E+00 ? 2.5E-02 2.5E-02 0.0E+00 ? 2.5E-02 2.5E-02 
AHMMPS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
AICART -? ? 8.5E-02 8.5E-02 -? ? 9.6E-02 9.6E-02 -? ? 9.6E-02 9.6E-02 
AIRC 0.0E+00 ? 8.5E-02 8.5E-02 0.0E+00 ? 9.6E-02 9.6E-02 0.0E+00 ? 9.6E-02 9.6E-02 
ALA_Lt6 -? ? 2.4E-01 2.4E-01 -? ? 1.4E-01 1.4E-01 -? ? 1.4E-01 1.4E-01 
ALALAC -? ? 6.6E-02 6.6E-02 -? ? 7.5E-02 7.5E-02 -? ? 7.5E-02 7.5E-02 
ALAR -? ? 6.6E-02 6.6E-02 -? ? 7.5E-02 7.5E-02 -? ? 7.5E-02 7.5E-02 
ALATA_L -? ? -2.9E-02 -2.9E-02 -? ? -1.7E-01 -1.7E-01 -? ? -1.7E-01 -1.7E-01 
ALATA_Lr -? ? -4.5E-07 -4.5E-07 -? ? -5.1E-07 -5.1E-07 -? ? -5.1E-07 -5.1E-07 
ALATRS 0.0E+00 ? 1.4E-01 1.4E-01 0.0E+00 ? 1.6E-01 1.6E-01 0.0E+00 ? 1.6E-01 1.6E-01 
ALCD19 -? ? -? ? -? ? -? ? -? ? -? ? 
ALCD19_D -? ? -? ? -? ? -? ? -? ? -? ? 
ALCD19_L -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
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Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
ALCD2x -? ? -4.7E+01 -1.6E+01 -? ? -4.7E+01 -6.9E-01 -? ? -2.5E+01 -6.9E-01 
ALDD2x 0.0E+00 ? 0.0E+00 2.8E-14 0.0E+00 ? 0.0E+00 -8.0E-13 0.0E+00 ? 0.0E+00 1.4E-13 
ALDD8x 0.0E+00 ? 0.0E+00 -2.5E-14 0.0E+00 ? 0.0E+00 -1.1E-12 0.0E+00 ? 0.0E+00 -4.1E-14 
ALKP 0.0E+00 ? 0.0E+00 -9.3E-14 0.0E+00 ? 0.0E+00 -7.0E-13 0.0E+00 ? 0.0E+00 1.5E-13 
ALOX 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
AMAA 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
AMANAPE 0.0E+00 ? 0.0E+00 1.2E-15 0.0E+00 ? 0.0E+00 -2.3E-13 0.0E+00 ? 0.0E+00 1.4E-13 
AMANK 0.0E+00 ? 0.0E+00 1.2E-15 0.0E+00 ? 0.0E+00 -2.3E-13 0.0E+00 ? 0.0E+00 1.4E-13 
AMMQT7 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
AMMQT8_2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ANTIMt1 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
AP4AH 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
APAT -? ? 6.6E-02 6.6E-02 -? ? 7.5E-02 7.5E-02 -? ? 7.5E-02 7.5E-02 
APRAUR 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ARABRr -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
ARAI -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
araphe2 -? ? -? ? -? ? -? ? -? ? -? ? 
aratry2 -? ? -? ? -? ? -? ? -? ? -? ? 
aratyr2 -? ? -? ? -? ? -? ? -? ? -? ? 
aratyr4 -? ? -? ? -? ? -? ? -? ? -? ? 
ARBt2 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
ARGabc 0.0E+00 ? 0.0E+00 3.6E-14 0.0E+00 ? 0.0E+00 -1.4E-12 0.0E+00 ? 0.0E+00 4.5E-13 
ARGDI 0.0E+00 ? 0.0E+00 8.2E-14 0.0E+00 ? 0.0E+00 -4.8E-13 0.0E+00 ? 0.0E+00 1.8E-13 
ARGORNt3 -? ? 0.0E+00 4.4E-02 -? ? 0.0E+00 5.0E-02 -? ? 0.0E+00 5.0E-02 
ARGSL -? ? 0.0E+00 -1.7E-14 -? ? 0.0E+00 -2.8E-13 -? ? 0.0E+00 1.0E-13 
ARGSS 0.0E+00 ? 0.0E+00 -1.7E-14 0.0E+00 ? 0.0E+00 -2.8E-13 0.0E+00 ? 0.0E+00 1.0E-13 
ARGt2 0.0E+00 ? 0.0E+00 4.4E-02 0.0E+00 ? 0.0E+00 5.0E-02 0.0E+00 ? 0.0E+00 5.0E-02 
ARGTRS 0.0E+00 ? 4.4E-02 4.4E-02 0.0E+00 ? 5.0E-02 5.0E-02 0.0E+00 ? 5.0E-02 5.0E-02 
ARSNAt1 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ARSt1 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ASAD -? ? -4.5E-02 -4.5E-02 -? ? -5.1E-02 -5.1E-02 -? ? -5.1E-02 -5.1E-02 
ASNN 0.0E+00 ? 0.0E+00 -4.5E-14 0.0E+00 ? 0.0E+00 -3.9E-13 0.0E+00 ? 0.0E+00 1.1E-13 
ASNS1 0.0E+00 ? 0.0E+00 -8.1E-14 0.0E+00 ? 0.0E+00 -1.3E-12 0.0E+00 ? 0.0E+00 3.1E-13 
ASNS2 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
ASNt6 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
ASNTRS 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
ASPCT 0.0E+00 ? 0.0E+00 8.2E-14 0.0E+00 ? 0.0E+00 -4.8E-13 0.0E+00 ? 0.0E+00 1.8E-13 
ASPK -? ? 4.5E-02 4.5E-02 -? ? 5.1E-02 5.1E-02 -? ? 5.1E-02 5.1E-02 
ASPR -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
ASPt6 -? ? 4.2E-01 4.2E-01 -? ? 6.1E-01 6.1E-01 -? ? 6.1E-01 6.1E-01 
ASPTA1 -? ? 9.5E-02 9.5E-02 -? ? 2.4E-01 2.4E-01 -? ? 2.4E-01 2.4E-01 
ASPTA2 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
ASPTA4 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
ASPTA5 -? ? -? ? -? ? -? ? -? ? -? ? 
ASPTA6 -? ? -? ? -? ? -? ? -? ? -? ? 
ASPTRS 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
ATPM 1.0E+00 1.0E+00 1.0E+00 1.0E+00 1.0E+00 1.0E+00 1.0E+00 1.0E+00 1.0E+00 1.0E+00 1.0E+00 1.0E+00 
ATPS3r -? ? -3.8E-01 -3.8E-01 -? ? -3.6E-01 -3.6E-01 -? ? -3.6E-01 -3.6E-01 
BTDD-RR -? ? -6.8E-13 0.0E+00 -? ? 1.2E-12 0.0E+00 -? ? -8.9E-13 0.0E+00 
BTDt1-RR -? ? 0.0E+00 6.8E-13 -? ? 0.0E+00 -1.2E-12 -? ? 0.0E+00 8.9E-13 
BTMAT1 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
BTNt2i 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
CBIA 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
CBIAT -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
CBMK2 0.0E+00 ? 0.0E+00 4.9E-14 0.0E+00 ? 0.0E+00 -2.9E-13 0.0E+00 ? 0.0E+00 1.1E-13 
CBPS 0.0E+00 ? 0.0E+00 -4.3E-14 0.0E+00 ? 0.0E+00 -2.1E-13 0.0E+00 ? 0.0E+00 6.5E-14 
CDPMEK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
CELBpts 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
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Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
CFAS180 0.0E+00 ? 2.2E-02 2.2E-02 0.0E+00 ? 2.5E-02 2.5E-02 0.0E+00 ? 2.5E-02 2.5E-02 
CGPT 0.0E+00 ? 6.2E-03 6.2E-03 0.0E+00 ? 7.1E-03 7.1E-03 0.0E+00 ? 7.1E-03 7.1E-03 
CHLabc 0.0E+00 ? 0.0E+00 -1.0E-13 0.0E+00 ? 0.0E+00 -1.1E-12 0.0E+00 ? 0.0E+00 6.3E-13 
CHLt6 -? ? 1.0E-13 0.0E+00 -? ? 1.1E-12 0.0E+00 -? ? -6.3E-13 0.0E+00 
CLPNS_LRE -? ? 8.2E-04 8.2E-04 -? ? 9.3E-04 9.3E-04 -? ? 9.3E-04 9.3E-04 
CMLDC 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
CO2t -? ? -4.8E+01 -1.8E+01 -? ? -4.9E+01 -1.4E+01 -? ? -3.7E+01 -1.4E+01 
Coabc 0.0E+00 ? 0.0E+00 -8.7E-15 0.0E+00 ? 0.0E+00 -7.5E-13 0.0E+00 ? 0.0E+00 1.6E-13 
COBALTt5 -? ? 0.0E+00 -8.7E-15 -? ? 0.0E+00 -7.5E-13 -? ? 0.0E+00 1.6E-13 
COBAT -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
COPREC2MT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
COPREC3MT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
COPREC4MT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
COPREC6MT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
COPREC6R 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
COPREC6R2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
COPRECI 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
COPRECT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
CPSS_LRE -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
CPSS_LRE2 -? ? 5.9E-02 5.9E-02 -? ? 6.7E-02 6.7E-02 -? ? 6.7E-02 6.7E-02 
CRCT 0.0E+00 ? 1.6E-01 1.6E-01 0.0E+00 ? 1.8E-01 1.8E-01 0.0E+00 ? 1.8E-01 1.8E-01 
CRPT_25 0.0E+00 ? 6.2E-03 6.2E-03 0.0E+00 ? 7.1E-03 7.1E-03 0.0E+00 ? 7.1E-03 7.1E-03 
CSND 0.0E+00 ? 0.0E+00 1.9E-14 0.0E+00 ? 0.0E+00 -4.1E-13 0.0E+00 ? 0.0E+00 6.8E-14 
CTPS1_#1 0.0E+00 ? 3.1E-02 3.9E-02 0.0E+00 ? 3.6E-02 4.5E-02 0.0E+00 ? 3.6E-02 4.5E-02 
CTPS2 0.0E+00 ? 0.0E+00 -7.3E-14 0.0E+00 ? 0.0E+00 -1.0E-12 0.0E+00 ? 0.0E+00 4.2E-13 
Cuabc 0.0E+00 ? 0.0E+00 -4.3E-15 0.0E+00 ? 0.0E+00 -3.7E-13 0.0E+00 ? 0.0E+00 7.9E-14 
Cut1 0.0E+00 ? 0.0E+00 -4.3E-15 0.0E+00 ? 0.0E+00 -3.7E-13 0.0E+00 ? 0.0E+00 7.9E-14 
CYSabc 0.0E+00 ? 0.0E+00 -1.0E-13 0.0E+00 ? 0.0E+00 -1.1E-12 0.0E+00 ? 0.0E+00 6.3E-13 
CYSDabc 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
CYSS 0.0E+00 ? 2.2E-02 2.2E-02 0.0E+00 ? 2.5E-02 2.5E-02 0.0E+00 ? 2.5E-02 2.5E-02 
CYSt6 -? ? -9.4E-03 -9.4E-03 -? ? -1.1E-02 -1.1E-02 -? ? -1.1E-02 -1.1E-02 
CYSTabc 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
CYSTGL 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
CYSTL 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
CYSTRS 0.0E+00 ? 1.2E-02 1.2E-02 0.0E+00 ? 1.4E-02 1.4E-02 0.0E+00 ? 1.4E-02 1.4E-02 
CYTB_B2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
CYTD 0.0E+00 ? 0.0E+00 1.9E-14 0.0E+00 ? 0.0E+00 -4.1E-13 0.0E+00 ? 0.0E+00 6.8E-14 
CYTDK1 0.0E+00 ? 0.0E+00 -1.5E-14 0.0E+00 ? 0.0E+00 -8.1E-13 0.0E+00 ? 0.0E+00 1.7E-13 
CYTDK2 0.0E+00 ? 0.0E+00 -1.8E-14 0.0E+00 ? 0.0E+00 -7.0E-13 0.0E+00 ? 0.0E+00 1.7E-13 
CYTDK3 0.0E+00 ? 0.0E+00 -1.8E-14 0.0E+00 ? 0.0E+00 -7.0E-13 0.0E+00 ? 0.0E+00 1.7E-13 
CYTK1 -? ? 3.5E-01 3.5E-01 -? ? 3.9E-01 3.9E-01 -? ? 3.9E-01 3.9E-01 
CYTK2 -? ? -7.8E-03 0.0E+00 -? ? -8.9E-03 0.0E+00 -? ? -8.9E-03 0.0E+00 
DADA 0.0E+00 ? 0.0E+00 1.1E-14 0.0E+00 ? 0.0E+00 -2.1E-13 0.0E+00 ? 0.0E+00 4.6E-14 
DADNK 0.0E+00 ? 0.0E+00 -1.5E-14 0.0E+00 ? 0.0E+00 -8.1E-13 0.0E+00 ? 0.0E+00 1.7E-13 
DAGGT_LRE 0.0E+00 ? 5.9E-03 5.9E-03 0.0E+00 ? 6.7E-03 6.7E-03 0.0E+00 ? 6.7E-03 6.7E-03 
DAGK_LRE 0.0E+00 ? 1.4E-01 1.4E-01 0.0E+00 ? 1.6E-01 1.6E-01 0.0E+00 ? 1.6E-01 1.6E-01 
DALTAL 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
DAPDC 0.0E+00 ? 0.0E+00 -2.0E-13 0.0E+00 ? 0.0E+00 -8.3E-13 0.0E+00 ? 0.0E+00 2.8E-13 
DAPE -? ? 6.6E-02 6.6E-02 -? ? 7.5E-02 7.5E-02 -? ? 7.5E-02 7.5E-02 
DARTAL 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
DASYN_LRE -? ? 1.8E-01 1.8E-01 -? ? 2.1E-01 2.1E-01 -? ? 2.1E-01 2.1E-01 
DB4PS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
DCYTD 0.0E+00 ? 0.0E+00 7.8E-03 0.0E+00 ? 0.0E+00 8.9E-03 0.0E+00 ? 0.0E+00 8.9E-03 
DDMAT5 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
DEMAT4 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
DGNSK 0.0E+00 ? 0.0E+00 -1.5E-14 0.0E+00 ? 0.0E+00 -8.1E-13 0.0E+00 ? 0.0E+00 1.7E-13 
DHAPT 0.0E+00 ? 0.0E+00 8.2E-04 0.0E+00 ? 0.0E+00 1.1E+01 0.0E+00 ? 0.0E+00 2.2E-13 
DHAt -? ? -6.6E-14 0.0E+00 -? ? 7.8E-13 0.0E+00 -? ? -6.8E-14 0.0E+00 
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Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
DHDPRy 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
DHDPS 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
DHFOR2 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
DHFR -? ? 7.8E-03 7.8E-03 -? ? 8.9E-03 8.9E-03 -? ? 8.9E-03 8.9E-03 
DHFS 0.0E+00 ? 4.5E-06 4.5E-06 0.0E+00 ? 5.1E-06 5.1E-06 0.0E+00 ? 5.1E-06 5.1E-06 
DHNPA 0.0E+00 ? 4.5E-06 4.5E-06 0.0E+00 ? 5.1E-06 5.1E-06 0.0E+00 ? 5.1E-06 5.1E-06 
DHORD6 -? ? 0.0E+00 8.2E-14 -? ? 0.0E+00 -4.8E-13 -? ? 0.0E+00 1.8E-13 
DHORTS -? ? -8.2E-14 0.0E+00 -? ? 4.8E-13 0.0E+00 -? ? -1.8E-13 0.0E+00 
DHPPDA_#1 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
DHPS3 0.0E+00 ? 4.5E-06 4.5E-06 0.0E+00 ? 5.1E-06 5.1E-06 0.0E+00 ? 5.1E-06 5.1E-06 
DIACTt -? ? 0.0E+00 1.8E-13 -? ? 0.0E+00 -4.6E-13 -? ? 0.0E+00 2.7E-13 
DINSK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
DKGLCNR1 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
DKGLCNR2x 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
DKGLCNR2y 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
D-LACt2 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
DMATT 0.0E+00 ? 9.1E-05 9.1E-05 0.0E+00 ? 1.0E-04 1.0E-04 0.0E+00 ? 1.0E-04 1.0E-04 
DNAS_LRE 0.0E+00 ? 2.8E-02 2.8E-02 0.0E+00 ? 3.2E-02 3.2E-02 0.0E+00 ? 3.2E-02 3.2E-02 
DNMPPA 0.0E+00 ? 4.5E-06 4.5E-06 0.0E+00 ? 5.1E-06 5.1E-06 0.0E+00 ? 5.1E-06 5.1E-06 
DNTPPA 0.0E+00 ? 4.5E-06 4.5E-06 0.0E+00 ? 5.1E-06 5.1E-06 0.0E+00 ? 5.1E-06 5.1E-06 
DPCOAK 0.0E+00 ? 9.1E-05 9.1E-05 0.0E+00 ? 1.0E-04 1.0E-04 0.0E+00 ? 1.0E-04 1.0E-04 
DPMVD 0.0E+00 ? 1.0E-03 1.0E-03 0.0E+00 ? 1.1E-03 1.1E-03 0.0E+00 ? 1.1E-03 1.1E-03 
DPR 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
DRBK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
DRIBt2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
DRPA 0.0E+00 ? 0.0E+00 2.1E-14 0.0E+00 ? 0.0E+00 -4.2E-13 0.0E+00 ? 0.0E+00 2.1E-13 
DTMPK -? ? 7.8E-03 7.8E-03 -? ? 8.9E-03 8.9E-03 -? ? 8.9E-03 8.9E-03 
DURADy -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
DURIK1 0.0E+00 ? 0.0E+00 7.8E-03 0.0E+00 ? 0.0E+00 8.9E-03 0.0E+00 ? 0.0E+00 8.9E-03 
DURIPP -? ? 0.0E+00 2.5E-14 -? ? 0.0E+00 -4.2E-13 -? ? 0.0E+00 2.1E-13 
DUTPDP 0.0E+00 ? 0.0E+00 7.8E-03 0.0E+00 ? 0.0E+00 8.9E-03 0.0E+00 ? 0.0E+00 8.9E-03 
DXPS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ENO -? ? 3.0E+01 3.0E+01 -? ? 2.3E+01 3.4E+01 -? ? 2.3E+01 2.3E+01 
EPPP 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
ETOHt1 -? ? -4.7E+01 -1.6E+01 -? ? -4.7E+01 -6.9E-01 -? ? -2.5E+01 -6.9E-01 
FA120ACPH -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
FA140ACPH -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
FA141ACPH -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
FA160ACPH -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
FA161ACPH -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
FA180ACPH -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
FA181ACPH -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
FA182ACPH -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
FABM1 -? ? 1.0E-02 1.0E-02 -? ? 1.2E-02 1.2E-02 -? ? 1.2E-02 1.2E-02 
FABM2 -? ? 4.9E-02 4.9E-02 -? ? 5.6E-02 5.6E-02 -? ? 5.6E-02 5.6E-02 
FBA -? ? 6.5E+00 6.5E+00 -? ? 5.0E+00 5.0E+00 -? ? 5.0E+00 5.0E+00 
FCLT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
FLVR 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
FMETDF 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
FMETTRS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
FMNAT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
FORt -? ? -4.5E-06 -4.5E-06 -? ? -5.1E-06 -5.1E-06 -? ? -5.1E-06 -5.1E-06 
FRTT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
FRUK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
FRUpts 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
FTHFCL 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
FTHFL 0.0E+00 ? 0.0E+00 -1.1E-14 0.0E+00 ? 0.0E+00 -8.1E-14 0.0E+00 ? 0.0E+00 1.8E-14 
FUCt -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
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Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
FUM -? ? 1.5E-01 1.5E-01 -? ? 1.7E-01 1.7E-01 -? ? 1.7E-01 1.7E-01 
G1PACT 0.0E+00 ? 1.4E-01 1.4E-01 0.0E+00 ? 1.6E-01 1.6E-01 0.0E+00 ? 1.6E-01 1.6E-01 
G1PPDM 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
G1PTMT 0.0E+00 ? 1.2E-01 1.2E-01 0.0E+00 ? 1.3E-01 1.3E-01 0.0E+00 ? 1.3E-01 1.3E-01 
G1SAT -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
G35DP 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
G3PCT 0.0E+00 ? 6.2E-03 6.2E-03 0.0E+00 ? 7.1E-03 7.1E-03 0.0E+00 ? 7.1E-03 7.1E-03 
G3PD1 -? ? -? ? -? ? -? ? -? 0.0E+00 -2.7E-01 0.0E+00 
G3PD2 -? ? -? ? -? ? -? ? -? 0.0E+00 -2.7E-01 0.0E+00 
G5SADs -? ? 4.8E-01 4.8E-01 -? ? 6.4E-01 6.4E-01 -? ? 6.4E-01 6.4E-01 
G5SD 0.0E+00 ? 4.8E-01 4.8E-01 0.0E+00 ? 6.4E-01 6.4E-01 0.0E+00 ? 6.4E-01 6.4E-01 
G6PDA 0.0E+00 ? 0.0E+00 -1.5E-13 0.0E+00 ? 0.0E+00 -1.2E-12 0.0E+00 ? 0.0E+00 4.6E-13 
G6PDHy 0.0E+00 ? 1.8E+01 1.8E+01 0.0E+00 ? 1.4E+01 1.4E+01 0.0E+00 ? 1.4E+01 1.4E+01 
G6PI -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
GALK2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GALM -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
GALS3 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GALSZ 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GALT -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
GALTpts 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GALU -? ? 2.9E-01 2.9E-01 -? ? 3.2E-01 3.2E-01 -? ? 3.2E-01 3.2E-01 
GAPD -? ? 3.0E+01 3.0E+01 -? ? 2.3E+01 3.4E+01 -? ? 2.3E+01 2.3E+01 
GARFT -? ? 8.5E-02 8.5E-02 -? ? 9.6E-02 9.6E-02 -? ? 9.6E-02 9.6E-02 
GAT1_LRE 0.0E+00 ? 4.3E-02 4.3E-02 0.0E+00 ? 4.9E-02 4.9E-02 0.0E+00 ? 4.9E-02 4.9E-02 
GCALDt -? ? -4.5E-06 -4.5E-06 -? ? -5.1E-06 -5.1E-06 -? ? -5.1E-06 -5.1E-06 
GDHYD -? ? 0.0E+00 8.2E-04 -? ? 1.1E+01 2.2E+01 -? ? 2.2E+01 2.2E+01 
GF6PTA 0.0E+00 ? 1.4E-01 1.4E-01 0.0E+00 ? 1.6E-01 1.6E-01 0.0E+00 ? 1.6E-01 1.6E-01 
GGLUGABH 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GHMT -? ? 1.8E-01 1.8E-01 -? ? 2.0E-01 2.0E-01 -? ? 2.0E-01 2.0E-01 
GK1 -? ? -? ? -? ? -? ? -? ? -? ? 
GK2 -? ? -? ? -? ? -? ? -? ? -? ? 
GLCNt2 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
GLCpts 0.0E+00 ? 2.5E+01 2.5E+01 0.0E+00 ? 1.9E+01 1.9E+01 0.0E+00 ? 1.9E+01 1.9E+01 
GLNabc 0.0E+00 ? 4.3E-01 4.3E-01 0.0E+00 ? 4.9E-01 4.9E-01 0.0E+00 ? 4.9E-01 4.9E-01 
GLNS 0.0E+00 ? 0.0E+00 5.7E-14 0.0E+00 ? 0.0E+00 -2.4E-12 0.0E+00 ? 0.0E+00 6.8E-13 
GLNTAL -? ? 9.1E-02 9.1E-02 -? ? 1.0E-01 1.0E-01 -? ? 1.0E-01 1.0E-01 
GLTAL 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GLU5K 0.0E+00 ? 4.8E-01 4.8E-01 0.0E+00 ? 6.4E-01 6.4E-01 0.0E+00 ? 6.4E-01 6.4E-01 
GLUCYSL 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GLUN 0.0E+00 ? 0.0E+00 -1.5E-13 0.0E+00 ? 0.0E+00 -1.2E-12 0.0E+00 ? 0.0E+00 4.6E-13 
GLUPRT 0.0E+00 ? 8.5E-02 8.5E-02 0.0E+00 ? 9.6E-02 9.6E-02 0.0E+00 ? 9.6E-02 9.6E-02 
GLUR -? ? -6.6E-02 -6.6E-02 -? ? -7.5E-02 -7.5E-02 -? ? -7.5E-02 -7.5E-02 
GLUt4 -? ? -? ? -? ? -? ? -? ? -? ? 
GLUt6 -? ? -? ? -? ? -? ? -? ? -? ? 
GLUTRR 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GLUTRS 0.0E+00 ? 1.2E-01 1.2E-01 0.0E+00 ? 1.3E-01 1.3E-01 0.0E+00 ? 1.3E-01 1.3E-01 
GLYBabc 0.0E+00 ? 0.0E+00 -1.0E-13 0.0E+00 ? 0.0E+00 -1.1E-12 0.0E+00 ? 0.0E+00 6.3E-13 
GLYBt6 -? ? 1.0E-13 0.0E+00 -? ? 1.1E-12 0.0E+00 -? ? -6.3E-13 0.0E+00 
GLYCDx -? ? 9.3E-14 8.2E-04 -? ? 7.0E-13 1.1E+01 -? 0.0E+00 -2.0E-13 0.0E+00 
GLYCK 0.0E+00 ? 0.0E+00 -2.5E-14 0.0E+00 ? 0.0E+00 -1.1E-12 0.0E+00 ? 0.0E+00 -4.1E-14 
GLYCt1 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 
GLYCt5 -? ? 0.0E+00 ? -? ? -2.2E+01 ? -? ? -2.2E+01 ? 
GLYK 0.0E+00 ? 0.0E+00 8.2E-04 0.0E+00 ? 0.0E+00 1.1E+01 0.0E+00 ? 0.0E+00 2.7E-01 
GLYt6 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
GLYTRS 0.0E+00 ? 9.2E-02 9.2E-02 0.0E+00 ? 1.1E-01 1.1E-01 0.0E+00 ? 1.1E-01 1.1E-01 
GMPR 0.0E+00 ? 0.0E+00 1.5E-14 0.0E+00 ? 0.0E+00 -2.6E-13 0.0E+00 ? 0.0E+00 6.7E-14 
GMPS2 0.0E+00 ? 2.1E-02 2.1E-02 0.0E+00 ? 2.4E-02 2.4E-02 0.0E+00 ? 2.4E-02 2.4E-02 
GNK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
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Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
GPDDA1 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GPDDA2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GPDDA3 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GPDDA4 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GPDDA5 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GRTAL 0.0E+00 ? 6.2E-03 6.2E-03 0.0E+00 ? 7.1E-03 7.1E-03 0.0E+00 ? 7.1E-03 7.1E-03 
GRTT 0.0E+00 ? 9.1E-05 9.1E-05 0.0E+00 ? 1.0E-04 1.0E-04 0.0E+00 ? 1.0E-04 1.0E-04 
GTHRD -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
GTHS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GTPCI 0.0E+00 ? 4.5E-06 4.5E-06 0.0E+00 ? 5.1E-06 5.1E-06 0.0E+00 ? 5.1E-06 5.1E-06 
GTPCII 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GTPDPK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
GUAPRT 0.0E+00 ? 2.5E-02 2.5E-02 0.0E+00 ? 2.9E-02 2.9E-02 0.0E+00 ? 2.9E-02 2.9E-02 
GUAt2 0.0E+00 ? 2.5E-02 2.5E-02 0.0E+00 ? 2.9E-02 2.9E-02 0.0E+00 ? 2.9E-02 2.9E-02 
H2Ot5 -? ? -4.6E+00 -4.6E+00 -? ? -1.6E+01 -1.6E+01 -? ? -1.6E+01 -1.6E+01 
HACD1 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
HBUHL1 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HBUR1 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HCO3E -? ? 6.5E-01 6.5E-01 -? ? 7.4E-01 7.4E-01 -? ? 7.4E-01 7.4E-01 
HCYSMT 0.0E+00 ? 0.0E+00 -4.6E-15 0.0E+00 ? 0.0E+00 -2.4E-13 0.0E+00 ? 0.0E+00 5.5E-14 
HDDHL5 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HDDR5 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HDEHL4 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HDER4 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HDMAT7 0.0E+00 ? 7.4E-02 7.4E-02 0.0E+00 ? 8.4E-02 8.4E-02 0.0E+00 ? 8.4E-02 8.4E-02 
HEMAT2 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HETZK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
HEXTT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
HHDHL7 0.0E+00 ? 8.4E-02 8.4E-02 0.0E+00 ? 9.5E-02 9.5E-02 0.0E+00 ? 9.5E-02 9.5E-02 
HHDR7 0.0E+00 ? 8.4E-02 8.4E-02 0.0E+00 ? 9.5E-02 9.5E-02 0.0E+00 ? 9.5E-02 9.5E-02 
HHYHL2 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HHYR2 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HISabc 0.0E+00 ? 1.9E-02 1.9E-02 0.0E+00 ? 2.1E-02 2.1E-02 0.0E+00 ? 2.1E-02 2.1E-02 
HISDC 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
HISTAap -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
HISTRS 0.0E+00 ? 1.9E-02 1.9E-02 0.0E+00 ? 2.1E-02 2.1E-02 0.0E+00 ? 2.1E-02 2.1E-02 
HMBS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
HMGCOAR -? ? -1.0E-03 -1.0E-03 -? ? -1.1E-03 -1.1E-03 -? ? -1.1E-03 -1.1E-03 
HMGCOAS -? ? -1.0E-03 -1.0E-03 -? ? -1.1E-03 -1.1E-03 -? ? -1.1E-03 -1.1E-03 
HMPabc 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
HMPK1 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
HOCHL3 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HOCR3 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HODHL8 0.0E+00 ? 5.1E-02 5.1E-02 0.0E+00 ? 5.8E-02 5.8E-02 0.0E+00 ? 5.8E-02 5.8E-02 
HODR8 0.0E+00 ? 5.1E-02 5.1E-02 0.0E+00 ? 5.8E-02 5.8E-02 0.0E+00 ? 5.8E-02 5.8E-02 
HPPK 0.0E+00 ? 4.5E-06 4.5E-06 0.0E+00 ? 5.1E-06 5.1E-06 0.0E+00 ? 5.1E-06 5.1E-06 
HSAT -? ? -2.2E-02 -2.2E-02 -? ? -2.5E-02 -2.5E-02 -? ? -2.5E-02 -2.5E-02 
HSDy -? ? 2.2E-02 2.2E-02 -? ? 2.5E-02 2.5E-02 -? ? 2.5E-02 2.5E-02 
HTDHL6 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HTDR6 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
HXANt2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
HXPRT 0.0E+00 ? 0.0E+00 -2.1E-13 0.0E+00 ? 0.0E+00 -4.8E-12 0.0E+00 ? 0.0E+00 1.6E-12 
HYPOE 0.0E+00 ? 0.0E+00 -8.7E-15 0.0E+00 ? 0.0E+00 -7.5E-13 0.0E+00 ? 0.0E+00 1.6E-13 
ICDHy -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
ILEt2 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 
ILEt6 -? ? -? 4.7E-02 -? ? -? 5.4E-02 -? ? -? 5.4E-02 
ILETRS 0.0E+00 ? 4.7E-02 4.7E-02 0.0E+00 ? 5.4E-02 5.4E-02 0.0E+00 ? 5.4E-02 5.4E-02 
IMPC -? ? -8.5E-02 -8.5E-02 -? ? -9.6E-02 -9.6E-02 -? ? -9.6E-02 -9.6E-02 
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Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
INSt2r -? ? -4.4E-16 1.9E-12 -? ? 3.9E-13 -4.9E-12 -? ? -4.9E-14 1.9E-12 
IPDDI -? ? 9.1E-05 9.1E-05 -? ? 1.0E-04 1.0E-04 -? ? 1.0E-04 1.0E-04 
kaasIII 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
Kabc 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
LAR -? ? -? ? -? ? -? ? -? ? -? ? 
LCTSt6 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
LDH_D -? ? -? ? -? ? -? ? -? ? -? ? 
LDH_L -? ? -? ? -? ? -? ? -? ? -? ? 
LEUt2 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 
LEUt6 -? ? -? 8.6E-02 -? ? -? 9.8E-02 -? ? -? 9.8E-02 
LEUTRS 0.0E+00 ? 8.6E-02 8.6E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
L-LACt2 -? ? -3.0E+01 0.0E+00 -? ? -3.5E+01 0.0E+00 -? ? -2.4E+01 0.0E+00 
LPGS_LRE 0.0E+00 ? 7.4E-03 7.4E-03 0.0E+00 ? 8.4E-03 8.4E-03 0.0E+00 ? 8.4E-03 8.4E-03 
LTAS_LRE 0.0E+00 ? 5.9E-03 5.9E-03 0.0E+00 ? 6.7E-03 6.7E-03 0.0E+00 ? 6.7E-03 6.7E-03 
LYSDC 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
LYSt6 -? ? 8.0E-02 8.0E-02 -? ? 9.1E-02 9.1E-02 -? ? 9.1E-02 9.1E-02 
LYSTRS 0.0E+00 ? 8.0E-02 8.0E-02 0.0E+00 ? 9.1E-02 9.1E-02 0.0E+00 ? 9.1E-02 9.1E-02 
M1PD -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
MACPMT 0.0E+00 ? 6.5E-01 6.5E-01 0.0E+00 ? 7.4E-01 7.4E-01 0.0E+00 ? 7.4E-01 7.4E-01 
MALLAC 0.0E+00 ? 2.4E-01 2.4E-01 0.0E+00 ? 4.1E-01 4.1E-01 0.0E+00 ? 4.1E-01 4.1E-01 
MALP -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
MALT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
MALt6 -? ? -8.0E-13 0.0E+00 -? ? 3.7E-12 0.0E+00 -? ? -5.8E-13 0.0E+00 
MAN6PI -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
MANpts 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
MCMAT2 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
MCMAT3 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
MCMAT4 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
MCMAT5 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
MCMAT6 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
MCMAT7 0.0E+00 ? 8.4E-02 8.4E-02 0.0E+00 ? 9.5E-02 9.5E-02 0.0E+00 ? 9.5E-02 9.5E-02 
MCMAT8 0.0E+00 ? 5.1E-02 5.1E-02 0.0E+00 ? 5.8E-02 5.8E-02 0.0E+00 ? 5.8E-02 5.8E-02 
MDH -? ? -9.5E-02 -9.5E-02 -? ? -2.4E-01 -2.4E-01 -? ? -2.4E-01 -2.4E-01 
METabc 0.0E+00 ? 0.0E+00 -1.0E-13 0.0E+00 ? 0.0E+00 -1.1E-12 0.0E+00 ? 0.0E+00 6.3E-13 
METACH -? ? -2.2E-02 -2.2E-02 -? ? -2.5E-02 -2.5E-02 -? ? -2.5E-02 -2.5E-02 
METAT 0.0E+00 ? 2.2E-02 2.2E-02 0.0E+00 ? 2.5E-02 2.5E-02 0.0E+00 ? 2.5E-02 2.5E-02 
METDabc 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
METt6 -? ? 4.6E-02 4.6E-02 -? ? 5.2E-02 5.2E-02 -? ? 5.2E-02 5.2E-02 
METTRS 0.0E+00 ? 2.4E-02 2.4E-02 0.0E+00 ? 2.8E-02 2.8E-02 0.0E+00 ? 2.8E-02 2.8E-02 
MEVK 0.0E+00 ? 0.0E+00 1.0E-03 0.0E+00 ? 0.0E+00 1.1E-03 0.0E+00 ? 0.0E+00 1.1E-03 
MEVK2 0.0E+00 ? 0.0E+00 1.0E-03 0.0E+00 ? 0.0E+00 1.1E-03 0.0E+00 ? 0.0E+00 1.1E-03 
MEVK3 0.0E+00 ? 0.0E+00 1.0E-03 0.0E+00 ? 0.0E+00 1.1E-03 0.0E+00 ? 0.0E+00 1.1E-03 
MEVK4 0.0E+00 ? 0.0E+00 1.0E-03 0.0E+00 ? 0.0E+00 1.1E-03 0.0E+00 ? 0.0E+00 1.1E-03 
MGt5 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
MI1PP 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
MNabc 0.0E+00 ? 0.0E+00 -1.0E-13 0.0E+00 ? 0.0E+00 -1.2E-12 0.0E+00 ? 0.0E+00 6.3E-13 
MNLpts 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
MNt2 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 
MNt6 -? ? -? 0.0E+00 -? ? -? 0.0E+00 -? ? -? 0.0E+00 
MNTD -? ? -? ? -? ? -? ? -? ? -? ? 
MNTD2 -? ? -? ? -? ? -? ? -? ? -? ? 
MOADCST 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
MTAN 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
MTHFC -? ? 1.7E-01 1.7E-01 -? ? 1.9E-01 1.9E-01 -? ? 1.9E-01 1.9E-01 
MTHFD -? ? 1.7E-01 1.7E-01 -? ? 1.9E-01 1.9E-01 -? ? 1.9E-01 1.9E-01 
MTHPTGHM 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
NACUP 0.0E+00 ? 9.1E-04 9.1E-04 0.0E+00 ? 1.0E-03 1.0E-03 0.0E+00 ? 1.0E-03 1.0E-03 
NADH4 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
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Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
NADK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
NADN 0.0E+00 ? 0.0E+00 -1.0E-14 0.0E+00 ? 0.0E+00 -1.3E-13 0.0E+00 ? 0.0E+00 2.3E-14 
NADPH12 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
NADS1 0.0E+00 ? 9.1E-04 9.1E-04 0.0E+00 ? 1.0E-03 1.0E-03 0.0E+00 ? 1.0E-03 1.0E-03 
NAPRT 0.0E+00 ? 9.1E-04 9.1E-04 0.0E+00 ? 1.0E-03 1.0E-03 0.0E+00 ? 1.0E-03 1.0E-03 
NAt7 -? ? -? ? -? ? -? ? -? ? -? ? 
NDPK1 -? ? 2.3E+00 2.4E+00 -? ? 2.6E+00 2.7E+00 -? ? 2.6E+00 2.7E+00 
NDPK2 -? ? 4.9E-01 5.0E-01 -? ? 5.6E-01 5.7E-01 -? ? 5.6E-01 5.7E-01 
NDPK3 -? ? 3.3E-01 3.5E-01 -? ? 3.8E-01 4.0E-01 -? ? 3.8E-01 4.0E-01 
NDPK4 -? ? 1.3E-01 1.3E-01 -? ? 1.4E-01 1.4E-01 -? ? 1.4E-01 1.4E-01 
NDPK5 -? ? 0.0E+00 6.1E-03 -? ? 0.0E+00 7.0E-03 -? ? 0.0E+00 7.0E-03 
NDPK6 -? ? 0.0E+00 7.8E-03 -? ? 0.0E+00 8.9E-03 -? ? 0.0E+00 8.9E-03 
NDPK7 -? ? -7.8E-03 6.1E-03 -? ? -8.9E-03 7.0E-03 -? ? -8.9E-03 7.0E-03 
NDPK8 -? ? -? ? -? ? -? ? -? ? -? ? 
NDPK9 -? ? 0.0E+00 6.7E-02 -? ? 0.0E+00 7.6E-02 -? ? 0.0E+00 7.6E-02 
NH3t -? ? -2.1E-01 -2.1E-01 -? ? -2.2E-01 -2.2E-01 -? ? -2.2E-01 -2.2E-01 
NH4DIS -? ? 2.1E-01 2.1E-01 -? ? 2.2E-01 2.2E-01 -? ? 2.2E-01 2.2E-01 
NH4DISex -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
NNAMr -? ? 0.0E+00 -1.0E-14 -? ? 0.0E+00 -1.3E-13 -? ? 0.0E+00 2.3E-14 
NNAT 0.0E+00 ? 9.1E-04 9.1E-04 0.0E+00 ? 1.0E-03 1.0E-03 0.0E+00 ? 1.0E-03 1.0E-03 
NNDMBRT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
NOX1 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
NOX2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
NPHS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
NTD1 0.0E+00 ? 0.0E+00 1.2E-13 0.0E+00 ? 0.0E+00 -7.9E-13 0.0E+00 ? 0.0E+00 2.9E-13 
NTD10 0.0E+00 ? 0.0E+00 -3.2E-14 0.0E+00 ? 0.0E+00 -4.0E-13 0.0E+00 ? 0.0E+00 7.8E-14 
NTD11 0.0E+00 ? 0.0E+00 -2.2E-14 0.0E+00 ? 0.0E+00 -4.3E-13 0.0E+00 ? 0.0E+00 1.0E-13 
NTD2 0.0E+00 ? 0.0E+00 -9.2E-15 0.0E+00 ? 0.0E+00 -7.4E-13 0.0E+00 ? 0.0E+00 1.1E-13 
NTD3 0.0E+00 ? 0.0E+00 7.8E-03 0.0E+00 ? 0.0E+00 8.9E-03 0.0E+00 ? 0.0E+00 8.9E-03 
NTD4 0.0E+00 ? 0.0E+00 5.2E-15 0.0E+00 ? 0.0E+00 -7.5E-13 0.0E+00 ? 0.0E+00 1.7E-13 
NTD5 0.0E+00 ? 0.0E+00 -1.5E-14 0.0E+00 ? 0.0E+00 -8.1E-13 0.0E+00 ? 0.0E+00 1.7E-13 
NTD6 0.0E+00 ? 0.0E+00 -1.5E-14 0.0E+00 ? 0.0E+00 -8.1E-13 0.0E+00 ? 0.0E+00 1.7E-13 
NTD7 0.0E+00 ? 0.0E+00 8.5E-14 0.0E+00 ? 0.0E+00 -4.6E-12 0.0E+00 ? 0.0E+00 1.2E-12 
NTD8 0.0E+00 ? 0.0E+00 -1.5E-14 0.0E+00 ? 0.0E+00 -8.1E-13 0.0E+00 ? 0.0E+00 1.7E-13 
NTD9 0.0E+00 ? 0.0E+00 3.2E-14 0.0E+00 ? 0.0E+00 -4.2E-13 0.0E+00 ? 0.0E+00 9.9E-14 
NTR3B 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
OCBT -? ? -8.2E-14 0.0E+00 -? ? 4.8E-13 0.0E+00 -? ? -1.8E-13 0.0E+00 
OCDMAT8 0.0E+00 ? 1.7E-03 1.7E-03 0.0E+00 ? 2.0E-03 2.0E-03 0.0E+00 ? 2.0E-03 2.0E-03 
OCMAT3 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
OMPDC 0.0E+00 ? 0.0E+00 8.2E-14 0.0E+00 ? 0.0E+00 -4.8E-13 0.0E+00 ? 0.0E+00 1.8E-13 
ORNt2 0.0E+00 ? 0.0E+00 4.4E-02 0.0E+00 ? 0.0E+00 5.0E-02 0.0E+00 ? 0.0E+00 5.0E-02 
OROt6 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
ORPT -? ? -8.2E-14 0.0E+00 -? ? 4.8E-13 0.0E+00 -? ? -1.8E-13 0.0E+00 
P5CRr -? ? 4.8E-01 4.8E-01 -? ? 6.4E-01 6.4E-01 -? ? 6.4E-01 6.4E-01 
PABAt -? ? 4.5E-06 4.5E-06 -? ? 5.1E-06 5.1E-06 -? ? 5.1E-06 5.1E-06 
PAPPT5 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
PDH 0.0E+00 ? 0.0E+00 3.0E+01 0.0E+00 ? 0.0E+00 3.5E+01 0.0E+00 ? 0.0E+00 2.4E+01 
PFK 0.0E+00 ? 6.5E+00 6.5E+00 0.0E+00 ? 5.0E+00 5.0E+00 0.0E+00 ? 5.0E+00 5.0E+00 
PGAMT -? ? -1.4E-01 -1.4E-01 -? ? -1.6E-01 -1.6E-01 -? ? -1.6E-01 -1.6E-01 
PGDH 0.0E+00 ? 1.8E+01 1.8E+01 0.0E+00 ? 1.4E+01 1.4E+01 0.0E+00 ? 1.4E+01 1.4E+01 
PGGH 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
PGGT4 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
PGI -? ? 6.7E+00 6.7E+00 -? ? 5.2E+00 5.2E+00 -? ? 5.2E+00 5.2E+00 
PGK -? ? 3.0E+01 3.0E+01 -? ? 2.3E+01 3.4E+01 -? ? 2.3E+01 2.3E+01 
PGL 0.0E+00 ? 1.8E+01 1.8E+01 0.0E+00 ? 1.4E+01 1.4E+01 0.0E+00 ? 1.4E+01 1.4E+01 
PGLYCP 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
PGM -? ? 3.0E+01 3.0E+01 -? ? 2.3E+01 3.4E+01 -? ? 2.3E+01 2.3E+01 
PGMT -? ? -4.0E-01 -4.0E-01 -? ? -4.6E-01 -4.6E-01 -? ? -4.6E-01 -4.6E-01 
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Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
PGMT_B -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
PGPP_LRE 0.0E+00 ? 1.8E-01 1.8E-01 0.0E+00 ? 2.1E-01 2.1E-01 0.0E+00 ? 2.1E-01 2.1E-01 
PGSA_LRE -? ? 1.8E-01 1.8E-01 -? ? 2.1E-01 2.1E-01 -? ? 2.1E-01 2.1E-01 
PHEt6 -? ? 3.7E-02 3.7E-02 -? ? 4.3E-02 4.3E-02 -? ? 4.3E-02 4.3E-02 
PHETRS 0.0E+00 ? 3.7E-02 3.7E-02 0.0E+00 ? 4.3E-02 4.3E-02 0.0E+00 ? 4.3E-02 4.3E-02 
PIabc 0.0E+00 ? 0.0E+00 -1.0E-13 0.0E+00 ? 0.0E+00 -1.1E-12 0.0E+00 ? 0.0E+00 6.3E-13 
PIt6 -? ? 5.7E-01 5.7E-01 -? ? 6.5E-01 6.5E-01 -? ? 6.5E-01 6.5E-01 
PKL -? ? 1.7E+01 1.7E+01 -? ? 1.3E+01 1.3E+01 -? ? 1.3E+01 1.3E+01 
PMANM -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
PMEVK 0.0E+00 ? 1.0E-03 1.0E-03 0.0E+00 ? 1.1E-03 1.1E-03 0.0E+00 ? 1.1E-03 1.1E-03 
PMPK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
PNS1 0.0E+00 ? 0.0E+00 4.6E-14 0.0E+00 ? 0.0E+00 -8.0E-13 0.0E+00 ? 0.0E+00 1.3E-13 
PNS2 0.0E+00 ? 0.0E+00 4.6E-14 0.0E+00 ? 0.0E+00 -8.0E-13 0.0E+00 ? 0.0E+00 1.3E-13 
PNS3 0.0E+00 ? 0.0E+00 4.6E-14 0.0E+00 ? 0.0E+00 -8.0E-13 0.0E+00 ? 0.0E+00 1.3E-13 
PNS4 0.0E+00 ? 0.0E+00 4.6E-14 0.0E+00 ? 0.0E+00 -8.0E-13 0.0E+00 ? 0.0E+00 1.3E-13 
PNTK 0.0E+00 ? 9.1E-05 9.1E-05 0.0E+00 ? 1.0E-04 1.0E-04 0.0E+00 ? 1.0E-04 1.0E-04 
PNTOt2 -? ? 9.1E-05 9.1E-05 -? ? 1.0E-04 1.0E-04 -? ? 1.0E-04 1.0E-04 
PPA 0.0E+00 ? 2.4E+00 2.4E+00 0.0E+00 ? 2.7E+00 2.7E+00 0.0E+00 ? 2.7E+00 2.7E+00 
PPBNGS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
PPCDC 0.0E+00 ? 9.1E-05 9.1E-05 0.0E+00 ? 1.0E-04 1.0E-04 0.0E+00 ? 1.0E-04 1.0E-04 
PPDt1 -? ? 0.0E+00 8.2E-04 -? ? 1.1E+01 2.2E+01 -? ? 2.2E+01 2.2E+01 
PPIK 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 
PPM -? ? -6.7E-02 -6.7E-02 -? ? -7.6E-02 -7.6E-02 -? ? -7.6E-02 -7.6E-02 
PPM2 -? ? 0.0E+00 2.1E-14 -? ? 0.0E+00 -4.2E-13 -? ? 0.0E+00 2.1E-13 
PPN13D -? ? -8.2E-04 0.0E+00 -? ? -2.2E+01 -1.1E+01 -? ? -2.2E+01 -2.2E+01 
PPNCL 0.0E+00 ? 9.1E-05 9.1E-05 0.0E+00 ? 1.0E-04 1.0E-04 0.0E+00 ? 1.0E-04 1.0E-04 
PRAGS 0.0E+00 ? 8.5E-02 8.5E-02 0.0E+00 ? 9.6E-02 9.6E-02 0.0E+00 ? 9.6E-02 9.6E-02 
PRAIS 0.0E+00 ? 8.5E-02 8.5E-02 0.0E+00 ? 9.6E-02 9.6E-02 0.0E+00 ? 9.6E-02 9.6E-02 
PRASCS -? ? 8.5E-02 8.5E-02 -? ? 9.6E-02 9.6E-02 -? ? 9.6E-02 9.6E-02 
PRFGS 0.0E+00 ? 8.5E-02 8.5E-02 0.0E+00 ? 9.6E-02 9.6E-02 0.0E+00 ? 9.6E-02 9.6E-02 
PROt6 -? ? -4.4E-01 -4.4E-01 -? ? -5.9E-01 -5.9E-01 -? ? -5.9E-01 -5.9E-01 
PROTRS 0.0E+00 ? 4.4E-02 4.4E-02 0.0E+00 ? 5.0E-02 5.0E-02 0.0E+00 ? 5.0E-02 5.0E-02 
PROTS_LRE_v6.0 0.0E+00 ? 1.1E+00 1.1E+00 0.0E+00 ? 1.3E+00 1.3E+00 0.0E+00 ? 1.3E+00 1.3E+00 
PRPPS -? ? 1.1E-01 1.1E-01 -? ? 1.3E-01 1.3E-01 -? ? 1.3E-01 1.3E-01 
PSUDS 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 
PTAr -? ? -1.7E+01 -1.7E+01 -? ? -1.3E+01 -1.8E+00 -? ? -2.0E+00 -1.8E+00 
PTPAT -? ? -? 9.1E-05 -? ? -? 1.0E-04 -? ? -? 1.0E-04 
PTPATi 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 
PTRCabc 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
PUNP1 -? ? -4.6E-14 8.5E-14 -? ? 8.0E-13 -4.6E-12 -? ? -1.2E-13 1.2E-12 
PUNP2 -? ? -1.1E-14 0.0E+00 -? ? 2.1E-13 0.0E+00 -? ? -4.6E-14 0.0E+00 
PUNP3 -? ? -2.3E-14 3.2E-14 -? ? 7.9E-13 -4.2E-13 -? ? -1.2E-13 9.9E-14 
PUNP4 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
PUNP5 -? ? -4.6E-14 -4.0E-13 -? ? 8.0E-13 -5.1E-12 -? ? -1.3E-13 1.6E-12 
PUNP6 -? ? 0.0E+00 1.1E-14 -? ? 0.0E+00 -2.1E-13 -? ? 0.0E+00 4.6E-14 
PUNP7 -? ? -4.6E-14 -3.2E-14 -? ? 8.0E-13 -4.0E-13 -? ? -1.3E-13 7.8E-14 
PYDAMK 0.0E+00 ? 0.0E+00 -8.7E-15 0.0E+00 ? 0.0E+00 -7.5E-13 0.0E+00 ? 0.0E+00 1.6E-13 
PYDAMt -? ? 4.5E-07 4.5E-07 -? ? 5.1E-07 5.1E-07 -? ? 5.1E-07 5.1E-07 
PYDXK 0.0E+00 ? 4.5E-07 4.5E-07 0.0E+00 ? 5.1E-07 5.1E-07 0.0E+00 ? 5.1E-07 5.1E-07 
PYDXPP 0.0E+00 ? 0.0E+00 -1.6E-14 0.0E+00 ? 0.0E+00 -8.1E-13 0.0E+00 ? 0.0E+00 1.5E-13 
PYK 0.0E+00 ? 5.4E+00 5.4E+00 0.0E+00 ? 3.7E+00 1.5E+01 0.0E+00 ? 3.7E+00 4.0E+00 
PYNP1 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 
PYNP1r -? ? -? 0.0E+00 -? ? -? 0.0E+00 -? ? -? 0.0E+00 
PYNP2 -? ? -6.7E-02 -6.7E-02 -? ? -7.6E-02 -7.6E-02 -? ? -7.6E-02 -7.6E-02 
PYNP3 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
PYNP4 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
PYRNS1 0.0E+00 ? 0.0E+00 4.6E-14 0.0E+00 ? 0.0E+00 -8.0E-13 0.0E+00 ? 0.0E+00 1.3E-13 
PYRt2 -? ? -1.7E-13 0.0E+00 -? ? 1.6E-12 0.0E+00 -? ? -3.6E-13 0.0E+00 
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Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
PYRZAM 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
QUIND 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
R05218 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
R05220 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
R05223 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
R05225 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
R05226 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
RAFGH 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
RBFK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
RBFSa 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
RBK 0.0E+00 ? 2.2E-02 2.2E-02 0.0E+00 ? 2.5E-02 2.5E-02 0.0E+00 ? 2.5E-02 2.5E-02 
RBLK1 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
RBLK2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
RBP4E -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
RBT5PDHy -? ? -1.6E-01 -1.6E-01 -? ? -1.8E-01 -1.8E-01 -? ? -1.8E-01 -1.8E-01 
RBZP 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
RHC 0.0E+00 ? 2.2E-02 2.2E-02 0.0E+00 ? 2.5E-02 2.5E-02 0.0E+00 ? 2.5E-02 2.5E-02 
RIBFLVt2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
RNAS_LRE 0.0E+00 ? 1.3E-01 1.3E-01 0.0E+00 ? 1.4E-01 1.4E-01 0.0E+00 ? 1.4E-01 1.4E-01 
RNDR1 0.0E+00 ? 0.0E+00 7.8E-03 0.0E+00 ? 0.0E+00 8.9E-03 0.0E+00 ? 0.0E+00 8.9E-03 
RNDR2 0.0E+00 ? 0.0E+00 6.1E-03 0.0E+00 ? 0.0E+00 7.0E-03 0.0E+00 ? 0.0E+00 7.0E-03 
RNDR3 0.0E+00 ? 0.0E+00 1.4E-02 0.0E+00 ? 0.0E+00 1.6E-02 0.0E+00 ? 0.0E+00 1.6E-02 
RNDR4 0.0E+00 ? 0.0E+00 7.8E-03 0.0E+00 ? 0.0E+00 8.9E-03 0.0E+00 ? 0.0E+00 8.9E-03 
RNTR1 0.0E+00 ? 0.0E+00 7.8E-03 0.0E+00 ? 0.0E+00 8.9E-03 0.0E+00 ? 0.0E+00 8.9E-03 
RNTR2 0.0E+00 ? 0.0E+00 6.1E-03 0.0E+00 ? 0.0E+00 7.0E-03 0.0E+00 ? 0.0E+00 7.0E-03 
RNTR3 0.0E+00 ? 0.0E+00 1.4E-02 0.0E+00 ? 0.0E+00 1.6E-02 0.0E+00 ? 0.0E+00 1.6E-02 
RNTR4 0.0E+00 ? 0.0E+00 7.8E-03 0.0E+00 ? 0.0E+00 8.9E-03 0.0E+00 ? 0.0E+00 8.9E-03 
RPE -? ? 1.7E+01 1.7E+01 -? ? 1.3E+01 1.3E+01 -? ? 1.3E+01 1.3E+01 
RPI -? ? -1.6E-01 -1.6E-01 -? ? -1.8E-01 -1.8E-01 -? ? -1.8E-01 -1.8E-01 
SBTpts 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
SDPDS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
SECYSL 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
SERAT -? ? 2.2E-02 2.2E-02 -? ? 2.5E-02 2.5E-02 -? ? 2.5E-02 2.5E-02 
SERD_L 0.0E+00 ? 3.1E-01 3.1E-01 0.0E+00 ? 3.3E-01 3.3E-01 0.0E+00 ? 3.3E-01 3.3E-01 
SERt3 0.0E+00 ? 0.0E+00 -3.7E-14 0.0E+00 ? 0.0E+00 -1.1E-12 0.0E+00 ? 0.0E+00 2.2E-13 
SERt6 -? ? 5.7E-01 5.7E-01 -? ? 6.3E-01 6.3E-01 -? ? 6.3E-01 6.3E-01 
SERTRS 0.0E+00 ? 6.2E-02 6.2E-02 0.0E+00 ? 7.0E-02 7.0E-02 0.0E+00 ? 7.0E-02 7.0E-02 
SHCHD 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
SHCHD2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
SPMDabc 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
SRCHCOC 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
SSALx 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
SSALy 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
SUCBZL 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
SUCpts 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
TAPGL4 0.0E+00 ? 6.2E-03 6.2E-03 0.0E+00 ? 7.1E-03 7.1E-03 0.0E+00 ? 7.1E-03 7.1E-03 
TDMAT6 0.0E+00 ? 8.7E-02 8.7E-02 0.0E+00 ? 9.8E-02 9.8E-02 0.0E+00 ? 9.8E-02 9.8E-02 
TDPDRE -? ? 1.2E-01 1.2E-01 -? ? 1.3E-01 1.3E-01 -? ? 1.3E-01 1.3E-01 
TDPDRR -? ? -1.2E-01 -1.2E-01 -? ? -1.3E-01 -1.3E-01 -? ? -1.3E-01 -1.3E-01 
TDPGDH 0.0E+00 ? 1.2E-01 1.2E-01 0.0E+00 ? 1.3E-01 1.3E-01 0.0E+00 ? 1.3E-01 1.3E-01 
THDPS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
THFGLUS -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
THMabc 0.0E+00 ? 4.5E-06 4.5E-06 0.0E+00 ? 5.1E-06 5.1E-06 0.0E+00 ? 5.1E-06 5.1E-06 
THMDt2r -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 -? ? 0.0E+00 0.0E+00 
THRPDC 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
THRt2 0.0E+00 ? 7.0E-02 7.0E-02 0.0E+00 ? 8.0E-02 8.0E-02 0.0E+00 ? 8.0E-02 8.0E-02 
THRt3 0.0E+00 ? 0.0E+00 -3.7E-14 0.0E+00 ? 0.0E+00 -1.1E-12 0.0E+00 ? 0.0E+00 2.2E-13 
THRTRS 0.0E+00 ? 7.0E-02 7.0E-02 0.0E+00 ? 8.0E-02 8.0E-02 0.0E+00 ? 8.0E-02 8.0E-02 
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Simulation A Simulation B Simulation C 
Reaction 
LB UB Min Max LB UB Min Max LB UB Min Max 
THZPSN 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
THZPSN2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
TMDK1 0.0E+00 ? 0.0E+00 -1.5E-14 0.0E+00 ? 0.0E+00 -8.1E-13 0.0E+00 ? 0.0E+00 1.7E-13 
TMDK2 0.0E+00 ? 0.0E+00 -1.8E-14 0.0E+00 ? 0.0E+00 -7.0E-13 0.0E+00 ? 0.0E+00 1.7E-13 
TMDPK 0.0E+00 ? 4.5E-06 4.5E-06 0.0E+00 ? 5.1E-06 5.1E-06 0.0E+00 ? 5.1E-06 5.1E-06 
TMDS 0.0E+00 ? 7.8E-03 7.8E-03 0.0E+00 ? 8.9E-03 8.9E-03 0.0E+00 ? 8.9E-03 8.9E-03 
TMPPP 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
TPI -? ? 6.3E+00 6.3E+00 -? ? 4.7E+00 1.6E+01 -? ? 4.7E+00 5.0E+00 
TRDR 0.0E+00 ? 2.8E-02 2.8E-02 0.0E+00 ? 3.2E-02 3.2E-02 0.0E+00 ? 3.2E-02 3.2E-02 
TREpts 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
TRPt6 -? ? 6.6E-03 6.6E-03 -? ? 7.5E-03 7.5E-03 -? ? 7.5E-03 7.5E-03 
TRPTRS 0.0E+00 ? 6.6E-03 6.6E-03 0.0E+00 ? 7.5E-03 7.5E-03 0.0E+00 ? 7.5E-03 7.5E-03 
TYRt6 -? ? 3.1E-02 3.1E-02 -? ? 3.5E-02 3.5E-02 -? ? 3.5E-02 3.5E-02 
TYRTRS 0.0E+00 ? 3.1E-02 3.1E-02 0.0E+00 ? 3.5E-02 3.5E-02 0.0E+00 ? 3.5E-02 3.5E-02 
UAAGDS 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
UAAGLS1 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
UAG2E -? ? 6.2E-03 6.2E-03 -? ? 7.1E-03 7.1E-03 -? ? 7.1E-03 7.1E-03 
UAG2EMA -? ? 0.0E+00 1.2E-15 -? ? 0.0E+00 -2.3E-13 -? ? 0.0E+00 1.4E-13 
UAGCVT 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
UAGDP 0.0E+00 ? 1.4E-01 1.4E-01 0.0E+00 ? 1.6E-01 1.6E-01 0.0E+00 ? 1.6E-01 1.6E-01 
UAGPT5 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
UAMAGS 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
UAMAS 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
UAPGR 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
UDCPDP 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
UDCPDPS 0.0E+00 ? 9.1E-05 9.1E-05 0.0E+00 ? 1.0E-04 1.0E-04 0.0E+00 ? 1.0E-04 1.0E-04 
UDCPK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
UDPDPS 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
UDPG4E -? ? 5.9E-02 5.9E-02 -? ? 6.7E-02 6.7E-02 -? ? 6.7E-02 6.7E-02 
UDPGALM 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
UGLDDS1 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
UGLDDS2 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
UGLDDS3 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
UGMDDS2 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
UNAGAMAMT 0.0E+00 ? 6.2E-03 6.2E-03 0.0E+00 ? 7.1E-03 7.1E-03 0.0E+00 ? 7.1E-03 7.1E-03 
UPP3MT 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
UPP3S 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
UPPRT 0.0E+00 ? 0.0E+00 -6.4E-14 0.0E+00 ? 0.0E+00 -8.2E-13 0.0E+00 ? 0.0E+00 1.3E-13 
URAt2 0.0E+00 ? 6.7E-02 6.7E-02 0.0E+00 ? 7.6E-02 7.6E-02 0.0E+00 ? 7.6E-02 7.6E-02 
URIDK1 0.0E+00 ? 2.0E-01 2.0E-01 0.0E+00 ? 2.3E-01 2.3E-01 0.0E+00 ? 2.3E-01 2.3E-01 
URIDK2 0.0E+00 ? 0.0E+00 -7.4E-15 0.0E+00 ? 0.0E+00 -4.1E-13 0.0E+00 ? 0.0E+00 8.5E-14 
URIK1 0.0E+00 ? 0.0E+00 6.7E-02 0.0E+00 ? 0.0E+00 7.6E-02 0.0E+00 ? 0.0E+00 7.6E-02 
URIK2 0.0E+00 ? 0.0E+00 6.7E-02 0.0E+00 ? 0.0E+00 7.6E-02 0.0E+00 ? 0.0E+00 7.6E-02 
URIK3 0.0E+00 ? 0.0E+00 6.7E-02 0.0E+00 ? 0.0E+00 7.6E-02 0.0E+00 ? 0.0E+00 7.6E-02 
VALt2 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 0.0E+00 ? 
VALt6 -? ? -? 6.6E-02 -? ? -? 7.5E-02 -? ? -? 7.5E-02 
VALTRS 0.0E+00 ? 6.6E-02 6.6E-02 0.0E+00 ? 7.5E-02 7.5E-02 0.0E+00 ? 7.5E-02 7.5E-02 
XANt2 0.0E+00 ? 0.0E+00 -1.7E-14 0.0E+00 ? 0.0E+00 -4.1E-13 0.0E+00 ? 0.0E+00 9.5E-14 
XPPT 0.0E+00 ? 0.0E+00 -3.2E-14 0.0E+00 ? 0.0E+00 -4.0E-13 0.0E+00 ? 0.0E+00 7.8E-14 
XYLK 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 0.0E+00 ? 0.0E+00 0.0E+00 
YUMPS -? ? -? 0.0E+00 -? ? -? 0.0E+00 -? ? -? 0.0E+00 
Note: LB, lower boundary constrain; UB, upper boundary constraint; Min, minimum flux within optimal solution; 
Max, maximum flux within optimal solution.  
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Table 4.S3.1. Complete list of transcripts from L. reuteri that are differentially expressed in 
response to glycerol
a
. Comparisons were established to identify mid-log (exp) and early-
stationary (sta) specific responses, and to detect the effect of glycerol in the differential 
response between mid-log and early-stationary growth phases (sta-exp). 
exp sta sta-exp 
Locus Product
b
 
M
c
 p
d
 M
c
 p
d
 M
c
 p
d
 
Lreu_0001 Chromosomal replication initiator protein dnaA - - 1.16 0.00 1.81 0.00 
Lreu_0003 Hypothetical cytosolic protein - - -2.18 0.00 -2.24 0.00 
Lreu_0004 DNA replication and repair protein recF - - -1.35 0.00 -1.22 0.03 
Lreu_0007 SSU ribosomal protein S6P - - - - 0.81 0.04 
Lreu_0008 Phage single-strand DNA binding protein - - - - 0.95 0.05 
Lreu_0010 Phosphoesterase, DHH family protein - - 1.63 0.05 1.78 0.03 
Lreu_0011 LSU ribosomal protein L9P - - 1.57 0.00 1.65 0.01 
Lreu_0012 Replicative DNA helicase (EC 3.6.1.-) - - 1.56 0.00 2.32 0.00 
Lreu_0015 Hypothetical protein -0.63 0.02 - - - - 
Lreu_0023 Zn-dependent hydrolase (beta-lactamase superfamily) - - - - 0.90 0.04 
Lreu_0030 1,3-propanediol dehydrogenase (EC 1.1.1.202) 1.43 0.00 1.52 0.00 1.69 0.00 
Lreu_0035 Hypothetical exported protein - - 0.98 0.00 1.08 0.04 
Lreu_0041  - - 1.24 0.02 - - 
Lreu_0044 
Aromatic amino acid aminotransferase (EC 2.6.1.57) / 
Acetyldiaminopimelate aminotransferase (EC 2.6.1.-) 
- - 1.37 0.03 - - 
Lreu_0045 ATP-dependent endopeptidase clp ATP-binding subunit clpL -0.64 0.03 -0.78 0.00 -0.98 0.02 
Lreu_0049 ATP-dependent nuclease subunit B - - 1.48 0.02 1.79 0.04 
Lreu_0053 Sucrose transport protein -2.23 0.00 - - - - 
Lreu_0054 maltose phosphorylase (EC 2.4.1.8) -0.76 0.01 - - - - 
Lreu_0055 
Beta-phosphoglucomutase (EC 5.4.2.6) / Glucose-1-phosphate 
phosphodismutase (EC 2.7.1.41) -0.81 0.00 - - - - 
Lreu_0059 Two component system histidine kinase (EC 2.7.3.-) - - 0.73 0.00 - - 
Lreu_0061  - - 1.87 0.00 - - 
Lreu_0063 Glutamine amidotransferase, class I - - 1.37 0.00 - - 
Lreu_0064 Aldo/keto reductase family - - -0.75 0.01 -1.32 0.01 
Lreu_0067 NADH oxidase H2O-forming (EC 1.6.-.-) - - -2.47 0.00 -2.47 0.01 
Lreu_0077  - - 0.73 0.01 1.22 0.02 
Lreu_0079  - - 0.77 0.02 - - 
Lreu_0083 Oligo-1,6-glucosidase (EC 3.2.1.10) -1.64 0.02 3.34 0.00 2.48 0.05 
Lreu_0085 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) - - -1.04 0.01 - - 
Lreu_0086 Carbamoyl-phosphate synthase small chain (EC 6.3.5.5) - - - - -3.09 0.02 
Lreu_0088 Transcriptional regulator, LacI family -3.24 0.00 1.43 0.01 - - 
Lreu_0089 tRNA (Uracil-5-) -methyltransferase (EC 2.1.1.35) - - 1.55 0.02 - - 
Lreu_0090 NADPH-dependent FMN reductase family protein -0.68 0.01 -1.36 0.00 -1.49 0.01 
Lreu_0091 Oxidoreductase (EC 1.1.1.-) -0.72 0.01 -1.24 0.00 -1.39 0.01 
Lreu_0092 Iron-sulfur cluster assembly/repair protein ApbE -0.63 0.02 -1.25 0.00 -1.56 0.01 
Lreu_0098 
Glutamine-binding protein / Glutamine transport system 
permease protein glnP 
- - 1.82 0.00 3.19 0.00 
Lreu_0099 Glutamine transport ATP-binding protein glnQ - - 1.31 0.02 1.85 0.03 
Lreu_0102 Inosine-uridine preferring nucleoside hydrolase (EC 3.2.2.1) -1.33 0.00 - - - - 
Lreu_0103 3-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.157) -2.72 0.00 -0.63 0.03 - - 
Lreu_0104 Methyltransferase gidB (EC 2.1.-.-) - - 1.36 0.00 1.47 0.03 
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exp sta sta-exp 
Locus Product
b
 
M
c
 p
d
 M
c
 p
d
 M
c
 p
d
 
Lreu_0106 Chromosome partitioning protein parA - - 1.04 0.00 1.07 0.02 
Lreu_0107 Stage 0 sporulation protein J - - 0.95 0.01 - - 
Lreu_0108 Hypothetical cytosolic protein - - 1.95 0.00 2.22 0.02 
Lreu_0111 Deoxyribose-phosphate aldolase (EC 4.1.2.4) -3.17 0.00 2.40 0.00 2.74 0.00 
Lreu_0112 Phosphopentomutase (EC 5.4.2.7) -3.26 0.00 2.17 0.00 2.57 0.00 
Lreu_0113 Pyrimidine-nucleoside phosphorylase (EC 2.4.2.2) - - - - 1.95 0.03 
Lreu_0114 Purine nucleoside phosphorylase II (EC 2.4.2.1) -3.15 0.00 2.25 0.00 2.46 0.00 
Lreu_0119 Branched-chain amino acid transport protein azlC - - 1.52 0.00 1.91 0.01 
Lreu_0123 Aspartate carbamoyltransferase (EC 2.1.3.2) 1.61 0.00 -2.51 0.00 -5.74 0.00 
Lreu_0124 Dihydroorotase (EC 3.5.2.3) 1.54 0.00 -3.07 0.00 -6.19 0.00 
Lreu_0125 Dihydroorotate dehydrogenase, catalytic subunit (EC 1.3.3.1) 1.47 0.01 -2.90 0.00 -6.07 0.00 
Lreu_0126 Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) 1.28 0.01 -3.22 0.00 -6.37 0.00 
Lreu_0127 Orotate phosphoribosyltransferase (EC 2.4.2.10) 1.31 0.01 -2.75 0.00 -5.80 0.00 
Lreu_0129 Cyclopropane-fatty-acyl-phospholipid synthase (EC 2.1.1.79) - - 0.68 0.01 - - 
Lreu_0133 Alpha-acetolactate decarboxylase (EC 4.1.1.5) 0.92 0.00 1.33 0.00 - - 
Lreu_0137 
Phosphoribosylamidoimidazole-succinocarboxamide synthase 
(EC 6.3.2.6) - - 2.45 0.00 2.88 0.00 
Lreu_0138 
Phosphoribosylformylglycinamidine synthase, purS component 
(EC 6.3.5.3) 
- - 2.97 0.00 3.66 0.00 
Lreu_0139 Phosphoribosylformylglycinamidine synthase (EC 6.3.5.3) - - 2.12 0.00 2.52 0.00 
Lreu_0140 Phosphoribosylformylglycinamidine synthase (EC 6.3.5.3) - - 2.28 0.00 2.91 0.00 
Lreu_0141 Amidophosphoribosyltransferase (EC 2.4.2.14) -0.59 0.02 2.66 0.00 3.40 0.00 
Lreu_0142 Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) - - 1.90 0.00 2.65 0.00 
Lreu_0143 Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) - - 1.50 0.00 2.15 0.00 
Lreu_0144 
Phosphoribosylaminoimidazolecarboxamide formyltransferase 
(EC 2.1.2.3) / IMP cyclohydrolase (EC 3.5.4.10) -0.61 0.02 1.17 0.00 1.88 0.00 
Lreu_0146 Phosphoglycerate mutase (EC 5.4.2.1) - - 0.89 0.00 1.00 0.02 
Lreu_0156 Pyrazinamidase (EC 3.5.1.-) / Nicotinamidase (EC 3.5.1.19) 0.59 0.03 - - - - 
Lreu_0157 ADP-ribosylglycohydrolase (EC 3.2.-.-) 0.71 0.02 - - - - 
Lreu_0158 Purine-cytosine permease 0.77 0.03 - - - - 
Lreu_0159 Ribokinase (EC 2.7.1.15) 0.80 0.04 - - - - 
Lreu_0161 Transporter, MFS superfamily - - 2.40 0.00 2.88 0.00 
Lreu_0162 3-oxoacyl-[acyl-carrier protein] reductase (EC 1.1.1.100) - - -1.68 0.00 -1.85 0.01 
Lreu_0163  - - -2.73 0.00 -2.82 0.00 
Lreu_0164 
Quinate/shikimate dehydrogenase [Pyrroloquinoline-quinone] 
(EC 1.1.99.25) 
- - -0.59 0.02 -1.17 0.01 
Lreu_0165 Hypothetical protein - - -1.69 0.00 -2.51 0.00 
Lreu_0166 Tyrosine transporter 0.94 0.05 - - - - 
Lreu_0169 Alpha/beta hydrolase fold protein - - 1.10 0.01 - - 
Lreu_0170  -1.52 0.01 1.65 0.01 - - 
Lreu_0172 Oxidoreductase (EC 1.1.1.-) - - 0.67 0.02 - - 
Lreu_0173 Phosphatidylglycerophosphatase B (EC 3.1.3.27) -0.96 0.00 - - - - 
Lreu_0174 DNA/RNA helicase (DEAD/DEAH box family) -0.82 0.03 - - - - 
Lreu_0176 
Pyridine nucleotide-disulphide oxidoreductase family protein 
(EC 1.-.-.-) - - 2.14 0.00 1.84 0.01 
Lreu_0177 Hypothetical membrane spanning protein -1.09 0.02 -4.93 0.00 -5.18 0.00 
Lreu_0180 
Lead, cadmium, zinc and mercury transporting ATPase (EC 
3.6.3.-) 
- - -1.12 0.05 -1.23 0.04 
Lreu_0181 Phosphopentomutase (EC 5.4.2.7) - - -0.82 0.02 - - 
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Lreu_0183 Rrf2 family protein - - 1.02 0.00 - - 
Lreu_0185 Glycine betaine transport system permease protein - - -0.71 0.02 -1.01 0.04 
Lreu_0186 Glycine betaine transport ATP-binding protein - - - - -0.71 0.02 
Lreu_0187 Glycine betaine transport system permease protein - - -0.84 0.01 -1.12 0.02 
Lreu_0190 Succinyl-diaminopimelate desuccinylase (EC 3.5.1.18) 1.22 0.01 - - - - 
Lreu_0191 ABC transporter permease protein 1.05 0.00 - - - - 
Lreu_0192 ABC transporter ATP-binding protein 1.16 0.00 - - - - 
Lreu_0193 ABC transporter substrate-binding protein 1.32 0.00 - - - - 
Lreu_0194 L-2-hydroxyisocaproate dehydrogenase (EC 1.1.1.-) 0.94 0.02 1.85 0.01 - - 
Lreu_0198 Amino acid permease 0.78 0.02 3.04 0.00 2.50 0.00 
Lreu_0199 4-aminobutyrate aminotransferase (EC 2.6.1.19) 0.70 0.01 2.52 0.00 1.97 0.00 
Lreu_0200 Na+/H+ antiporter napA - - 1.07 0.03 - - 
Lreu_0202 Nucleoside diphosphate kinase (EC 2.7.4.6) -1.54 0.00 1.76 0.00 1.39 0.01 
Lreu_0203 Adenine-specific methyltransferase (EC 2.1.1.72) - - 1.63 0.01 - - 
Lreu_0206 
3-hydroxy-3-methylglutaryl-coenzyme A reductase (EC 
1.1.1.34) / 3-hydroxy-3-methylglutaryl-coenzyme A reductase 
(EC 1.1.1.88) 
- - 1.14 0.02 1.56 0.05 
Lreu_0210 
Methionyl-tRNA synthetase (EC 6.1.1.10) / Protein secretion 
chaperonin CsaA 
- - 2.63 0.00 2.70 0.00 
Lreu_0211 DNase, TatD family (EC 3.1.-.-) - - 2.16 0.00 2.12 0.00 
Lreu_0212 Ribonuclease M5 (EC 3.1.26.8) - - 1.68 0.00 1.74 0.01 
Lreu_0213 Dimethyladenosine transferase (EC 2.1.1.-) - - 1.94 0.00 2.04 0.00 
Lreu_0214 VEG protein - - 1.53 0.00 1.49 0.02 
Lreu_0219 Pur operon repressor - - 2.70 0.00 2.80 0.00 
Lreu_0220 
Glucosamine-1-phosphate acetyltransferase (EC 2.3.1.157) / 
UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) 
- - 2.34 0.00 2.50 0.00 
Lreu_0221 Ribose-phosphate pyrophosphokinase (EC 2.7.6.1) - - -0.72 0.00 -0.76 0.03 
Lreu_0223 Hydrolase (HAD superfamily) - - -2.60 0.00 -2.54 0.00 
Lreu_0224 dGTP triphosphohydrolase - - -2.69 0.00 -2.68 0.00 
Lreu_0225 Lipoate-protein ligase A (EC 6.3.2.-) - - -2.19 0.00 -2.39 0.00 
Lreu_0226 Transposase - - -0.99 0.00 -1.27 0.02 
Lreu_0227 Transposase - - -1.33 0.01 -1.41 0.02 
Lreu_0229 DNA-directed RNA polymerase delta chain (EC 2.7.7.6) 0.79 0.01 - - - - 
Lreu_0232 
UDP-N-acetylglucosamine 1-carboxyvinyltransferase (EC 
2.5.1.7) 
- - 1.78 0.00 1.88 0.04 
Lreu_0233 LSU ribosomal protein L31P - - 1.95 0.00 1.78 0.02 
Lreu_0238 Fructose-bisphosphate aldolase (EC 4.1.2.13) - - 3.73 0.00 3.96 0.00 
Lreu_0239 Phosphoglycerate mutase family protein - - 3.69 0.00 3.67 0.00 
Lreu_0240 Protein tyrosine phosphatase (EC 3.1.3.48) - - -1.80 0.00 -2.54 0.00 
Lreu_0241 LemA protein - - - - -0.66 0.02 
Lreu_0242 Endopeptidase htpX (EC 3.4.24.-) - - -0.85 0.00 -1.01 0.02 
Lreu_0252 D-alanine-activating enzyme (EC 6.3.2.-) - - 1.08 0.00 0.98 0.02 
Lreu_0253 Hypothetical protein - - 1.49 0.00 1.43 0.00 
Lreu_0254 Holo-[acyl-carrier protein] synthase (EC 2.7.8.7) - - 0.61 0.03 - - 
Lreu_0259 2-oxo-hepta-3-ene-1,7-dioic acid hydratase (EC 4.2.-.-) 0.90 0.04 0.92 0.04 - - 
Lreu_0260 CBS domain containing protein - - 1.34 0.02 - - 
Lreu_0263 Heat shock protein 15 - - - - 0.85 0.03 
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Lreu_0264 Cell division protein DIVIC - - -0.99 0.00 - - 
Lreu_0268 Cell division protein ftsH (EC 3.4.24.-) - - 1.30 0.00 1.37 0.01 
Lreu_0276  - - -1.69 0.00 -1.67 0.02 
Lreu_0282 Aspartate racemase (EC 5.1.1.13) - - 1.08 0.05 - - 
Lreu_0283 Transcriptional regulator, GntR family - - 0.72 0.03 - - 
Lreu_0284 Nicotinate phosphoribosyltransferase (EC 2.4.2.11) - - 1.51 0.03 1.57 0.05 
Lreu_0285 NH(3)-dependent NAD(+) synthetase (EC 6.3.5.1) - - 1.44 0.03 - - 
Lreu_0286 Transcription accessory protein (S1 RNA binding domain) - - 1.00 0.00 1.48 0.02 
Lreu_0288 Beta-galactosidase large subunit (EC 3.2.1.23) -2.82 0.00 - - 0.86 0.05 
Lreu_0289 Beta-galactosidase small subunit (EC 3.2.1.23) -2.75 0.00 - - - - 
Lreu_0293 
Cystathionine beta-lyase (EC 4.4.1.8) / Cystathionine gamma-
lyase (EC 4.4.1.1) - - 1.77 0.00 1.99 0.00 
Lreu_0294 Cystine transport system permease protein - - 2.55 0.00 3.04 0.00 
Lreu_0295 Cystine transport ATP-binding protein -1.05 0.04 2.25 0.00 - - 
Lreu_0296 Cystine-binding protein - - 1.65 0.01 - - 
Lreu_0297 Aminopeptidase C (EC 3.4.22.40) - - -0.95 0.00 -0.94 0.05 
Lreu_0298 Ribose 5-phosphate isomerase (EC 5.3.1.6) - - -1.19 0.00 -1.19 0.02 
Lreu_0299 Acetyltransferase (EC 2.3.1.-) - - -1.20 0.00 -1.29 0.01 
Lreu_0303 Cysteinyl-tRNA synthetase (EC 6.1.1.16) - - 0.99 0.00 - - 
Lreu_0304 Hypothetical protein - - 0.68 0.01 - - 
Lreu_0313 LSU ribosomal protein L10P - - 0.67 0.02 1.26 0.02 
Lreu_0315  - - -1.79 0.00 -2.32 0.01 
Lreu_0317 Large-conductance mechanosensitive channel -0.84 0.03 -0.93 0.03 -1.18 0.05 
Lreu_0318 Transcriptional regulator, PadR family - - -1.31 0.00 -1.10 0.04 
Lreu_0319 Hypothetical protein - - -1.14 0.00 -0.97 0.04 
Lreu_0320  - - -1.16 0.01 - - 
Lreu_0321 
Alcohol dehydrogenase (EC 1.1.1.1) / Acetaldehyde 
dehydrogenase [acetylating] (EC 1.2.1.10) 
-2.01 0.00 -6.18 0.00 -7.18 0.00 
Lreu_0322 Ribonucleoside-diphosphate reductase beta chain (EC 1.17.4.1) - - 1.20 0.00 - - 
Lreu_0324 Glutaredoxin - - 1.63 0.00 1.89 0.01 
Lreu_0327  - - -0.88 0.00 - - 
Lreu_0328 Recombination protein recR - - -1.01 0.00 -0.71 0.05 
Lreu_0329  - - -1.06 0.00 - - 
Lreu_0330 Thymidylate kinase (EC 2.7.4.9) - - -1.06 0.00 - - 
Lreu_0331 Hypothetical cytosolic protein - - -1.04 0.02 - - 
Lreu_0332 DNA polymerase III, delta' subunit (EC 2.7.7.7) - - -1.33 0.00 -0.95 0.02 
Lreu_0333 Initiation-control protein - - -1.25 0.00 - - 
Lreu_0334 Tetrapyrrole (Corrin/Porphyrin) methylase family protein - - -1.11 0.00 - - 
Lreu_0335 Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14) - - -1.14 0.01 - - 
Lreu_0339 UDP-glucose 4-epimerase (EC 5.1.3.2) - - -0.61 0.01 -0.96 0.03 
Lreu_0341 Non-proteolytic protein, peptidase family M22 - - 0.78 0.01 - - 
Lreu_0345 Gamma-glutamyl phosphate reductase (EC 1.2.1.41) - - 0.64 0.02 - - 
Lreu_0346 Glutamate 5-kinase (EC 2.7.2.11) - - 0.93 0.05 - - 
Lreu_0347 Carbon-nitrogen hydrolase family protein 1.19 0.00 - - - - 
Lreu_0348 Aspartate aminotransferase (EC 2.6.1.1) 0.99 0.00 -0.79 0.05 -1.35 0.05 
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Lreu_0353 10 kDa chaperonin GROES - - 0.85 0.00 - - 
Lreu_0354 60 kDa chaperonin GROEL - - 0.86 0.01 - - 
Lreu_0356 Amino acid permease - - 0.84 0.05 - - 
Lreu_0357 Amino acid permease - - 1.38 0.02 2.16 0.01 
Lreu_0363 COMF operon protein 3 - - -1.39 0.03 - - 
Lreu_0364 Ribosome-associated factor Y - - -0.78 0.00 -1.40 0.00 
Lreu_0372 UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) - - 0.91 0.00 - - 
Lreu_0373 Hypothetical protein -1.32 0.00 - - - - 
Lreu_0375 Cysteine-rich domain of 2-hydroxy-acid oxidase GlcF homolog -1.58 0.00 -1.16 0.00 -1.49 0.02 
Lreu_0377 Succinyl-diaminopimelate desuccinylase (EC 3.5.1.18) - - 1.52 0.02 - - 
Lreu_0379 Acyl-CoA hydrolase (EC 3.1.2.20) - - - - -0.88 0.04 
Lreu_0381 Hydrolase (HAD superfamily) 1.14 0.01 - - - - 
Lreu_0382  - - -1.24 0.00 -2.47 0.00 
Lreu_0387 Hypothetical membrane associated protein - - 0.83 0.02 - - 
Lreu_0392 Protein translocase subunit secG - - 1.29 0.04 - - 
Lreu_0393 Carboxylesterase (EC 3.1.1.1) - - 1.31 0.00 - - 
Lreu_0394 Exoribonuclease II (EC 3.1.13.1) - - 0.91 0.01 0.90 0.02 
Lreu_0395 SsrA-binding protein - - 0.83 0.01 - - 
Lreu_0396  - - 2.28 0.00 2.23 0.00 
Lreu_0397 Uracil-DNA glycosylase (EC 3.2.2.-) -1.04 0.02 1.77 0.00 2.26 0.01 
Lreu_0398 Phosphate acetyltransferase (EC 2.3.1.8) -1.22 0.00 -0.99 0.01 -1.18 0.03 
Lreu_0399 ATP/GTP hydrolase - - 1.38 0.00 1.41 0.04 
Lreu_0400 Acetyltransferase (EC 2.3.1.-) - - 0.72 0.04 - - 
Lreu_0401 Hypothetical cytosolic protein - - 1.63 0.04 - - 
Lreu_0402 DNA polymerase III, epsilon chain (EC 2.7.7.7) - - 1.83 0.00 1.58 0.03 
Lreu_0415 Peptidoglycan binding protein - - 3.00 0.03 - - 
Lreu_0417 Two-component sensor kinase yclK (EC 2.7.3.-) - - 0.76 0.04 - - 
Lreu_0418 Glucose uptake protein homolog -1.20 0.00 1.76 0.00 2.16 0.00 
Lreu_0419 O-acetyltransferase (EC 2.3.1.-) -1.90 0.00 1.40 0.01 - - 
Lreu_0420 Glucose-6-phosphate isomerase (EC 5.3.1.9) -0.96 0.00 - - - - 
Lreu_0425 Ornithine carbamoyltransferase (EC 2.1.3.3) 1.21 0.00 - - - - 
Lreu_0426 Carbamate kinase (EC 2.7.2.2) 1.29 0.00 - - - - 
Lreu_0429 Copper-transporting ATPase (EC 3.6.3.10) - - -1.54 0.00 -1.90 0.00 
Lreu_0430 Copper-transporting ATPase (EC 3.6.3.10) - - -1.54 0.00 -1.79 0.01 
Lreu_0431 Copper-exporting ATPase (EC 3.6.3.4) - - -0.94 0.00 -1.19 0.01 
Lreu_0432  -0.65 0.01 -0.93 0.00 -1.41 0.01 
Lreu_0438  - - -1.38 0.02 - - 
Lreu_0439  - - -1.12 0.01 -1.28 0.05 
Lreu_0441 Transposase - - -0.66 0.02 - - 
Lreu_0442 Transposase - - -1.42 0.01 - - 
Lreu_0443  - - -5.03 0.00 -5.08 0.00 
Lreu_0445 Arginine deiminase (EC 3.5.3.6) - - -0.80 0.00 -0.72 0.01 
Lreu_0447 Arginine/ornithine antiporter -0.89 0.05 -1.29 0.00 -1.23 0.02 
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Lreu_0448 Arginine/ornithine antiporter -0.93 0.03 - - - - 
Lreu_0455 Serine hydroxymethyltransferase (EC 2.1.2.1) - - -0.90 0.04 -0.86 0.01 
Lreu_0456 Uracil phosphoribosyltransferase (EC 2.4.2.9) - - - - -1.49 0.02 
Lreu_0460 Uracil permease 1.06 0.02 -1.53 0.00 -3.17 0.00 
Lreu_0461 ATP synthase A chain (EC 3.6.3.14) - - -0.84 0.01 - - 
Lreu_0462 ATP synthase C chain (EC 3.6.3.14) - - -0.95 0.00 -1.24 0.01 
Lreu_0463 ATP synthase B chain (EC 3.6.3.14) - - -0.98 0.00 -1.26 0.02 
Lreu_0464 ATP synthase delta chain (EC 3.6.3.14) - - -0.99 0.00 -1.31 0.01 
Lreu_0465 ATP synthase alpha chain (EC 3.6.3.14) - - -0.99 0.00 -1.25 0.02 
Lreu_0466 ATP synthase gamma chain (EC 3.6.3.14) - - -0.99 0.00 -1.22 0.01 
Lreu_0467 ATP synthase beta chain (EC 3.6.3.14) - - -1.02 0.00 -1.30 0.01 
Lreu_0468 ATP synthase epsilon chain (EC 3.6.3.14) - - -0.69 0.03 -1.26 0.01 
Lreu_0473  - - -0.63 0.04 - - 
Lreu_0474 Rod shape-determining protein rodA - - -0.73 0.03 - - 
Lreu_0477 D-alanine--D-alanine ligase (EC 6.3.2.4) - - - - 1.47 0.03 
Lreu_0479 Arabinose-proton symporter -3.21 0.01 -1.62 0.01 - - 
Lreu_0480 L-ribulokinase (EC 2.7.1.16) -4.12 0.00 -1.68 0.02 - - 
Lreu_0481 L-ribulose-5-phosphate 4-epimerase (EC 5.1.3.4) -3.36 0.00 -1.67 0.00 - - 
Lreu_0482 L-arabinose isomerase (EC 5.3.1.4) -2.96 0.00 -1.82 0.00 - - 
Lreu_0483 Bacterial transferase family (hexapeptide motif) - - -1.43 0.03 - - 
Lreu_0486 Universal stress protein family - - -2.08 0.00 -2.91 0.00 
Lreu_0492 Integral membrane protein - - -1.45 0.05 - - 
Lreu_0503 Thiamine biosynthesis protein thiI - - - - 1.22 0.04 
Lreu_0505 Cytochrome d ubiquinol oxidase subunit I (EC 1.10.3.-) -0.66 0.01 -2.40 0.00 -2.48 0.00 
Lreu_0506 Cytochrome d ubiquinol oxidase subunit II (EC 1.10.3.-) -0.72 0.01 -2.31 0.00 -2.38 0.00 
Lreu_0507 Transport ATP-binding protein cydD - - -1.38 0.02 - - 
Lreu_0508 Transport ATP-binding protein cydC -0.59 0.03 -1.36 0.00 -0.77 0.03 
Lreu_0510 
Folylpolyglutamate synthase (EC 6.3.2.17) / Dihydrofolate 
synthase (EC 6.3.2.12) 0.97 0.00 - - - - 
Lreu_0511 DNA repair protein radC 0.90 0.01 - - - - 
Lreu_0513 Rod shape-determining protein mreC - - 1.05 0.01 1.28 0.04 
Lreu_0514 Rod shape-determining protein mreD - - - - 0.91 0.03 
Lreu_0515 Histidine transport system permease protein hisM 1.40 0.01 - - - - 
Lreu_0517 Histidine-binding protein 1.43 0.02 - - - - 
Lreu_0520 Transcriptional regulator - - 0.80 0.01 1.27 0.02 
Lreu_0524 Hydrolase (HAD superfamily) - - 0.94 0.03 - - 
Lreu_0529 Queuine tRNA-ribosyltransferase (EC 2.4.2.29) - - - - 0.89 0.05 
Lreu_0530 Protein translocase subunit YajC - - 1.22 0.00 1.33 0.01 
Lreu_0533 Alanyl-tRNA synthetase (EC 6.1.1.7) - - 1.55 0.00 1.63 0.02 
Lreu_0534 Hypothetical cytosolic protein - - 1.75 0.00 1.56 0.00 
Lreu_0535 Endonuclease involved in recombination - - 2.12 0.00 1.86 0.00 
Lreu_0536 Hypothetical cytosolic protein - - 2.42 0.00 2.05 0.00 
Lreu_0537 CvpA family membrane protein - - - - 0.80 0.05 
Lreu_0539 Thioredoxin - - 0.67 0.04 - - 
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Lreu_0542 Xanthosine triphosphate pyrophosphatase (EC 3.6.1.-) - - 2.00 0.00 2.33 0.01 
Lreu_0543 Phosphoesterase family protein - - 1.65 0.01 2.24 0.02 
Lreu_0544 CBS domain containing protein - - 1.35 0.01 1.84 0.02 
Lreu_0548  - - -0.75 0.01 -0.95 0.04 
Lreu_0550 Catabolite control protein A - - 0.79 0.01 1.51 0.01 
Lreu_0551  - - - - 0.93 0.05 
Lreu_0553 ComG operon protein 1 - - -1.10 0.04 - - 
Lreu_0558 Hypothetical protein - - -1.63 0.05 - - 
Lreu_0559 Adenine-specific methyltransferase (EC 2.1.1.72) - - 1.02 0.00 0.93 0.03 
Lreu_0560 Acetate kinase (EC 2.7.2.1) - - 0.70 0.01 - - 
Lreu_0561 Phosphohydrolase - - 1.79 0.04 - - 
Lreu_0562 Hypothetical cytosolic protein - - 1.62 0.00 1.49 0.05 
Lreu_0568 Negative regulator of genetic competence mecA - - -1.19 0.00 -1.51 0.01 
Lreu_0569 Putative competence protein/transcription factor 1.09 0.02 - - - - 
Lreu_0584 Cell division protein mraZ - - 2.76 0.00 3.07 0.00 
Lreu_0585 S-adenosyl-methyltransferase mraW (EC 2.1.1.-) - - 2.18 0.00 2.56 0.00 
Lreu_0586 Cell division protein ftsL - - 2.37 0.00 2.81 0.00 
Lreu_0588 
Phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 
2.7.8.13) - - - - 1.25 0.04 
Lreu_0591 Cell-division initiation protein DivIB - - 1.04 0.03 1.68 0.03 
Lreu_0592 Cell division protein ftsA - - 1.91 0.00 1.85 0.00 
Lreu_0594 Hypothetical cytosolic protein - - 1.69 0.00 1.77 0.00 
Lreu_0595 Integral membrane protein - - 1.40 0.00 1.55 0.02 
Lreu_0596 RNA binding protein - - 0.98 0.00 1.09 0.02 
Lreu_0597 Cell division initiation protein DivIVA - - 1.33 0.00 1.31 0.01 
Lreu_0599 Cold shock protein - - 0.70 0.03 - - 
Lreu_0600 ADP-ribose pyrophosphatase (EC 3.6.1.13) - - 1.22 0.00 1.03 0.03 
Lreu_0601  - - 0.97 0.01 - - 
Lreu_0602 
5'-methylthioadenosine nucleosidase (EC 3.2.2.16) / S-
adenosylhomocysteine nucleosidase (EC 3.2.2.9) 
- - 0.84 0.01 - - 
Lreu_0605 
tRNA (5-methylaminomethyl-2-thiouridylate)-
methyltransferase (EC 2.1.1.61) - - 1.49 0.00 1.36 0.02 
Lreu_0606 Phosphoglycerate mutase family protein - - 1.21 0.00 - - 
Lreu_0607 Tetratricopeptide repeat family protein - - 1.08 0.00 - - 
Lreu_0610 Diaminopimelate epimerase (EC 5.1.1.7) 1.10 0.01 1.69 0.00 1.21 0.04 
Lreu_0611 Aspartokinase (EC 2.7.2.4) 1.02 0.01 - - - - 
Lreu_0612 Diaminopimelate decarboxylase (EC 4.1.1.20) 1.36 0.00 - - - - 
Lreu_0613 Tetrahydrodipicolinate N-acetyltransferase (EC 2.3.1.89) 1.25 0.01 -0.69 0.01 - - 
Lreu_0614 Putative N-acetyldiaminopimelate deacetylase (EC 3.5.1.47) 1.22 0.01 -0.82 0.02 - - 
Lreu_0615 Dihydrodipicolinate synthase (EC 4.2.1.52) 1.19 0.00 -1.09 0.00 - - 
Lreu_0616 Dihydrodipicolinate reductase (EC 1.3.1.26) 1.06 0.05 -0.83 0.05 - - 
Lreu_0617 
Aromatic amino acid aminotransferase (EC 2.6.1.57) / 
Acetyldiaminopimelate aminotransferase (EC 2.6.1.-) 
1.36 0.00 -0.99 0.03 - - 
Lreu_0618 Aspartate-semialdehyde dehydrogenase (EC 1.2.1.11) - - -0.63 0.02 - - 
Lreu_0622 Glycerate kinase (EC 2.7.1.31) - - -1.50 0.00 -1.58 0.02 
Lreu_0625 Cell wall-associated glycosyl hydrolase -0.89 0.01 - - - - 
Lreu_0629 Hypothetical exported protein - - -2.37 0.00 -3.13 0.01 
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Lreu_0631 
Pyruvate dehydrogenase E1 component alpha subunit (EC 
1.2.4.1) -3.17 0.00 - - - - 
Lreu_0632 
Pyruvate dehydrogenase E1 component beta subunit (EC 
1.2.4.1) 
-3.26 0.00 - - - - 
Lreu_0633 
Dihydrolipoamide acetyltransferase component of pyruvate 
dehydrogenase complex (EC 2.3.1.12) -3.36 0.00 - - - - 
Lreu_0634 Dihydrolipoamide dehydrogenase (EC 1.8.1.4) -3.28 0.00 - - - - 
Lreu_0639 Hypothetical cytosolic protein - - - - 0.60 0.03 
Lreu_0640 Methyltransferase (EC 2.1.1.-) - - - - 1.77 0.04 
Lreu_0642 ATP-dependent endopeptidase Lon (EC 3.4.21.53) - - 0.78 0.04 - - 
Lreu_0647 SSU ribosomal protein S20P 0.85 0.03 - - - - 
Lreu_0652 Trigger factor, ppiase (EC 5.2.1.8) - - 1.52 0.00 1.42 0.01 
Lreu_0659 Ribonuclease Z (EC 3.1.26.11) - - 1.14 0.01 1.16 0.05 
Lreu_0669 Phage Terminase Small Subunit - - -0.91 0.05 - - 
Lreu_0674 Phage protein - - - - -1.85 0.04 
Lreu_0676 Hydroxymethylglutaryl-CoA synthase (EC 2.3.3.10) - - 0.61 0.04 - - 
Lreu_0677 LexA repressor (EC 3.4.21.88) - - 0.67 0.03 - - 
Lreu_0678 Hypothetical cytosolic protein - - -1.01 0.00 -1.40 0.01 
Lreu_0679 Hypothetical cytosolic protein 0.74 0.00 -0.72 0.01 -1.32 0.01 
Lreu_0690 Undecaprenyl pyrophosphate synthetase (EC 2.5.1.31) - - 1.63 0.00 - - 
Lreu_0691 Phosphatidate cytidylyltransferase (EC 2.7.7.41) - - 1.73 0.00 2.00 0.01 
Lreu_0692 Membrane endopeptidase, M50 family - - 1.43 0.00 1.85 0.01 
Lreu_0693 Prolyl-tRNA synthetase (EC 6.1.1.15) - - 1.04 0.05 1.49 0.03 
Lreu_0695 Hypothetical cytosolic protein - - -0.62 0.02 - - 
Lreu_0698 LSU ribosomal protein L7AE - - -0.62 0.04 - - 
Lreu_0701 tRNA pseudouridine synthase B (EC 4.2.1.70) - - -0.76 0.03 - - 
Lreu_0703  1.19 0.02 - - - - 
Lreu_0704 Heat-inducible transcription repressor hrcA - - 1.86 0.00 1.35 0.02 
Lreu_0705 GrpE protein 0.59 0.03 1.60 0.00 1.31 0.03 
Lreu_0706 Chaperone protein dnaK - - 1.62 0.00 1.22 0.05 
Lreu_0707 Chaperone protein dnaJ 0.60 0.03 - - - - 
Lreu_0710 Hypothetical protein - - -0.78 0.05 - - 
Lreu_0711  - - -1.09 0.01 -1.43 0.02 
Lreu_0712  - - -0.89 0.00 -1.10 0.02 
Lreu_0714 Dipeptidase A (EC 3.4.13.-) -1.01 0.03 - - - - 
Lreu_0715 Malate dehydrogenase (EC 1.1.1.37) - - 1.12 0.02 - - 
Lreu_0726 Arginine transport ATP-binding protein artP - - 1.90 0.00 - - 
Lreu_0727 
Arginine-binding protein / Arginine transport system permease 
protein artQ 
-5.10 0.00 2.34 0.00 - - 
Lreu_0731 Argininosuccinate synthase (EC 6.3.4.5) -6.32 0.00 1.18 0.02 - - 
Lreu_0732 Argininosuccinate lyase (EC 4.3.2.1) -5.98 0.00 - - - - 
Lreu_0735 PhoH protein - - 0.60 0.05 - - 
Lreu_0736 Hypothetical metal-binding protein - - 0.67 0.02 - - 
Lreu_0741 Glycyl-tRNA synthetase beta chain (EC 6.1.1.14) - - 0.64 0.05 - - 
Lreu_0742 DNA primase (EC 2.7.7.-) - - 1.63 0.01 2.18 0.01 
Lreu_0743 RNA polymerase sigma factor rpoD - - 1.13 0.00 1.38 0.02 
Lreu_0744 
Aromatic amino acid aminotransferase (EC 2.6.1.57) / 
Acetyldiaminopimelate aminotransferase (EC 2.6.1.-) - - 1.71 0.00 1.62 0.01 
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Lreu_0749  0.82 0.00 - - - - 
Lreu_0750 DNA polymerase III alpha subunit (EC 2.7.7.7) - - -1.74 0.00 -2.00 0.02 
Lreu_0758 Riboflavin transporter - - 3.67 0.00 3.57 0.00 
Lreu_0760 ATP-dependent DNA helicase recQ (EC 3.6.1.-) - - 1.07 0.03 1.30 0.04 
Lreu_0761 Peptidoglycan-specific endopeptidase, M23 family - - 1.88 0.00 2.21 0.00 
Lreu_0763 SSU ribosomal protein S1P - - - - 1.59 0.05 
Lreu_0765 DNA-binding protein HU - - -1.57 0.00 -2.32 0.01 
Lreu_0772 Fatty acid-binding protein, DegV family - - 0.69 0.01 - - 
Lreu_0775 Hypothetical cytosolic protein - - 0.60 0.01 0.79 0.05 
Lreu_0787 Transcriptional regulator - - 1.09 0.00 - - 
Lreu_0789 Phosphinothricin N-acetyltransferase (EC 2.3.1.-) - - 0.97 0.02 - - 
Lreu_0790 General stress protein, Gls24 family -0.76 0.03 -1.48 0.00 -1.95 0.01 
Lreu_0792  - - -1.31 0.00 -1.81 0.01 
Lreu_0801 Transcriptional regulator, Cro/CI family - - 0.80 0.01 - - 
Lreu_0802  - - -1.79 0.00 -2.40 0.00 
Lreu_0803 Phage antirepressor protein - - -2.20 0.00 -2.94 0.00 
Lreu_0806  - - -2.32 0.00 -2.77 0.00 
Lreu_0811 RecT protein - - -2.60 0.00 -3.22 0.01 
Lreu_0812 Phage protein -0.60 0.03 -2.57 0.00 -3.15 0.00 
Lreu_0813 Phage replication protein -0.62 0.04 -2.54 0.00 -3.26 0.00 
Lreu_0814  - - -2.58 0.00 -3.35 0.00 
Lreu_0815  -0.64 0.05 -2.62 0.00 -3.24 0.00 
Lreu_0816  - - -2.52 0.00 -3.01 0.00 
Lreu_0821  - - -2.51 0.00 -3.13 0.00 
Lreu_0822  - - -2.30 0.00 -2.59 0.00 
Lreu_0823  - - -2.25 0.00 -2.68 0.00 
Lreu_0827  - - -2.42 0.00 -2.94 0.00 
Lreu_0829  - - -2.30 0.00 -2.78 0.00 
Lreu_0830  - - -2.02 0.00 -2.64 0.00 
Lreu_0831  - - -1.77 0.00 -2.34 0.01 
Lreu_0832  - - -1.68 0.00 -2.10 0.00 
Lreu_0833 Terminase large subunit - - -1.79 0.00 -2.32 0.00 
Lreu_0834 Portal protein - - -1.84 0.00 -2.49 0.00 
Lreu_0835 Phage protein - - -1.78 0.00 -2.38 0.00 
Lreu_0836  - - -1.91 0.00 -2.21 0.00 
Lreu_0837  - - -1.82 0.00 -2.58 0.00 
Lreu_0838 Major capsid protein - - -1.77 0.00 -2.46 0.00 
Lreu_0839 Phage protein - - -1.87 0.00 -2.73 0.00 
Lreu_0840  - - -1.86 0.00 -2.64 0.00 
Lreu_0841 Phage protein - - -1.90 0.00 -2.61 0.00 
Lreu_0842  - - -2.08 0.00 -2.83 0.00 
Lreu_0843 Phage protein - - -1.91 0.00 -2.78 0.00 
Lreu_0844 Phage protein - - -1.83 0.00 -2.76 0.00 
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Lreu_0845  - - -1.98 0.00 -2.74 0.00 
Lreu_0846 Phage protein - - -1.75 0.00 -2.37 0.00 
Lreu_0847  - - -1.73 0.00 -2.40 0.00 
Lreu_0848 Phage protein - - -1.62 0.00 -2.35 0.00 
Lreu_0849 Phage protein - - -1.25 0.00 -1.89 0.00 
Lreu_0850  - - -1.80 0.00 -2.41 0.00 
Lreu_0851  - - -1.98 0.00 -2.67 0.00 
Lreu_0852  - - -1.66 0.03 - - 
Lreu_0854  - - -1.83 0.00 -2.60 0.00 
Lreu_0856  - - -1.25 0.00 -2.09 0.00 
Lreu_0857  - - -1.68 0.01 -2.34 0.01 
Lreu_0864  - - -1.06 0.00 -1.05 0.03 
Lreu_0866 Amidase family protein -1.53 0.00 1.87 0.01 2.13 0.03 
Lreu_0867  - - -0.89 0.00 -1.43 0.01 
Lreu_0868 Integral membrane protein - - -1.59 0.00 -2.23 0.00 
Lreu_0877 Inosine-uridine preferring nucleoside hydrolase (EC 3.2.2.1) -1.95 0.00 - - - - 
Lreu_0878 
Diaminohydroxyphosphoribosylaminopyrimidine deaminase 
(EC 3.5.4.26) / 5-amino-6-(5-phosphoribosylamino)uracil 
reductase (EC 1.1.1.193) 
- - 4.36 0.00 4.89 0.00 
Lreu_0879 Riboflavin synthase alpha chain (EC 2.5.1.9) - - 3.25 0.00 3.70 0.00 
Lreu_0880 
GTP cyclohydrolase II (EC 3.5.4.25) / 3,4-dihydroxy-2-
butanone-4-phosphate synthase (EC 4.1.2.-) 
- - 3.96 0.00 4.46 0.00 
Lreu_0885 RNA polymerase ECF-type sigma factor - - 1.59 0.00 - - 
Lreu_0889  - - -2.37 0.00 -2.63 0.00 
Lreu_0890 Ferrous iron transport protein B - - -2.31 0.00 -2.23 0.02 
Lreu_0891 ATP-dependent transporter sufC -1.22 0.00 -1.24 0.00 -1.02 0.02 
Lreu_0892 SufD protein -1.28 0.00 - - - - 
Lreu_0893 
Cysteine desulfurase (EC 2.8.1.7) / Selenocysteine lyase (EC 
4.4.1.16) 
-1.27 0.00 -0.75 0.02 - - 
Lreu_0894 IscU protein -1.32 0.00 -0.72 0.05 - - 
Lreu_0895 ABC transporter-associated protein sufB -1.15 0.03 - - - - 
Lreu_0896 Hypothetical cytosolic protein -0.62 0.01 -0.84 0.05 - - 
Lreu_0897 Transcriptional regulator, Xre family -0.72 0.01 - - - - 
Lreu_0898 Two-component response regulator - - -0.84 0.01 - - 
Lreu_0910 Alpha-galactosidase (EC 3.2.1.22) -3.11 0.00 - - - - 
Lreu_0920 Multimodular transpeptidase-transglycosylase PBP 1A - - 0.95 0.01 0.99 0.05 
Lreu_0922 Hypothetical cytosolic protein - - -1.41 0.00 -1.51 0.01 
Lreu_0923 Cell division initiation protein DivIVA - - 0.96 0.00 0.87 0.05 
Lreu_0926 Ribonuclease HI (EC 3.1.26.4) / Cell wall enzyme EBSB - - -1.33 0.01 -1.39 0.04 
Lreu_0931 Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) -0.67 0.02 -0.94 0.02 - - 
Lreu_0932 Fibronectin-binding protein / Fibrinogen-binding protein - - 1.21 0.01 1.43 0.04 
Lreu_0933 Fatty acid-binding protein, DegV family - - 1.25 0.01 1.35 0.02 
Lreu_0936 Lipopolysaccharide 1,2-glucosyltransferase (EC 2.4.1.58) - - -0.99 0.01 -1.13 0.05 
Lreu_0940 Hypothetical protein 0.67 0.03 - - - - 
Lreu_0941 ACT domain-containing protein 0.91 0.02 1.51 0.00 1.52 0.03 
Lreu_0950 2-polyprenylphenol 6-hydroxylase accessory protein ubiB - - -1.89 0.00 -1.88 0.01 
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Lreu_0951 EpiH/GdmH-related protein - - -1.84 0.00 -1.81 0.02 
Lreu_0952 Lactoylglutathione lyase family protein - - 0.74 0.02 - - 
Lreu_0954 CrcB family protein - - -0.83 0.00 -0.78 0.03 
Lreu_0959  - - -0.77 0.02 - - 
Lreu_0968 
putative acyltransferases and hydrolases with the alpha/beta 
hydrolase fold - - -0.98 0.02 - - 
Lreu_0970 nucleoside deoxyribosyltransferase (EC 2.4.2.6) - - -0.98 0.00 -1.35 0.01 
Lreu_0972 Hypothetical protein - - 0.96 0.01 - - 
Lreu_0978 Lipase (EC 3.1.1.3) - - -1.39 0.01 - - 
Lreu_0981 Enoyl-[acyl-carrier protein] reductase (NADH) (EC 1.3.1.9) - - -0.78 0.05 - - 
Lreu_0991 3-oxoacyl-[acyl-carrier-protein] synthase III (EC 2.3.1.41) - - 0.68 0.05 - - 
Lreu_0992 Transcriptional regulator, MarR family - - 0.91 0.01 - - 
Lreu_0999 Transporter, Drug/Metabolite Exporter family - - -2.34 0.00 -2.61 0.00 
Lreu_1003 Transposase - - -0.59 0.03 - - 
Lreu_1005  - - -3.61 0.00 -3.55 0.00 
Lreu_1006  - - -3.04 0.00 -2.88 0.00 
Lreu_1007 Transcription regulator, crp family - - 1.13 0.00 1.10 0.02 
Lreu_1008  - - 0.87 0.00 1.24 0.01 
Lreu_1017 Alpha-glucosidase (EC 3.2.1.20) -1.80 0.00 - - - - 
Lreu_1018 Phosphatidylglycerophosphatase B homolog - - -1.06 0.00 - - 
Lreu_1029 5'-nucleotidase (EC 3.1.3.5) -1.55 0.00 1.66 0.02 1.49 0.01 
Lreu_1030  - - -2.35 0.00 -3.02 0.01 
Lreu_1033 Lysozyme (EC 3.2.1.17) - - -1.03 0.01 - - 
Lreu_1034 
Phosphotyrosine-protein phosphatase (capsular polysaccharide 
biosynthesis) (EC 3.1.3.48) 
- - -0.96 0.00 - - 
Lreu_1035 SWF/SNF family helicase - - -1.35 0.00 - - 
Lreu_1036 SWF/SNF family helicase - - -0.92 0.01 - - 
Lreu_1058  - - -1.63 0.00 -2.15 0.00 
Lreu_1061 Transposase - - -0.99 0.00 -1.27 0.02 
Lreu_1078 Bis(5'-nucleosyl)-tetraphosphatase (symmetrical) (EC 3.6.1.41) - - -1.59 0.00 -1.81 0.00 
Lreu_1081 
5-methyltetrahydropteroyltriglutamate--homocysteine 
methyltransferase (EC 2.1.1.14) 1.37 0.03 - - - - 
Lreu_1082 Polyketide cyclase family protein 1.34 0.03 - - - - 
Lreu_1084 
Farnesyl pyrophosphate synthetase (EC 2.5.1.1) / 
Geranyltranstransferase (EC 2.5.1.10) / Farnesyltransferase (EC 
2.5.1.29) / Heptaprenyl diphosphate synthase component II (EC 
2.5.1.30) 
- - 0.82 0.02 - - 
Lreu_1085 Beta-galactosidase (EC 3.2.1.23) - - -1.27 0.01 - - 
Lreu_1086 Lactose permease -1.65 0.01 -1.33 0.02 - - 
Lreu_1087 Transcriptional regulator, LacI family - - 0.59 0.04 - - 
Lreu_1090 Exodeoxyribonuclease III (EC 3.1.11.2) - - 0.92 0.02 - - 
Lreu_1091 Transcriptional regulator, Cro/CI family - - 0.88 0.04 - - 
Lreu_1092  - - - - -1.39 0.01 
Lreu_1095  - - -2.62 0.00 -3.16 0.02 
Lreu_1096  - - -2.33 0.00 -2.80 0.00 
Lreu_1097  - - -2.03 0.00 -2.73 0.00 
Lreu_1098  - - -1.25 0.00 -2.09 0.00 
Lreu_1099  - - -1.83 0.00 -2.60 0.00 
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Lreu_1100  - - -1.76 0.00 -2.46 0.00 
Lreu_1101  - - -1.66 0.03 - - 
Lreu_1102  - - -1.98 0.00 -2.67 0.00 
Lreu_1103  - - -1.92 0.00 -2.59 0.00 
Lreu_1104 Phage protein - - -1.97 0.00 -2.64 0.00 
Lreu_1105  - - -1.99 0.00 -2.70 0.03 
Lreu_1106 Phage protein -0.64 0.05 -2.31 0.00 -2.84 0.01 
Lreu_1107 Phage protein -0.97 0.03 -2.10 0.02 - - 
Lreu_1108  - - -2.65 0.00 -3.12 0.01 
Lreu_1109 Phage tail protein -0.71 0.02 -2.65 0.00 -3.54 0.00 
Lreu_1110 Phage tail protein -0.73 0.01 -2.67 0.00 -3.68 0.00 
Lreu_1111 Phage protein -0.65 0.03 -2.27 0.00 -2.96 0.00 
Lreu_1112  -0.80 0.01 -2.63 0.00 -3.47 0.00 
Lreu_1113 Phage protein -0.79 0.01 -2.58 0.00 -3.46 0.00 
Lreu_1114 Phage protein -0.86 0.01 -2.70 0.00 -3.61 0.00 
Lreu_1115 
ATP-dependent endopeptidase clp proteolytic subunit clpP (EC 
3.4.21.92) -0.95 0.01 -2.75 0.00 -3.72 0.00 
Lreu_1116 Portal protein -0.81 0.03 -3.09 0.00 -3.69 0.00 
Lreu_1117 Terminase large subunit -0.71 0.03 -2.63 0.00 -3.21 0.00 
Lreu_1118  - - -2.57 0.00 -2.88 0.00 
Lreu_1119  - - -2.02 0.02 - - 
Lreu_1120 Terminase small subunit -0.82 0.02 -2.52 0.00 -3.21 0.00 
Lreu_1121 Phage endonuclease - - -2.42 0.00 -2.81 0.01 
Lreu_1122  - - -1.89 0.00 -2.24 0.00 
Lreu_1124  - - -1.63 0.00 -2.04 0.00 
Lreu_1127  - - -2.35 0.00 -2.75 0.00 
Lreu_1138 Phage protein -0.60 0.03 -2.57 0.00 -3.15 0.00 
Lreu_1139 RecT protein - - -2.71 0.00 -3.08 0.01 
Lreu_1140  -0.98 0.04 -3.38 0.00 -3.84 0.00 
Lreu_1141  - - -1.43 0.01 -1.53 0.03 
Lreu_1142 Phage antirepressor protein - - -2.29 0.00 -3.05 0.00 
Lreu_1143  - - -2.92 0.00 -3.80 0.00 
Lreu_1144  - - -1.36 0.00 -1.71 0.00 
Lreu_1145  - - -1.35 0.00 -1.60 0.01 
Lreu_1175 DNA-directed RNA polymerase omega chain (EC 2.7.7.6) - - 1.05 0.01 - - 
Lreu_1176 Guanylate kinase (EC 2.7.4.8) - - 1.63 0.00 1.19 0.01 
Lreu_1184 
Methylenetetrahydrofolate dehydrogenase (NADP+) (EC 
1.5.1.5) / Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9) 
- - -0.72 0.03 - - 
Lreu_1185 N utilization substance protein B - - 1.54 0.00 1.35 0.02 
Lreu_1186 General stress protein, Gls24 family - - 1.16 0.00 - - 
Lreu_1191 hypothetical ribosome-associated protein - - 0.77 0.02 - - 
Lreu_1192 LSU ribosomal protein L21P - - 0.64 0.01 0.92 0.03 
Lreu_1193 Transcriptional regulator, TetR family -1.01 0.02 -2.47 0.00 -2.59 0.01 
Lreu_1197 Hypothetical cytosolic protein - - -1.28 0.02 - - 
Lreu_1198 Peptide methionine sulfoxide reductase msrA (EC 1.8.4.11) 0.62 0.02 -1.97 0.00 -2.53 0.00 
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Lreu_1199 ABC transporter substrate-binding protein 1.22 0.03 - - - - 
Lreu_1201 Glutamyl-tRNA synthetase (EC 6.1.1.17) - - -0.68 0.01 -0.92 0.05 
Lreu_1202 Glutamine synthetase (EC 6.3.1.2) - - -0.66 0.04 - - 
Lreu_1220 Hydrolase (HAD superfamily) - - -2.88 0.00 -3.23 0.00 
Lreu_1221 23S rRNA methyltransferase (EC 2.1.1.-) - - -3.34 0.00 -3.44 0.00 
Lreu_1226 Glutamate/gamma-aminobutyrate antiporter -1.27 0.00 - - - - 
Lreu_1227 Transmembrane histidine kinase CsrS - - 2.10 0.03 2.43 0.04 
Lreu_1228 Response regulator CsrR - - 2.35 0.00 2.62 0.00 
Lreu_1243 Replication initiation and membrane attachment protein - - 0.98 0.02 0.99 0.04 
Lreu_1248 Hypothetical membrane spanning protein - - -2.74 0.01 -2.81 0.04 
Lreu_1249 Integral membrane protein - - 0.99 0.01 - - 
Lreu_1251 tRNA binding domain protein - - 0.68 0.01 - - 
Lreu_1252 Thioredoxin - - 1.07 0.00 - - 
Lreu_1255 IolS protein -1.64 0.02 -1.73 0.00 -1.70 0.00 
Lreu_1256 
Poly(Glycerol-phosphate) alpha-glucosyltransferase (EC 
2.4.1.52) -1.93 0.03 -2.20 0.00 -2.14 0.01 
Lreu_1265 Peptidyl-prolyl cis-trans isomerase (EC 5.2.1.8) - - 0.63 0.04 - - 
Lreu_1268 Hypothetical cytosolic protein - - 0.72 0.03 - - 
Lreu_1270 Arginyl-tRNA synthetase (EC 6.1.1.19) -1.06 0.04 2.91 0.00 3.31 0.00 
Lreu_1277 
Folylpolyglutamate synthase (EC 6.3.2.17) / Dihydrofolate 
synthase (EC 6.3.2.12) 
- - 0.71 0.02 - - 
Lreu_1278  - - 0.79 0.02 - - 
Lreu_1286 Ribose operon repressor - - -2.69 0.00 -2.53 0.00 
Lreu_1287  - - -2.99 0.00 -3.28 0.00 
Lreu_1290 Universal stress protein family - - -0.76 0.01 -1.39 0.01 
Lreu_1291 Xaa-His dipeptidase (EC 3.4.13.3) - - 1.73 0.01 1.55 0.04 
Lreu_1294 Phage protein 0.87 0.03 - - - - 
Lreu_1295 Leucyl-tRNA synthetase (EC 6.1.1.4) - - 1.26 0.00 1.01 0.03 
Lreu_1296 S-adenosylmethionine synthetase (EC 2.5.1.6) - - 1.31 0.00 1.40 0.02 
Lreu_1298 Transposase - - 0.61 0.01 - - 
Lreu_1299 Multidrug resistance protein B 0.88 0.02 - - - - 
Lreu_1307 Small heat shock protein -0.84 0.01 - - - - 
Lreu_1308 Aldo/keto reductase family protein - - -1.89 0.00 -2.19 0.00 
Lreu_1309 
Dihydropyrimidine dehydrogenase [NADP+] beta subunit (EC 
1.3.1.2) -1.63 0.00 -3.59 0.00 -3.62 0.00 
Lreu_1310 
Dihydropyrimidine dehydrogenase [NADP+] alpha subunit (EC 
1.3.1.2) 
-1.85 0.00 -2.89 0.00 -2.92 0.00 
Lreu_1311 Exodeoxyribonuclease III (EC 3.1.11.2) - - - - -0.98 0.03 
Lreu_1312 peptidoglycan binding protein (LysM domain) - - 2.98 0.02 - - 
Lreu_1313 Hypothetical protein - - 1.25 0.00 - - 
Lreu_1314 peptidoglycan binding protein (LysM domain) - - 3.32 0.02 - - 
Lreu_1318 Multidrug resistance protein B - - -1.28 0.03 - - 
Lreu_1323 1,2-diacylglycerol 3-glucosyltransferase (EC 2.4.1.157) - - - - 1.74 0.04 
Lreu_1325 Phosphocarrier protein HPr - - 1.03 0.00 - - 
Lreu_1327 ATP-dependent endopeptidase clp ATP-binding subunit clpE - - 1.03 0.00 - - 
Lreu_1329 Hypothetical membrane associated protein - - -0.84 0.01 -1.16 0.02 
Lreu_1348 Cell wall-associated glycosyl hydrolase -1.76 0.00 - - - - 
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Lreu_1353 Hypothetical membrane spanning protein - - - - 1.50 0.05 
Lreu_1358 Transposase - - -1.42 0.01 - - 
Lreu_1363  - - 1.22 0.02 - - 
Lreu_1364 Cell wall-associated glycosyl hydrolase - - 3.03 0.00 2.50 0.00 
Lreu_1365 N-acetylmuramoyl-L-alanine amidase (EC 3.5.1.28) - - 0.81 0.05 - - 
Lreu_1367 Phage-associated cell wall hydrolase - - 2.41 0.00 2.11 0.01 
Lreu_1368 Acyltransferase - - 1.33 0.04 - - 
Lreu_1369 Putative galactofuranosyltransferase (EC 2.4.1.-) - - 1.74 0.02 2.54 0.03 
Lreu_1372  - - 1.04 0.01 1.32 0.05 
Lreu_1373  - - 1.22 0.00 1.90 0.00 
Lreu_1375 
Undecaprenyl-phosphate beta-glucosephosphotransferase (EC 
2.7.8.-) - - 1.08 0.01 - - 
Lreu_1376 Bactoprenol glucosyl transferase (EC 2.4.1.-) - - 1.41 0.00 1.98 0.01 
Lreu_1378 Regulatory protein recX - - 1.69 0.01 2.12 0.01 
Lreu_1381 Ribonuclease BN (EC 3.1.-.-) - - 1.98 0.00 1.87 0.03 
Lreu_1382 Glutamate/gamma-aminobutyrate antiporter -1.24 0.02 - - - - 
Lreu_1383 Arginine/ornithine antiporter -1.50 0.02 -0.91 0.03 -0.99 0.04 
Lreu_1384 Pyridoxal-dependent aminotransferase, arginine catabolism -2.17 0.00 - - -0.95 0.05 
Lreu_1388 Hypothetical protein - - - - -2.06 0.04 
Lreu_1389 UDP-N-acetylglucosamine 2-epimerase (EC 5.1.3.14) - - -0.96 0.03 - - 
Lreu_1392 Hypothetical cytosolic protein - - 2.96 0.00 2.73 0.01 
Lreu_1394 L-2-hydroxyisocaproate dehydrogenase (EC 1.1.1.-) - - 1.52 0.05 - - 
Lreu_1395  - - 1.65 0.00 1.48 0.01 
Lreu_1401 Transcriptional regulator -0.68 0.03 -2.78 0.00 -3.14 0.00 
Lreu_1402 Hypothetical membrane spanning protein -0.65 0.04 -2.96 0.00 -3.27 0.00 
Lreu_1407 O6-methylguanine-DNA methyltransferase (EC 2.1.1.63) - - 1.06 0.03 - - 
Lreu_1408 Nitrobenzoate nitroreductase (EC 1.6.6.-) - - 1.23 0.00 - - 
Lreu_1409  - - 0.92 0.01 - - 
Lreu_1410 IAA acetyltransferase (EC 2.3.1.-) - - 1.10 0.01 - - 
Lreu_1416 DNA/RNA helicase (DEAD/DEAH box family) - - -1.60 0.00 -1.50 0.02 
Lreu_1417  - - -1.90 0.00 -2.08 0.02 
Lreu_1422 Hypothetical cytosolic protein - - -1.03 0.00 -1.15 0.02 
Lreu_1423  - - -1.20 0.00 -1.28 0.04 
Lreu_1426 
Non-specific DNA-binding protein Dps / Iron-binding ferritin-
like antioxidant protein / Ferroxidase (EC 1.16.3.1) 
- - -1.55 0.00 -1.75 0.02 
Lreu_1427 Heavy metal binding protein - - -1.71 0.00 -2.17 0.01 
Lreu_1433 Type I restriction-modification system specificity subunit - - - - 1.00 0.02 
Lreu_1434 Integrase/recombinase (XerC/CodV family) - - 0.73 0.05 - - 
Lreu_1440 
Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B 
(EC 6.3.5.-) - - 1.37 0.00 1.34 0.02 
Lreu_1441 
Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit A 
(EC 6.3.5.-) 
- - 1.37 0.00 1.38 0.01 
Lreu_1442 
Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C 
(EC 6.3.5.-) - - 1.45 0.01 - - 
Lreu_1443 Lipoprotein (pheromone precursor) - - 1.11 0.01 - - 
Lreu_1447 Xanthine phosphoribosyltransferase (EC 2.4.2.-) - - 1.21 0.00 - - 
Lreu_1448 Peptidoglycan hydrolase (3.2.1.-) - - 1.05 0.00 0.63 0.02 
Lreu_1449 
(R,R)-butanediol dehydrogenase (EC 1.1.1.4) / Acetoin 
dehydrogenase (EC 1.1.1.5) 
- - - - -1.16 0.02 
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Lreu_1451 LSU ribosomal protein L13P - - 0.60 0.03 - - 
Lreu_1455 Cobalt transport ATP-binding protein cbiO - - 1.85 0.01 - - 
Lreu_1456 LSU ribosomal protein L17P - - 0.76 0.02 1.08 0.04 
Lreu_1457 DNA-directed RNA polymerase alpha chain (EC 2.7.7.6) - - 0.73 0.01 1.12 0.02 
Lreu_1491 DNA-directed RNA polymerase beta' chain (EC 2.7.7.6) - - 1.15 0.01 - - 
Lreu_1492 DNA-directed RNA polymerase beta chain (EC 2.7.7.6) - - 1.86 0.00 1.93 0.01 
Lreu_1493 Transcriptional regulator, TetR family - - -0.88 0.02 -1.13 0.05 
Lreu_1496 Alcohol dehydrogenase (EC 1.1.1.1) -0.87 0.01 -2.22 0.00 -2.95 0.00 
Lreu_1498 Deoxyguanosine kinase (EC 2.7.1.113) - - - - 1.60 0.03 
Lreu_1500 Lysine-specific permease 2.02 0.00 - - - - 
Lreu_1505 Cold shock protein 0.93 0.05 - - - - 
Lreu_1508 Hypothetical membrane associated protein 1.01 0.00 - - - - 
Lreu_1509 Hypothetical membrane associated protein 0.97 0.01 - - - - 
Lreu_1510 Universal stress protein family - - -0.63 0.05 -1.50 0.01 
Lreu_1511 Glutamine transport ATP-binding protein glnQ - - 1.43 0.00 - - 
Lreu_1513 Glutamine transport system permease protein glnM - - 1.21 0.00 1.38 0.02 
Lreu_1514 Glutamine transport system permease protein glnP - - 0.72 0.01 - - 
Lreu_1517  - - -1.99 0.00 -2.11 0.00 
Lreu_1518 Transcriptional regulator, MerR family - - -0.93 0.03 - - 
Lreu_1525 Multidrug resistance protein B - - -1.12 0.03 - - 
Lreu_1529 2-oxoglutarate/malate translocator - - -3.63 0.00 -3.96 0.00 
Lreu_1531 Fumarate hydratase (EC 4.2.1.2) -1.73 0.00 -4.15 0.00 -4.31 0.00 
Lreu_1534 Peptidyl-prolyl cis-trans isomerase (EC 5.2.1.8) 0.81 0.01 - - - - 
Lreu_1536  - - -0.80 0.02 -0.93 0.05 
Lreu_1538 Aldose 1-epimerase (EC 5.1.3.3) -2.83 0.00 - - - - 
Lreu_1539  1.47 0.04 - - - - 
Lreu_1542 Sucrose phosphorylase (EC 2.4.1.7) - - -2.12 0.00 -2.14 0.03 
Lreu_1544 Xaa-His dipeptidase (EC 3.4.13.3) -2.32 0.02 - - - - 
Lreu_1545 Arginine/ornithine antiporter -2.71 0.00 - - - - 
Lreu_1546 Dyp-type peroxidase family protein -1.73 0.00 - - - - 
Lreu_1547 ABC transporter ATP-binding protein uup -1.26 0.05 - - - - 
Lreu_1549 Endo-1,4-beta-xylanase (EC 3.2.1.8) - - -0.66 0.05 - - 
Lreu_1552 IRON-SULFUR FLAVOPROTEIN - - -1.08 0.03 - - 
Lreu_1554 Ferrochelatase (EC 4.99.1.1) - - 1.29 0.02 - - 
Lreu_1559 Myosin-crossreactive antigen -1.86 0.00 -1.18 0.00 -1.17 0.03 
Lreu_1560 
Chromate reductase (EC 1.-.-.-) / NADPH-dependent FMN 
reductase (EC 1.5.1.-) / Oxygen-insensitive NADPH 
nitroreductase (EC 1.-.-.-) 
-1.66 0.00 - - - - 
Lreu_1574 Acetyltransferase (EC 2.3.1.-) - - 0.78 0.02 - - 
Lreu_1581 Protein Translation Elongation Factor P (EF-P) - - 1.19 0.00 1.03 0.05 
Lreu_1582 regulatory protein (pfoS/R) 1.27 0.03 - - - - 
Lreu_1584 Transposase - - -0.67 0.05 - - 
Lreu_1585 ABC transporter substrate-binding protein 0.78 0.02 - - - - 
Lreu_1586 
Autoinducer-2 production protein luxS / 
Ribosylhomocysteinase (EC 4.4.1.21) 
0.89 0.01 2.07 0.00 2.27 0.01 
Lreu_1587  - - 0.83 0.04 - - 
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Lreu_1588 integral membrane protein - - 0.98 0.02 - - 
Lreu_1593 Transposase - - 1.08 0.04 - - 
Lreu_1594 Hypothetical protein - - - - -1.25 0.02 
Lreu_1608 Hypothetical protein - - -0.95 0.02 - - 
Lreu_1613 
Neopullulanase (EC 3.2.1.135) / Cyclomaltodextrinase (EC 
3.2.1.54) / Maltogenic alpha-amylase (EC 3.2.1.133) -2.09 0.00 - - - - 
Lreu_1614 Sucrose transport protein -1.95 0.00 - - - - 
Lreu_1617 GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) 0.59 0.03 1.52 0.00 - - 
Lreu_1618 Hypothetical ATPase -1.47 0.00 0.76 0.02 - - 
Lreu_1619 Pantothenate kinase (EC 2.7.1.33) -0.78 0.01 - - - - 
Lreu_1622 NADH oxidase H2O-forming (EC 1.6.-.-) - - -2.10 0.00 -1.80 0.01 
Lreu_1623 Transposase - - -1.33 0.01 -1.41 0.02 
Lreu_1624 Transposase - - -0.99 0.00 -1.27 0.02 
Lreu_1625 ATP-dependent DNA helicase rep (EC 3.6.1.-) - - 0.61 0.00 0.68 0.01 
Lreu_1627 Phosphoglycerate mutase (EC 5.4.2.1) - - 1.51 0.00 1.48 0.01 
Lreu_1628 GTP-binding protein hflX - - 1.22 0.00 1.22 0.05 
Lreu_1629 Integral membrane protein -1.85 0.00 - - - - 
Lreu_1630 Hypothetical protein -1.44 0.00 - - - - 
Lreu_1631 D-2-hydroxyacid dehydrogenase (EC 1.1.1.-) -2.10 0.00 - - - - 
Lreu_1632 Phage infection protein - - -1.03 0.05 - - 
Lreu_1640 Amino acid permease - - 1.98 0.00 - - 
Lreu_1646 Spermidine/putrescine transport ATP-binding protein potA - - 1.34 0.00 1.43 0.04 
Lreu_1650 
Non-specific DNA-binding protein Dps / Iron-binding ferritin-
like antioxidant protein / Ferroxidase (EC 1.16.3.1) 
-2.25 0.00 - - - - 
Lreu_1652 Phosphoglycolate phosphatase (EC 3.1.3.18) 0.67 0.04 1.33 0.01 - - 
Lreu_1657  - - -0.97 0.02 -1.11 0.04 
Lreu_1658 Inosine-uridine preferring nucleoside hydrolase (EC 3.2.2.1) -0.87 0.01 - - - - 
Lreu_1663  - - -1.24 0.02 - - 
Lreu_1664 Hypothetical membrane spanning protein - - -2.68 0.00 -2.97 0.00 
Lreu_1665 Na+/H+ antiporter nhaP - - -1.56 0.00 -1.77 0.01 
Lreu_1666 Hypothetical membrane spanning protein 0.81 0.04 - - - - 
Lreu_1677 Lipoate-protein ligase A (EC 6.3.2.-) -2.39 0.00 - - - - 
Lreu_1678 Universal stress protein family - - -0.92 0.00 -1.16 0.02 
Lreu_1679 Translation elongation and release factors (GTPases) - - -1.07 0.00 -1.14 0.03 
Lreu_1681 Branched-chain amino acid transport system carrier protein - - -0.63 0.05 - - 
Lreu_1684 cinnamoyl ester hydrolase (EC 3.1.1.-) - - -2.07 0.00 -2.51 0.00 
Lreu_1688 Transcriptional regulator - - -0.83 0.00 -0.79 0.04 
Lreu_1690 
Multidrug/protein/lipid ABC transporter family, ATP-binding 
and permease protein - - -1.42 0.03 - - 
Lreu_1692 D-2-hydroxyacid dehydrogenase (EC 1.1.1.-) -1.32 0.00 -1.60 0.00 -2.16 0.00 
Lreu_1695 
Nicotinate-nucleotide--dimethylbenzimidazole 
phosphoribosyltransferase (EC 2.4.2.21) 
-1.09 0.00 0.79 0.04 1.31 0.03 
Lreu_1696  -1.28 0.00 1.68 0.00 2.53 0.00 
Lreu_1697 Alpha-ribazole-5'-phosphate phosphatase (EC 3.1.3.73) -0.93 0.02 1.50 0.04 2.14 0.01 
Lreu_1698 Adenosylcobinamide-GDP ribazoletransferase (EC 2.7.8.26) -0.80 0.03 1.26 0.01 1.79 0.02 
Lreu_1699 
Adenosylcobinamide kinase (EC 2.7.1.156) / 
Adenosylcobinamide-phosphate guanylyltransferase (EC 
2.7.7.62) 
-0.71 0.04 1.42 0.01 1.82 0.03 
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Lreu_1700 Glutamate-1-semialdehyde 2,1-aminomutase (EC 5.4.3.8) - - 1.08 0.02 1.87 0.01 
Lreu_1701 Delta-aminolevulinic acid dehydratase (EC 4.2.1.24) - - 1.09 0.00 1.75 0.01 
Lreu_1702 Porphobilinogen deaminase (EC 2.5.1.61) - - 1.07 0.01 2.08 0.01 
Lreu_1704 
Precorrin-2 dehydrogenase (EC 1.3.1.76) / Sirohydrochlorin 
ferrochelatase (EC 4.99.1.4) - - - - 1.24 0.03 
Lreu_1706 Cobalt transport ATP-binding protein cbiO - - - - 1.57 0.02 
Lreu_1707 Cobalt transport protein cbiQ - - - - 1.66 0.01 
Lreu_1708 Cobalt transport protein cbiN - - - - 1.52 0.01 
Lreu_1709 CbiM protein - - - - 1.45 0.02 
Lreu_1710 Precorrin-2 C20-methyltransferase (EC 2.1.1.130) - - - - 1.72 0.01 
Lreu_1711 Sirohydrochlorin cobaltochelatase (EC 4.99.1.3) - - - - 1.62 0.01 
Lreu_1712 
Uroporphyrin-III C-methyltransferase (EC 2.1.1.107) / 
Uroporphyrinogen-III synthase (EC 4.2.1.75) 
- - - - 1.79 0.01 
Lreu_1713 Precorrin-6X reductase (EC 1.3.1.54) - - - - 1.51 0.01 
Lreu_1716 Precorrin-4 C11-methyltransferase (EC 2.1.1.133) - - - - 1.17 0.02 
Lreu_1717 
Precorrin-6Y C5,15-methyltransferase [decarboxylating] 
subunit CbiT (EC 2.1.1.132) - - - - 1.54 0.01 
Lreu_1718 
Precorrin-6Y C5,15-methyltransferase [decarboxylating] 
subunit CbiE (EC 2.1.1.132) 
- - - - 1.38 0.01 
Lreu_1720 Precorrin-8X methylmutase (EC 5.4.1.2) - - - - 1.39 0.01 
Lreu_1721 Adenosylcobinamide-phosphate synthase (EC 6.3.1.10) - - 0.80 0.01 1.57 0.01 
Lreu_1722 Cobyrinic acid a,c-diamide synthase (EC 6.3.1.-) - - 1.25 0.00 1.89 0.00 
Lreu_1723 Threonine-phosphate decarboxylase (EC 4.1.1.81) - - 1.45 0.00 1.86 0.01 
Lreu_1726 Oxidoreductase (EC 1.1.1.-) - - 1.10 0.00 1.53 0.01 
Lreu_1727 Flavodoxin -1.98 0.00 0.75 0.02 1.39 0.01 
Lreu_1728 Propanediol utilization protein pduV -1.86 0.00 - - - - 
Lreu_1729  0.83 0.02 1.19 0.01 2.06 0.01 
Lreu_1730 Phosphoglycerate mutase family protein - - 1.56 0.00 2.20 0.01 
Lreu_1731 Protein tyrosine phosphatase (EC 3.1.3.48) 1.15 0.00 1.40 0.00 1.73 0.00 
Lreu_1732 Ethanolamine utilization protein eutS 0.90 0.00 0.82 0.00 1.02 0.02 
Lreu_1734 Propanol dehydrogenase (EC 1.1.1.-) 0.90 0.00 0.62 0.01 0.90 0.03 
Lreu_1735 Propionaldehyde dehydrogenase [CoA-acylating] (EC 1.2.1.-) 0.81 0.00 - - 0.82 0.04 
Lreu_1736 Protein glcG 0.86 0.00 - - - - 
Lreu_1737 Cobalamin adenosyltransferase family protein 0.82 0.00 - - 0.80 0.05 
Lreu_1738 Ethanolamine utilization protein eutN 0.88 0.00 0.71 0.02 0.99 0.03 
Lreu_1739  0.80 0.02 0.69 0.03 - - 
Lreu_1740 PduL 0.73 0.01 - - - - 
Lreu_1741 Propanediol utilization protein pduA 0.81 0.00 0.66 0.02 0.95 0.04 
Lreu_1742  0.76 0.01 0.64 0.02 - - 
Lreu_1743  0.84 0.00 0.60 0.01 0.96 0.03 
Lreu_1744 Glycerol dehydratase reactivation factor large subunit 0.74 0.01 - - 0.84 0.03 
Lreu_1745 Diol dehydratase gamma subunit (EC 4.2.1.28) 0.80 0.00 0.73 0.01 1.00 0.03 
Lreu_1746 Diol dehydratase beta subunit (EC 4.2.1.28) - - 0.72 0.03 - - 
Lreu_1747 Diol dehydratase large subunit (EC 4.2.1.28) 0.71 0.01 0.88 0.00 1.18 0.02 
Lreu_1748 Propanediol utilization protein pduB 0.72 0.00 0.86 0.00 0.99 0.02 
Lreu_1749 Propanediol utilization protein pduA 0.81 0.00 0.78 0.01 1.08 0.03 
Lreu_1751 Ethanolamine utilization protein eutJ - - 1.19 0.01 1.82 0.04 
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Lreu_1752 Glycerol uptake facilitator protein - - 0.66 0.02 0.92 0.04 
Lreu_1754 Hypothetical cytosolic protein - - -1.47 0.00 -1.79 0.01 
Lreu_1755 Hypothetical membrane spanning protein - - -1.82 0.00 -1.98 0.01 
Lreu_1762 NrdI protein - - 1.72 0.00 1.35 0.02 
Lreu_1763 PhnB protein - - 0.70 0.02 - - 
Lreu_1768 Lactose permease -3.68 0.00 - - - - 
Lreu_1769 Universal stress protein family - - -2.28 0.00 -2.84 0.00 
Lreu_1771 Proton/sodium-glutamate symport protein 0.73 0.02 - - - - 
Lreu_1775 Ebg operon repressor -1.15 0.00 - - - - 
Lreu_1776 Galactose-1-phosphate uridylyltransferase (EC 2.7.7.10) -2.22 0.00 - - - - 
Lreu_1777 Galactokinase (EC 2.7.1.6) - - - - 0.72 0.05 
Lreu_1778  - - -1.56 0.00 -1.84 0.01 
Lreu_1779 Protein tyrosine phosphatase (EC 3.1.3.48) - - -0.83 0.02 -1.23 0.02 
Lreu_1781  - - -0.66 0.02 -0.95 0.04 
Lreu_1783  - - 0.87 0.04 - - 
Lreu_1785 Nicotinamide mononucleotide transporter 0.78 0.05 - - - - 
Lreu_1789 ABC transporter ATP-binding protein - - -1.00 0.02 - - 
Lreu_1790 ABC transporter permease protein - - -1.60 0.01 - - 
Lreu_1791 Homoserine O-succinyltransferase (EC 2.3.1.46) - - 0.99 0.01 - - 
Lreu_1802 Hypothetical cytosolic protein - - 0.93 0.03 - - 
Lreu_1808  - - -1.95 0.00 -2.53 0.00 
Lreu_1812 Peptidoglycan hydrolase (3.2.1.-) - - -1.35 0.00 -1.72 0.01 
Lreu_1813 Hypothetical membrane spanning protein - - -2.29 0.00 -2.41 0.01 
Lreu_1814 ABC transporter ATP-binding protein 0.84 0.04 - - - - 
Lreu_1816 NlpC/P60 family protein - - 1.09 0.02 1.15 0.02 
Lreu_1825 
Ribosomal large subunit pseudouridine synthase D (EC 
4.2.1.70) - - 0.70 0.00 0.85 0.02 
Lreu_1826 Magnesium and cobalt transport protein corA - - 1.82 0.00 1.76 0.04 
Lreu_1828 Xanthine permease - - 1.14 0.00 1.48 0.01 
Lreu_1829 Tyrosine transporter - - -0.95 0.02 - - 
Lreu_1830 Histidyl-tRNA synthetase (EC 6.1.1.21) - - -1.03 0.01 - - 
Lreu_1837 Phosphoglycerate mutase family protein -0.91 0.05 -0.72 0.02 - - 
Lreu_1840 Glycerol dehydrogenase (EC 1.1.1.6) -1.74 0.00 -3.42 0.00 -3.60 0.00 
Lreu_1848 Histidyl-tRNA synthetase (EC 6.1.1.21) - - - - 0.92 0.04 
Lreu_1853 Phage-associated cell wall hydrolase - - 2.34 0.00 - - 
Lreu_1854 Transcriptional regulator, ArsR family - - -1.05 0.00 -1.36 0.01 
Lreu_1855  - - -1.44 0.02 -1.96 0.01 
Lreu_1857 ABC transporter ATP-binding protein - - 0.95 0.01 - - 
Lreu_1860 Mannitol 2-dehydrogenase (EC 1.1.1.67) - - -1.97 0.05 - - 
Lreu_1866 Amino acid permease - - 2.14 0.00 3.32 0.00 
Lreu_1867 2-dehydropantoate 2-reductase (EC 1.1.1.169) 1.53 0.00 - - - - 
Lreu_1868 Transcriptional regulator, Cro/CI family - - -1.69 0.00 -2.24 0.00 
Lreu_1870 
5-methyltetrahydropteroyltriglutamate--homocysteine 
methyltransferase (EC 2.1.1.14) 
1.45 0.03 - - - - 
Lreu_1872 Hypothetical protein -0.69 0.01 - - 0.78 0.04 
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exp sta sta-exp 
Locus Product
b
 
M
c
 p
d
 M
c
 p
d
 M
c
 p
d
 
Lreu_1873 Hypothetical protein -1.10 0.01 - - - - 
Lreu_1874 Acetyltransferase, GNAT family - - 2.85 0.04 - - 
Lreu_1875 Putative NAD-dependent dehydrogenase - - 4.89 0.00 4.63 0.00 
Lreu_1877 Nitroreductase family protein - - 3.58 0.00 2.88 0.00 
Lreu_1878 Transcriptional regulator, MarR family - - 2.71 0.00 2.46 0.01 
Lreu_1882 Putative NAD-dependent dehydrogenase - - 1.54 0.00 0.62 0.04 
Lreu_1883 Aminopeptidase N (EC 3.4.11.15) - - 2.54 0.00 2.29 0.01 
Lreu_1884 Hypothetical membrane spanning protein - - 3.42 0.00 3.33 0.00 
Lreu_1886 Asparaginyl-tRNA synthetase (EC 6.1.1.22) - - -1.15 0.00 -1.25 0.01 
Lreu_1893 GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) - - 1.08 0.00 - - 
Lreu_1894 Hypothetical cytosolic protein - - 2.18 0.01 2.03 0.04 
Lreu_1897 Transcriptional regulator, TetR family - - -1.05 0.01 -1.28 0.03 
Lreu_1899 Transcriptional regulators, LysR family - - -1.14 0.00 -1.26 0.04 
Lreu_1902 Aminotransferase class I family 0.99 0.01 1.49 0.03 - - 
Lreu_1904 2-oxo-hepta-3-ene-1,7-dioic acid hydratase (EC 4.2.-.-) 0.90 0.05 1.05 0.05 1.00 0.05 
Lreu_1907 Transcriptional regulators, LysR family - - -1.02 0.04 -1.38 0.05 
Lreu_1911 Hypothetical cytosolic protein - - -1.26 0.01 -1.41 0.04 
Lreu_1918 
Bacteriocin processing peptidase (EC 3.4.22.-) / Bacteriocin 
export ABC transporter - - 2.32 0.04 4.27 0.03 
Lreu_1923  -1.56 0.02 - - - - 
Lreu_1924 Beta-lactamase family protein - - -0.84 0.01 -1.13 0.03 
Lreu_1926 Membrane protein, MgtC/SapB family 1.22 0.01 - - - - 
Lreu_1927 Hypothetical cytosolic protein 0.85 0.01 - - - - 
Lreu_1932 Exoenzymes regulatory protein aepA precursor -1.72 0.00 1.67 0.00 1.49 0.01 
Lreu_1934 Phosphinothricin N-acetyltransferase (EC 2.3.1.-) - - 1.65 0.02 - - 
Lreu_1935 Signal peptidase I (EC 3.4.21.89) - - 1.97 0.01 - - 
Lreu_1937 
UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--lysine ligase 
(EC 6.3.2.7) 
- - - - 1.02 0.05 
Lreu_1938 Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) - - - - 2.37 0.01 
Lreu_1943 Ribonuclease P protein component (EC 3.1.26.5) - - 1.40 0.01 2.08 0.02 
Lreu_1944 LSU ribosomal protein L34P - - - - 0.70 0.04 
a 
Transcripts were considered for analysis if p-value < 0.05 and M > |0.585|. 
b 
Annotation retrieved from ERGO (http://ergo.integratedgenomics.com/ERGO) (1). 
c 
M, log2(intensity of signal with glycerol/intensity of signal without glycerol). 
d 
p, p-value. 
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Table 4.S3.2. Distribution of transcriptomic data through out the different categories of 
clusters of orthologous groups
a
 (2). 
  
upregulated 
with glycerol 
(%) 
downregulated 
with glycerol 
(%) 
regulated 
with glycerol 
(%) 
exp 8.47 25.42 33.90 
sta 18.64 28.81 47.46 
C - Energy production and 
conversion (59) 
mid-sta 8.47 25.42 33.90 
exp 0.00 0.00 0.00 
sta 23.53 11.76 35.29 
D - Cell cycle control, cell 
division, chromosome 
partitioning (17) 
mid-sta 23.53 5.88 29.41 
exp 14.62 10.77 25.38 
sta 29.23 13.08 42.31 
E - Amino acid transport and 
metabolism (130) 
mid-sta 15.38 9.23 24.62 
exp 10.67 14.67 25.33 
sta 29.33 14.67 44.00 
F - Nucleotide transport and 
metabolism (75) 
mid-sta 25.33 13.33 38.67 
exp 1.25 23.75 25.00 
sta 18.75 12.50 31.25 
G - Carbohydrate transport 
and metabolism (80) 
mid-sta 17.50 3.75 21.25 
exp 4.23 8.45 12.68 
sta 28.17 4.23 32.39 
H - Coenzyme transport and 
metabolism (71) 
mid-sta 33.80 2.82 36.62 
exp 0.00 5.88 5.88 
sta 17.65 14.71 32.35 
I - Lipid transport and 
metabolism (34) 
mid-sta 5.88 5.88 11.76 
exp 0.72 1.44 2.16 
sta 17.27 5.76 23.02 
J - Translation, ribosomal 
structure and biogenesis 
(139) 
mid-sta 17.27 3.60 20.86 
exp 3.23 6.45 9.68 
sta 22.58 15.05 37.63 K - Transcription (93) 
mid-sta 10.75 15.05 25.81 
L - Replication, exp 0.57 1.70 2.27 
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upregulated 
with glycerol 
(%) 
downregulated 
with glycerol 
(%) 
regulated 
with glycerol 
(%) 
sta 10.23 11.36 21.59 
recombination and repair 
(176) 
mid-sta 8.52 9.66 18.18 
exp 1.25 6.25 7.50 
sta 26.25 10.00 36.25 
M - Cell 
wall/membrane/envelope 
biogenesis (80) 
mid-sta 22.50 6.25 28.75 
exp 0.00 0.00 0.00 
sta 0.00 0.00 0.00 N - Cell motility (1) 
mid-sta 0.00 0.00 0.00 
exp 11.90 14.29 26.19 
sta 30.95 16.67 47.62 
O - Posttranslational 
modification, protein 
turnover, chaperones (42) 
mid-sta 11.90 16.67 28.57 
exp 12.07 3.45 15.52 
sta 6.90 13.79 20.69 
P - Inorganic ion transport 
and metabolism (58) 
mid-sta 10.34 10.34 20.69 
exp 50.00 0.00 50.00 
sta 53.85 0.00 53.85 
Q - Secondary metabolites 
biosynthesis, transport and 
catabolism (26) 
mid-sta 38.46 0.00 38.46 
exp 3.83 7.23 11.06 
sta 13.19 15.32 28.51 
R - General function 
prediction only (235) 
mid-sta 5.53 10.21 15.74 
exp 6.04 8.72 14.77 
sta 16.78 19.46 36.24 S - Function unknown (149) 
mid-sta 12.08 16.11 28.19 
exp 7.55 3.77 11.32 
sta 24.53 24.53 49.06 
T - Signal transduction 
mechanisms (53) 
mid-sta 13.21 22.64 35.85 
exp 0.00 4.35 4.35 
sta 26.09 13.04 39.13 
U - Intracellular trafficking, 
secretion, and vesicular 
transport (23) 
mid-sta 13.04 8.70 21.74 
V - Defense mechanisms (34) exp 0.00 5.88 5.88 
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upregulated 
with glycerol 
(%) 
downregulated 
with glycerol 
(%) 
regulated 
with glycerol 
(%) 
sta 2.94 20.59 23.53 
 
mid-sta 2.94 11.76 14.71 
a
 COG assignment retrieved from ERGO (http://ergo.integratedgenomics.com/ERGO) (1). 
Note: number between brackets refers to the total number of genes of L. reuteri associated 
to COG. 
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CHAPTER 5 
POCR REGULATES GLYCEROL REDUCTION, ASSEMBLY OF 
METABOLOSOMES AND VITAMIN B12 BIOSYNTHESIS IN 
LACTOBACILLUS REUTERI JCM1112 AS IN OTHERWISE 
UNRELATED ENTERIC BACTERIA 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract  
Lactobacillus reuteri has been shown to encode a vitamin B12 biosynthesis 
pathway that is phylogenetically related to the one present in some representatives of ?-
Proteobacteria, such as Salmonella and Yersinia. Here we present evidence supporting that 
the similarities between these otherwise unrelated organisms extend to their regulatory 
mechanisms. 
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Lactobacillus reuteri is a heterofermentative lactic acid bacterium colonizing the 
gastro-intestinal tract (GI-tract) of various mammals, including humans (12). It is able to 
reduce glycerol to 1,3-propanediol in a two-step enzymatic conversion, yielding NAD
+
 (8). 
The first reaction, glycerol dehydratase (EC 4.1.2.30), converts glycerol to 3-
hydroxypropanaldehyde (reuterin) requiring the presence of B12 as a co-factor (4). Reuterin 
is a potent antimicrobial, bestowing L. reuteri with an important growth advantage over 
other residents of the GI-tract, such as Gram-negative enteric bacteria (3). 
Recently, we have shown that L. reuteri CRL1098 encodes the complete 
machinery necessary for de novo synthesis of vitamin B12 in a single chromosomal gene 
cluster (9). Unexpectedly, this cluster was shown to be very similar to that present in 
various representatives of Salmonella and stands out against the canonical phylogeny 
deduced from 16S RNA sequences. Complete genome sequence analysis of the type strain 
of L. reuteri (http://www.jgi.doe.gov/) revealed that the region immediately upstream of the 
vitamin B12 biosynthesis cluster also maintains a gene order similar to that of Salmonella. 
Moreover, the functionality of this upstream region was demonstrated to match that of 
Salmonella as it encodes the assembly machinery of metabolosomes and the several 
subunits of a large diol dehydratase that can metabolize both glycerol and 1,2-propanediol 
(11). Within this cluster resides a gene (lreu_1750) predicted to encode a putative 
transcription factor of the AraC type family, containing a typical helix-turn-helix- domain. 
Based on its conserved genomic context, this gene has been suggested to encode a homolog 
of PocR, a regulatory protein of the propanediol utilization (pdu) and B12 biosynthesis 
clusters of enteric bacteria (8, 11). However, detailed comparisons between Lreu_1750 and 
PocR revealed only limited similarities in amino acid sequence (Fig. 5.S1, supplementary 
material 5S). Moreover, genes that code for products very similar to PocR of enteric 
bacteria have been found in other B12-producing Bacilli, such as representatives of Listeria 
and Clostridium. The closest homolog of Lreu_1750 present in the complete genomes is 
found in L. brevis ATCC367 (GI:116334199). L. brevis is one of the few other lactobacilli 
for which the B12-dependent production of 1,3-propanediol has been demonstrated (4), 
although it does not have the capability to synthesize B12. The predicted products of 
lreu_1750 and its homolog in L. brevis are approximately 60 amino acid residues longer in 
the C-terminus in comparison to PocR from S. typhimurium LT2, which could affect its 
functionality.  
Here we provide the first experimental evidence to support the functional 
assignment of Lreu_1750. This was achieved by overexpression of lreu_1750 and assessing 
its impact on central carbon metabolism and vitamin B12 biosynthesis. In addition, we 
characterize the genome-wide transcriptional response of the overexpression in comparison 
to the wild-type leading to the identification of the PocR regulon.  
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Construction of a strain overexpressing lreu_1750. Gene lreu_1750 was 
overexpressed constitutively under control of the pepN promoter in a similar fashion as 
previously described (10). Chromosomal DNA of L. reuteri JCM1112 was isolated 
according to standard procedures (7). A fragment containing lreu_1750 was amplified 
using Herculase II DNA polymerase (Stratagene, La Jolla, USA), and primers P180 and 
P181 (Table 5.1). After digestion with KpnI, the modified amplicon was purified with the 
JETPURE PCR Product Purification Kit (GENOMED, Bad Oeynhausen, Germany) and 
cloned in pNZ7021 making use of the KpnI and PmlI restriction sites directly downstream 
of the pepN promoter. The resulting plasmid, termed pNZ7748, was used directly from the 
ligation reactions to transform L. lactis NZ9000 by electroporation (13). Subsequently, 
pNZ7748 was purified from L. lactis as previously described (7) and, after verification of 
its structure, used to transform L. reuteri also by electroporation (12). 
 
Table 5.1. Strains, plasmids and primers used in this study. 
Materials Relevant features Source or reference 
Strains   
L. reuteri 
JCM1112 
Type strain, synonymous to ATCC 23272, DSM 
20016 and F275. Human isolate. 
Japanese Collection 
of Microorganisms 
(Riken, Japan) 
L. lactis 
NZ9000 
MG1363 pepN:nisRK, cloning host. 
NIZO culture 
collection (Ede, 
Netherlands) 
L. delbrueckii 
NIZO235 
L. delbrueckii subsp. lactis ATCC 7830. Vitamin 
B12 assay indicator strain. 
idem 
Plasmids   
pNZ7021 
Cm
R
, pNZ8148 derivative with the nisin 
promoter replaced by the pepN promoter 
(13) 
pNZ7748 
Cm
R
, pNZ7021 derivative harbouring Lreu_1750 
downstream of the pepN promoter. 
this study 
Primers 5’ – 3’ Application 
P180 AAAAGGTACCGTAGGCGAAATTCAAATGTACG 
Amplification of 
Lreu_1750 and 
addition of KpnI site 
P181 GAATAAATAAGAGGCTGGGCAC 
Amplification of 
Lre231  
P182 ATGAACTCTATTCAGGAATTG Control of pNZ7748 
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The physiological effects of the overexpression of lreu_1750 were studied by 
cultivating Lb reuteri pNZ7748 (lreu_1750 overexpression) and Lb reuteri pNZ7021 
(empty plasmid) in chemically defined medium (CDM) in pH-controlled batch 
fermentations in the presence or absence of glycerol carried out as described previously (8). 
At different time points, samples were taken for transcriptome, supernatant and B12 analysis 
(Fig. 5.1). 
 
 
Figure 5.1. Biomass formation and sampling scheme in pH-controlled batch fermentations 
of CDM in the presence (white squares) or absence (black square) of glycerol by L. reuteri 
transformed with pNZ7021 (solid lines) or pNZ7748 (dashed lines). 
 
Phenotypic characterization of overexpressing of lreu_1750. In order to 
investigate the involvement of Lreu_1750 in regulating glycerol reduction and B12 
biosynthesis, we determined the levels of B12 production and the extracellular concentration 
of main fermentation substrates and products, as described elsewhere (8). In CDM with 
glycerol we observed a clear enhancement in the shift from ethanol to acetate formation in 
the overexpressing strain. Ethanol production dropped sharply to  about 0.2 molecules 
formed per molecule of glucose consumed. This resulted in a 22.5% increase of 1,3-
propanediol production, which, as previously noted (8), is produced on a 2:1 molar ratio 
with acetate to assure the regeneration of reducing equivalents
 
(Fig. 5.2c. and d.). In 
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contrast, when glycerol was not added to CDM, there was hardly any distinctive phenotype 
attribuTable 5.to the overexpression of lreu_1750 (Fig. 5.2a. and b), except for a slight 
impairment of μmax (< 10%). The involvement of Lreu_1750 in the regulation of vitamin 
B12 synthesis is supported by the 40-45% increase in vitamin B12 production that 
accompanies its overexpression (Fig. 5.3). This increase was obtained regardless of the 
addition of glycerol, and did not alter the approximately five-fold higher B12 production 
observed in the presence of glycerol. 
 
 
 
Figure 5.2. Substrate consumption and product formation by different constructs of L. 
reuteri in CDM and in CDM with 0.5% glycerol (v/v). a. L. reuteri pNZ7021 in CDM; b. L. 
reuteri pNZ7021 in CDM with glycerol; c. L. reuteri pNZ7748 in CDM; d. L. reuteri 
pNZ7748 in CDM with glycerol. 
 
Transcriptional response of L. reuteri to the overexpression of Lreu_1750. The 
transcriptomes of cells transformed with pNZ7748 and pNZ7021 were compared using 
cDNA microarrays as previously detailed (8) using a hybridization scheme comprising 17 
arrays in a loop-design (supplementary material 5S). The custom probe design of the 
Agilent 11K microarray platform (Agilent Technologies, Santa Clara, CA, USA) used is 
available at the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under 
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accession number GPL6856, and the data obtained were deposited in the same repository 
(accession number pending). We compared the response of L. reuteri to overexpressing 
lreu_1750 in CDM and in CDM supplemented with glycerol. However, since there is a 
large overlap between the two (more than 70%), and since glycerol has been shown to 
induce the expression of lreu_1750, reducing the effect of the overexpression, only the data 
from CDM without glycerol will be discussed. Nonetheless, the complete list of 
differentially regulated genes is available in Table 5.S1 (supplementary material 5S). 
 
 
 
Figure 5.3. B12 production by L. reuteri pNZ7021 (empty plasmid) and L. reuteri pNZ7748 
(lreu_1750 overexpression) in CDM (white bars) and in CDM supplemented with glycerol 
(grey bars). 
 
The most striking feature of overexpressing lreu_1750 is that only 120 genes 
(approximately 6% of the genome) are differentially regulated, of which, all but two are up-
regulated. Three functional classes were overrepresented, namely the ones related to 
coenzymes, secondary metabolites and energy production (Table 5.S2, supplementary 
material 5S). A closer inspection of the list of differentially regulated genes shows that 
lreu_1750 is clearly involved in the regulation of the same processes that have been linked 
to PocR in Salmonella (1). These include the activation of the pdu cluster flanking 
lreu_1750, encoding the several subunits of the diol dehydratase and the metabolosome-
assembly proteins, along with the up-regulation of the two operons of the B12 biosynthesis 
cluster (9).  Besides these genes stretching from lreu_1695 to lreu_1752, which are 
expected to be regulated by PocR by homology with Salmonella (2), we found two genes 
within the same operon with unknown function (Lreu_0429 and 0430), which were ~3.5-
fold up-regulated (Table 5.2). A closer look at their sequence indicates that these are most 
likely subunits of an ATPase transporter (5), which is in accordance with annotations from 
ERGO (6). We speculate that these are cobalt-transporters, rather then being involved in the 
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transport of copper, based on the fact that cobalt availability can limit the synthesis of B12. 
We also found genes related to sugar uptake and carbon metabolism to be regulated. These 
are presumably related to the up-regulation of lreu_0088 (transcription factor of LacI 
family), but could also be a consequence of a slight drop in growth rate caused by the 
overexpression (Fig. 5.1). A considerable number of enzymes involved in recombination 
and DNA repair proteins were also up-regulated, but this has most likely to do with the 
homologous region to the genome of L. reuteri present in plasmid pNZ7748 and not in 
pNZ7021. 
 
Table 5.2. Selection of loci associated to PocR and not within its flanking region.
a.
 
Locus Function M p 
Accession 
number 
Lreu_0088 Transcriptional regulator, LacI family 1.11 0.03 gi|148543330 
Lreu_0103 
3-hydroxybutyryl-CoA dehydrogenase (EC 
1.1.1.157) 
0.89 0.03 gi|148543342 
Lreu_0429 Putative cobalt-transporting ATPase
b.
 1.85 0.00 gi|148543665 
Lreu_0430 Putative cobalt-transporting ATPase
b.
 1.76 0.00 gi|148543666 
Lreu_0479 Arabinose-proton symporter 1.67 0.00 gi|148543714 
Lreu_0631 
Pyruvate dehydrogenase alpha subunit (EC 
1.2.4.1) 
0.88 0.02 gi|148543863 
Lreu_0632 
Pyruvate dehydrogenase beta subunit (EC 
1.2.4.1) 
0.86 0.04 gi|148543864 
Lreu_0633 
Dihydrolipoamide acetyltransferase component 
of pyruvate dehydrogenase complex (EC 
2.3.1.12) 
0.81 0.03 gi|148543865 
Lreu_0910 Alpha-galactosidase (EC 3.2.1.22) 0.90 0.03 gi|148544139 
Lreu_1007 Transcription regulator, Crp family 
-
0.82 
0.04 gi|148544234 
Lreu_1531 Fumarate hydratase (EC 4.2.1.2) 1.09 0.05 gi|148544743 
Lreu_1768 Lactose permease 0.97 0.05 gi|148544974 
Lreu_1832 Histidine decarboxylase (EC 4.1.1.22) 
-
1.67 
0.03 gi|148545038 
a. 
Genes predicted to encode phage-related proteins, recombinases, mobile elements, DNA repair and 
general or unknown functions were omitted (for full list, please see supplementary material, Table 
5.S1.1)
  
b. 
Annotated as hypothetical protein in GenBank and as copper-transporting ATPase (EC 3.6.3.10) in 
ERGO database (6). 
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Final remarks. In this study, we have provided experimental evidence for the 
annotation of Lreu_1750 as PocR and identified the genes associated to the PocR regulon in 
L. reuteri by global transcriptional analysis of the impacts of its overexpression. 
Furthermore, we have demonstrated its stimulatory effects in B12 and 1,3-propanediol 
productions, for which we observed a 40-45% and 22.5% increase, respectively. The 
findings reported here could be applied to improving the yields of these two industrially 
relevant compounds. 
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Figure 5.S1. Amino acid sequence alignment of Lreu_1750 and its closest homolog in 
Listeria monocytogenes (LMO), Listeria innocua (LIN), Salmonella typhimurium LT2 
(STL) and Lb. brevis (LEB). Obtained using ClustalW with default settings (3). 
 
 
Hybridization Scheme of cDNA microarray experiments 
The following samples were hybridized per array labeled with cyanine3 and 
cyanine5, respectively: sta-F6 and sta-F5, sta-F7 and sta-F8, sta-F5 and sta-F7, sta-F8 and 
sta-F6, sta-F3 and sta-F4, sta-F1 and sta-F3, sta-F2 and sta-F1, sta-F4 and sta-F2, exp-F3 
and exp-F4, exp-F1 and exp-F3, exp-F2 and exp-F1, exp-F4 and exp-F2, exp-F4 and sta-
F4, sta-F3 and exp-F3, sta-F2 and sta-F8, sta-F4 and sta-F6, exp-F2 and sta-F2. Here, F1 
and F5 represent completely independent biological duplicates of L. reuteri pNZ7021 
cultured in the absence of glycerol; F2 and F6 represent completely independent biological 
duplicates of L. reuteri pNZ7748 cultured in the absence of glycerol; F3 and F7 represent 
completely independent biological duplicates of L. reuteri pNZ7021 cultured in the 
presence of glycerol; and F4 and F8 represent completely independent biological duplicates 
of L. reuteri pNZ7748 cultured in the presence of glycerol The prefix exp- and sta- stand 
for cells harvested at mid logarithmic and early stationary growth phases, respectively. 
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Table 5.S1. Complete list of genes from L. reuteri that are differentially expressed by the 
overexpression of lreu_1750
a
. Comparisons were established for cells cultured in CDM and 
in CDM supplemented with glycerol. 
 
CDM CDMglycerol 
Locus Function
b
 
M
c
 p
d
 M
c
 p
d
 
COG 
Accession 
number 
Lreu_0539  Thioredoxin    0.97 0.02 C gi|148543774 
Lreu_0631  Pyruvate dehydrogenase E1 component alpha subunit 
(EC 1.2.4.1)  0.88 0.02 -1.53 0.00 C gi|148543863 
Lreu_0632  Pyruvate dehydrogenase E1 component beta subunit 
(EC 1.2.4.1)  
0.86 0.04 -1.66 0.00 C gi|148543864 
Lreu_0633  Dihydrolipoamide acetyltransferase component of 
pyruvate dehydrogenase complex (EC 2.3.1.12)  0.81 0.03 -1.44 0.00 C gi|148543865 
Lreu_0634  Dihydrolipoamide dehydrogenase (EC 1.8.1.4)    -1.17 0.02 C gi|148543866 
Lreu_1531  Fumarate hydratase (EC 4.2.1.2)  1.09 0.05   C gi|148544743 
Lreu_1727  Flavodoxin  0.92 0.01   C gi|148544933 
Lreu_1734  Propanol dehydrogenase (EC 1.1.1.-)  1.86 0.00   C gi|148544940 
Lreu_1735  Propionaldehyde dehydrogenase [CoA-acylating] (EC 
1.2.1.-)  1.94 0.00   C gi|148544941 
Lreu_0098  Glutamine-binding protein / Glutamine transport 
system permease protein glnP  
  1.23 0.00 E gi|148543337 
Lreu_1544  Xaa-His dipeptidase (EC 3.4.13.3)    -0.94 0.01 E gi|148544756 
Lreu_1728  Propanediol utilization protein pduV    -1.05 0.02 E gi|148544934 
Lreu_1732  Ethanolamine utilization protein eutS  1.87 0.00   E gi|148544938 
Lreu_1748  Propanediol utilization protein pduB  2.22 0.00   E gi|148544954 
Lreu_1751  Ethanolamine utilization protein eutJ  0.87 0.03   E gi|148544957 
Lreu_0111  Deoxyribose-phosphate aldolase (EC 4.1.2.4)    -1.90 0.00 F gi|148543350 
Lreu_0114  Purine nucleoside phosphorylase II (EC 2.4.2.1)    -1.75 0.00 F gi|148543353 
Lreu_0112  Phosphopentomutase (EC 5.4.2.7)    -1.89 0.00 G gi|148543351 
Lreu_0288  Beta-galactosidase large subunit (EC 3.2.1.23)    -1.27 0.00 G gi|148543525 
Lreu_0289  Beta-galactosidase small subunit (EC 3.2.1.23)    -1.21 0.00 G gi|148543526 
Lreu_0418  Glucose uptake protein homolog    -0.87 0.03 G gi|148543654 
Lreu_0910  Alpha-galactosidase (EC 3.2.1.22)  0.90 0.03   G gi|148544139 
Lreu_1017  Alpha-glucosidase (EC 3.2.1.20)    -1.64 0.00 G gi|148544244 
Lreu_1538  Aldose 1-epimerase (EC 5.1.3.3)    -0.89 0.02 G gi|148544750 
Lreu_1752  Glycerol uptake facilitator protein  0.93 0.02   G gi|148544958 
Lreu_1768  Lactose permease  0.97 0.05 -1.49 0.00 G gi|148544974 
Lreu_1776  Galactose-1-phosphate uridylyltransferase (EC 
2.7.7.10)  
  -0.97 0.04 G gi|148544982 
Lreu_0155  Nicotinate phosphoribosyltransferase (EC 2.4.2.11)    0.98 0.04 H gi|148543394 
Lreu_1677  Lipoate-protein ligase A (EC 6.3.2.-)    -1.17 0.01 H gi|148544883 
Lreu_1705  Adenosylcobyric acid synthase (glutamine-
hydrolysing) (EC 6.3.5.10)  
  0.96 0.03 H gi|148544911 
Lreu_1710  Precorrin-2 C20-methyltransferase (EC 2.1.1.130)    0.96 0.01 H gi|148544916 
Lreu_1711  Sirohydrochlorin cobaltochelatase (EC 4.99.1.3)  0.83 0.05 1.03 0.01 H gi|148544917 
Lreu_1712  Uroporphyrin-III C-methyltransferase (EC 2.1.1.107) / 
Uroporphyrinogen-III synthase (EC 4.2.1.75)  
0.86 0.03 0.82 0.05 H gi|148544918 
Lreu_1713  Precorrin-6X reductase (EC 1.3.1.54)  0.84 0.04   H gi|148544919 
Lreu_1714  Precorrin-3B C17-methyltransferase (EC 2.1.1.131)  0.93 0.05   H gi|148544920 
Lreu_1716  Precorrin-4 C11-methyltransferase (EC 2.1.1.133)  0.98 0.02   H gi|148544922 
Lreu_1717  Precorrin-6Y C5,15-methyltransferase 
[decarboxylating] subunit CbiT (EC 2.1.1.132)  
1.04 0.02   H gi|148544923 
Lreu_1718  Precorrin-6Y C5,15-methyltransferase 
[decarboxylating] subunit CbiE (EC 2.1.1.132)  
1.10 0.02   H gi|148544924 
Lreu_0103  3-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.157)  0.89 0.03   I gi|148543342 
Lreu_0088  Transcriptional regulator, LacI family  1.11 0.03   K gi|148543330 
Lreu_0801  Transcriptional regulator, Cro/CI family    0.81 0.04 K gi|148544031 
Lreu_0831     1.21 0.01 1.77 0.00 K gi|148544061 
Lreu_1109  Phage tail protein  2.29 0.00 1.48 0.00 K gi|148544333 
Lreu_1111  Phage protein  2.00 0.00 1.44 0.01 K gi|148544335 
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CDM CDMglycerol 
Locus Function
b
 
M
c
 p
d
 M
c
 p
d
 
COG 
Accession 
number 
Lreu_1112     2.18 0.00 1.69 0.00 K gi|148544336 
Lreu_1750  Transcriptional regulator, AraC family  3.11 0.00 3.58 0.00 K gi|148544956 
Lreu_1796 Transcriptional regulator   0.84 0.05 K gi|148545002 
Lreu_0383  Excinuclease ABC subunit B  1.05 0.05   L gi|148543619 
Lreu_0384  Excinuclease ABC subunit A  0.94 0.03   L gi|148543620 
Lreu_0523  RecA protein    1.18 0.02 L gi|148543758 
Lreu_0796  Site-specific recombinase  1.32 0.04   L gi|148544026 
Lreu_0811  RecT protein  1.95 0.00 1.73 0.00 L gi|148544041 
Lreu_1120  Terminase small subunit  2.28 0.00 1.46 0.00 L gi|148544344 
Lreu_1139  RecT protein  1.76 0.02 1.55 0.03 L gi|148544363 
Lreu_1114  Phage protein  2.15 0.00 1.61 0.00 M gi|148544338 
Lreu_0539  Thioredoxin    0.97 0.02 O gi|148543774 
Lreu_0891  ATP-dependent transporter sufC    -0.81 0.03 O gi|148544121 
Lreu_0216  Manganese-binding protein    -1.68 0.05 P gi|148543453 
Lreu_0217  Manganese transport system ATP-binding protein    -1.44 0.02 P gi|148543454 
Lreu_1650  Non-specific DNA-binding protein Dps / Iron-binding 
ferritin-like antioxidant protein / Ferroxidase (EC 
1.16.3.1)  
1.08 0.02 0.83 0.04 P gi|148544857 
Lreu_1706  Cobalt transport ATP-binding protein cbiO    1.06 0.03 P gi|148544912 
Lreu_1707  Cobalt transport protein cbiQ    1.14 0.03 P gi|148544913 
Lreu_1708  Cobalt transport protein cbiN    1.14 0.03 P gi|148544914 
Lreu_1709  CbiM protein  0.81 0.04 1.04 0.01 P gi|148544915 
Lreu_0156  Pyrazinamidase (EC 3.5.1.-) / Nicotinamidase (EC 
3.5.1.19)  
  1.04 0.04 Q gi|148543395 
Lreu_1738  Ethanolamine utilization protein eutN  2.05 0.00   Q gi|148544944 
Lreu_1740  PduL  2.17 0.00   Q gi|148544946 
Lreu_1741  Propanediol utilization protein pduA  2.18 0.00   Q gi|148544947 
Lreu_1742     2.23 0.00   Q gi|148544948 
Lreu_1743     2.29 0.00   Q gi|148544949 
Lreu_1744  Glycerol dehydratase reactivation factor large subunit  2.18 0.00   Q gi|148544950 
Lreu_1745  Diol dehydratase gamma subunit (EC 4.2.1.28)  2.20 0.00   Q gi|148544951 
Lreu_1747  Diol dehydratase large subunit (EC 4.2.1.28)  2.23 0.00   Q gi|148544953 
Lreu_1749  Propanediol utilization protein pduA  2.18 0.00   Q gi|148544955 
Lreu_0419  O-acetyltransferase (EC 2.3.1.-)    -0.93 0.04 R gi|148543655 
Lreu_0479  Arabinose-proton symporter  1.67 0.00   R gi|148543714 
Lreu_0833  Terminase large subunit  1.30 0.01 1.67 0.00 R gi|148544063 
Lreu_1117  Terminase large subunit  2.13 0.00 1.37 0.01 R gi|148544341 
Lreu_1795 ATPase associated with chromosome 
architecture/replication 
1.35 0.01   R gi|148545001 
Lreu_0429  Copper-transporting ATPase (EC 3.6.3.10)  1.85 0.00 0.87 0.03 S gi|148543665 
Lreu_0430  Copper-transporting ATPase (EC 3.6.3.10)  1.76 0.00 0.86 0.04 S gi|148543666 
Lreu_0803  Phage antirepressor protein  1.60 0.00 1.70 0.00 S gi|148544033 
Lreu_0838  Major capsid protein  1.16 0.04 1.65 0.01 S gi|148544068 
Lreu_0846  Phage protein  1.47 0.00 1.50 0.00 S gi|148544076 
Lreu_1104  Phage protein  1.92 0.00 1.30 0.02 S gi|148544328 
Lreu_1106  Phage protein  2.50 0.00 1.32 0.02 S gi|148544330 
Lreu_1110  Phage tail protein  2.41 0.00 1.47 0.00 S gi|148544334 
Lreu_1116  Portal protein  2.17 0.00 1.32 0.01 S gi|148544340 
Lreu_1142  Phage antirepressor protein  1.62 0.00 1.70 0.00 S gi|148544366 
Lreu_1545  Arginine/ornithine antiporter    -1.57 0.00 S gi|148544757 
Lreu_1629  Integral membrane protein  1.53 0.00 0.83 0.04 S gi|148544836 
Lreu_1736  Protein glcG  2.09 0.00   S gi|148544942 
Lreu_1737  Cobalamin adenosyltransferase family protein  2.17 0.00   S gi|148544943 
Lreu_0240  Protein tyrosine phosphatase (EC 3.1.3.48)    0.85 0.03 T gi|148543477 
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CDM CDMglycerol 
Locus Function
b
 
M
c
 p
d
 M
c
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COG 
Accession 
number 
Lreu_0677  LexA repressor (EC 3.4.21.88)  1.29 0.00 1.46 0.00 T gi|148543909 
Lreu_0834  Portal protein  1.33 0.01 1.68 0.00 T gi|148544064 
Lreu_1007  Transcription regulator, crp family  -
0.82 
0.04   T gi|148544234 
Lreu_1731  Protein tyrosine phosphatase (EC 3.1.3.48)  1.88 0.00   T gi|148544937 
Lreu_1115  ATP-dependent endopeptidase clp proteolytic subunit 
clpP (EC 3.4.21.92)  
2.22 0.00 1.66 0.00 U gi|148544339 
Lreu_0812  Phage protein  1.96 0.00 1.65 0.01 V gi|148544042 
Lreu_1121  Phage endonuclease  1.88 0.01 1.37 0.02 V gi|148544345 
Lreu_1138  Phage protein  1.96 0.00 1.65 0.01 V gi|148544362 
Lreu_0178     0.92 0.02 1.38 0.00  gi|148543415 
Lreu_0802     1.52 0.00 1.76 0.00  gi|148544032 
Lreu_0806     1.84 0.00 1.73 0.00  gi|148544036 
Lreu_0813  Phage replication protein  1.97 0.00 1.56 0.00  gi|148544043 
Lreu_0814     2.03 0.00 1.57 0.00  gi|148544044 
Lreu_0815     1.98 0.00 1.58 0.01  gi|148544045 
Lreu_0816     1.92 0.00 1.82 0.00  gi|148544046 
Lreu_0821     1.91 0.00 1.73 0.00  gi|148544051 
Lreu_0822     1.74 0.00 1.58 0.00  gi|148544052 
Lreu_0823     1.73 0.00 1.70 0.00  gi|148544053 
Lreu_0827     1.82 0.00 1.95 0.00  gi|148544057 
Lreu_0829     1.10 0.01 1.91 0.00  gi|148544059 
Lreu_0830     0.99 0.02 1.79 0.00  gi|148544060 
Lreu_0832     1.22 0.01 1.80 0.00  gi|148544062 
Lreu_0835  Phage protein  1.37 0.01 1.57 0.00  gi|148544065 
Lreu_0836     1.43 0.00 1.44 0.00  gi|148544066 
Lreu_0837     1.15 0.03 1.63 0.00  gi|148544067 
Lreu_0839  Phage protein  1.26 0.03 1.66 0.01  gi|148544069 
Lreu_0840     1.34 0.02 1.79 0.00  gi|148544070 
Lreu_0841  Phage protein  1.18 0.04 1.67 0.01  gi|148544071 
Lreu_0842     1.29 0.03 1.58 0.01  gi|148544072 
Lreu_0843  Phage protein  1.32 0.01 1.64 0.00  gi|148544073 
Lreu_0844  Phage protein  1.31 0.01 1.59 0.00  gi|148544074 
Lreu_0845     1.51 0.01 1.49 0.01  gi|148544075 
Lreu_0847     1.62 0.00 1.57 0.00  gi|148544077 
Lreu_0848  Phage protein  1.58 0.00 1.44 0.00  gi|148544078 
Lreu_0850     1.49 0.00 1.45 0.00  gi|148544080 
Lreu_0851     1.44 0.00 1.55 0.00  gi|148544081 
Lreu_0852     1.38 0.04    gi|148544082 
Lreu_0854     1.35 0.00 1.56 0.00  gi|148544084 
Lreu_0856     1.26 0.01 1.43 0.00  gi|148544086 
Lreu_0857       1.17 0.01  gi|148544087 
Lreu_1095     1.91 0.01 1.55 0.01  gi|148544319 
Lreu_1096     1.96 0.00 1.34 0.00  gi|148544320 
Lreu_1097     1.43 0.01 1.47 0.00  gi|148544321 
Lreu_1098     1.26 0.01 1.43 0.00  gi|148544322 
Lreu_1099     1.35 0.00 1.56 0.00  gi|148544323 
Lreu_1100     1.32 0.01 1.43 0.00  gi|148544324 
Lreu_1101     1.38 0.04    gi|148544325 
Lreu_1102     1.44 0.00 1.55 0.00  gi|148544326 
Lreu_1103     1.82 0.00 1.41 0.00  gi|148544327 
Lreu_1105     2.11 0.05    gi|148544329 
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CDM CDMglycerol 
Locus Function
b
 
M
c
 p
d
 M
c
 p
d
 
COG 
Accession 
number 
Lreu_1108     2.45 0.00 1.24 0.01  gi|148544332 
Lreu_1113  Phage protein  2.20 0.00 1.66 0.00  gi|148544337 
Lreu_1122     1.46 0.01 1.12 0.01  gi|148544346 
Lreu_1127     1.68 0.00 1.69 0.00  gi|148544351 
Lreu_1140     1.57 0.04 1.81 0.02  gi|148544364 
Lreu_1143     1.78 0.00 1.73 0.00  gi|148544367 
Lreu_1630  Hypothetical protein  1.08 0.01 0.89 0.01  gi|148544837 
Lreu_1739     1.79 0.00    gi|148544945 
Lreu_1832 Histidine decarboxylase (EC 4.1.1.22) -
1.67 
0.03 -1.95 0.01  gi|148545038 
Lreu_1838     1.16 0.02  gi|148545044 
Lreu_1855       1.12 0.05  gi|148545060 
a Transcripts were considered for analysis if p-value < 0.05 and M > |0.585|. 
b Annotation retrieved from ERGO (http://ergo.integratedgenomics.com/ERGO) (1). 
c M, log2(intensity of signal with glycerol/intensity of signal without glycerol). 
d p, p-value. 
 
Table 5.S2. Distribution of differentially expressed genes through out the several categories 
of clusters of orthologuous groups (COG) (2). 
 
COG category  
up-regulated 
when 
lreu_1750 is 
overexpressed 
down-
regulated 
when 
lreu_1750 is 
overexpressed 
regulated 
lreu_1750 is 
overexpressed 
CDM 11.86 0.00 11.86 C - Energy production and 
conversion (59) 
CDMglycerol 1.69 6.78 8.47 
CDM 0.00 0.00 0.00 D - Cell cycle control, cell division, 
chromosome partitioning (17) CDMglycerol 0.00 0.00 0.00 
CDM 2.31 0.00 2.31 E - Amino acid transport and 
metabolism (130) CDMglycerol 0.77 1.54 2.31 
CDM 0.00 0.00 0.00 F - Nucleotide transport and 
metabolism (75) CDMglycerol 0.00 2.67 2.67 
CDM 3.75 0.00 3.75 G - Carbohydrate transport and 
metabolism (80) CDMglycerol 0.00 10.00 10.00 
CDM 9.86 0.00 9.86 H - Coenzyme transport and 
metabolism (71) CDMglycerol 7.04 1.41 8.45 
CDM 2.94 0.00 2.94 I - Lipid transport and metabolism 
(34) CDMglycerol 0.00 0.00 0.00 
CDM 0.00 0.00 0.00 J - Translation, ribosomal structure 
and biogenesis (139) CDMglycerol 0.00 0.00 0.00 
CDM 6.45 0.00 6.45 
K - Transcription (93) 
CDMglycerol 7.53 0.00 7.53 
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COG category  
up-regulated 
when 
lreu_1750 is 
overexpressed 
down-
regulated 
when 
lreu_1750 is 
overexpressed 
regulated 
lreu_1750 is 
overexpressed 
CDM 3.41 0.00 3.41 L - Replication, recombination and 
repair (176) 
CDMglycerol 2.27 0.00 2.27 
CDM 1.25 0.00 1.25 M - Cell wall/membrane/envelope 
biogenesis (80) CDMglycerol 1.25 0.00 1.25 
CDM 0.00 0.00 0.00 
N - Cell motility (1) 
CDMglycerol 0.00 0.00 0.00 
CDM 0.00 0.00 0.00 O - Posttranslational modification, 
protein turnover, chaperones (42) CDMglycerol 2.38 2.38 4.76 
CDM 3.45 0.00 3.45 P - Inorganic ion transport and 
metabolism (58) CDMglycerol 8.62 3.45 12.07 
CDM 34.62 0.00 34.62 Q - Secondary metabolites 
biosynthesis, transport and 
catabolism (26) CDMglycerol 3.85 0.00 3.85 
CDM 1.70 0.00 1.70 R - General function prediction only 
(235) CDMglycerol 0.85 0.43 1.28 
CDM 8.72 0.00 8.72 
S - Function unknown (149) 
CDMglycerol 7.38 0.67 8.05 
CDM 5.66 1.89 7.55 T - Signal transduction mechanisms 
(53) CDMglycerol 5.66 0.00 5.66 
CDM 4.35 0.00 4.35 U - Intracellular trafficking, 
secretion, and vesicular transpor 
(23) CDMglycerol 4.35 0.00 4.35 
CDM 8.82 0.00 8.82 
V - Defense mechanisms (34) 
CDMglycerol 8.82 0.00 8.82 
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EFFECT OF AMINO ACID AVAILABILITY ON VITAMIN B12 
PRODUCTION IN LACTOBACILLUS REUTERI 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Recent functional genomics and genome-scale modeling approaches indicated that 
B12 production in Lactobacillus reuteri could be improved by medium optimization. Here 
we show that a series of systematic single amino acid omissions could significantly 
modulate the production of B12 from nearly undetectable levels (by isoleucine omission) to 
20-fold higher than previously reported through omission of cysteine. We analyzed, by 
cDNA microarray experiments, the transcriptional response of L. reuteri to the medium 
lacking cysteine. These results supported the observed high B12 production and provided 
new avenues for future improvement of production of vitamin B12. 
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Introduction 
Vitamin B12 analogues (generally termed B12) form a diverse subgroup of the 
tetrapyrroles, and consist of structurally complex molecules that contain a ring-contracted 
porphinoid with cobalt chelated at the core (5, 10). Synthesis of B12 is restricted to a few 
clades of bacteria and archaea, while vitamin B12 auxotrophies are widely spread in 
prokaryotes, protists and animals, including humans (11). 
Vitamin B12 is a relevant compound from an anthropocentric perspective. It is an 
essential dietary compound (vitamin) with a recommended nutrient intake of 2.4 μg/day for 
healthy adults (4) and its deficiency has been associated with several pathologies, namely 
different forms of anemia and neurological dysfunction, amongst others (19). Additionally, 
it is also an industrially relevant compound since it is an essential co-factor in reactions 
incorporated in biotechnological processes, such as the production of 1,3-propanediol (2). 
Production of vitamin B12 relies solely on microbial production, since chemical 
methods remain economically unviable due to the technical complexity of the synthesis 
process (8). Pseudomonas denitrificans and Propionibacteria subsp. are accounTable 6.for 
most of the industrially produced vitamin B12, with a productivity as high as 300 mg.L
-1
 (8).  
Lactobacillus reuteri is a heterofermentative lactic acid bacterium that colonizes  
the gastro-intestinal tract of humans and other animals (23). It has been shown to contain a 
functionally active B12 biosynthetic gene cluster that encodes all the enzymes required for 
the synthesis of this important co-factor from 5-aminolevulinate (13, 14). Catalyzed by 
glycerol dehydratase (EC 4.2.1.30), a B12-dependent reaction, L. reuteri is able to 
synthesize 3-hydroxypropanaldehyde (reuterin) (20). This compound with broad-spectrum 
antimicrobial activity (1) can be further reduced to 1,3-propanediol restoring NAD
+
, if 
coupled to the oxidation of another carbon source.  
We have recently studied the glucose and glycerol co-fermentation by L. reuteri 
using functional genomics and genome-scale modeling techniques. This enabled us to 
broaden our view of the physiological responses of L. reuteri to glycerol, evidencing strong 
implications in amino acid metabolism and B12 biosynthesis (12). Here, we have focused on 
these new targets and attempted to engineer the production of B12 in L. reuteri using 
physiological approaches. This led to the discovery that single amino acid omissions can 
significantly affect the production of B12 in L. reuteri. Hence, we studied the genome-wide 
transcriptional response of L. reuteri to the omission of cysteine in search of mechanistic 
insights and new leads for metabolic engineering.  
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Materials and Methods 
Strains, media and culture conditions. We obtained L. reuteri JCM1112 (type-
strain, human isolate) from the Japanese Collection of Microorganisms (Riken, Japan). It 
was cultured at 37ªC in an adapted version of chemically defined medium (CDM) from 
which vitamin B12 was omitted (22). When appropriate, 0.5% of glycerol was added. Cells 
were cultured under microaerophilic conditions (i.e. no stirring), unless stated otherwise. 
When mentioned, conditioned oxygen availability was ensured by cultivating L. reuteri in 
anaerobic jars filled with either O2-free N2, or a mixture of 95% N2 and 5% CO2 cultures. 
Single omission growth experiments. We investigated for L. reuteri, the effect on 
B12 production and growth behavior, of omitting separately every single amino acid that 
enters in the composition of CDM. Parallel experiments were performed in the presence 
and absence of glycerol, omitting an amino acid per culture and using a culture without any 
omission as a reference. Independent biological duplos were carried out as described. An 
overnight culture of L. reuteri washed twice in 0.85 % NaCl (w/v) was used to inoculate all 
media combinations to an initial optical density at 600 nm (OD600) of 0.05. Cultures were 
propagated in batch for five consecutive transfers in the corresponding media monitoring 
growth every 24 hours. After 48 hours, if we could not measure at least two doublings 
(OD600 < 0.2), the culture would be discarded and not used for further analysis. If the fourth 
transfer had an OD600 above 0.5 after 24 hours of incubation, it was used to inoculate 20 ml 
of the corresponding media. This last culture was used to determine the maximum specific 
growth rate (μmax) and the B12 content.  
Growth rate determination. L. reuteri JCM1112 was cultivated in the several 
variations of CDM, in 96 well microtiterplates (Greiner, Alphen a/d Rijn, The Netherlands). 
Different replicates were positioned on the plate using a checkerboard format distribution 
(3). Plates were incubated at 37°C in a Genios microtiterplate reader (Tecan, Zurich, 
Switzerland) set to monitor growth by measuring OD595 every 15 min. All measurements 
were independently performed at least twice in at least 8 biological replicates. μmax was 
determined in a high-throughput fashion by in-house scripts that calculate μ for every five 
consecutive time points through out the growth curve and return its maximum value per 
well. 
Coenzyme B12 determination. B12 production by L. reuteri in the different CDM 
variations was determined according to the Official Methods of Analysis of AOAC 
International, using the L. delbrueckii subsp. lactis ATCC 7830 vitamin B12 assay (6). Cell 
extracts for B12 analysis were prepared as described elsewhere (13). 
Fermentation conditions. pH-controlled batch fermentations of L. reuteri in the 
presence or absence of cysteine were carried out in an experimental set-up consisting of 
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four vessels with a reaction volume of 400 ml. Prior to inoculation, the media vessels were 
gassed with O2-free N2 (15 ml/min) for 1 hour. Temperature was kept constant at 37°C and 
pH was fixed to 5.8 by titration with 5 M NaOH. Homogeneity was assured by 
continuously stirring throughout the whole fermentation. An exponentially growing culture 
in the corresponding media was used to inoculate the fermentors to an initial OD600 of 0.05. 
Periodic measurements of OD600 were used to monitor biomass formation. Samples for 
transcriptome analysis were harvested at mid-logarithmic growth phase (OD600 1), and in 
early-stationary phase, 15 minutes after exponential growth ceased (Fig. 6.1). At this stage 
of the growth curve, we also sampled for B12 analysis (idem). 
 
 
 
Figure 6.1. Biomass formation and sampling scheme in pH-controlled batch fermentations 
of CDM in the presence (solid line) or absence (dashed line) of cysteine. 
 
Microarray design. Dedicated microarrays for L. reuteri JCM1112 were spotted in 
the high density Agilent 44K platform (Agilent Technologies, Santa Clara, CA, USA), 
based on the draft genome sequence of L. reuteri JCM1112 released by JGI (retrieved in 
03/2006). We used the custom probe design covering 1700 (out of 1900) predicted coding 
regions (~90% coverage) that we had developed for the 11K format available at GEO 
(http://www.ncbi.nlm.nih.gov/geo) under accession number GPL6856, and had it printed 
four fold per array. Oligos were designed to probe the predicted coding regions, 
representing 82.9% with 24 probes (6 unique) or more, and only 3.9% with 12 (3 unique) or 
less.  
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RNA isolation. Cells harvested from cultures in the presence or absence of cysteine 
were sampled by rapid quenching using a cold methanol method (9). Extraction and 
purification of total RNA was carried out as previously described (12). RNA concentration 
was measured on a ND-1000 spectrophotometer (NanoDrop Technologies Inc., USA). The 
integrity of the mRNA species was confirmed on a 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA, USA). A threshold for the 23S/16S RNA ratio of 1.6 was 
set for the samples to be considered satisfactory. Only samples above were used for 
transcriptome analysis. 
cDNA synthesis and labeling. For each sample, 20 μg of RNA were used for first 
strand cDNA synthesis using Superscript III reverse transcriptase (Invitrogen, Breda, The 
Netherlands) according to the recommendations of the manufacture. All samples of newly 
synthesized cDNA were purified and labeled with cyanine 3 and cyanine 5. Indirect 
labeling was executed resorting to the CyScribe first-strand cDNA labeling kit (Amersham, 
United Kingdom) following manufacturer’s recommendations. cDNA concentration and 
labeling incorporation were verified using the ND-1000 spectrophotometer (NanoDrop 
Technologies Inc., USA). 
Microarray hybridization. We used 0.8 μg of labeled cDNA of each dye per 
hybridization. All samples were hybridized with each label at least once to facilitate the 
recognition of possible dye effects. A hybridization scheme consisting of a loop design 
comprising 16 microarrays was implemented to scrutinize the transcriptome of mid-
logarithmic and early-stationary growth phase cells cultured in pH-controlled batch 
fermentations of CDM from which cysteine was omitted, or not. The following samples 
were hybridized per array labeled with cyanine3 and cyanine5, respectively: exp-F1 and 
exp-F2, exp-F2 and exp-F3, exp-F3 and exp-F4, exp-F4 and exp-F1, sta-F3 and sta-F4, sta-
F4 and exp-F1, exp-F1 and exp-F3, exp-F3 and sta-F3, sta-F2 and sta-F1, sta-F3 and exp-
F2, sta-F4 and sta-F3, sta-F1 and sta-F4, sta-F1 and exp-F1, exp-F2 and exp-F2, sta-F3 and 
exp-F3, exp-F1 and sta-F4. Here, the prefix exp- stands for cells harvested at mid 
logarithmic growth phase and sta- for cells harvested during early stationary. F1 and F3 
represent totally independent biological duplicates cultured in CDM, and F2 and F4 
represent also independent biological duplicates, but cultured in CDM lacking cysteine. The 
hybridizations were performed at 60°C for 17 h, after which, the slides were washed 
according to the recommendations of the manufacturer. Scanning took place immediately 
after drying the slides as described elsewhere (16). 
Scanning and microarray data analysis. Slides were scanned with a ScanArray 
Express scanner (Perkin-Elmer) set to maximum resolution (5 μm). ImaGene 
(BioDiscovery) version 5.6 was used for image analysis, spot quantification and data 
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extraction. After normalizing the transcriptome data by local fitting of an M-A plot 
applying the loess algorithm (24) using the Limma package (17) in R (http://www.r-
project.org), we analyzed the transcriptome data as described elsewhere (16). Statistical 
significance was tested from the deviation between biological duplicates by implementation 
of the eBayes function included in Limma (cross-probe variance estimation) and false 
discovery rate adjustment of the p-values (18). Two comparisons were established to 
characterize the impact in L. reuteri of removing cysteine (i) during exponential growth 
phase (mid-logarithmic phase response), and (ii) during early stationary growth phase 
(early-stationary phase response). Transcripts were considered for analysis if the p-value 
was smaller than 0.05 and the absolute Log2 (ratio) greater than 0.585. The transcriptome 
data was visualized by projection on metabolic maps of the genome-scale model developed 
previously for L. reuteri (12).  
Microarray accession numbers. The microarray platform developed in this study 
is available at the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) (accession 
number pending). The microarray data obtained were deposited in the same repository 
(accession number pending). 
 
Results 
We have recently observed that cultivation of L. reuteri in a chemically defined 
medium (CDM) with glycerol has profound implications on B12 production and amino acid 
metabolism (12). Here, we followed these newly obtained leads and attempt to modulate 
the production of B12 by changing the amino acid composition of CDM and describing the 
phenotypic changes observed related to growth and to the production of this co-factor. 
Single amino acid omissions and growth of L. reuteri. We found that eight amino 
acids could be omitted from CDM without completely inhibiting the growth of L. reuteri. 
These affected growth rate and final biomass formation to variable degrees (Table 6.1). The 
omission of Serine (Ser) profoundly reduced the specific growth rate and final optical 
density both in the absence or presence of glycerol. In CDM lacking isoleucine (Ile) the 
final biomass formation is much more affected than the growth rate. Omission of the other 
amino acids alanine (Ala), aspartate (Asp), cysteine (Cys), glycine (Gly), lysine (Lys), or 
proline (Pro) only slightly affected final biomass formation. The growth rates measured in 
all single amino acid omissions increased with the addition of glycerol, except for CDM 
lacking Gly, which was only mildly affected (6% reduction). 
Single amino acid omissions and vitamin B12 production. L. reuteri JCM1112 
produces approximately 20 μg.L-1.OD600-1 of B12 in complete CDM without glycerol. If the 
latter is added, B12 production in L. reuteri increases about five fold to 100 μg.L-1.OD600-1. 
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Table 6.1. Growth properties of L. reuteri in single amino acid deficient CDM 
supplemented or not with glycerol
 a. 
 
CDM CDM + glycerol Amino 
acid 
omission 
Conc.
b.
 
(mM) μmax (h-1) 
Final 
OD595 
μmax (h-1) 
Final 
OD595 
Variation 
CDM to 
CDM + 
glycerol 
None n.a. 
0.453 
(100%) 
1.21 
(100%) 
0.575 
(100%) 
1.29 
(100%) 
27% 
Ala 2.69 0.368 (81%) 1.17 (97%) 0.519 (90%) 
1.31 
(102%) 
41% 
Asp 3.16 0.445 (98%) 1.20 (99%) 0.551 (96%) 
1.31 
(102%) 
24% 
Cys 0.83 0.387 (85%) 1.16 (96%) 0.512 (89%) 1.26 (98%) 32% 
Gly 2.33 0.370 (82%) 1.17 (97%) 0.349 (61%) 1.21 (94%) -6% 
Ile 1.60 0.356 (79%) 0.41 (34%) 0.411 (72%) 0.46 (36%) 15% 
Lys 2.68 0.433 (96%) 1.20 (99%) 0.540 (94%) 1.27 (98%) 25% 
Pro 5.86 0.424 (94%) 1.19 (98%) 0.555 (97%) 1.28 (99%) 31% 
Ser 3.24 0.106 (23%) 0.25 (21%) 0.131 (23%) 0.24 (19%) 24% 
a.
 Values are expressed as average (% of same condition without any amino acid omission) of at least 
eight biological replicates. Experiment was repeated twice with similar results. 
b.
 Concentration of amino acid in CDM when present (n.a., not applicable). 
When B12 production was compared between L. reuteri cultures grown in complete, as 
opposed to single amino acid deficient-CDM, a great disparity of effects was clearly 
observed. (Table 6.2). The omission of Cys is the most remarkable since, even without the 
addition of glycerol, it leads to a 5-fold increase in B12 production relative to complete 
CDM. Furthermore, the boost in B12 synthesis can also be further incremented by the 
presence of glycerol, enabling the accumulation of stimulatory effects, resulting in over 350 
μg.L-1.OD600-1. 
The increase in B12 production due to the addition of glycerol, although to varying 
proportions, was observed regardless of the amino acid omissions from the composition of 
CDM. When Ile is lacking, the largest stimulatory effect of glycerol is registered (20-fold). 
However, this is caused by the sharp reduction (greater than 10-fold) in B12 production to 
levels barely detectable when glycerol is absent, rather then by an increase of B12 
production in CDM with glycerol.  
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Besides the effects already mention, in the absence of glycerol, L. reuteri produced 
higher amounts of vitamin B12 in CDM lacking Lys, Ala, Gly and Asp, whilst in its 
presence, only the omission of Ala and Asp had a positive effect. 
 
Table 6.2. Vitamin B12 production by L. reuteri in single amino acid deficient CDM 
supplemented or not with glycerol
 a. 
 
Amino 
acid 
omission 
CDM 
CDM + 
glycerol 
Fold change 
from CDM to 
CDMglycerol 
Fold change 
relative to 
reference 
condition
b.
 
None 
21.2 ± 3.6 
(100%) 
105.0 ± 17.0 
(100%) 
5 5 
Ala 
43.2 ± 4.7 
(204%) 
143.3 ± 10.9 
(136%) 
3 7 
Asp 
29.0 ± 4.8 
(137%) 
146.8 ± 10.4 
(140%) 
5 7 
Cys 
103.2 ± 13.0 
(488%) 
351.8 ± 28.4 
(335%) 
3 17 
Gly 
33.0 ± 3.3 
(156%) 
113.9 ± 14.1 
(108%) 
3 5 
Ile 
2.1 ± 0.4 
(10%) 
42.4 ± 5.8 
(40%) 
20 2 
Lys 
50.5 ± 5.1 
(239%) 
114.0 ± 22.5 
(109%) 
2 5 
Pro 
22.0 ± 4.7 
(104%) 
72.6 ± 11.9 
(69%) 
3 3 
Ser 
16.1 ± 3.6 
(76%) 
76.0 ± 10.4 
(72%) 
5 4 
a.
 Values are expressed as average ± SD (% of same condition without any amino acid omission) of at 
least three technical replicates. Experiment was repeated twice with similar results. 
b.
 Reference condition is CDM without glycerol added and without any amino acid omission. 
 
Effect of oxygen on B12 production. Cysteine is known as a potent reducing agent. 
Omission of cysteine will lead to increased redox potential and oxygen availability in the 
growth medium. The concentration of oxygen has been reported to affect the production of 
B12 in Propionibacteria (7). For this reason, we decided to check whether the stimulatory 
effect caused by the omission of Cys, could be altered by varying oxygen availability. This 
was done by cultivating in parallel L. reuteri under microaerophilic conditions, and in an 
anaerobic vessel containing either pure N2 or a mixture of 95% N2 with 5% CO2, and 
checking B12 production in all possible variations of CDM combining the presence and 
absence of glycerol and cysteine (Fig. 6.2). In 100% N2, the production of B12 was slightly 
increased by about 30%. The only exception was the condition in which cysteine is absent 
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and glycerol is present, for which there is only a trend, but no significant increase (p-value 
> 0.05). Cultivation in the presence of 95% N2 with 5% CO2, caused the B12 content to 
increase slightly more, this time about 50%. The trend observed for the cultures that 
combine the absence of cysteine with the presence of glycerol is even more pronounced. 
Under this last condition B12 production was raised to 428 ± 40 μg.L-1.OD600-1. 
 
Figure 6.2. Vitamin B12 production by L. reuteri under different gas environments in 
variations of CDM. -Cys, cysteine omitted; +Glyc, supplemented with glycerol. 
 
Transcriptomics of L. reuteri in absence of cysteine. To gain further insight on the 
stimulatory effect of Cys in B12 production, we studied the genome-wide transcriptional 
response of L. reuteri to cultivation in the absence of Cys, by developing and performing 
cDNA microarray experiments. We determined the specific responses in mid-exponential 
and early-stationary growth phases. The complete list of loci that were found to be 
differentially regulated is available in Table 6.S1 (supplementary material) and a small 
selection that is discussed in the tesxt is present at Table 6.3. 
In mid-exponential phase, we found 140 genes differentially regulated, of which 
only 8 were found to be down-, while 132 were up-regulated. Concerning genes differently 
regulated in the stationary growth phase, we found 294 genes differentially regulated, 125 
down- and 169 up-regulated. A total of 58 genes are shared between both data sets, while 
82 were exclusively differentially regulated in exponential phase and 236 are specific for 
stationary phase. 
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Table 6.3. Selection of differentially regulated genes mentioned in the text (see Table 6.S1 
for full list) 
 
Locus Product Mexp Msta 
Amino acid transport and metabolism 
Lreu_0190 Succinyl-diaminopimelate desuccinylase (EC 3.5.1.18)   -0.70 
Lreu_0293 
Cystathionine beta-lyase (EC 4.4.1.8) / Cystathionine 
gamma-lyase (EC 4.4.1.1) 
1.72   
Lreu_0294 Cystine transport system permease protein 1.94 3.23 
Lreu_0295 Cystine transport ATP-binding protein 2.26 3.16 
Lreu_0348 Aspartate aminotransferase (EC 2.6.1.1)   -0.87 
Lreu_0377 Succinyl-diaminopimelate desuccinylase (EC 3.5.1.18)   -1.24 
Lreu_0425 Ornithine carbamoyltransferase (EC 2.1.3.3) -3.38 -0.69 
Lreu_0426 Carbamate kinase (EC 2.7.2.2) -2.27   
Lreu_0445 Arginine deiminase (EC 3.5.3.6) -2.09   
Lreu_0502 
Cysteine desulfurase (EC 2.8.1.7)/Selenocysteine lyase 
(EC 4.4.1.16) 
  1.16 
Lreu_0610 Diaminopimelate epimerase (EC 5.1.1.7)   -1.07 
Lreu_0611 Aspartokinase (EC 2.7.2.4)   -1.51 
Lreu_0612 Diaminopimelate decarboxylase (EC 4.1.1.20)   -0.70 
Lreu_0613 Tetrahydrodipicolinate N-acetyltransferase (EC 2.3.1.89)   -0.65 
Lreu_1553 Cysteine synthase (EC 2.5.1.47) 1.27 2.06 
Lreu_1791 Homoserine O-succinyltransferase (EC 2.3.1.46) 0.80 1.27 
Lreu_1792 Cysteine synthase (EC 2.5.1.47) 0.96 1.16 
Nucleotide transport and metabolism 
Lreu_0123 Aspartate carbamoyltransferase (EC 2.1.3.2)   -5.32 
Lreu_0124 Dihydroorotase (EC 3.5.2.3)   -5.36 
Lreu_0125 
Dihydroorotate dehydrogenase, catalytic subunit (EC 
1.3.3.1) 
  -5.09 
Lreu_0126 Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23)   -4.91 
Lreu_0127 Orotate phosphoribosyltransferase (EC 2.4.2.10)   -4.82 
Coenzyme transport and metabolism 
Lreu_0510 
Folylpolyglutamate synthase (EC 6.3.2.17)/Dihydrofolate 
synthase (EC 6.3.2.12) 
  -2.33 
Lreu_0878 
Diaminohydroxyphosphoribosylaminopyrimidine 
deaminase (EC 3.5.4.26) / 5-amino-6-(5-
phosphoribosylamino)uracil reductase 
  -0.92 
Lreu_0879 Riboflavin synthase alpha chain (EC 2.5.1.9)   -0.81 
Lreu_0880 
GTP cyclohydrolase II (EC 3.5.4.25) / 3,4-dihydroxy-2-
butanone-4-phosphate synthase (EC 4.1.2.-) 
  -0.75 
Lreu_1279 
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine 
pyrophosphokinase (EC 2.7.6.3) 
  -0.63 
Lreu_1280 Dihydroneopterin aldolase (EC 4.1.2.25)   -0.73 
Lreu_1710 Precorrin-2 C20-methyltransferase (EC 2.1.1.130)   0.71 
Lreu_1711 Sirohydrochlorin cobaltochelatase (EC 4.99.1.3)   0.72 
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Locus Product Mexp Msta 
Lreu_1712 
Uroporphyrin-III C-methyltransferase (EC 2.1.1.107) / 
Uroporphyrinogen-III synthase (EC 4.2.1.75) 
  0.60 
Posttranslational modification, protein turnover, chaperones 
Lreu_0324 Glutaredoxin   0.71 
Lreu_0353 10 kDa chaperonin GROES   -0.83 
Lreu_0354 60 kDa chaperonin GROEL   -0.84 
Lreu_0376 Thioredoxin reductase (EC 1.8.1.9) 1.11 0.67 
Lreu_0539 Thioredoxin 1.45 0.96 
Inorganic ion transport and metabolism 
Lreu_1707 Cobalt transport protein cbiQ   0.85 
Lreu_1708 Cobalt transport protein cbiN   0.63 
Lreu_1709 CbiM protein   0.69 
 
In order to facilitate the analysis of the transcriptome data, we examined the 
distribution of the genes found to be differentially regulated according to the functional 
class of the predicted encoded protein, using the COG classification system (21). The full 
distribution is available at Table 6.S2 (supplementary material 6S) and a selection is 
presented here based on its relevance for the topics here discussed (Fig. 6.4). 
Not surprisingly, the COG category associated with amino acid transport and metabolism 
was found to be overrepresented both mid-exponential and stationary phase. The split 
within this category between up- and down-regulated is quite even. Specific attention was 
given to genes involved in cysteine metabolism. There are 2 genes (lreu_1553 and 
lreu_1792) annotated in the chromosome of L. reuteri that are predicted to encode cysteine 
synthase (EC 2.5.1.47) and both are up-regulated in the absence of cysteine. The same 
holds for the genes (lreu_0293-0295, lreu_0502, lreu_1791) coding for enzymes involved 
in the metabolism of sulfur-containing compounds, such as cysteine desulfurase (EC 
2.8.1.7), selenocysteine lyase (EC 4.4.1.16) and cystathionine beta- and gamma-lyases 
(respectively, EC 4.4.1.8 and EC 4.4.1.1), amongst others. Genes predicted to encode 
enzymes related to arginine, aspartate and ornithine tended to be down-regulated 
(lreu_0425, lreu_0426 and lreu_0445). The latter have in common that they lead to the 
synthesis of carbomyl phosphate, a precursor of pyrimidines. 
Harmoniously, genes associated with the COG category that includes proteins 
assigned to nucleotide transport and metabolism, are not only overrepresented, but also 
display a clear tendency to be down-regulated. Indeed, a closer look clearly shows that a 
complete cluster starting from lreu_0123 to lreu_0127 is drastically down-regulated in the 
absence of cysteine (M-value around -5). 
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Co-factors such as folate derivatives are important in the synthesis of DNA and 
RNA precursors. The folate biosynthesis gene cluster (lreu_0510 and lreu_1279-1280, 
along with the one for riboflavin (lreu_0878-880) appear down-regulated when cysteine is 
omitted from CDM and account for roughly half of the regulated genes assigned to 
coenzyme transport and metabolism (Table 6.S1). As expected the B12 biosynthesis gene 
cluster was up-regulated. 
 
 
Figure 6.3. Distribution of transcripts whose expression was affected by glycerol during 
early-stationary growth phase throughout a selection of COGs (see Suplementary Material 
1, Table 6.S2 for full distribution). Transcripts were considered to be differentially 
regulated for M > |0.585| and p-value < 0.05. Light and dark grey bars represent proportion 
of up-regulated transcripts in the absence or presence of cysteine, respectively. Between 
brackets is the total number of genes from the genome of L. reuteri included in the 
corresponding COG. 
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An overrepresentation was observed for genes encoding proteins assigned to COG 
category related to posttranslational modification and chaperons. Again the split between 
up- and down- regulated appears quite even, implying that the absence of cysteine will not 
affect indiscriminately all chaperons. Amongst others, in the down-regulated group we find 
loci predicted to encode the co-chaperonin complex GroES and GroEL (lreu_353-354), 
while in the up-regulated we can find thioredoxin, thioredoxin reductase (EC 1.8.1.9) and 
glutaredoxin (lreu_539, lreu_0376 and lreu_0324, respectively). 
One final category is the ion transport and metabolism proteins. Within this 
category, most genes were down-regulated, which can be ascribed mainly to the down-
regulation of unspecific ABC transporters. Highly relevant is the finding that the up-
regulated group includes genes involved in the scavenging of cobalt from the environment 
(lreu_1707-1709).  
 
Discussion 
The average B12 content of an early-stationary culture of L. reuteri JCM1112 in 
CDM is approximately 20 μg.L-1.OD600-1. This amount is increased about five fold if CDM 
is supplemented with glycerol. In these conditions, L. reuteri uses glycerol to recycle 
NAD+ via the conversion of glycerol to 3-hydroxypropanaldehyde, which is subsequently 
reduced to 1,3-propanediol (2). The co-fermentation of glucose and glycerol by L. reuteri 
has recently been reported to have a major effect on the amino acid metabolism (12). In this 
study, we have determined the effect on growth behavior and B12 production of individually 
omitting the amino acids present in CDM. This was carried out in parallel in the presence 
and absence of glycerol. 
In this screening exercise, we have identified eight amino acids to be essential for 
L. reuteri to grow at least two generations in the first two days after inoculation. The well-
established positive effect of glycerol on the growth rate and B12 production of L. reuteri 
cultivated in complete CDM was observed regardless of the omission of the single amino 
acids with the exception of glycine (Table 6.1). When glycine is omitted, the addition of 
glycerol to CDM still has a positive effect on B12 production (Table 6.2), but the effect on 
μmax is lost. An explanation for this might reside in the fact that the consumption rate of this 
amino acid in the presence of glycerol is nearly twice as fast as the one measured in the 
absence of it (12). This is indicative of an increase demand for glycine in the presence of 
glycerol, which apparently cannot be met when L. reuteri has to rely solely on its own 
native production. This hypothesis is in agreement with the sharp decrease in μmax observed 
in the absence of glycine and glycerol, both for L. reuteri and L. plantarum (22). 
In the absence of glycerol, the single omission of several amino acids lead to 
important increments in B12 production, for instance aspartate 40%, glycine 60%, alanine 
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200% and lysine 240%. Any of these findings per se could lead to great improvements in 
B12 production processes, especially the omission of lysine since it has a very little impact 
on the growth behavior of L. reuteri. However, they are completely overshadowed by the 
500% increase in B12 production caused by the omission of cysteine alone. Combined with 
the stimulatory effect of glycerol, a 17-fold increase in B12 production was achieved (Table 
6.2). In the presence of glycerol, the omission of the other amino acids from CDM had 
relatively little effect on vitamin B12 production.  
We have attempted to gain mechanistic insights and new clues on how to further 
increase the synthesis of B12 in L. reuteri by studying its genome-wide transcriptional 
response to the omission of cysteine. Due to the properties of cysteine as a reducing agent 
we decided to first carry out an exploratory experiment under controlled oxygen 
availability. When cultured anaerobically, Lb reuteri was the first organism reported to 
produce exclusively pseudovitamin B12, presenting a great convenience if one attempts to 
purify it. Under tight anaerobic conditions, B12 production was increased in L. reuteri by 
little more than 30%. This could be anticipated, since L. reuteri has been shown to encode 
the oxygen-independent biosynthetic route towards B12 (14), and the initial step of the 
industrial production of B12 using Propionibacteria is carried out under strict anaerobic 
conditions (7). However, the increase caused by the absence of cysteine from the medium 
was not diminished under anaerobiosis, implying that this amino acid does indeed have 
other effects in the metabolism of L. reuteri. When we compare B12 production of cells 
grown anaerobically versus microaerophilically, combining the omission of cysteine with 
the addition of glycerol, it is clear that even though the trend is still there, the increase is not 
as high as expected. This suggests that after increasing 20-fold the production of B12 
another bottleneck is encountered. 
The transcriptome analysis of cells grown in the absence of cysteine in comparison 
to the ones grown in complete CDM confirms that indeed in L. reuteri cysteine is made 
from serine via cysteine synthase, and using sulfur groups derived from methionine. As 
mentioned, L. reuteri contains two copies of cysteine synthase genes (lreu_1553 and 
lreu_1792), which are up-regulated in the absence of cysteine. We noticed that while the 
increased expression of the copy encoded by lreu_1792 changes very little between the 
exponential and stationary data sets, its paralog, lreu_1553 seems to be preferred in the 
later stages of growth. All pathways from amino acids to carbomyl phosphate appeared 
downregulated along with the operon that encodes the machinery necessary to channel it to 
pyrimidine biosynthesis. This is most likely related to the drop in growth rate that we have 
characterized when cysteine is omitted from CDM (~15% reduction).  
The presence of the B12-biosynthesis gene cluster among the genes that are 
upregulated in the absence of Cys was quite expected taking into account the phenotype 
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that we have exposed here. The fact that we cannot find the full length of the cluster back as 
up-regulated can be easily explained by the large size and fragility of the transcribed 
mRNA species as previously noted while performing Northern blotting analysis (14). 
Nonetheless, if we loosen the stringency of our established thresholds, the whole cluster 
will prove to have a positive M-value, instead of just the genes in its centre. Based on the 
transcriptome data alone, de novo production of riboflavin and folate seem to be negatively 
affected by the omission of Cys. Since both of these vitamins are actually present in CDM 
in relative excess and we have recently illustrated metabolic engineering strategies to 
increase folate production in L. reuteri (15), we decided not to pursue this any further.  
The omission of Cys has implications on sulfur metabolism that extend beyond its 
own biosynthesis. The ubiquity of the loci encoding thioredoxin and thioredoxin reductase 
(EC 1.8.1.9) in both data sets and glutaredoxin in the stationary phase set is illustrative of 
such. These are known to reduce other proteins by cysteine thiol-disulfide exchange, acting 
as antioxidants. Here, seems to reside interactions yet to clarify, which could lead to even 
higher B12 production. Partially, related is cobalt bioavailability. We observed the up-
regulation of genes for proteins involved in the uptake of cobalt, which is logical since this 
metal is positioned at the core of the tetrapyrrole macrocycle of B12 (10). Adding more 
cobalt to CDM supplemented with glycerol and without cysteine does not yield significant 
increase in B12 production (data not shown), which was not unexpected since CDM 
contains an excess of cobalt. This indicates that the rate of cobalt supply is a limiting factor 
that is compensated by increased expression of one or more cobalt transporters. 
Bioavailability of cobalt could be the bottleneck that did not allow us to engineer the 
production past the 20-fold increase. 
We have used physiological approaches to modulate the production of B12 in L. 
reuteri JCM1112 from nearly undetecTable 6.levels to 20-fold higher than previously 
reported (15). Furthermore, we have characterized the impact on growth behavior of all 
cultivation conditions tested, and analyzed by cDNA microarray experiments the 
transcriptional response of L. reuteri to the omission of cysteine. This has lead to new 
insights that could be used to increase even further the production of B12. 
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Table 6.S1. Complete list of transcripts from L. reuteri that are differentially expressed in 
the absence of cysteine
a
. Comparisons were established to identify mid-log and early-
stationary specific responses. 
Exp Sta 
Locus Product
b
 
M
c
 p
d
 M
c
 p
d
 
COG 
Acession 
number 
  
 Energy production and 
conversion  
            
Lreu_0539 Thioredoxin 1.45 0.00 0.96 0.00 C gi|148543774 
Lreu_0631 
Pyruvate dehydrogenase E1 component alpha 
subunit (EC 1.2.4.1) 1.15 0.00     C gi|148543863 
Lreu_0632 
Pyruvate dehydrogenase E1 component beta 
subunit (EC 1.2.4.1) 
1.24 0.00     C gi|148543864 
Lreu_0633 
Dihydrolipoamide acetyltransferase 
component of pyruvate dehydrogenase 
complex (EC 2.3.1.12) 
1.23 0.00     C gi|148543865 
Lreu_0634 
Dihydrolipoamide dehydrogenase (EC 
1.8.1.4) 
1.07 0.01     C gi|148543866 
Lreu_1734 Propanol dehydrogenase (EC 1.1.1.-) 0.93 0.00     C gi|148544940 
Lreu_1735 
Propionaldehyde dehydrogenase [CoA-
acylating] (EC 1.2.1.-) 
0.92 0.00     C gi|148544941 
  
 Cell cycle control, cell division, 
chromosome partitioning  
            
Lreu_1027 Cell filamentation protein fic     -1.92 0.00 D gi|148544254 
Lreu_1939 Glucose inhibited division protein A     1.29 0.02 D gi|148545138 
  
 Amino acid transport and 
metabolism 
            
Lreu_0076 Amino acid permease     0.80 0.02 E gi|148543318 
Lreu_0098 
Glutamine-binding protein / Glutamine 
transport system permease protein glnP 
    1.22 0.00 E gi|148543337 
Lreu_0099 
Glutamine transport ATP-binding protein 
glnQ     1.59 0.01 E gi|148543338 
Lreu_0185 
Glycine betaine transport system permease 
protein 
    -0.60 0.02 E gi|148543422 
Lreu_0190 
Succinyl-diaminopimelate desuccinylase (EC 
3.5.1.18)     -0.70 0.03 E gi|148543427 
Lreu_0293 
Cystathionine beta-lyase (EC 4.4.1.8) / 
Cystathionine gamma-lyase (EC 4.4.1.1) 
1.72 0.06     E gi|148543530 
Lreu_0294 Cystine transport system permease protein 1.94 0.00 3.23 0.00 E gi|148543531 
Lreu_0295 Cystine transport ATP-binding protein 2.26 0.00 3.16 0.01 E gi|148543532 
Lreu_0348 Aspartate aminotransferase (EC 2.6.1.1)     -0.87 0.01 E gi|148543584 
Lreu_0357 Amino acid permease     0.70 0.01 E gi|148543593 
Lreu_0377 
Succinyl-diaminopimelate desuccinylase (EC 
3.5.1.18)     -1.24 0.00 E gi|148543613 
Lreu_0385 Amino acid permease     -0.78 0.00 E gi|148543621 
Lreu_0425 Ornithine carbamoyltransferase (EC 2.1.3.3) -3.38 0.00 -0.69 0.02 E gi|148543661 
Lreu_0426 Carbamate kinase (EC 2.7.2.2) -2.27 0.00     E gi|148543662 
Lreu_0445 Arginine deiminase (EC 3.5.3.6) -2.09 0.02     E gi|148543680 
Lreu_0502 
Cysteine desulfurase (EC 2.8.1.7) / 
Selenocysteine lyase (EC 4.4.1.16) 
    1.16 0.04 E gi|148543737 
Lreu_0515 
Histidine transport system permease protein 
hisM -0.99 0.00     E gi|148543750 
Lreu_0570 Dipeptidase A (EC 3.4.13.-)     -1.32 0.00 E gi|148543805 
Lreu_0610 Diaminopimelate epimerase (EC 5.1.1.7)     -1.07 0.00 E gi|148543844 
Lreu_0611 Aspartokinase (EC 2.7.2.4)     -1.51 0.00 E gi|148543845 
Lreu_0612 Diaminopimelate decarboxylase (EC 4.1.1.20)     -0.70 0.02 E gi|148543846 
Lreu_0613 
Tetrahydrodipicolinate N-acetyltransferase 
(EC 2.3.1.89) 
    -0.65 0.02 E gi|148543847 
Lreu_0726 Arginine transport ATP-binding protein artP     1.95 0.01 E gi|148543957 
Lreu_0727 Arginine-binding protein / Arginine transport     1.73 0.04 E gi|148543958 
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Exp Sta 
Locus Product
b
 
M
c
 p
d
 M
c
 p
d
 
COG 
Acession 
number 
system permease protein artQ 
Lreu_0731 Argininosuccinate synthase (EC 6.3.4.5) 6.71 0.00     E gi|148543962 
Lreu_0732 Argininosuccinate lyase (EC 4.3.2.1) 6.43 0.00     E gi|148543963 
Lreu_1081 
5-methyltetrahydropteroyltriglutamate--
homocysteine methyltransferase (EC 2.1.1.14) 
    -1.36 0.05 E gi|148544305 
Lreu_1313 Hypothetical protein     -0.68 0.00 E gi|148544537 
Lreu_1383 Arginine/ornithine antiporter 0.68 0.00     E gi|148544599 
Lreu_1384 
Pyridoxal-dependent aminotransferase, 
arginine catabolism 1.69 0.00     E gi|148544600 
Lreu_1500 Lysine-specific permease -0.64 0.05     E gi|148544712 
Lreu_1544 Xaa-His dipeptidase (EC 3.4.13.3) 0.67 0.02     E gi|148544756 
Lreu_1553 Cysteine synthase (EC 2.5.1.47) 1.27 0.00 2.06 0.00 E gi|148544763 
Lreu_1732 Ethanolamine utilization protein eutS 0.87 0.00     E gi|148544938 
Lreu_1748 Propanediol utilization protein pduB 1.04 0.00     E gi|148544954 
Lreu_1791 
Homoserine O-succinyltransferase (EC 
2.3.1.46) 
0.80 0.00 1.27 0.00 E gi|148544997 
Lreu_1792 Cysteine synthase (EC 2.5.1.47) 0.96 0.00 1.16 0.00 E gi|148544998 
Lreu_1866 Amino acid permease     1.45 0.00 E gi|148545070 
Lreu_1938 
Asparagine synthetase [glutamine-
hydrolyzing] (EC 6.3.5.4)     0.92 0.00 E gi|148545137 
  
 Nucleotide transport and 
metabolism  
            
Lreu_0085 
Carbamoyl-phosphate synthase large chain 
(EC 6.3.5.5) 
    -2.76 0.03 F gi|148543327 
Lreu_0086 
Carbamoyl-phosphate synthase small chain 
(EC 6.3.5.5) 
    -2.80 0.03 F gi|148543328 
Lreu_0102 
Inosine-uridine preferring nucleoside 
hydrolase (EC 3.2.2.1) 
0.73 0.00 -0.77 0.01 F gi|148543341 
Lreu_0111 Deoxyribose-phosphate aldolase (EC 4.1.2.4) 0.77 0.00     F gi|148543350 
Lreu_0114 
Purine nucleoside phosphorylase II (EC 
2.4.2.1) 
0.94 0.00     F gi|148543353 
Lreu_0123 Aspartate carbamoyltransferase (EC 2.1.3.2)     -5.32 0.00 F gi|148543362 
Lreu_0124 Dihydroorotase (EC 3.5.2.3)     -5.36 0.00 F gi|148543363 
Lreu_0125 
Dihydroorotate dehydrogenase, catalytic 
subunit (EC 1.3.3.1) 
    -5.09 0.00 F gi|148543364 
Lreu_0126 
Orotidine 5'-phosphate decarboxylase (EC 
4.1.1.23) 
    -4.91 0.00 F gi|148543365 
Lreu_0127 
Orotate phosphoribosyltransferase (EC 
2.4.2.10) 
    -4.82 0.00 F gi|148543366 
Lreu_0323 
Ribonucleoside-diphosphate reductase alpha 
chain (EC 1.17.4.1) 
    1.01 0.00 F gi|148543560 
Lreu_0456 Uracil phosphoribosyltransferase (EC 2.4.2.9)     -1.27 0.00 F gi|148543691 
Lreu_0460 Uracil permease     -2.14 0.00 F gi|148543695 
Lreu_0644 ComE operon protein 2     -0.88 0.05 F gi|148543876 
Lreu_1498 Deoxyguanosine kinase (EC 2.7.1.113)     1.78 0.04 F gi|148544710 
Lreu_1617 
GMP synthase [glutamine-hydrolyzing] (EC 
6.3.5.2) 
    -1.21 0.00 F gi|148544824 
Lreu_1828 Xanthine permease     0.73 0.01 F gi|148545034 
  
 Carbohydrate transport and 
metabolism  
            
Lreu_0083 Oligo-1,6-glucosidase (EC 3.2.1.10)     -1.79 0.03 G gi|148543325 
Lreu_0112 Phosphopentomutase (EC 5.4.2.7) 0.76 0.00     G gi|148543351 
Lreu_0289 
Beta-galactosidase small subunit (EC 
3.2.1.23) 
0.61 0.01     G gi|148543526 
Lreu_0380 
Phosphoglucomutase (EC 5.4.2.2) / 
Phosphomannomutase (EC 5.4.2.8) 
    -0.69 0.00 G gi|148543616 
Lreu_0405 D-ribose mutarotase (EC 5.1.3.-)     1.56 0.00 G gi|148543641 
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Exp Sta 
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b
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c
 p
d
 M
c
 p
d
 
COG 
Acession 
number 
Lreu_0406 Deoxyribose transporter     1.34 0.00 G gi|148543642 
Lreu_0480 L-ribulokinase (EC 2.7.1.16) 1.21 0.00 0.85 0.01 G gi|148543715 
Lreu_0481 
L-ribulose-5-phosphate 4-epimerase (EC 
5.1.3.4) 
0.94 0.00 0.73 0.01 G gi|148543716 
Lreu_0723 Fructosamine kinase family protein     -0.63 0.02 G gi|148543954 
Lreu_0751 Pyruvate kinase (EC 2.7.1.40)     -0.94 0.02 G gi|148543982 
Lreu_0910 Alpha-galactosidase (EC 3.2.1.22) 1.09 0.01     G gi|148544139 
Lreu_1026 
Glucosamine-6-phosphate isomerase (EC 
3.5.99.6)     -0.60 0.03 G gi|148544253 
Lreu_1319 Acetyltransferase (EC 2.3.1.-) -0.58 0.00     G gi|148544543 
Lreu_1686 
Xylulose-5-phosphate (EC 4.1.2.9) / Fructose-
6-phosphate phosphoketolase (EC 4.1.2.22) 
    -0.71 0.03 G gi|148544892 
Lreu_1765 
Glucose-6-phosphate 1-dehydrogenase (EC 
1.1.1.49) 
    -1.05 0.00 G gi|148544971 
Lreu_1768 Lactose permease 1.38 0.00 1.03 0.04 G gi|148544974 
Lreu_1777 Galactokinase (EC 2.7.1.6) 0.63 0.02     G gi|148544983 
Lreu_1875 Putative NAD-dependent dehydrogenase 0.96 0.00 1.31 0.00 G gi|148545079 
Lreu_1882 Putative NAD-dependent dehydrogenase 1.41 0.01 1.36 0.00 G gi|148545086 
  
 Coenzyme transport and 
metabolism  
            
Lreu_0155 
Nicotinate phosphoribosyltransferase (EC 
2.4.2.11) 
    -0.79 0.00 H gi|148543394 
Lreu_0503 Thiamine biosynthesis protein thiI     1.32 0.00 H gi|148543738 
Lreu_0510 
Folylpolyglutamate synthase (EC 6.3.2.17) / 
Dihydrofolate synthase (EC 6.3.2.12) 
    -2.33 0.00 H gi|148543745 
Lreu_0641 
Phosphopantetheine adenylyltransferase (EC 
2.7.7.3) 
    0.59 0.01 H gi|148543873 
Lreu_0734 
Biotin operon repressor / Biotin--[acetyl-
CoA-carboxylase] synthetase (EC 6.3.4.15) 
    -1.45 0.00 H gi|148543965 
Lreu_0878 
Diaminohydroxyphosphoribosylaminopyrimi
dine deaminase (EC 3.5.4.26) / 5-amino-6-(5-
phosphoribosylamino)uracil reductase 
    -0.92 0.00 H gi|148544108 
Lreu_0879 Riboflavin synthase alpha chain (EC 2.5.1.9)     -0.81 0.00 H gi|148544109 
Lreu_0880 
GTP cyclohydrolase II (EC 3.5.4.25) / 3,4-
dihydroxy-2-butanone-4-phosphate synthase 
(EC 4.1.2.-) 
    -0.75 0.01 H gi|148544110 
Lreu_1080 
S-adenosylmethionine:2-
demethylmenaquinone methyltransferase (EC 
2.1.-.-) 
    1.52 0.00 H gi|148544304 
Lreu_1279 
2-amino-4-hydroxy-6-
hydroxymethyldihydropteridine 
pyrophosphokinase (EC 2.7.6.3) 
    -0.63 0.00 H gi|148544503 
Lreu_1280 Dihydroneopterin aldolase (EC 4.1.2.25)     -0.73 0.00 H gi|148544504 
Lreu_1602 LysM domain protein     1.36 0.02 H gi|148544809 
Lreu_1710 
Precorrin-2 C20-methyltransferase (EC 
2.1.1.130) 
    0.71 0.00 H gi|148544916 
Lreu_1711 
Sirohydrochlorin cobaltochelatase (EC 
4.99.1.3) 
    0.72 0.00 H gi|148544917 
Lreu_1712 
Uroporphyrin-III C-methyltransferase (EC 
2.1.1.107) / Uroporphyrinogen-III synthase 
(EC 4.2.1.75) 
    0.60 0.01 H gi|148544918 
Lreu_1785 Nicotinamide mononucleotide transporter     0.64 0.03 H gi|148544991 
   Lipid transport and metabolism              
Lreu_0103 
3-hydroxybutyryl-CoA dehydrogenase (EC 
1.1.1.157) 
0.93 0.01 -1.12 0.01 I gi|148543342 
Lreu_0335 
Acyl-[acyl-carrier-protein] hydrolase (EC 
3.1.2.14) 
    0.82 0.00 I gi|148543572 
  
 Translation, ribosomal structure 
and biogenesis  
            
Lreu_0007 SSU ribosomal protein S6P     0.60 0.02 J gi|148543250 
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Lreu_0009 SSU ribosomal protein S18P     1.87 0.00 J gi|148543252 
Lreu_0261 Peptidyl-tRNA hydrolase (EC 3.1.1.29)     0.77 0.01 J gi|148543498 
Lreu_0263 Heat shock protein 15     0.89 0.01 J gi|148543500 
Lreu_0313 LSU ribosomal protein L10P     0.66 0.02 J gi|148543550 
Lreu_0314 LSU ribosomal protein L12P (L7/L12)     1.97 0.00 J gi|148543551 
Lreu_0454 Sua5/YciO/YrdC/YwlC family protein     0.66 0.00 J gi|148543689 
Lreu_0529 
Queuine tRNA-ribosyltransferase (EC 
2.4.2.29) 
    1.10 0.00 J gi|148543764 
Lreu_0647 SSU ribosomal protein S20P     1.33 0.00 J gi|148543879 
Lreu_0698 LSU ribosomal protein L7AE     0.70 0.01 J gi|148543930 
Lreu_0699 
Bacterial Protein Translation Initiation Factor 
2 (IF-2)     0.75 0.00 J gi|148543931 
Lreu_0700 Ribosome-binding factor A     0.84 0.00 J gi|148543932 
Lreu_1190 LSU ribosomal protein L27P     1.20 0.00 J gi|148544414 
Lreu_1191 hypothetical ribosome-associated protein     0.73 0.01 J gi|148544415 
Lreu_1224 Peptide deformylase (EC 3.5.1.88)     -1.32 0.00 J gi|148544448 
Lreu_1270 Arginyl-tRNA synthetase (EC 6.1.1.19) 1.66 0.01 0.99 0.00 J gi|148544494 
Lreu_1521 
Ribosomal large subunit pseudouridine 
synthase D (EC 4.2.1.70) 
    0.73 0.03 J gi|148544733 
Lreu_1605 23S rRNA methyltransferase (EC 2.1.1.-)     1.36 0.05 J gi|148544812 
Lreu_1943 
Ribonuclease P protein component (EC 
3.1.26.5)     0.82 0.00 J gi|148545142 
   Transcription              
Lreu_0088 Transcriptional regulator, LacI family 0.84 0.03     K gi|148543330 
Lreu_0272 Hypothetical membrane spanning protein     -1.02 0.00 K gi|148543509 
Lreu_0485 Transcriptional regulator, GntR family     -0.62 0.01 K gi|148543720 
Lreu_0550 Catabolite control protein A     0.82 0.00 K gi|148543785 
Lreu_0696 N utilization substance protein A     0.59 0.01 K gi|148543928 
Lreu_0697 Hypothetical cytosolic protein     0.67 0.01 K gi|148543929 
Lreu_0704 Heat-inducible transcription repressor hrcA     -0.71 0.00 K gi|148543936 
Lreu_0831   1.30 0.00     K gi|148544061 
Lreu_0932 
Fibronectin-binding protein / Fibrinogen-
binding protein 
    0.93 0.00 K gi|148544161 
Lreu_1109 Phage tail protein 1.81 0.00 0.59 0.01 K gi|148544333 
Lreu_1111 Phage protein 1.76 0.00 0.59 0.02 K gi|148544335 
Lreu_1112   1.77 0.00     K gi|148544336 
Lreu_1505 Cold shock protein     1.44 0.00 K gi|148544717 
Lreu_1528 Transcriptional regulators, LysR family     -0.81 0.00 K gi|148544740 
Lreu_1577 Transcriptional regulators, LysR family     -1.38 0.00 K gi|148544786 
Lreu_1876 Transcriptional regulator, MarR family 0.92 0.01 1.22 0.00 K gi|148545080 
Lreu_1878 Transcriptional regulator, MarR family 1.74 0.00 2.04 0.00 K gi|148545082 
  
 Replication, recombination and 
repair  
            
Lreu_0001 
Chromosomal replication initiator protein 
dnaA 
    0.76 0.00 L gi|148543244 
Lreu_0002 DNA polymerase III, beta chain (EC 2.7.7.7)     0.97 0.00 L gi|148543245 
Lreu_0008 Phage single-strand DNA binding protein     0.65 0.05 L gi|148543251 
Lreu_0012 Replicative DNA helicase (EC 3.6.1.-)     0.73 0.00 L gi|148543255 
Lreu_0050 ATP-dependent nuclease subunit A     0.60 0.05 L gi|148543293 
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Lreu_0151 Transposase     -1.03 0.05 L gi|148543390 
Lreu_0262 Transcription-repair coupling factor     0.67 0.04 L gi|148543499 
Lreu_0383 Excinuclease ABC subunit B     0.81 0.01 L gi|148543619 
Lreu_0384 Excinuclease ABC subunit A     1.03 0.01 L gi|148543620 
Lreu_0511 DNA repair protein radC     -2.12 0.00 L gi|148543746 
Lreu_0526 DNA mismatch repair protein mutL     0.94 0.00 L gi|148543761 
Lreu_0527 Holliday junction DNA helicase ruvA     0.88 0.00 L gi|148543762 
Lreu_0528 Holliday junction DNA helicase ruvB     0.96 0.00 L gi|148543763 
Lreu_0640 Methyltransferase (EC 2.1.1.-)     0.60 0.00 L gi|148543872 
Lreu_0643 COME operon protein 1     -0.96 0.01 L gi|148543875 
Lreu_0661 
Single-stranded-DNA-specific exonuclease 
recJ (EC 3.1.-.-) 
    0.73 0.03 L gi|148543893 
Lreu_0811 RecT protein 1.26 0.01 0.94 0.04 L gi|148544041 
Lreu_0849 Phage protein 1.49 0.04     L gi|148544079 
Lreu_0918 DNA replication protein dnaD     0.98 0.00 L gi|148544147 
Lreu_1070 Transposase     -0.66 0.02 L gi|148544294 
Lreu_1120 Terminase small subunit 1.54 0.00     L gi|148544344 
Lreu_1139 RecT protein 1.00 0.01 1.04 0.01 L gi|148544363 
Lreu_1369 
Putative galactofuranosyltransferase (EC 
2.4.1.-)     0.62 0.01 L gi|148544585 
Lreu_1656 Transposase     -0.65 0.03 L gi|148544862 
Lreu_1773 Transposase     -0.88 0.04 L gi|148544979 
  
 Cell wall/membrane/envelope 
biogenesis  
            
Lreu_0317 Large-conductance mechanosensitive channel     0.90 0.02 M gi|148543554 
Lreu_1114 Phage protein 1.75 0.00     M gi|148544338 
Lreu_1370 
alpha-D-Glcp alpha-1,6-galactosyltransferase 
(EC 2.4.1.-) 
    0.63 0.01 M gi|148544586 
Lreu_1372       0.99 0.00 M gi|148544588 
Lreu_1374 UDP-galactopyranose mutase (EC 5.4.99.9)     0.64 0.00 M gi|148544590 
Lreu_1375 
Undecaprenyl-phosphate beta-
glucosephosphotransferase (EC 2.7.8.-) 
    0.69 0.00 M gi|148544591 
Lreu_1562 N-acetylglucosaminyltransferase (EC 2.4.1.-)     0.64 0.03 M gi|148544772 
Lreu_1875 Putative NAD-dependent dehydrogenase 0.96 0.00 1.31 0.00 M gi|148545079 
Lreu_1882 Putative NAD-dependent dehydrogenase 1.41 0.01 1.36 0.00 M gi|148545086 
Lreu_1890 
Cellulose synthase catalytic subunit [UDP-
forming] (EC 2.4.1.12) 
    0.68 0.05 M gi|148545094 
  
 Posttranslational modification, 
protein turnover, chaperones  
            
Lreu_0324 Glutaredoxin     0.71 0.01 O gi|148543561 
Lreu_0353 10 kDa chaperonin GROES     -0.83 0.00 O gi|148543589 
Lreu_0354 60 kDa chaperonin GROEL     -0.84 0.00 O gi|148543590 
Lreu_0376 Thioredoxin reductase (EC 1.8.1.9) 1.11 0.00 0.67 0.01 O gi|148543612 
Lreu_0508 Transport ATP-binding protein cydC     0.70 0.04 O gi|148543743 
Lreu_0539 Thioredoxin 1.45 0.00 0.96 0.00 O gi|148543774 
Lreu_0705 GrpE protein     -0.61 0.00 O gi|148543937 
Lreu_0707 Chaperone protein dnaJ     -0.74 0.00 O gi|148543939 
Lreu_1388 Hypothetical protein     -1.08 0.01 O gi|148544604 
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 Inorganic ion transport and 
metabolism  
            
Lreu_0191 ABC transporter permease protein     -0.86 0.00 P gi|148543428 
Lreu_0192 ABC transporter ATP-binding protein     -0.94 0.00 P gi|148543429 
Lreu_0193 ABC transporter substrate-binding protein     -0.93 0.00 P gi|148543430 
Lreu_0567 Arsenate reductase family protein 1.62 0.00 1.76 0.00 P gi|148543802 
Lreu_1016 Chloride channel protein     0.61 0.01 P gi|148544243 
Lreu_1199 ABC transporter substrate-binding protein     -0.77 0.05 P gi|148544423 
Lreu_1507 Cobalt-zinc-cadmium resistance protein czcD     -0.71 0.03 P gi|148544719 
Lreu_1707 Cobalt transport protein cbiQ     0.85 0.00 P gi|148544913 
Lreu_1708 Cobalt transport protein cbiN     0.63 0.02 P gi|148544914 
Lreu_1709 CbiM protein     0.69 0.00 P gi|148544915 
  
 Secondary metabolites 
biosynthesis, transport and 
catabolism  
            
Lreu_0133 
Alpha-acetolactate decarboxylase (EC 
4.1.1.5) 
    -1.24 0.02 Q gi|148543372 
Lreu_0156 
Pyrazinamidase (EC 3.5.1.-) / Nicotinamidase 
(EC 3.5.1.19) 
    -0.69 0.00 Q gi|148543395 
Lreu_1738 Ethanolamine utilization protein eutN 0.96 0.00     Q gi|148544944 
Lreu_1740 PduL 1.06 0.00     Q gi|148544946 
Lreu_1741 Propanediol utilization protein pduA 1.02 0.00     Q gi|148544947 
Lreu_1742   1.08 0.00     Q gi|148544948 
Lreu_1743   1.07 0.00     Q gi|148544949 
Lreu_1744 
Glycerol dehydratase reactivation factor large 
subunit 
1.07 0.00     Q gi|148544950 
Lreu_1745 
Diol dehydratase gamma subunit (EC 
4.2.1.28) 
1.12 0.00     Q gi|148544951 
Lreu_1747 Diol dehydratase large subunit (EC 4.2.1.28) 1.09 0.00     Q gi|148544953 
Lreu_1749 Propanediol utilization protein pduA 1.04 0.00     Q gi|148544955 
   General function prediction only              
Lreu_0128       -1.73 0.00 R gi|148543367 
Lreu_0334 
Tetrapyrrole (Corrin/Porphyrin) methylase 
family protein 
    0.79 0.00 R gi|148543571 
Lreu_0347 Carbon-nitrogen hydrolase family protein     -0.91 0.05 R gi|148543583 
Lreu_0381 Hydrolase (HAD superfamily)     -2.02 0.00 R gi|148543617 
Lreu_0386 ATP-binding protein (contains P-loop)     0.59 0.01 R gi|148543622 
Lreu_0479 Arabinose-proton symporter 1.20 0.00 0.70 0.04 R gi|148543714 
Lreu_0519 Peptidase, M16 family     0.97 0.00 R gi|148543754 
Lreu_0522 Colligrin     -1.31 0.00 R gi|148543757 
Lreu_0569 
Putative competence protein/transcription 
factor 
    -2.84 0.00 R gi|148543804 
Lreu_0614 
Putative N-acetyldiaminopimelate deacetylase 
(EC 3.5.1.47) 
    -0.61 0.02 R gi|148543848 
Lreu_0645 COME operon protein 3     -0.79 0.01 R gi|148543877 
Lreu_0665 DNA primase     1.64 0.00 R gi|148543897 
Lreu_0833 Terminase large subunit 1.29 0.00     R gi|148544063 
Lreu_0919 Transporter, drug/metabolite exporter family     0.94 0.01 R gi|148544148 
Lreu_0999 Transporter, Drug/Metabolite Exporter family     -1.22 0.00 R gi|148544227 
Lreu_1079 Multidrug resistance efflux pump     1.31 0.00 R gi|148544303 
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Lreu_1082 Polyketide cyclase family protein     -1.64 0.01 R gi|148544306 
Lreu_1117 Terminase large subunit 1.43 0.00     R gi|148544341 
Lreu_1283 CAAX amino terminal protease family     -0.92 0.00 R gi|148544507 
Lreu_1299 Multidrug resistance protein B     -0.60 0.02 R gi|148544523 
Lreu_1449 
(R,R)-butanediol dehydrogenase (EC 1.1.1.4) 
/ Acetoin dehydrogenase (EC 1.1.1.5) 
    -0.61 0.01 R gi|148544662 
Lreu_1516 Zn-dependent hydrolase (EC 3.-.-.-)     0.63 0.00 R gi|148544728 
Lreu_1519 Multidrug resistance protein B     0.81 0.02 R gi|148544731 
Lreu_1552 IRON-SULFUR FLAVOPROTEIN 0.92 0.03 1.04 0.00 R gi|148544762 
Lreu_1582 regulatory protein (pfoS/R)     -0.81 0.05 R gi|148544791 
Lreu_1606 Transporter, MFS superfamily     1.42 0.05 R gi|148544813 
Lreu_1652 Phosphoglycolate phosphatase (EC 3.1.3.18)     -0.79 0.01 R gi|148544859 
Lreu_1659 Short chain dehydrogenase     -2.11 0.00 R gi|148544865 
Lreu_1795 
ATPase associated with chromosome 
architecture/replication 0.79 0.00     R gi|148545001 
Lreu_1877 Nitroreductase family protein 2.69 0.00 3.20 0.00 R gi|148545081 
Lreu_1906 O-acetyltransferase (cell wall biosynthesis)     -0.80 0.02 R gi|148545110 
Lreu_1940 
tRNA (5-carboxymethylaminomethyl-2-
thiouridylate) synthase 
    1.66 0.00 R gi|148545139 
   Function unknown              
Lreu_0022 Hypothetical protein     0.59 0.01 S gi|148543265 
Lreu_0177 Hypothetical membrane spanning protein     1.26 0.00 S gi|148543414 
Lreu_0333 Initiation-control protein     0.69 0.00 S gi|148543570 
Lreu_0387 Hypothetical membrane associated protein     0.68 0.01 S gi|148543623 
Lreu_0429 Copper-transporting ATPase (EC 3.6.3.10) 1.74 0.00     S gi|148543665 
Lreu_0430 Copper-transporting ATPase (EC 3.6.3.10) 1.79 0.00     S gi|148543666 
Lreu_0565 DedA family protein     0.62 0.03 S gi|148543800 
Lreu_0665 DNA primase     1.64 0.00 S gi|148543897 
Lreu_0733 BioY protein     -1.26 0.00 S gi|148543964 
Lreu_0752 S1 RNA binding domain     -0.77 0.00 S gi|148543983 
Lreu_0758 Riboflavin transporter     -0.66 0.01 S gi|148543989 
Lreu_0759 Hypothetical protein     -1.20 0.00 S gi|148543990 
Lreu_0803 Phage antirepressor protein 1.11 0.00 0.60 0.05 S gi|148544033 
Lreu_0838 Major capsid protein 1.68 0.00     S gi|148544068 
Lreu_0846 Phage protein 1.57 0.00     S gi|148544076 
Lreu_0946 Hypothetical membrane spanning protein     -1.06 0.01 S gi|148544175 
Lreu_1104 Phage protein 1.67 0.00     S gi|148544328 
Lreu_1106 Phage protein 1.62 0.00     S gi|148544330 
Lreu_1110 Phage tail protein 1.81 0.00     S gi|148544334 
Lreu_1116 Portal protein 1.66 0.00     S gi|148544340 
Lreu_1142 Phage antirepressor protein 1.10 0.00     S gi|148544366 
Lreu_1248 Hypothetical membrane spanning protein     -0.77 0.01 S gi|148544472 
Lreu_1368 Acyltransferase     0.82 0.00 S gi|148544584 
Lreu_1387 
Cell wall teichoic acid glycosylation protein 
gtcA     -0.72 0.01 S gi|148544603 
Lreu_1508 Hypothetical membrane associated protein     -0.98 0.00 S gi|148544720 
Lreu_1509 Hypothetical membrane associated protein     -0.88 0.00 S gi|148544721 
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Lreu_1520 Hypothetical membrane spanning protein     0.75 0.02 S gi|148544732 
Lreu_1629 Integral membrane protein     1.07 0.00 S gi|148544836 
Lreu_1736 Protein glcG 0.97 0.00     S gi|148544942 
Lreu_1737 Cobalamin adenosyltransferase family protein 0.98 0.00     S gi|148544943 
Lreu_1802 Hypothetical cytosolic protein     -0.72 0.02 S gi|148545008 
Lreu_1926 Membrane protein, MgtC/SapB family     -1.86 0.00 S gi|148545125 
Lreu_1927 Hypothetical cytosolic protein     -1.32 0.02 S gi|148545126 
   Signal transduction mechanisms              
Lreu_0058 Two-component response regulator     -0.73 0.00 T gi|148543300 
Lreu_0059 
Two component system histidine kinase (EC 
2.7.3.-) 
    -0.60 0.00 T gi|148543301 
Lreu_0256 MazF protein     -0.66 0.01 T gi|148543493 
Lreu_0296 Cystine-binding protein 1.61 0.00 2.94 0.00 T gi|148543533 
Lreu_0486 Universal stress protein family     -0.66 0.02 T gi|148543721 
Lreu_0834 Portal protein 1.46 0.00     T gi|148544064 
Lreu_1401 Transcriptional regulator     -0.59 0.02 T gi|148544617 
Lreu_1510 Universal stress protein family     -0.89 0.01 T gi|148544722 
Lreu_1731 Protein tyrosine phosphatase (EC 3.1.3.48) 0.92 0.00     T gi|148544937 
  
 Intracellular trafficking, 
secretion, and vesicular transport  
            
Lreu_0553 ComG operon protein 1     -1.08 0.04 U gi|148543788 
Lreu_0778 Smf protein     -0.91 0.05 U gi|148544009 
Lreu_1115 
ATP-dependent endopeptidase clp proteolytic 
subunit clpP (EC 3.4.21.92) 
1.78 0.00 0.59 0.01 U gi|148544339 
Lreu_1289 N-acetylmuramidase (EC 3.2.1.17)     -1.33 0.02 U gi|148544513 
Lreu_1942 60 kDa inner membrane protein YIDC     0.83 0.00 U gi|148545141 
   Defense mechanisms              
Lreu_0812 Phage protein 1.24 0.00 1.12 0.01 V gi|148544042 
Lreu_0869 
Type I restriction-modification system 
methylation subunit 
    -0.64 0.05 V gi|148544099 
Lreu_1121 Phage endonuclease 1.53 0.00     V gi|148544345 
Lreu_1138 Phage protein 1.24 0.00 1.12 0.01 V gi|148544362 
Lreu_1433 
Type I restriction-modification system 
specificity subunit 
    0.64 0.02 V gi|148544646 
Lreu_1597       -1.29 0.00 V gi|148544804 
Lreu_1856 
ABC transporter ATP-binding protein / ABC 
transporter permease protein 
    0.68 0.02 V gi|148545061 
  Unassigned             
Lreu_0120 
Branched-chain amino acid transport protein 
azlD 
    0.64 0.01   gi|148543359 
Lreu_0175       0.62 0.01   gi|148543412 
Lreu_0382   0.96 0.05       gi|148543618 
Lreu_0551       0.95 0.00   gi|148543786 
Lreu_0656       -0.78 0.01   gi|148543888 
Lreu_0662       0.81 0.03   gi|148543894 
Lreu_0663       1.43 0.03   gi|148543895 
Lreu_0664       1.25 0.03   gi|148543896 
Lreu_0666       1.66 0.00   gi|148543898 
Lreu_0703       -1.09 0.00   gi|148543935 
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Lreu_0749       1.13 0.00   gi|148543980 
Lreu_0802   1.04 0.00       gi|148544032 
Lreu_0806   1.33 0.00 0.83 0.03   gi|148544036 
Lreu_0813 Phage replication protein 1.29 0.00 1.07 0.00   gi|148544043 
Lreu_0814   1.36 0.00 1.25 0.01   gi|148544044 
Lreu_0815   1.17 0.00 1.14 0.00   gi|148544045 
Lreu_0816   1.30 0.00 1.31 0.00   gi|148544046 
Lreu_0821   1.09 0.00 0.92 0.00   gi|148544051 
Lreu_0822   1.19 0.00 1.02 0.01   gi|148544052 
Lreu_0823   1.11 0.00 0.95 0.00   gi|148544053 
Lreu_0827   1.00 0.00 0.87 0.00   gi|148544057 
Lreu_0829   1.43 0.00       gi|148544059 
Lreu_0830   1.34 0.00       gi|148544060 
Lreu_0832   1.29 0.00       gi|148544062 
Lreu_0835 Phage protein 1.38 0.00       gi|148544065 
Lreu_0836   1.59 0.00       gi|148544066 
Lreu_0837   1.68 0.00       gi|148544067 
Lreu_0839 Phage protein 1.61 0.00       gi|148544069 
Lreu_0840   1.57 0.00       gi|148544070 
Lreu_0841 Phage protein 1.62 0.00       gi|148544071 
Lreu_0842   1.67 0.00       gi|148544072 
Lreu_0843 Phage protein 1.67 0.00       gi|148544073 
Lreu_0844 Phage protein 1.76 0.00       gi|148544074 
Lreu_0845   1.57 0.00       gi|148544075 
Lreu_0847   1.66 0.00       gi|148544077 
Lreu_0848 Phage protein 1.47 0.00       gi|148544078 
Lreu_0850   1.78 0.00 0.62 0.04   gi|148544080 
Lreu_0851   1.89 0.00       gi|148544081 
Lreu_0852   1.52 0.03       gi|148544082 
Lreu_0854   1.85 0.00 0.73 0.01   gi|148544084 
Lreu_0856   1.39 0.00       gi|148544086 
Lreu_0857   1.69 0.04       gi|148544087 
Lreu_0959       -1.17 0.02   gi|148544188 
Lreu_1005   -1.06 0.00 -2.09 0.00   gi|148544232 
Lreu_1006   -1.10 0.00 -2.07 0.00   gi|148544233 
Lreu_1028       -2.11 0.00   gi|148544255 
Lreu_1037       1.12 0.00   gi|148544264 
Lreu_1043       0.98 0.03   gi|148544270 
Lreu_1069 Transposase     -0.69 0.04   gi|148544293 
Lreu_1095   1.84 0.00       gi|148544319 
Lreu_1096   1.82 0.00 0.66 0.05   gi|148544320 
Lreu_1097   1.84 0.00 0.60 0.04   gi|148544321 
Lreu_1098   1.39 0.00       gi|148544322 
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Exp Sta 
Locus Product
b
 
M
c
 p
d
 M
c
 p
d
 
COG 
Acession 
number 
Lreu_1099   1.85 0.00 0.73 0.01   gi|148544323 
Lreu_1100   1.64 0.00 0.61 0.03   gi|148544324 
Lreu_1101   1.52 0.03       gi|148544325 
Lreu_1102   1.89 0.00       gi|148544326 
Lreu_1103   1.81 0.00 0.67 0.04   gi|148544327 
Lreu_1108   1.73 0.00       gi|148544332 
Lreu_1113 Phage protein 1.78 0.00       gi|148544337 
Lreu_1122   0.69 0.00       gi|148544346 
Lreu_1127   1.17 0.00 0.88 0.01   gi|148544351 
Lreu_1143   0.90 0.00 0.61 0.02   gi|148544367 
Lreu_1259       -0.79 0.00   gi|148544483 
Lreu_1273       0.64 0.00   gi|148544497 
Lreu_1284       -0.91 0.00   gi|148544508 
Lreu_1294 Phage protein     -0.86 0.00   gi|148544518 
Lreu_1305       0.83 0.01   gi|148544529 
Lreu_1363       0.66 0.02   gi|148544579 
Lreu_1373       1.08 0.00   gi|148544589 
Lreu_1501       -1.49 0.00   gi|148544713 
Lreu_1541 Hypothetical secreted protein     0.87 0.00   gi|148544753 
Lreu_1573       0.69 0.02   gi|148544782 
Lreu_1580       0.59 0.02   gi|148544789 
Lreu_1601       1.51 0.02   gi|148544808 
Lreu_1630 Hypothetical protein     0.93 0.00   gi|148544837 
Lreu_1739   0.85 0.04       gi|148544945 
Lreu_1774 Transposase     -1.05 0.00   gi|148544980 
Lreu_1798       0.60 0.03   gi|148545004 
Lreu_1831   0.86 0.00       gi|148545037 
Lreu_1832 Histidine decarboxylase (EC 4.1.1.22) 0.99 0.00       gi|148545038 
Lreu_1884 
Hypothetical 
membrane 
spanning 
protein 
0.92 0.00 0.62 0.00   gi|148545088 
a Transcripts were considered for analysis if p-value < 0.05 and M > |0.585|. 
b Annotation retrieved from ERGO (http://ergo.integratedgenomics.com/ERGO) (1). 
c M, log2(intensity of signal with glycerol/intensity of signal without glycerol). 
d p, p-value. 
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Table 6.S2. Distribution of differentially regulated genes through out the several categories 
of clusters of orthologuous groups (COG) (2). 
 
COG category  
up-regulated 
when 
cysteine is 
omitted 
down-
regulated 
when 
cysteine is 
omitted 
regulated 
when 
cysteine is 
omitted 
exp 11.86 0.00 11.86 C - Energy production and 
conversion (59) sta 1.69 0.00 1.69 
exp 0.00 0.00 0.00 D - Cell cycle control, cell 
division, chromosome 
partitioning (17) sta 5.88 5.88 11.76 
exp 9.23 3.85 13.08 E - Amino acid transport and 
metabolism (130) sta 10.77 10.00 20.77 
exp 4.00 0.00 4.00 F - Nucleotide transport and 
metabolism (75) sta 4.00 16.00 20.00 
exp 11.25 0.00 11.25 G - Carbohydrate transport and 
metabolism (80) sta 8.75 8.75 17.50 
exp 0.00 0.00 0.00 H - Coenzyme transport and 
metabolism (71) sta 11.27 11.27 22.54 
exp 2.94 0.00 2.94 I - Lipid transport and 
metabolism (34) sta 2.94 2.94 5.88 
exp 0.72 0.00 0.72 J - Translation, ribosomal 
structure and biogenesis (139) sta 12.95 0.72 13.67 
exp 7.53 0.00 7.53 
K - Transcription (93) 
sta 9.68 5.38 15.05 
exp 2.27 0.00 2.27 L - Replication, recombination 
and repair (176) sta 9.66 3.41 13.07 
exp 3.75 0.00 3.75 M - Cell 
wall/membrane/envelope 
biogenesis (80) sta 11.25 0.00 11.25 
exp 0.00 0.00 0.00 
N - Cell motility (1) 
sta 0.00 0.00 0.00 
exp 4.76 0.00 4.76 O - Posttranslational 
modification, protein turnover, 
chaperones (42) sta 9.52 11.90 21.43 
exp 1.72 0.00 1.72 P - Inorganic ion transport and 
metabolism (58) sta 8.62 8.62 17.24 
exp 34.62 0.00 34.62 Q - Secondary metabolites 
biosynthesis, transport and 
catabolism (26) sta 0.00 7.69 7.69 
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COG category  
up-regulated 
when 
cysteine is 
omitted 
down-
regulated 
when 
cysteine is 
omitted 
regulated 
when 
cysteine is 
omitted 
exp 2.55 0.00 2.55 R - General function prediction 
only (235) sta 5.53 6.81 12.34 
exp 8.05 0.00 8.05 
S - Function unknown (149) 
sta 6.71 8.05 14.77 
exp 5.66 0.00 5.66 T - Signal transduction 
mechanisms (53) sta 1.89 11.32 13.21 
exp 4.35 0.00 4.35 U - Intracellular trafficking, 
secretion, and vesicular transpor 
(23) sta 8.70 13.04 21.74 
exp 8.82 0.00 8.82 
V - Defense mechanisms (34) 
sta 11.76 5.88 17.65 
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CHAPTER 7 
FUNCTIONAL ENRICHMENT OF FERMENTED FOODS BY 
INCREASED FOLATE PRODUCTION IN THE B12 PRODUCER 
LACTOBACILLUS REUTERI JCM1112 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
We observed that Lactobacillus reuteri JCM1112 produces B12 and folate. 
However, the folate/B12 mass-to-mass ratio found was far below that desired for human 
consumption (~170:1). We used metabolic engineering applying genetic and physiological 
approaches to improve this ratio, and developed a generic and natural process that 
significantly increases folate production. 
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Humans have an auxotrophic requirement for vitamin B12 and folate, with a 
recommended nutrient intake for healthy adults of 2.4 and 400 μg/day, respectively (6). 
Sub-optimal intake of either of these compounds has been linked to cardiovascular disease, 
neuropathy, birth defects, cancer, and different types of anemia, amongst other pathologies 
(4). Remarkably, the onset of vitamin B12 deficiency symptoms is often delayed by the 
increased intake of folate (22). This masking of B12 deficiency has resulted in the restriction 
of folate intake levels and prevented folate fortification in many countries (6). Strict 
vegetarian dietary regimes tend to be poor in vitamin B12 and rich in folic acid, increasing 
the risk of vitamin B12 deficiency masking. This has boosted the popularity of fortifying 
vegetarian foodstuffs with B12 (1). 
Coenzyme B12 is synthesized by a few members of bacteria and archaea (15). In 
situ microbial B12 production is a convenient strategy to achieve the natural enrichment of 
fermented foods, notably from vegeTable 7.sources. Lactobacillus reuteri is a Gram-
positive, heterofermentative lactic acid bacterium with a long history of safe use by the 
food industry (12). This microorganism ferments several sugars and this flexibility leads to 
its capacity to thrive on several substrates of vegeTable 7.origin (16). Strain CRL1098 has 
been reported to produce different forms of B12 (20, 27) and the draft genome sequence of 
strain JCM1112 (accession n.° CP000705) (11) suggests the ability to produce folate, as 
well as, B12. In this study, we investigated the possibility of using L. reuteri for the 
combined production of both vitamins in a ratio desired for human consumption, ~170:1 
(w/w).  
In silico analysis of the folate biosynthesis genes of L. reuteri JCM1112. Folate is 
a tripartite molecule assembled from guanosine-5’triphosphate (GTP), para-aminobenzoic 
acid (pABA) and one or more L-glutamate moieties. Its biosynthesis pathway has been 
extensively characterized in several lactic acid bacteria, namely L. plantarum WCFS1 (Fig. 
7.1). The predicted product of each folate biosynthesis gene of this bacterium was used to 
search the genome of L. reuteri JCM1112 using the BLAST algorithm (3). Sequence 
identity of the bi-directional best hit was calculated on a nucleotide and amino acid level 
based on separate Needleman-Wunsch global alignments (17) determined using the needle 
script included in EMBOSS: European Molecular Biology Open Software Suite (19), with 
default settings. Gene order was analyzed using the ERGO bioinformatics suite 
(http://ergo.integratedgenomics.com/ERGO/) (18). Both clusters are very similar as 
expected from the close phylogeny of their hosts (Table 7.1). Sequence identity is high on 
both the amino acid and nucleotide level, on average 43% and 51%, respectively. Gene 
order is completely conserved throughout the entire extension of the approximately 4.5 kb 
cluster composed of six genes. 
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Figure 7.1. The folate biosynthesis pathway in L. plantarum WCFS1. GTP, guanosine-
5’triphosphate; pABA, para-aminobenzoic acid. 
 
Characterization of B12 and folate production in CDM by L. reuteri JCM1112 and 
derivatives. The human isolate L. reuteri JCM1112
T
 was obtained from the Japanese 
Collection of Microorganisms (Riken, Japan). It was cultured at 37° C in chemically 
defined medium (CDM) containing 10 mg/L of pABA and lacking vitamin B12 and folic 
acid (28). Folate was quantified from stationary phase cultures as described before (7), with 
a bioassay using L. casei ATCC 7469 as the indicator strain, and including an enzymatic 
deconjugation of polyglutamate tails (25). Vitamin B12 content was determined according 
to the Official Methods of Analysis of AOAC International, using the L. delbrueckii subsp. 
lactis ATCC 7830 vitamin B12 assay (8). Cell extracts of stationary phase cultures for B12 
analysis were prepared as previously described (20). L. reuteri JCM1112 produces in CDM 
around 20 μg.L-1.OD600-1 of folate, approximately on a 1:1 ratio (w/w) with B12 (Fig. 7.2).  
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Table 7.1. Presence of folate biosynthesis genes in the genome of L. reuteri JCM1112 by 
homology searches with L. plantarum WCFS1 
 
L. plantarum WCFS1 L. reuteri JCM1112 
    Orthologue Identity (%) 
ORF # Name 
Length 
(aa)* 
Assigned function ORF # 
Length 
(aa)* 
Amino 
acid 
Nucleotide 
lp3299 folB 122 Dihydroneopterin aldolase 
(EC 4.1.2.25) 
Lreu1280 111 48 58 
lp3298 folK 170 2-amino-4-hydroxy-6-
hydroxymethyldihydropteridine 
pyrophosphokinase (EC 
2.7.6.3) 
Lreu1279 170 43 55 
lp3297 folE 189 GTP cyclohydrolase I 
(EC 3.5.4.16) 
Lreu1278 192 57 59 
lp3296 folC2 454 Folylpolyglutamate synthase 
(EC 6.3.2.17) / Dihydrofolate 
synthase (EC 6.3.2.12) 
Lreu1277 419 38 47 
lp3295 xtp2 195 Xanthosine triphosphate 
pyrophosphatase 
(EC 3.6.1.-) 
Lreu1276 195 35 48 
lp3294 folP 263 Dihydropteroate synthase 
(EC 2.5.1.15) 
Lreu1275 387 37 39 
* Length based on the number of amino acid residues (aa) predicted in the gene product.  
 
We implemented a metabolic engineering strategy as proof of principle for the 
possibility to influence the ratio of production of these two vitamins. We aimed at 
increasing folate production through the overexpression of the complete folate biosynthesis 
gene cluster, as described previously for other lactic acid bacteria (32, 33), ideally leaving 
unchanged the native B12 production. The constructs used in this study cannot be directly 
used by the food industry, but the application of food-grade alternatives is possible. A wide 
variety of food-grade systems have been developed for lactic acid bacteria, namely for 
representatives of the genus Lactobacillus (29). L. reuteri was transformed by 
electroporation as described elsewhere (30) with plasmids pNZ7021 (empty vector) and 
pNZ7026 harboring the folate biosynthesis gene cluster of L. plantarum WCFS1 under 
control of the pepN promoter (31). These derivative strains of JCM1112 were cultured and 
analyzed for folate and B12 content in a similar fashion as the parent strain. 
Chloroamphenicol was used as a selection marker in a final concentration of 10 μg/ml. The 
constitutive overexpression of the folate biosynthesis genes of L. plantarum WCFS1, in 
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cultures of L. reuteri JCM1112 pNZ7026 resulted in an increment of almost 100-fold in 
folate levels (Fig. 7.2), while the control (L. reuteri JCM1112 pNZ7021) did not show any 
change in folate and B12 production. The overproduction of folate was found to have a very 
small effect on B12 production (<10% reduction) resulting in a folate/B12 ratio of 
approximately 100:1 (w/w), sTable 7.over five consecutive transfers (data not shown). The 
high levels of folate overproduction for the strain transformed with pNZ7026 were as 
expected, provided that pABA is supplied in the medium. The same construct has been 
tested with L. plantarum resulting in similar folate production levels (31), and similar 
results were obtained when the same strategy was applied to Lactococcus lactis (33) and L. 
gasseri (32). 
 
 
 
 
Figure 7.2. Folate (white bars) and B12 (grey bars) production by L. reuteri wild-type and 
derivative strains and by L. plantarum WCFS1 in different media. Plasmid pNZ7021 is the 
empty plasmid and plasmid pNZ7026 contains the folate biosynthesis gene cluster of L. plantarum. 
Each bar represents the average of three biological replicates (error bars show standard deviation). All 
experiments were repeated in at least two different batches of media with similar results. 
 
Characterization of B12 and folate production in fruit fermentations. We assessed 
the applicability of the principle of improving folate/B12 ratios through genetic engineering 
to different media, other than CDM. Most (sub)tropical fruits are perishable and sensitive to 
chill damage, leading to losses of up to 40% in industrialized countries and far over 50% in 
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less economically developed nations (5, 14). Fermentation is a secular process of food 
preservation, which in this case could increase the vitamin content of a raw material. Juice 
derived from two Cucumis spp. (melon and cucumber) was selected for natural enrichment, 
since this material is low in folate and deficient in B12 according to the USDA National 
Nutrient Database for Standard Reference (9). Melon juice medium was made from 
Cucumis melo var. reticulatus after peeling and removal of seeds. The pulp was liquefied 
using a kitchen blender (Moulinex, Masterchef 370, France) and the resulting paste was 
squeezed through a cotton cloth. The flow-through was centrifuged twice at 8000 ? g for 10 
min using a Sorvall centrifuge (Newton, Connecticut, USA). The supernatant was stored at 
-20ºC until further use. Before inoculation, the melon juice was diluted in a 4:1 ratio (v/v) 
with potassium-phosphate buffer (0.1 M, final concentration; pH 5.8). Further dilution was 
found to result in growth impairment (data not shown). The final pH was adjusted to 6.0 
and the melon juice medium was forced through a 0.22 ?m filter to assure sterility. 
Cucumber juice medium was prepared from intact cucumber (Cucumis sativus) and 
sterilized using the procedure described for melon with the following modifications: (i) an 
additional filtration step using a cellulose filter (0.15 mm) was implemented before 
centrifugation; (ii) the cucumber juice was diluted in 1 volume of potassium-phosphate 
buffer (0.1 M, final concentration; pH 5.8). When mentioned, both media were 
supplemented with 10 mg/L pABA. This concentration does not conflict with exiting food 
legislation as pABA is listed as a GRAS (generally regarded as safe) compound with an 
upper intake limit of 30 mg/day (10). If appropriate, 10 μg/ml chloroamphenicol was also 
added. Biomass formation in the different growth media is indicated in Table 7.2.. 
 
Table 7.2. Biomass formation (final OD600) in the different growth media 
 
 CDM 
Melon 
juice 
Melon juice 
enriched with 
pABA* 
Cucumber 
juice 
Cucumber juice 
enriched with 
pABA* 
L. reuteri 
JCM1112 
2.8 2.9 2.5 n.d. n.d. 
L. reuteri 
JCM1112 
pNZ7021 
2.8 2.3 2.0 1.4 1.2 
L. reuteri 
JCM1112 
pNZ7026 
2.5 1.9 2.9 1.6 1.1 
L. plantarum 
WCFS1 
3.5 3.9 3.0 n.d. n.d. 
* Supplemented with 10 mg/L pABA; n.d., not determined. 
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Folate and B12 content were determined from cultures of L. reuteri transformed 
with pNZ7026 and pNZ7021. Background folate levels in melon and cucumber media were 
found to be 22.5 ± 0.9 and 10.0 ± 0.4 μg/L, respectively. As expected, B12 could not be 
detected in these media. The overexpression of the folate biosynthesis cluster of WCFS1 in 
L. reuteri JCM1112 pNZ7026 leads to high production of folate (2518.2 ± 182.1 μg.L-
1
.OD600
-1
) and a folate/B12 ratio of ~250:1 (w/w), but only when pABA is added (Fig. 7.2). 
pABA availability has been shown to limit folate biosynthesis in several lactic acid bacteria 
(26, 33). The control experiment using L. reuteri JCM1112 with the empty vector 
(pNZ7021) resulted in the production, in melon media, of 131.7 ± 5.5 μg.L-1.OD600-1 of 
folate, which is already more than five times higher than in CDM (P < 0.001, pairwise t 
test). In cucumber media, folate production by JCM1112 pNZ7021 was negatively affected 
in comparison to CDM, regardless of the addition of pABA (Fig. 7.2). The overexpression 
of the folate biosynthesis genes has a similar affect as described for CDM, but the final 
folate/B12 ratios remain one order of magnitude lower than desired. The 2-fold reduction in 
B12 production observed for the melon juice fermentation can be attributed to the amount of 
sugars present (~1.5% glucose and ~2% fructose as determined by HPLC analyses 
performed as described elsewhere (23)). Such concentrations have been shown in previous 
studies to repress B12 biosynthesis at the transcriptional level (2, 21). 
The remarkable feature of melon fermentation in comparison to CDM and 
cucumber is the 5-10 fold higher production of folate for the strain carrying the empty 
plasmid (pNZ7021). To establish the unique ability of melon juice to induce high folate 
production, we tested the parent strain, L. reuteri JCM1112, and another lactic acid 
bacterium, L. plantarum WCFS1 (13). Both L. reuteri and L. plantarum showed a 5- to 10-
fold increase of folate production in melon juice media compared to CDM (Fig. 7.2). Folate 
biosynthesis relies on three building blocks (Fig. 7.1) whose availability does not seem to 
explain this unsuspected observation. We have experimentally ruled out pABA and L-
glutamate since both of these compounds are present in excess in CDM. Regarding the 
other building block, it has been shown that GTP is not the rate limiting substrate in folate 
biosynthesis (26), which can be explained by the small flux from GTP to folate in 
comparison to the total GTP pool. This implies that an increase in GTP availability for 
folate synthesis cannot reasonably explain the increase in folate production observed in 
melon juice. Folate production is tightly regulated on both transcriptional and translational 
level (24, 25, 31). We suspect that there might be an interaction between a compound 
present in melon juice and one of these regulatory factors. However, the nature of the 
postulated interaction is unclear to us and remains to be elucidated. 
In this study, we have demonstrated the possibility of combining the production of 
folate and B12 in L. reuteri. We implemented, as proof of principle, a metabolic engineering 
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strategy to optimize the ratio of production of these two vitamins, and assessed its 
applicability to fruit fermentations. This resulted in the development of a natural 
fermentation process to increase folate production by lactobacilli, to levels substantially 
higher than previously published (26). The findings reported here may lead to the 
development of (fermented) foods based on perishable fruits, such as melons, with an 
extended durability and higher nutritional value. A well-tasting fermented melon juice or 
melon squash, containing high folate and vitamin B12 could be the start of a longer shelf-
life product line specially targeting vitamin deficient populations. 
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Introduction 
The observation that a compound isolated from Lactobacillus reuteri CRL1098 
cultured in B12-free media was found to satisfy the auxotrophic B12 requirement of three 
different indicator strains, led to the first report in 2003 of a B12-producing lactic acid 
bacterium (38). L. reuteri has a long history of safe use in the food and feed industries and 
it was suggested that L. reuteri could be used to increase the vitamin B12 content of 
fermented foods. 
The aim of this thesis was to characterize the biochemical, genetic and 
physiological aspects related to vitamin B12 production by L. reuteri using a 
multidisciplinary approach, and to explore its potential applications. Chapter 1 provides an 
overview of the state of the art of vitamin B12 research and attempts to place this into an 
historical perspective. It also describes the industrial and scientific importance of lactic acid 
bacteria, focusing on L. reuteri. Moreover, it briefly addresses the opportunities created by 
the availability of genome sequences and the scientific tools that can derive thereof. 
 
 
Pseudovitamin B12 – an ubiquitous vitamin B12 co-factor 
In Chapter 2, using powerful analytical chemistry techniques, including HPLC, 
MS and NMR, evidence is provided that the native corrinoid extracted from L. reuteri 
grown under anaerobic conditions is Co?-[?-(7-adenyl)]-Co?-cyanocobamide (27). 
Commonly known as pseudovitamin B12, this compound differs in the ?-ligand, where 
adenine instead of 5,6-dimethylbenzimidazole is the aglycon bound by a glycosyl link from 
its N-1 to the C-1 of the ribose. 
It has been proposed that L. reuteri is a suiTable 8.source of vitamin B12. (38). 
However, in vivo studies validating the ability of pseudovitamin B12 to correct vitamin B12 
deficiency remain to be carried out. In absence of these, some theoretical considerations can 
be deduced based on presently available in vitro data and knowledge on the processing of 
vitamin B12. Human absorption of vitamin B12 is a complex process involving at least three 
enzymes, namely haptocorrin (HC), intrinsic factor (IF) and transcobalamin II (TCII) (Fig. 
8.1). One complicating factor in the utilization of pseudovitamin B12 by humans may be the 
500-fold lower binding affinity of human-IF for pseudovitamin B12 than for vitamin B12 as 
measured in vitro (33). The other enzymes that participate in the absorption of vitamin B12 
in humans do not seem to pose a bottleneck in the uptake of pseudovitamin B12. HC binds 
all corrinoids with similar efficiency independently of the strength of their Co-N 
coordination, or the structure of their Co?-ligands. In addition, TCII is able to bind to 
pseudovitamin B12 at a significant rate, although, in vitro, it displays a slightly decreased 
affinity (80%) in comparison to cyanocobalamin (33).   
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Figure 8.1. Proposed fate of dietary vitamin B12 and pseudovitamin B12 in healthy adults 
based on in vitro studies (33). In the stomach, haptocorrin (HC) produced in the salivary glands 
binds both dietary vitamin B12 (B12) and pseudovitamin B12 (PB12). In the duodenum, intrinsic factor 
(IF) produced in the gastric parietal cells binds vitamin B12, but not pseudovitamin B12, once they are 
released from haptocorrin following its degradation by pancreatic proteases. At the distal third of the 
ileum, vitamin B12 is internalized, mediated by specific receptors, cubilin (C), that recognize the 
intrinsic factor-vitamin B12 complex. Vitamin B12 is distributed to other tissues by serum transport 
aided by transcobalamin II (TCII).  
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It has been proposed that B12-analogues, such as pseudovitamin B12, could play a 
role in assessing the capability of B12-dependent enzymes to utilize alternative cofactors 
(21), and in understanding the impact of B12 analogues in vitamin B12 metabolism (13, 16). 
Hitherto, the provision of pseudovitamin B12 relied on guided biosynthesis or chemical 
synthesis (9, 36, 42) since it is not commercially available. The fact that L. reuteri is 
capable of producing pseudovitamin B12 as its sole corrinoid under anaerobic conditions, 
turns it into an attractive source for this compound (27). The cultivation of L. reuteri as 
described in Chapter 2 results in the production of pseudovitamin B12 in an accessible 
manner, with no need for further separation from different corrinoid species. This might 
instigate research on the role of the lower ligand and Co-N coordination for enzymatic 
activity, helping to unravel yet unknown enzyme-cofactor interactions. 
Another important aspect of the identification of pseudovitamin B12 as the sole 
corrinoid produced by L. reuteri under anaerobic conditions, concerns the physiological 
role of B12 co-factors. Cobalamin, the most intensively studied corrinoid, has generally 
been regarded as the most important, because it was the only form that was thought to be 
physiologically active in all organism, including microbes (37). However, the finding that 
5,6-dimethylbenzimidazole is not in the Co?-ligand of the corrinoid produced by L. reuteri 
(27), and also not in those of some genera of cyanobacteria (41, 42), Salmonella enterica 
(2) and Clostridium cochlearium (12), amongst a few others (37), clearly illustrates that 
cobalamin is not the only biologically active form of vitamin B12. Furthermore, amongst 
Firmicutes and ?-Proteobacteria it seems that adenine or adenine derived moieties are 
particularly abundant in the lower ligand of B12 co-factors. 
During the course of the studies described here, an important discovery was made 
when an enzyme capable of synthesizing 5,6-dimethylbenzimidazole was identified (8). In 
subsequent studies, it was shown that the product of bluB from Sinorhizobium meliloti 
catalyses the oxygen-dependent fragmentation and contraction of flavin mononucleotide 
originating D-erythrose 4-phosphate and 5,6-dimethylbenzimidazole (36). 
We determined the phylogeny of the deduced amino acid sequences found to be 
homologous to BluB using the same methodology as described previously (28). We found 
that BluB is only present in B12-producing ?- and ?-Proteobacteria, in some Crenarchaeota 
and in Actinobacteria (Fig. 8.2). This could explain the role of different bases in other 
clades of Eubacteria, since it is unlikely that 5,6-dimethylbenzimidazole will be abundantly 
available in naturally occurring environments. The phylogenetic tree deduced for BluB is 
mostly in accordance to canonical phylogeny. One exception is the BluB homologue of the 
Bacteroid Chlorobium tepidum, which could be indicative of a possible horizontal gene 
transfer event, but further evidence to challenge this hypothesis, has to be gathered. 
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Figure 8.2. Bootstrapped neighbor-joining phylogenetic tree of BluB protein. CRE, 
Crenarchaeota; ACT, Actinobacteria; PRO, ?- or ?- Proteobacteria; BAC, Bacteroides.  
 
Vitamin B12 biosynthesis in L. reuteri 
In Chapter 3, we report the complete sequence analysis of the flanking regions of 
the original fragment found to contain genes associated to the anaerobic vitamin B12-
biosynthesis pathway. Quite remarkably, and unlike any other vitamin B12-biosynthesis 
gene cluster found before (or since), L. reuteri encodes the complete enzymatic machinery 
necessary for vitamin B12 production in a single continuous stretch of the chromosome. In 
this same study, we also looked at the transcriptional organization of the cluster and found 
that it was expressed in two multicistronic operons of 22 and 4 kb, and that vitamin B12 
influenced its expression by a negative feedback loop mechanism (28). We found that the 
genes encoding the synthesis of uroporphyrinogen III, the synthesis of the corrin ring, and 
the active transport of cobalt are transcribed together in the large transcript. The smaller 
transcript encodes the attachment of the amino-propanol arm and assembly of the 
nucleotide loop connecting the ?-ligand to the Co at the centre of the corrin ring. 
Cobalt is likely to be transported into the cell using the ATP-dependent transporter 
complex CbiMNQO. In Chapter 5, while studying the regulation of vitamin B12-
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biosynthesis in L. reuteri, we have identified another operon containing hypothetical ATP-
dependent transporters, which could also be putatively assigned to the transport of cobalt. It 
is not surprising that L. reuteri possesses multiple systems to scavenge cobalt from the 
environment, since the availability of metal ions is often the limiting factor of microbial 
growth in natural environments (30). The synthesis of uroporphyrinogen III in L. reuteri 
derives from the five-carbon backbone of glutamate as evidenced by the presence of hemA 
(Fig. 8.3). This is expected since only ?-Proteobacteria are known to use the Shemin-way, 
which starts with glycine and succinyl-CoA (20). The synthesis of the tetrapyrrole-derived 
corrin ring is achieved in L. reuteri via the early cobalt insertion route (non-oxygen 
dependent) (Fig. 8.3). This is suggested by the presence of several genes which are unique 
to this route, including cbiDGK (25). 
There is great interest in analyzing the genes encoding the assembly of the lower 
ligand, however we could not find genetic evidence that could help predict whether an 
organism incorporates 5,6-dimethylbenzimidazole or adenine. It has been shown in vitro for 
Salmonella, that the phosphorybosyltransferase encoded by cobT can use substrates other 
than 5,6-dimethylbenzimidazol (19). We presumed that this was also the case in L. reuteri 
(28). Very recently, evidence gathered in vivo for Salmonella indicates that not only can 
adenine be incorporated in the lower ligand, but that the resulting corrinoid, pseudovitamin 
B12, is also physiologically active (2).  
The major step, which truly remains enigmatic, is the reduction of cobalt 
cob(II)yrinic acid a,c-diamide to cob(I)yrinic acid a,c-diamide before adenosylation. The 
nature of this reaction has remained elusive until very recently, when a cob(II)yrinic acid 
a,c-diamide reductase (cobR) was identified in Brucella melitensis (17). However, in L. 
reuteri we have not found any suitable candidate to encode this activity.  
In early 2006 the draft genome sequence of L. reuteri JCM1112 was made 
available by JGI. The comparisons established in Chapter 3 between the B12 biosynthesis 
clusters of the strains JCM1112 and our strain CRL1098 were indicative that much of the 
work carried out until this stage would be applicable, and so we decided to focus on the 
newly sequenced strain. In the meantime, the genome of yet another L. reuteri, strain100-
23, was also released. This resident of the GI-tract of rodents does not seem to have the 
vitamin B12 biosynthesis cluster, although this cannot be confirmed at this point since the 
genome has not yet been circularized. In retrospect, the fact that the genome of JCM1112 
was released and closed before the one of 100-23 had a huge impact on the way we directed 
our research – we entered the -omics phase. 
In order to integrate and visualize the large data sets that are typical of -omics 
experiments (11), we developed a genome-scale network model of L. reuteri. This was 
done in a semi-automated way (22), benefiting from the manually-curate models that were  
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Figure 8.3. Overview of the proposed pseudovitamin B12 biosynthesis pathway of L. 
reuteri based on current biochemical knowledge and on the gene content of the B12 
biosynthesis cluster. 
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available, including those of Lb. plantarum (39), L. lactis (24), B. subtilis (23) and E. coli 
(26). Meanwhile, we designed a custom-made cDNA microarray platform for L. reuteri and 
used the highly studied glucose/glycerol co-fermentation to benchmark our newly 
developed toolbox (Chapter 4).  
The model enabled us to identify stoichiometrically equivalent metabolic routes, 
attuned with the maximal flux towards an objective function. Additionally, it aided us in 
comparing measured with predicted fluxes and allowed us to visualize the transcriptomic 
data sets. Modeling L. reuteri turned out to be a lot more predictive than it had previously 
been for other lactic acid bacteria (39). Paradoxically, the model was crucial in addressing 
this issue as well. It turned out that it is the absence of pyruvate formate lyase that makes 
Flux Balance Analysis (FBA) more predictive since the production of acetate, in detriment 
of lactate, yielding extra free energy (39), is no longer stoichiometrically possible. 
One of the remaining questions that are tentatively addressed in Chapter 4 is why 
some lactic acid bacteria, including L. reuteri, display a heterofermentative behavior. 
Recently, the phosphoketolase pathway has been shown to be dominant over the Embden-
Meyerhof glycolytic route in L. reuteri (3). FBA made it clear that without this constraint 
heterofermentation could not be predicted. This does not fully explain why natural selection 
would favor such a behavior in central carbon distribution. Nonetheless, it certainly sheds 
some light on the issue, by pinpointing what is crucial for it to take place. A consequence of 
the heterofermentative pathway is a chronic dependency on external electron acceptors, 
which is quite revealing of the sort of niche where such a trait may come to evolve.  
Another important outcome of this study were leads for follow-up 
experimentation. The global transcriptome response revealed targets for metabolic 
engineering of industrially relevant compounds, such as vitamin B12 and 1,3-propanediol, 
which we pursued in Chapter 5. Additionally, it revealed some previously unsuspected 
liaisons between the central carbon metabolism, and amino acid and secondary metabolite 
metabolism, which were pursued in Chapter 6. 
 
Regulation of vitamin B12 synthesis in L. reuteri 
The evidence that considering vitamin B12 production, L. reuteri is related to 
enteric bacteria, more specifically to representatives of ?-Proteobacteria, started building up 
when we identified pseudovitamin B12 as its native corrinoid [Chapter 2, (27)]. However, 
this was not recognized immediately, since it had not yet been reported that Salmonella also 
produces pseudovitamin B12 (2). Nevertheless, once the sequence of the cluster was 
deduced (Chapter 3) comparative genomics made this association obvious. The gene order 
of the vitamin B12 clusters is strikingly similar, and the phylogeny of the predicted gene 
products clearly contrasts that of 16S RNA sequences. The fact that the G+C skew is not 
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drastic between the vitamin B12 clusters and their hosts implies that the postulated 
horizontal gene transfer event was not recent.  
The regulation of vitamin B12 biosynthesis in Salmonella is well-characterized (1, 
4), and due to the arguments just stated, we hypothesized that vitamin B12-biosynthesis in L. 
reuteri would be controlled in a similar fashion. In Salmonella, a single regulatory protein, 
PocR, regulates both vitamin B12 biosynthesis and diol dehydratase activity. In the genome 
of L. reuteri, lreu_1750 is the most likely ortholog of the gene encoding PocR but some 
uncertainty surrounds this functional annotation, mostly related to lack of homology. In 
Chapter 5 we overexpressed this putative transcription factor of the AraC family and 
quantified its biotechnologically relevant impact on the production of vitamin B12 and 1,3-
propanediol. Furthermore, the characterization of the transcriptome in response to the 
overexpression of lreu_1750 led to the identification of the PocR regulon in L. reuteri. 
Again the similarity between L. reuteri and Salmonella is striking, adding one more 
argument to the already long list that supports the occurrence of a lateral gene transfer event 
between Firmicutes and ?-Proteobacteria (18, 28, 40). 
Included in the same regulon as vitamin B12 biosynthesis, we found the genes 
encoding the several subunits of the diol dehydratase, and the genes encoding the assembly 
of metabolosomes (Fig. 8.4). The presence of such structures in L. reuteri has recently been 
shown (32), indicating some kind of primordial compartmentalization of a cell. The diol 
dehydratase is localized inside these polyhedral organelles and L. reuteri appears to possess 
5-15 of these compartments per cell, when the genes encoding their assembly are induced 
(32). 
The metabolosomes have been suggested to be important in the encapsulation of 
toxic intermediates such as 3-hydroxypropanaldehyde (reuterin) or propionyl-CoA (32). 
Additionally, it has been proposed that they might be important in isolating the diol 
dehydratase from molecular oxygen (5). It has been reported for Salmonella that, with as 
little as 100 molecules of vitamin B12 per cell, growth dependent on the activity of the B12-
dependent diol dehydratase can occur (2). Another role that the metabolosomes might play 
is in increasing the local concentration of vitamin B12 around the enzyme. How vitamin B12 
enters the metabolosomes, or even whether (part of) it is synthesized there, remains unclear 
at this stage. It is pertinent to emphasize that the entire genetic sequences necessary to 
encode vitamin B12-biosynthesis, cobalt transport, metabolosome assembly and diol 
dehydratase activity, are located in one single stretch of the chromosome (Fig. 8.4). They 
account for as much as 2% of the whole length of the genome. 
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Figure 8.4. (A) Schematic representation of genomic region comprising pdu and B12 
clusters (not to scale). (B) Proposed pathway for the B12-dependent glycerol reduction in a 
metabolosome in a L. reuteri growing cell. 
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Strategies to increase vitamin B12 production in L. reuteri.  
Following the leads obtained in Chapter 4, we pursued two different strategies to 
increase vitamin B12 production in L. reuteri. One was the already mentioned 
overexpression of PocR, which yielded little over 40% increase, and the second was the 
systematic omission of amino acids from the growth media, described in Chapter 6. The 
latter proved to be much more effective in increasing production levels. In fact, by omitting 
either isoleucine or cysteine, we were able to modulate the production from barely 
detecTable 8.to nearly 20-fold higher, respectively. cDNA microarray experiments revealed 
that it is most likely previously unreported effects of sulfur metabolism on vitamin B12 
biosynthesis that are responsible for this phenotype, but conclusive evidence remains to be 
gathered. 
The transport of cobalt was highlighted in both Chapter 5 and Chapter 6 as a 
potential target that could lead to further improvements of vitamin B12 production. We 
added extra cobalt to the growth broth in an initial attempt to follow this lead, but no 
significant changes in vitamin B12 production were observed. This is not surprising since 
cobalt is already available in great excess in the media used. However, the omission of 
other metals has to the best of our knowledge never been tried. Some ion transporters have 
a very small specificity and in the absence of certain metals, might permit the scavenging of 
more cobalt from the environment, increasing its bioavailibity. 
 
Vitamin B12-research in lactic acid bacteria – open questions. 
The work presented in this thesis, was built up from an isolated report of B12 
production in lactic acid bacteria (38). This implied, that vitamin B12 research in relation to 
lactic acid bacteria was an open field. By studying it, we exposed several research 
questions/opportunities that remain to be addressed. Illustrative, are the several leads for 
increased vitamin B12 production generated in this study. Like in most, if not all, research 
efforts carried out, not all the lines pursued turned out to be successful. Amongst these, 
there are two that we consider to be worth highlighting here. 
(i) Attempt to transfer vitamin B12 biosynthesis cluster to other lactic acid 
bacteria. As previously mentioned, the vitamin B12 biosynthesis cluster of L. reuteri has the 
idiosyncrasy of encoding in one continuous fragment, the full machinery to make this 
industrially relevant compound. Furthermore, we have provided evidence supporting that 
this cluster has a precedent of shifting between genomes. We attempted to transfer the 
cluster to L. plantarum WCFS1 (14), because of its close proximity with L. reuteri, and 
because a considerable functional genomics platform had already been developed for this 
organism. 
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We started by trying to turn L. plantarum into a vitamin B12-dependent organism 
hoping that this would provide the basis for a high throughput screening method for 
conjugants. L. plantarum WCFS1 is known to contain two genes annotated to convert L-
homocysteine in L-methionine, namely metE (lp_1375) and metH (lp_1374). The latter is 
known to encode the well characterized vitamin B12 dependent methionine synthase (10). 
We hypothesized that a metE deletion mutant would not be able to sustain growth in CDM 
lacking methionine unless vitamin B12 was exogenously supplied. A derivative of WCFS1 
(NZ7740) containing a lox66-P32-cat-lox71 replacement of metE (lp_1375) was constructed 
using a system described elsewhere (15). We compared the growth behavior of L. 
plantarum WCFS1 and NZ7740 in CDM variations including or not methionine and 
vitamin B12 in its composition (Fig. 8.5). The result did not quite match up to our 
expectations as it turned out that lp_1374 was wrongly annotated as metH. Strain NZ7740 
cannot grow in CDM unless methionine is supplied regardless of the presence of vitamin 
B12. The WCFS1 derivative with the metE::lox66-P32-cat-lox71 genotype is available upon 
request for further studies. 
At this stage, we tried to transfer the cluster to L. plantarum by cloning it in a low 
copy vector, pIL252 (31). We were able to amplify by PCR the full extension of the cluster, 
and purify it by gel extraction with low melting agarose followed by an agarase treatment 
and dialyses (details available upon request). However, the cloning proved to be the 
bottleneck and none of the many attempts turned out to be successful. 
 
Figure 8.5. Growth of L. plantarum strains WCFS1 [(wild type) black bars] and NZ7740 
[(metE::lox66-P32-cat-lox71) white bars] on CDM variations including or not methionine 
and vitamin B12 in its composition. 
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(ii) Attempts to engineer the production of different corrinoids in L. reuteri. Since 
the identification of pseudovitamin B12 as the sole corrinoid produced by L. reuteri under 
anaerobic conditions, that we have been trying to devise strategies to engineer the 
production of different corrinoid species in L. reuteri. We first tried the physiological 
approaches described in Chapter 2 (27). Since these did not yield any major breakthrough, 
when BluB was implicated in the synthesis of DMB (8, 36), we decided to switch to a 
metabolic engineering strategy. This was done in collaboration with Dr. Amanda A. 
Brindley and Prof. Martin J. Warren of the Department of Biosciences, University of Kent, 
United Kingdom. We constitutively overexpressed bluB from Rhodobacter capsulans under 
control of the pepN promoter in a similar fashion as described in Chapter 5. Unfortunately, 
to date this strategy has also not been successful. Western blotting (data not shown) 
indicated that there might be a problem in the expression of bluB, and currently efforts are 
underway to try to overcome this bottlekneck. 
 
Mining the genomes of lactic acid bacteria for the production of vitamins. 
We consider vitamin B12 research in lactic acid bacteria to be far from an 
exhausted field. However, we present here the highlights of a genome mining exercise for 
the production of vitamins and co-factors in non-pathogenic lactic acid bacteria (Table 8.1), 
which might constitute the basis for future research. Folate is the vitamin that has been 
more extensively studied. Yet, in Chapter 7 we describe how folate can still have 
unexplored features, which can be interesting both from a scientific and industrial 
perspective. It provides an example of how the production of multiple vitamins can be 
combined in one single host, like it has been done for folate and riboflavin in Lactococcus 
lactis (34). In this study, we combined the production of folate and vitamin B12 in L. reuteri 
(29) and stumbled across an unexpected interaction between melon fermentation and 
increased folate production which is extendable to other lactobacilli (43). 
Concerning potential targets for research, riboflavin has been extensively studied 
in Lactococcus lactis (7), but very little in other lactic acid bacteria, which could potentially 
be better cell factories or have certain appealing phenotypic traits, such as fermenting cheap 
substrates. The presence of biotin genes in Leuconostoc mesenteroides ATCC8293 is a very 
odd observation, since this is the only lactic acid bacterium to putatively encode such 
pathway. It was a peculiarity like this that led to the study of vitamin B12 in L. reuteri in the 
first place. Finally, the production of vitamin K and molybdenum cofactor can also in 
principle be possible, based on the genome content alone. 
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Table 8.1. Mining the genome of non-pathogenic lactic acid bacteria for the production of 
vitamins and co-factors. Black square means that over 90% of the pathway is predicted to be 
encoded. Grey squares indicate that between 50 to 89% of the pathway is present. Numbers in 
brackets refer to studies were experimental data has been gathered that supports our assetions. 
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Lactobacillaceae family        
Lactobacillus acidophilus NCFM    (35)   1 
Lactobacillus brevis ATCC367  10    10 3 
Lactobacillus casei ATCC334    (35)   2 
Lactobacillus delbrueckii bulgaricus ATCC11842    (35)   1 
Lactobacillus delbrueckii bulgaricus ATCCBAA-365    (35)   1 
Lactobacillus fermentum IFO 3956 10 10  10  10 1 
Lactobacillus gasseri ATCC-33323    (44)   1 
Lactobacillus helveticus DPC 4571    10   1 
Lactobacillus johnsonii NCC 533       1 
Lactobacillus plantarum WCFS1 10   (35)   1 
Lactobacillus reuteri F275  10  (29) (28) 10 1 
Lactobacillus sakei sakei 23K    10   1 
Lactobacillus salivarius salivarius UCC118      5 4 
Pediococcus pentosaceus ATCC25745  10     1 
Leuconostocacaea family        
Leuconostoc mesenteroides ATCC8293  10 5   10 2 
Oenococcus oeni PSU-1      10 1 
Streptococcaceae family        
Lactococcus lactis lactis IL1403  10  (35)   1 
Lactococcus lactis cremoris MG1363  (7)  (35)  (6) 1 
Lactococcus lactis cremoris SK11  10  (35)   6 
Streptococcus thermophilus CNRZ1066    (35)   1 
Streptococcus thermophilus LMD-9    (35)   3 
Streptococcus thermophilus LMG18311    (35)   1 
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Final remarks 
We have used a wide array of techniques ranging amongst the several disciplines 
of science to characterize and understand the role of vitamin B12 in L. reuteri. This resulted 
in findings that might be considered of interest to the scientific community and at the same 
time be applicable in the improvement/development of industrial processes. Ultimately, the 
work developed here might also be used to ensure an adequate vitamin B12 intake in 
humans. 
Vitamin B12 is definitely a challenging and ancient molecule. While studying it, 
one will always be surprised to find how much it reveals about the world and its workings. 
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Samenvatting* 
 
Vitamine B12 is een fascinerend molekuul dat in veel organismen als cofactor dient 
bij cruciale processen. Het is een essentiele component van ons dieet en tevens een 
belangrijke cofactor voor industriele biokatalyse processen, zoals de productie van 1,3-
propaandiol. De novo synthese van vitamine B12 vindt in slechts een beperkt aantal 
vertegenwoordigers van de bacteria en de archaea plaats. Eerder was beschreven dat 
Lactobacillus reuteri vitamin B12 produceert. De kennis over dit proces was echter, voor 
aanvang van het hier beschreven onderzoek zeer beperkt. Het hier beschreven werk had als 
doel om alle aspecten van de vitamin B12 productie in L. reuteri door middel van een 
interdisciplinaire benadering te onderzoeken, en om potentiele toepassingen te ontwikkelen. 
Het natieve, door L. reuteri onder anaerobe omstandigheden geproduceerde 
corrinoide werd door middel van HPLC, MS and NMR geanalyseerd, en bleek adenine in 
plaats van 5,6-dimethlbenzimidazool in het Co?-ligand te bevatten. Deze verbinding, 
bekend onder de naam pseudovitamine B12, kan gebruikt worden om vast te stellen of 
vitamin B12 afhankelijke enzymen alternatieve cofactoren kunnen gebruiken, en om kennis 
op te doen over de effecten van analoga van vitamin B12 in het metabolisme. 
We vonden dat de anaerobe biosynthese route, welke de omzetting van glutamaat 
in vitamine B12 katalyseert, op een aaneengesloten gebied op het chromosoom gecodeerd 
ligt, naast genclusters welke betrokken zijn bij glycerol reductie, metabolosoom assemblage 
en transport van kobalt. De expressie van deze clusters blijkt onder controle te staan van 
een regulon waarin één enkel regulatieeiwit een doorslaggevende rol speelt. Genoom brede 
analyses door middel van cDNA microarrays en metabole netwerkmodellen openbaarden 
onverwachte verbanden tussen het gebruik van glycerol, vitamine B12 synthese en 
aminozuur metabolisme. De hieruit opgedane inzichten leidden tot een proces waarin, 
zonder gebruik van genetische manipulatie, een 20-voudige verhoging van de vitamine B12 
produktie gehaald kon worden. Tevens werd aangetoond dat het mogelijkis om de 
produktie van folaat en vitamine B12 in L. reuteri te combineren. Dit proces werd toegepast 
in een fermentatie op basis van plantaardige substraten. 
Afgezien van hun wetenschappelijke betekenis kunnen de hier beschreven 
vindingen toegepast worden in de ontwikkeling en verbetering van vitamine B12 
productieprocessen.En uiteindelijk kunnen ze dienen om een toereikende inname van 
vitamine B12 door de mens zeker te stellen. 
 
 
 
* Kindly translated from English by Douwe Molenaar 
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Sumário 
 
A vitamina B12 é uma molécula fascinante que actua como co-factor em diversos 
processos essências a vários organismos. É ainda, um constituinte essencial da nossa dieta 
e um co-factor importante em processos industriais de biocatalise, tal como a produção de 
1,3-propanodiol. A síntese de vitamina B12 está limitada a alguns microorganismos. A 
produção de vitamina B12 pelo Lactobacillus reuteri já tinha sido relatada, mas antes deste 
estudo, muito pouco era conhecido sobre este processo. O trabalho aqui apresentado 
ambicionava esclarecer os vários aspectos da síntese de vitamina B12 em L. reuteri usando 
uma abordagem multi-disciplinares e explorando as suas potenciais aplicações. 
 O corrinoide produzido por L. reuteri em condições de anaerobiose foi analisado 
por HPLC, MS e NMR (siglas internacionais), tendo sido descoberto que continha adenina 
em vez de 5,6-dimethylbenzimidazol no ligando Co-. Conhecido por pseudovitamina B12, 
este composto pode ser importante para determinar a capacidade de enzimas dependentes de 
vitamina B12 actuarem utilizando moléculas análogas, e ainda compreender o impacto das 
últimas no metabolismo da vitamina B12. 
A via biosintética que converte ácido glutâmico em vitamina B12 foi encontrada 
codificada num único pedaço do cromossoma, rodeado por genes envolvidos na redução do 
glicerol, formação de metabolossomas, e transporte de cobalto. O controle da transcrição 
destes genes aparenta fazer parte de uma mesma unidade de regulação, controlada por uma 
única proteína reguladora. Instrumentos de análise à escala do genoma como cADN 
microarrays e modelos da rede metabólica, expuseram ligações inesperadas entre a utilização 
do glicerol, a síntese de vitamina B12 e o metabolismo de amino ácidos. Isto serviu de base 
a novas hipóteses que resultaram num incremento de 20 vezes na produção de vitamina B12 
sem recorrer à manipulação genética de organismos. A possibilidade de combinar a 
produção de ácido fólico juntamente com vitamina B12 nas mesmas células de L. reuteri 
também foi exemplificado e aplicado à fermentação de substractos de origem vegetal. 
As descobertas aqui relatadas, para além da sua relevância cientifica, podem ser 
aplicadas ao melhoramento e desenvolvimento de fermentações com um maior conteúdo de 
vitamina B12. Em última instancia, o trabalho aqui apresentado poderá contribuir para 
assegurar um aporte de vitamina B12 adequado.  
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Training and Supervision Plan 
 
Discipline specific activities  
• Food Fermentation, VLAG, Wageningen, 2004 
• Bioinformation Technology-1, VLAG, Wageningen, 2004 
• Genetics and Physiology of Food-associated Micro-organisms, VLAG, Wageningen, 
2004 
• Microbial Physiology & Fermentation Technology, BODL, Delft, 2005 
• Cell Physiology & NMR Laboratory of ITQB, Oeiras, Portugal, 2005 
• Kluyver Center for Genomics of Industrial Fermentation Symposium (oral and poster 
presentations), 2004-8 
• 8
th
 International Symposium on Lactic Acid Bacteria, Egmond aan Zee (poster 
presentation), 2005 
• Netherlands Bioinformatics Conference, Ede, 2006 
• 232
nd
 American Chemical Society National Meeting, San Francisco, USA (oral and 
poster presentations), 2006 
• Gordon Research Conference on Vitamin B12 & Corphins, University of New 
England, USA (poster presentation), 2007 
• 9th International Symposium on Lactic Acid Bacteria, Egmond aan Zee (oral and 
poster presentations), 2008 
 
General courses 
• Safe Handling with Radioactive Materials and Sources, Larenstein, Velp, 2003 
• Teaching and Supervising Thesis Students, OWU, Wageningen, 2004 
 
Optional courses and activities  
• Attendance of PhD Study Trip to Japan, 2004 
• Organization and Attendance of Programme 3 WCFS Fall WE-days, Cork - Ireland, 
2005 
• PhD/Postdoc meetings, Laboratory of Microbiology Wageningen University, 2005-7 
• Organization and attendance of PhD Study Trip to California, 2006 
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